P-value | ln(P) | Term | GO Tree | GO ID | # of Genes in Term | # of Target Genes in Term | # of Total Genes | # of Target Genes | Common Genes |
2.587e-12 | -26.68 | myelodysplastic_syndrome | COSMIC cancer mutations | myelodysplastic_syndrome | 1174 | 21 | 16828 | 49 |
HPSE2,SOX5,KALRN,NAV2,CAMK2G,DCLK2,NTRK2,PARD3,ATP1A2,SLC1A2,ADCY2,LRP1B,NTRK3,RYR3,PRKCA,RPS6KA2,LSAMP,NKAIN3,NPAS3,ERBB4,NRG3 |
2.587e-12 | -26.68 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic_syndrome | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic_syndrome | 1174 | 21 | 16828 | 49 |
NKAIN3,LSAMP,ERBB4,NRG3,NPAS3,ADCY2,LRP1B,RPS6KA2,RYR3,NTRK3,PRKCA,PARD3,ATP1A2,SLC1A2,HPSE2,NAV2,DCLK2,NTRK2,CAMK2G,SOX5,KALRN |
5.207e-11 | -23.68 | nervous system development | biological process | GO:0007399 | 2185 | 25 | 18204 | 50 |
LSAMP,CTNNA2,CTNND2,SOX5,GPM6A,PARD3,NTRK3,RFX4,RORA,NRXN1,ATP1A2,DCLK2,NRG3,MSI2,NTRK2,SLC1A2,NAV2,DGKG,GFAP,ERBB4,CAMK2G,NTM,NDRG2,KALRN,TNC |
1.654e-10 | -22.52 | upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma | 6953 | 42 | 16828 | 49 |
NTRK3,RYR3,PRKCA,NTM,DGKG,FMN2,RPS6KA2,NEBL,RFX4,DTNA,GFAP,TRPM3,SFXN5,NRG3,RORA,KALRN,GPM6A,NAV2,DCLK2,MACF1,PITPNC1,MGAT4C,ABLIM1,SYNE1,SORBS1,SLC1A2,PARD3,NDRG2,ADCY2,LRP1B,CDH20,GPC5,SLC4A4,NRXN1,ERBB4,LSAMP,SOX5,CAMK2G,CTNND2,PSD2,TNC,ATP1A2 |
2.292e-10 | -22.20 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm | 764 | 16 | 16828 | 49 |
ERBB4,NRG3,NKAIN3,LSAMP,RYR3,ADCY2,GPC5,LRP1B,SLC1A2,PARD3,ATP1A2,NAV2,NTRK2,SOX5,KALRN,HPSE2 |
6.541e-10 | -21.15 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-mantle_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-mantle_cell_lymphoma | 476 | 13 | 16828 | 49 |
GPM6A,NAV2,SYNE1,CTNND2,PRKCA,RYR3,GPC5,LRP1B,TRPM3,SFXN5,ERBB4,NRG3,LSAMP |
2.718e-09 | -19.72 | lymph_node | COSMIC cancer mutations | lymph_node | 1703 | 21 | 16828 | 49 |
SYNE1,CTNND2,PARD3,SOX5,CAMK2G,NTRK2,GPM6A,NAV2,TRPM3,SFXN5,ERBB4,NRG3,LSAMP,PRKCA,NTRK3,RYR3,RPS6KA2,LRP1B,DTNA,GPC5,NEBL |
6.313e-09 | -18.88 | mouth | COSMIC cancer mutations | mouth | 9004 | 45 | 16828 | 49 |
HPSE2,ABLIM1,RORA,MACF1,GPM6A,NAV2,SLC1A2,SORBS1,RFX4,NEBL,NTRK3,TRPM3,GFAP,SOX5,NTRK2,TNC,CTNND2,CDH20,LSAMP,NPAS3,PITPNC1,MGAT4C,KALRN,DCLK2,PARD3,SYNE1,DTNA,PRKCA,NTM,RYR3,RPS6KA2,FMN2,DGKG,SFXN5,NRG3,CAMK2G,ATP1A2,PSD2,NDRG2,LRP1B,GPC5,ADCY2,NRXN1,SLC4A4,ERBB4 |
8.164e-09 | -18.62 | mantle_cell_lymphoma | COSMIC cancer mutations | mantle_cell_lymphoma | 2849 | 26 | 16828 | 49 |
ERBB4,LSAMP,LRP1B,GPC5,ADCY2,PSD2,CTNND2,TNC,NTRK2,SOX5,NRG3,TRPM3,SFXN5,NKAIN3,FMN2,PRKCA,RYR3,RFX4,NEBL,SLC1A2,SYNE1,PARD3,NAV2,GPM6A,KALRN,HPSE2 |
1.026e-08 | -18.39 | system development | biological process | GO:0048731 | 3533 | 28 | 18204 | 50 |
KALRN,TNC,NDRG2,NTM,DGKG,GFAP,ERBB4,CAMK2G,SYNE1,NAV2,MSI2,SLC1A2,NTRK2,ATP1A2,DCLK2,NRG3,RORA,NRXN1,RFX4,PRKCA,GPM6A,PARD3,NTRK3,NEBL,SOX5,CTNNA2,CTNND2,LSAMP |
1.793e-08 | -17.84 | acute_myeloid_leukaemia_therapy_related | COSMIC cancer mutations | acute_myeloid_leukaemia_therapy_related | 1523 | 19 | 16828 | 49 |
CTNND2,PARD3,NTRK2,NAV2,KALRN,RORA,SOX5,HPSE2,NRG3,ERBB4,NKAIN3,LSAMP,FMN2,DGKG,RYR3,LRP1B,GPC5,ADCY2,NEBL |
1.793e-08 | -17.84 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related | 1523 | 19 | 16828 | 49 |
GPC5,LRP1B,ADCY2,NEBL,DGKG,FMN2,RYR3,NKAIN3,LSAMP,ERBB4,NRG3,HPSE2,NTRK2,NAV2,KALRN,RORA,SOX5,PARD3,CTNND2 |
1.947e-08 | -17.75 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma | 2737 | 25 | 16828 | 49 |
ERBB4,LSAMP,ADCY2,LRP1B,GPC5,CTNND2,PSD2,TNC,SOX5,NTRK2,SFXN5,NRG3,NKAIN3,RYR3,PRKCA,FMN2,NEBL,RFX4,SYNE1,SLC1A2,PARD3,KALRN,NAV2,GPM6A,HPSE2 |
2.762e-08 | -17.40 | multicellular organism development | biological process | GO:0007275 | 3957 | 29 | 18204 | 50 |
NDRG2,TNC,KALRN,SYNE1,NAV2,SLC1A2,NTRK2,MSI2,NTM,CAMK2G,ERBB4,GFAP,DGKG,RFX4,PRKCA,NRG3,DCLK2,ATP1A2,NRXN1,RORA,CTNND2,CTNNA2,LSAMP,CDH20,NEBL,NTRK3,GPM6A,PARD3,SOX5 |
2.915e-08 | -17.35 | chondroblastoma | COSMIC cancer mutations | chondroblastoma | 534 | 12 | 16828 | 49 |
ADCY2,GPC5,LRP1B,RYR3,FMN2,LSAMP,NKAIN3,SFXN5,NRG3,SOX5,GPM6A,CTNND2 |
4.276e-08 | -16.97 | acute_lymphoblastic_B_cell_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_B_cell_leukaemia | 3828 | 29 | 16828 | 49 |
MGAT4C,HPSE2,GPM6A,NAV2,KALRN,RORA,PARD3,SLC1A2,SYNE1,NEBL,FMN2,RYR3,NTRK3,NTM,NKAIN3,NRG3,GLIS3,NTRK2,SOX5,TNC,CTNND2,PSD2,ADCY2,GPC5,LRP1B,LSAMP,ERBB4,SLC4A4,NRXN1 |
4.276e-08 | -16.97 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia | 3828 | 29 | 16828 | 49 |
NEBL,NTM,NTRK3,RYR3,FMN2,NKAIN3,GLIS3,NRG3,HPSE2,MGAT4C,KALRN,RORA,GPM6A,NAV2,PARD3,SYNE1,SLC1A2,GPC5,LRP1B,ADCY2,LSAMP,NRXN1,SLC4A4,ERBB4,SOX5,NTRK2,TNC,PSD2,CTNND2 |
5.023e-08 | -16.81 | prostate-carcinoma | COSMIC cancer mutations | prostate-carcinoma | 9000 | 44 | 16828 | 49 |
PSD2,ADCY2,LRP1B,GPC5,ERBB4,SLC4A4,NRXN1,PITPNC1,DCLK2,KALRN,MSI2,SLC14A1,PARD3,SYNE1,DTNA,DGKG,FMN2,RPS6KA2,RYR3,PRKCA,NTM,NKAIN3,NRG3,GLIS3,SFXN5,NTRK2,SOX5,TNC,CTNND2,CDH20,LSAMP,NPAS3,ABLIM1,HPSE2,GPM6A,NAV2,MACF1,RORA,SORBS1,SLC1A2,NEBL,RFX4,NTRK3,TRPM3 |
5.055e-08 | -16.80 | brainstem | COSMIC cancer mutations | brainstem | 3102 | 26 | 16828 | 49 |
SYNE1,SLC1A2,SLC14A1,PARD3,KALRN,RORA,GPM6A,NAV2,HPSE2,SFXN5,NRG3,NKAIN3,RYR3,PRKCA,FMN2,CTNND2,PSD2,TNC,SOX5,NPAS3,ERBB4,LSAMP,ADCY2,GPC5,LRP1B,CDH20 |
1.045e-07 | -16.07 | nodular | COSMIC cancer mutations | nodular | 1515 | 18 | 16828 | 49 |
NTRK3,DGKG,FMN2,NEBL,CDH20,LRP1B,SLC4A4,GLIS3,NPAS3,ERBB4,KALRN,NTRK2,DCLK2,MACF1,ABLIM1,CTNND2,SYNE1,ATP1A2 |
1.173e-07 | -15.96 | central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV | COSMIC cancer mutations | central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV | 2531 | 23 | 16828 | 49 |
SYNE1,SLC14A1,PARD3,NAV2,GPM6A,RORA,KALRN,HPSE2,NRG3,SFXN5,NKAIN3,FMN2,PRKCA,RYR3,PSD2,CTNND2,SOX5,ERBB4,LSAMP,GPC5,LRP1B,CDH20,ADCY2 |
1.314e-07 | -15.84 | Burkitt_lymphoma | COSMIC cancer mutations | Burkitt_lymphoma | 2119 | 21 | 16828 | 49 |
LRP1B,RFX4,GPC5,ADCY2,RYR3,FMN2,DGKG,LSAMP,NKAIN3,NPAS3,NRG3,ERBB4,HPSE2,KALRN,SOX5,NTRK2,NAV2,GPM6A,PARD3,CTNND2,SLC1A2 |
1.314e-07 | -15.84 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma | 2119 | 21 | 16828 | 49 |
RYR3,DGKG,FMN2,RFX4,LRP1B,GPC5,ADCY2,NPAS3,ERBB4,NRG3,LSAMP,NKAIN3,KALRN,SOX5,NTRK2,NAV2,GPM6A,HPSE2,CTNND2,SLC1A2,PARD3 |
1.551e-07 | -15.68 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma | 7205 | 39 | 16828 | 49 |
ADCY2,LRP1B,GPC5,ERBB4,NPAS3,SLC4A4,NRXN1,LSAMP,NTRK2,SOX5,CTNND2,PSD2,DGKG,FMN2,RPS6KA2,NTRK3,RYR3,NTM,PRKCA,NEBL,RFX4,NRG3,GLIS3,TRPM3,SFXN5,NKAIN3,GPM6A,NAV2,MACF1,DCLK2,KALRN,RORA,ABLIM1,HPSE2,PITPNC1,SORBS1,SLC1A2,SYNE1,PARD3 |
1.886e-07 | -15.48 | trunk | COSMIC cancer mutations | trunk | 3554 | 27 | 16828 | 49 |
LSAMP,NRXN1,NPAS3,ERBB4,CDH20,LRP1B,ATP1A2,TNC,CTNND2,SOX5,NTRK2,GLIS3,NRG3,NEBL,RYR3,NTRK3,RPS6KA2,DGKG,PARD3,SLC14A1,SYNE1,HPSE2,ABLIM1,MGAT4C,KALRN,MACF1,DCLK2 |
1.955e-07 | -15.45 | cerebellum | COSMIC cancer mutations | cerebellum | 769 | 13 | 16828 | 49 |
NRG3,ERBB4,NPAS3,NRXN1,RYR3,NEBL,LRP1B,GPC5,CTNND2,PARD3,NTRK2,ABLIM1,HPSE2 |
2.603e-07 | -15.16 | central_nervous_system-cerebellum-primitive_neuroectodermal_tumour-medulloblastoma-SHH_subtype | COSMIC cancer mutations | central_nervous_system-cerebellum-primitive_neuroectodermal_tumour-medulloblastoma-SHH_subtype | 653 | 12 | 16828 | 49 |
PARD3,NRXN1,NPAS3,CTNND2,NRG3,ERBB4,HPSE2,ABLIM1,LRP1B,NEBL,RYR3,NTRK2 |
2.608e-07 | -15.16 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 3608 | 27 | 16828 | 49 |
PSD2,CTNND2,ATP1A2,TNC,SOX5,ERBB4,LSAMP,LRP1B,CDH20,GPC5,ADCY2,SLC1A2,SYNE1,PARD3,MACF1,GPM6A,NAV2,RORA,KALRN,HPSE2,NRG3,NKAIN3,FMN2,DGKG,PRKCA,RYR3,NEBL |
2.646e-07 | -15.15 | SHH_subtype | COSMIC cancer mutations | SHH_subtype | 654 | 12 | 16828 | 49 |
CTNND2,PARD3,NTRK2,ABLIM1,HPSE2,ERBB4,NRG3,NRXN1,NPAS3,RYR3,LRP1B,NEBL |
2.803e-07 | -15.09 | diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | diffuse_large_B_cell_lymphoma | 4151 | 29 | 16828 | 49 |
NEBL,DTNA,RYR3,PRKCA,FMN2,DGKG,NKAIN3,NRG3,HPSE2,KALRN,RORA,NAV2,GPM6A,MACF1,PARD3,SYNE1,SLC1A2,ADCY2,LRP1B,CDH20,GPC5,LSAMP,ERBB4,SOX5,NTRK2,TNC,ATP1A2,CTNND2,PSD2 |
2.811e-07 | -15.08 | generation of neurons | biological process | GO:0048699 | 1158 | 15 | 18204 | 50 |
GPM6A,PARD3,NTM,DGKG,SOX5,GFAP,ERBB4,CTNNA2,CTNND2,NTRK2,DCLK2,RORA,NRXN1,KALRN,TNC |
2.862e-07 | -15.07 | neurogenesis | biological process | GO:0022008 | 1334 | 16 | 18204 | 50 |
NTRK2,NAV2,CTNNA2,CTNND2,GFAP,SOX5,DGKG,ERBB4,GPM6A,PARD3,NTM,NRXN1,KALRN,RORA,TNC,DCLK2 |
2.879e-07 | -15.06 | plasma_cell_myeloma | COSMIC cancer mutations | plasma_cell_myeloma | 1263 | 16 | 16828 | 49 |
NRG3,NTM,RYR3,RPS6KA2,FMN2,LRP1B,ADCY2,NEBL,SYNE1,CTNND2,TNC,MACF1,NTRK2,GPM6A,HPSE2,ABLIM1 |
2.879e-07 | -15.06 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-plasma_cell_myeloma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-plasma_cell_myeloma | 1263 | 16 | 16828 | 49 |
LRP1B,ADCY2,NEBL,NTM,RYR3,RPS6KA2,FMN2,NRG3,HPSE2,ABLIM1,NTRK2,MACF1,GPM6A,TNC,SYNE1,CTNND2 |
3.602e-07 | -14.84 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | 1117 | 15 | 16828 | 49 |
SOX5,KALRN,NAV2,PARD3,SYNE1,SLC1A2,ADCY2,GPC5,CDH20,LRP1B,RYR3,DGKG,FMN2,NRG3,ERBB4 |
3.877e-07 | -14.76 | skin-trunk-malignant_melanoma-nodular | COSMIC cancer mutations | skin-trunk-malignant_melanoma-nodular | 1291 | 16 | 16828 | 49 |
ATP1A2,SYNE1,CTNND2,ABLIM1,KALRN,MACF1,DCLK2,NTRK2,GLIS3,NPAS3,ERBB4,CDH20,LRP1B,NEBL,NTRK3,DGKG |
3.882e-07 | -14.76 | lung-right_lower_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-right_lower_lobe-carcinoma-adenocarcinoma | 5692 | 34 | 16828 | 49 |
SOX5,NTRK2,ATP1A2,TNC,PSD2,CTNND2,GPC5,LRP1B,CDH20,ADCY2,LSAMP,SLC4A4,NPAS3,ERBB4,HPSE2,MGAT4C,KALRN,MACF1,GPM6A,NAV2,SLC14A1,PARD3,SYNE1,SORBS1,DTNA,NEBL,NTM,NTRK3,RYR3,FMN2,DGKG,NKAIN3,TRPM3,NRG3 |
3.882e-07 | -14.76 | right_lower_lobe | COSMIC cancer mutations | right_lower_lobe | 5692 | 34 | 16828 | 49 |
ERBB4,SLC4A4,NPAS3,LSAMP,ADCY2,GPC5,LRP1B,CDH20,CTNND2,PSD2,TNC,ATP1A2,NTRK2,SOX5,NRG3,TRPM3,NKAIN3,DGKG,FMN2,RYR3,NTRK3,NTM,NEBL,DTNA,SORBS1,SYNE1,PARD3,SLC14A1,GPM6A,NAV2,MACF1,KALRN,MGAT4C,HPSE2 |
5.510e-07 | -14.41 | cell periphery | cellular component | GO:0071944 | 6020 | 33 | 19108 | 50 |
LSAMP,SLC4A4,NAV2,SLC1A2,ERBB4,GPM6A,TNC,NTM,CDH20,PARD3,CTNND2,CTNNA2,GPC5,DTNA,HPSE2,SYNE1,FMN2,RYR3,PRKCA,SLC14A1,MACF1,NTRK3,LRP1B,NRXN1,NKAIN3,DGKG,TRPM3,NRG3,SORBS1,ATP1A2,NTRK2,ADCY2,PSD2 |
6.636e-07 | -14.23 | chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | COSMIC cancer mutations | chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | 3511 | 26 | 16828 | 49 |
NPAS3,SLC4A4,ERBB4,LSAMP,LRP1B,GPC5,ADCY2,PSD2,CTNND2,NTRK2,TRPM3,NRG3,PRKCA,NTRK3,RYR3,FMN2,DTNA,SYNE1,PARD3,MSI2,KALRN,MACF1,NAV2,PITPNC1,HPSE2,MGAT4C |
6.636e-07 | -14.23 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | 3511 | 26 | 16828 | 49 |
ADCY2,GPC5,LRP1B,ERBB4,SLC4A4,NPAS3,LSAMP,NTRK2,CTNND2,PSD2,FMN2,NTRK3,RYR3,PRKCA,DTNA,NRG3,TRPM3,NAV2,MACF1,KALRN,MGAT4C,HPSE2,PITPNC1,SYNE1,MSI2,PARD3 |
7.801e-07 | -14.06 | neuron differentiation | biological process | GO:0030182 | 1081 | 14 | 18204 | 50 |
CTNNA2,CTNND2,NTRK2,GPM6A,PARD3,NTM,GFAP,DGKG,ERBB4,DCLK2,KALRN,NRXN1,RORA,TNC |
8.252e-07 | -14.01 | intestinal_adenocarcinoma | COSMIC cancer mutations | intestinal_adenocarcinoma | 7225 | 38 | 16828 | 49 |
LRP1B,CDH20,ADCY2,LSAMP,NRXN1,SLC4A4,NPAS3,ERBB4,SOX5,NTRK2,ATP1A2,TNC,PSD2,CTNND2,RFX4,NEBL,NTM,PRKCA,NTRK3,RYR3,RPS6KA2,DGKG,FMN2,SFXN5,TRPM3,GFAP,NRG3,PITPNC1,HPSE2,RORA,KALRN,MACF1,DCLK2,NAV2,SLC14A1,PARD3,SYNE1,SLC1A2 |
8.252e-07 | -14.01 | stomach-carcinoma-intestinal_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-intestinal_adenocarcinoma | 7225 | 38 | 16828 | 49 |
CTNND2,PSD2,TNC,ATP1A2,SOX5,NTRK2,SLC4A4,NPAS3,NRXN1,ERBB4,LSAMP,ADCY2,CDH20,LRP1B,SYNE1,SLC1A2,PARD3,SLC14A1,KALRN,RORA,NAV2,DCLK2,MACF1,HPSE2,PITPNC1,GFAP,TRPM3,SFXN5,NRG3,RYR3,NTRK3,NTM,PRKCA,FMN2,DGKG,RPS6KA2,NEBL,RFX4 |
8.927e-07 | -13.93 | anatomical structure development | biological process | GO:0048856 | 5207 | 31 | 18204 | 50 |
CTNND2,CTNNA2,LSAMP,CDH20,NEBL,PARD3,GPM6A,NTRK3,SOX5,RFX4,ABLIM1,PRKCA,NRG3,ATP1A2,FMN2,DCLK2,RORA,NRXN1,SYNE1,NAV2,MSI2,SLC1A2,NTRK2,NTM,ERBB4,CAMK2G,DGKG,GFAP,NDRG2,TNC,KALRN |
9.499e-07 | -13.87 | cell projection | cellular component | GO:0042995 | 2398 | 20 | 19108 | 50 |
SYNE1,CTNNA2,NDRG2,ATP1A2,DTNA,CTNND2,NTRK3,CAMK2G,PSD2,MACF1,PRKCA,ADCY2,NTRK2,FMN2,GPM6A,SLC1A2,ABLIM1,NRXN1,GFAP,PARD3 |
9.933e-07 | -13.82 | cell junction assembly | biological process | GO:0034329 | 285 | 8 | 18204 | 50 |
NRXN1,ERBB4,PARD3,GPM6A,NRG3,CDH20,SORBS1,PRKCA |
1.170e-06 | -13.66 | soft_tissue-blood_vessel-angiosarcoma | COSMIC cancer mutations | soft_tissue-blood_vessel-angiosarcoma | 2192 | 20 | 16828 | 49 |
NKAIN3,LSAMP,NRG3,ERBB4,NEBL,ADCY2,GPC5,CDH20,LRP1B,FMN2,RYR3,PARD3,SLC1A2,CTNND2,SYNE1,HPSE2,GPM6A,NAV2,NTRK2,SOX5 |
1.170e-06 | -13.66 | angiosarcoma | COSMIC cancer mutations | angiosarcoma | 2192 | 20 | 16828 | 49 |
FMN2,RYR3,CDH20,LRP1B,GPC5,NEBL,ADCY2,ERBB4,NRG3,NKAIN3,LSAMP,NTRK2,GPM6A,NAV2,SOX5,HPSE2,SLC1A2,SYNE1,CTNND2,PARD3 |
1.224e-06 | -13.61 | plasma membrane | cellular component | GO:0005886 | 5538 | 31 | 19108 | 50 |
CDH20,PARD3,NTM,LSAMP,ERBB4,GPM6A,SLC1A2,SLC4A4,PRKCA,RYR3,SLC14A1,FMN2,NTRK3,MACF1,CTNND2,SYNE1,CTNNA2,GPC5,HPSE2,DTNA,NRG3,LRP1B,NRXN1,DGKG,TRPM3,NKAIN3,ADCY2,NTRK2,PSD2,SORBS1,ATP1A2 |
1.235e-06 | -13.60 | NTRK2 (neurotrophic receptor tyrosine kinase 2) | protein interactions | 4915 | 135 | 6 | 19454 | 50 |
PARD3,NTRK3,NTRK2,ERBB4,DTNA,ABLIM1 |
1.343e-06 | -13.52 | blood_vessel | COSMIC cancer mutations | blood_vessel | 2211 | 20 | 16828 | 49 |
CTNND2,SYNE1,SLC1A2,PARD3,SOX5,NAV2,GPM6A,NTRK2,HPSE2,NRG3,ERBB4,LSAMP,NKAIN3,RYR3,FMN2,ADCY2,NEBL,LRP1B,GPC5,CDH20 |
1.499e-06 | -13.41 | cell junction organization | biological process | GO:0034330 | 532 | 10 | 18204 | 50 |
CDH20,SORBS1,PRKCA,CTNND2,NRXN1,ERBB4,TNC,PARD3,GPM6A,NRG3 |
1.623e-06 | -13.33 | CTNNA1 (catenin alpha 1) | protein interactions | 1495 | 325 | 8 | 19454 | 50 |
PARD3,CTNNA2,MACF1,SORBS1,NTRK3,ABLIM1,NEBL,DTNA |
1.693e-06 | -13.29 | NS-malignant_melanoma | COSMIC cancer mutations | NS-malignant_melanoma | 3420 | 25 | 16828 | 49 |
PSD2,CTNND2,ATP1A2,TNC,GPC5,LRP1B,ADCY2,ERBB4,NRXN1,MACF1,NAV2,KALRN,MGAT4C,PITPNC1,SYNE1,PARD3,RPS6KA2,FMN2,DGKG,PRKCA,RFX4,NEBL,NRG3,TRPM3,GLIS3 |
1.742e-06 | -13.26 | pharynx | COSMIC cancer mutations | pharynx | 2696 | 22 | 16828 | 49 |
GPC5,LRP1B,RFX4,DTNA,FMN2,DGKG,RPS6KA2,RYR3,PRKCA,NRG3,SLC4A4,NPAS3,SFXN5,PITPNC1,MACF1,NTRK2,SLC14A1,ATP1A2,SORBS1,SLC1A2,CTNND2,SYNE1 |
1.826e-06 | -13.21 | right_upper_lobe | COSMIC cancer mutations | right_upper_lobe | 10376 | 45 | 16828 | 49 |
DTNA,RFX4,NEBL,FMN2,DGKG,PRKCA,NTM,NTRK3,RYR3,NKAIN3,NRG3,TRPM3,SFXN5,GFAP,GLIS3,ABLIM1,MGAT4C,PITPNC1,HPSE2,DCLK2,MACF1,GPM6A,NAV2,KALRN,RORA,PARD3,SLC1A2,SORBS1,SYNE1,CDH20,LRP1B,GPC5,ADCY2,NDRG2,LSAMP,ERBB4,NRXN1,SLC4A4,NPAS3,NTRK2,SOX5,ATP1A2,TNC,PSD2,CTNND2 |
1.826e-06 | -13.21 | lung-right_upper_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-right_upper_lobe-carcinoma-adenocarcinoma | 10376 | 45 | 16828 | 49 |
CTNND2,PSD2,TNC,ATP1A2,SOX5,NTRK2,SLC4A4,NPAS3,NRXN1,ERBB4,LSAMP,NDRG2,ADCY2,GPC5,LRP1B,CDH20,SYNE1,SORBS1,SLC1A2,PARD3,RORA,KALRN,GPM6A,NAV2,MACF1,DCLK2,HPSE2,PITPNC1,MGAT4C,ABLIM1,GLIS3,GFAP,TRPM3,SFXN5,NRG3,NKAIN3,RYR3,NTRK3,PRKCA,NTM,DGKG,FMN2,NEBL,RFX4,DTNA |
1.926e-06 | -13.16 | central nervous system development | biological process | GO:0007417 | 995 | 13 | 18204 | 50 |
NDRG2,RFX4,RORA,NRG3,ATP1A2,DCLK2,MSI2,NTRK2,SLC1A2,CTNNA2,NAV2,ERBB4,GFAP |
2.070e-06 | -13.09 | LCK (LCK proto-oncogene, Src family tyrosine kinase) | protein interactions | 3932 | 455 | 9 | 19454 | 50 |
DTNA,PRKCA,CTNND2,ERBB4,FMN2,KALRN,CAMK2G,MACF1,PARD3 |
2.123e-06 | -13.06 | plasma membrane bounded cell projection | cellular component | GO:0120025 | 2285 | 19 | 19108 | 50 |
MACF1,PSD2,CAMK2G,NTRK3,NTRK2,FMN2,ADCY2,PRKCA,DTNA,ATP1A2,CTNNA2,NDRG2,SYNE1,CTNND2,PARD3,ABLIM1,SLC1A2,GPM6A,GFAP |
2.277e-06 | -12.99 | bone-humerus-other-chondroblastoma | COSMIC cancer mutations | bone-humerus-other-chondroblastoma | 301 | 8 | 16828 | 49 |
GPC5,LRP1B,ADCY2,GPM6A,FMN2,SOX5,NKAIN3,SFXN5 |
2.359e-06 | -12.96 | upper_aerodigestive_tract-mouth-carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma | 6426 | 35 | 16828 | 49 |
SOX5,TNC,CTNND2,PSD2,NDRG2,ADCY2,GPC5,CDH20,LRP1B,SLC4A4,NPAS3,ERBB4,HPSE2,PITPNC1,MGAT4C,ABLIM1,KALRN,RORA,GPM6A,NAV2,MACF1,PARD3,SYNE1,SORBS1,SLC1A2,RFX4,NTRK3,RYR3,NTM,DGKG,FMN2,GFAP,SFXN5,TRPM3,NRG3 |
2.609e-06 | -12.86 | neuron development | biological process | GO:0048666 | 859 | 12 | 18204 | 50 |
PARD3,GPM6A,NTM,GFAP,DGKG,CTNNA2,CTNND2,NTRK2,DCLK2,NRXN1,KALRN,TNC |
3.025e-06 | -12.71 | scalp | COSMIC cancer mutations | scalp | 2110 | 19 | 16828 | 49 |
TNC,ATP1A2,SORBS1,SYNE1,MACF1,CAMK2G,SOX5,RORA,LSAMP,ERBB4,GFAP,SLC4A4,NRXN1,NEBL,GPC5,FMN2,RPS6KA2,NTRK3,NTM |
3.130e-06 | -12.67 | humerus | COSMIC cancer mutations | humerus | 546 | 10 | 16828 | 49 |
SOX5,KALRN,FMN2,GPM6A,NEBL,ADCY2,GPC5,LRP1B,SFXN5,NKAIN3 |
3.587e-06 | -12.54 | multicellular organismal process | biological process | GO:0032501 | 6177 | 33 | 18204 | 50 |
RFX4,PRKCA,ABLIM1,DCLK2,ATP1A2,NRG3,NRXN1,RORA,CTNNA2,CTNND2,CDH20,LSAMP,NTRK3,PARD3,DTNA,GPM6A,NEBL,SOX5,RYR3,NDRG2,KALRN,TNC,NAV2,SYNE1,SLC1A2,NTRK2,MSI2,NTM,GFAP,DGKG,SLC4A4,CAMK2G,ERBB4 |
3.650e-06 | -12.52 | MAPT (microtubule associated protein tau) | protein interactions | 4137 | 948 | 12 | 19454 | 50 |
LSAMP,NDRG2,CTNND2,PRKCA,ABLIM1,NEBL,ATP1A2,SORBS1,SLC1A2,GPM6A,CTNNA2,NTM |
5.140e-06 | -12.18 | neuron projection | cellular component | GO:0043005 | 1331 | 14 | 19108 | 50 |
CTNND2,SYNE1,DTNA,NDRG2,CTNNA2,ATP1A2,ADCY2,NTRK2,NTRK3,CAMK2G,PSD2,GPM6A,SLC1A2,PARD3 |
5.182e-06 | -12.17 | FRS2 (fibroblast growth factor receptor substrate 2) | protein interactions | 10818 | 98 | 5 | 19454 | 50 |
NTRK2,NTRK3,PARD3,SORBS1,RPS6KA2 |
6.215e-06 | -11.99 | upper_aerodigestive_tract | COSMIC cancer mutations | upper_aerodigestive_tract | 13181 | 49 | 16828 | 49 |
SLC14A1,PARD3,MSI2,SYNE1,PITPNC1,MGAT4C,KALRN,DCLK2,NKAIN3,SFXN5,GLIS3,NRG3,DTNA,PRKCA,NTM,RYR3,RPS6KA2,FMN2,DGKG,ATP1A2,PSD2,CAMK2G,NRXN1,SLC4A4,ERBB4,NDRG2,LRP1B,GPC5,ADCY2,SLC1A2,SORBS1,HPSE2,ABLIM1,RORA,MACF1,GPM6A,NAV2,TRPM3,GFAP,RFX4,NEBL,NTRK3,TNC,CTNND2,SOX5,NTRK2,LSAMP,NPAS3,CDH20 |
6.519e-06 | -11.94 | cell junction | cellular component | GO:0030054 | 2224 | 18 | 19108 | 50 |
CTNND2,SORBS1,ATP1A2,CTNNA2,DTNA,SYNE1,NTRK2,KALRN,RPS6KA2,PSD2,NRXN1,SLC1A2,ERBB4,GPM6A,NRG3,TNC,CDH20,PARD3 |
6.705e-06 | -11.91 | carcinoid-endocrine_tumour | COSMIC cancer mutations | carcinoid-endocrine_tumour | 7752 | 38 | 16828 | 49 |
RFX4,NEBL,PRKCA,NTRK3,RYR3,RPS6KA2,FMN2,DGKG,NKAIN3,TRPM3,SFXN5,GLIS3,NRG3,HPSE2,ABLIM1,RORA,KALRN,DCLK2,MACF1,NAV2,GPM6A,PARD3,SYNE1,SLC1A2,CDH20,LRP1B,GPC5,ADCY2,LSAMP,SLC4A4,ERBB4,SOX5,CAMK2G,NTRK2,ATP1A2,TNC,PSD2,CTNND2 |
6.961e-06 | -11.88 | Protein_kinase_ATP_BS | interpro domains | IPR017441 | 377 | 8 | 18521 | 50 |
NTRK3,ERBB4,PRKCA,RPS6KA2,CAMK2G,KALRN,NTRK2,DCLK2 |
7.657e-06 | -11.78 | autonomic_ganglia-neuroblastoma | COSMIC cancer mutations | autonomic_ganglia-neuroblastoma | 3970 | 26 | 16828 | 49 |
PITPNC1,KALRN,MACF1,NAV2,GPM6A,PARD3,SYNE1,SLC1A2,RFX4,NEBL,NTRK3,RYR3,DGKG,FMN2,GLIS3,CAMK2G,NTRK2,ATP1A2,TNC,PSD2,CTNND2,LRP1B,ADCY2,SLC4A4,NPAS3,ERBB4 |
7.694e-06 | -11.78 | neuroblastoma | COSMIC cancer mutations | neuroblastoma | 3971 | 26 | 16828 | 49 |
NTRK2,CAMK2G,PSD2,CTNND2,ATP1A2,TNC,LRP1B,ADCY2,NPAS3,SLC4A4,ERBB4,KALRN,MACF1,GPM6A,NAV2,PITPNC1,SYNE1,SLC1A2,PARD3,NTRK3,RYR3,FMN2,DGKG,RFX4,NEBL,GLIS3 |
7.914e-06 | -11.75 | developmental process | biological process | GO:0032502 | 5716 | 31 | 18204 | 50 |
CAMK2G,ERBB4,GFAP,DGKG,NTM,SLC1A2,NTRK2,MSI2,NAV2,SYNE1,TNC,KALRN,NDRG2,SOX5,NEBL,NTRK3,GPM6A,PARD3,LSAMP,CDH20,CTNND2,CTNNA2,NRXN1,RORA,NRG3,DCLK2,FMN2,ATP1A2,ABLIM1,PRKCA,RFX4 |
8.070e-06 | -11.73 | skin-face-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-face-carcinoma-squamous_cell_carcinoma | 2036 | 18 | 16828 | 49 |
LSAMP,GFAP,TRPM3,ERBB4,NRG3,NEBL,GPC5,LRP1B,FMN2,RPS6KA2,PARD3,MSI2,SYNE1,ABLIM1,RORA,NAV2,GPM6A,MACF1 |
9.076e-06 | -11.61 | autonomic_ganglia | COSMIC cancer mutations | autonomic_ganglia | 4005 | 26 | 16828 | 49 |
SLC1A2,SYNE1,PARD3,MACF1,GPM6A,NAV2,KALRN,PITPNC1,GLIS3,DGKG,FMN2,NTRK3,RYR3,RFX4,NEBL,PSD2,CTNND2,ATP1A2,TNC,NTRK2,CAMK2G,ERBB4,SLC4A4,NPAS3,LRP1B,ADCY2 |
9.407e-06 | -11.57 | bone-tibia-other-chondroblastoma | COSMIC cancer mutations | bone-tibia-other-chondroblastoma | 98 | 5 | 16828 | 49 |
GPM6A,CTNND2,NKAIN3,LRP1B,LSAMP |
9.576e-06 | -11.56 | basal_(triple-negative)_carcinoma | COSMIC cancer mutations | basal_(triple-negative)_carcinoma | 2981 | 22 | 16828 | 49 |
KALRN,MACF1,NAV2,PARD3,MSI2,SYNE1,NEBL,PRKCA,NTM,NTRK3,RPS6KA2,FMN2,TRPM3,NRG3,NTRK2,ATP1A2,NDRG2,LRP1B,ADCY2,SLC4A4,NPAS3,ERBB4 |
9.576e-06 | -11.56 | breast-carcinoma-basal_(triple-negative)_carcinoma | COSMIC cancer mutations | breast-carcinoma-basal_(triple-negative)_carcinoma | 2981 | 22 | 16828 | 49 |
MACF1,NTRK2,NAV2,KALRN,SYNE1,MSI2,ATP1A2,PARD3,RPS6KA2,FMN2,PRKCA,NTM,NTRK3,LRP1B,ADCY2,NEBL,NDRG2,NRG3,ERBB4,TRPM3,SLC4A4,NPAS3 |
9.764e-06 | -11.54 | telencephalon development | biological process | GO:0021537 | 276 | 7 | 18204 | 50 |
ERBB4,DCLK2,ATP1A2,NRG3,NTRK2,SLC1A2,RFX4 |
1.167e-05 | -11.36 | oesophagus-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-carcinoma-squamous_cell_carcinoma | 6486 | 34 | 16828 | 49 |
NDRG2,ADCY2,GPC5,LRP1B,SLC4A4,NPAS3,NRXN1,ERBB4,SOX5,CTNND2,PSD2,TNC,ATP1A2,RYR3,PRKCA,FMN2,RPS6KA2,NEBL,GLIS3,SFXN5,TRPM3,NRG3,KALRN,GPM6A,NAV2,DCLK2,MACF1,HPSE2,PITPNC1,MGAT4C,ABLIM1,SYNE1,SORBS1,PARD3 |
1.174e-05 | -11.35 | superficial_spreading | COSMIC cancer mutations | superficial_spreading | 1110 | 13 | 16828 | 49 |
SLC4A4,ERBB4,LRP1B,ADCY2,NTM,NTRK3,TNC,SYNE1,CTNND2,SORBS1,MGAT4C,KALRN,MACF1 |
1.215e-05 | -11.32 | oesophagus-middle_third-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-middle_third-carcinoma-squamous_cell_carcinoma | 3531 | 24 | 16828 | 49 |
SYNE1,PARD3,NAV2,GPM6A,MACF1,ABLIM1,HPSE2,NRG3,GFAP,TRPM3,FMN2,DGKG,RPS6KA2,NTRK3,RYR3,NEBL,CTNND2,TNC,ATP1A2,SOX5,SLC4A4,ADCY2,LRP1B,GPC5 |
1.227e-05 | -11.31 | middle_third | COSMIC cancer mutations | middle_third | 3533 | 24 | 16828 | 49 |
TRPM3,GFAP,NRG3,NEBL,RYR3,NTRK3,RPS6KA2,DGKG,FMN2,PARD3,SYNE1,HPSE2,ABLIM1,MACF1,NAV2,GPM6A,SLC4A4,LRP1B,GPC5,ADCY2,ATP1A2,TNC,CTNND2,SOX5 |
1.229e-05 | -11.31 | TIAM1 (TIAM Rac1 associated GEF 1) | protein interactions | 7074 | 201 | 6 | 19454 | 50 |
PARD3,ATP1A2,RYR3,DTNA,CAMK2G,PRKCA |
1.331e-05 | -11.23 | adenoid_cystic_carcinoma | COSMIC cancer mutations | adenoid_cystic_carcinoma | 1123 | 13 | 16828 | 49 |
RPS6KA2,NTRK3,RYR3,PRKCA,LRP1B,ERBB4,NAV2,NTRK2,CAMK2G,RORA,MGAT4C,CTNND2,SYNE1 |
1.548e-05 | -11.08 | salivary_gland | COSMIC cancer mutations | salivary_gland | 1139 | 13 | 16828 | 49 |
RPS6KA2,PRKCA,RYR3,NTRK3,LRP1B,ERBB4,CAMK2G,NTRK2,NAV2,RORA,MGAT4C,SYNE1,CTNND2 |
1.611e-05 | -11.04 | face | COSMIC cancer mutations | face | 2139 | 18 | 16828 | 49 |
MSI2,PARD3,SYNE1,ABLIM1,MACF1,GPM6A,NAV2,RORA,LSAMP,ERBB4,NRG3,TRPM3,GFAP,GPC5,LRP1B,NEBL,RPS6KA2,FMN2 |
1.786e-05 | -10.93 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-follicular_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-follicular_lymphoma | 981 | 12 | 16828 | 49 |
LSAMP,PARD3,NKAIN3,CTNND2,NRG3,HPSE2,LRP1B,GPC5,ADCY2,RORA,PRKCA,SOX5 |
1.850e-05 | -10.90 | FLOT1 (flotillin 1) | protein interactions | 10211 | 453 | 8 | 19454 | 50 |
ABLIM1,DTNA,FMN2,MACF1,SORBS1,PARD3,SOX5,SLC14A1 |
2.030e-05 | -10.80 | adenoma | COSMIC cancer mutations | adenoma | 2873 | 21 | 16828 | 49 |
GPM6A,MACF1,NTRK2,DCLK2,SOX5,KALRN,HPSE2,CTNND2,SYNE1,PARD3,TNC,RYR3,PRKCA,ADCY2,NEBL,GPC5,CDH20,LRP1B,ERBB4,NPAS3,TRPM3 |
2.139e-05 | -10.75 | NTRK | interpro domains | IPR020777 | 3 | 2 | 18521 | 50 |
NTRK2,NTRK3 |
2.139e-05 | -10.75 | NTRK_LRRCT | interpro domains | IPR031635 | 3 | 2 | 18521 | 50 |
NTRK2,NTRK3 |
2.224e-05 | -10.71 | LRRCT_2 | pfam domains | PF16920 | 3 | 2 | 17795 | 49 |
NTRK3,NTRK2 |
2.258e-05 | -10.70 | brain development | biological process | GO:0007420 | 724 | 10 | 18204 | 50 |
CTNNA2,RFX4,NDRG2,SLC1A2,NTRK2,DCLK2,ATP1A2,NRG3,RORA,ERBB4 |
2.529e-05 | -10.59 | regulation of neuron projection development | biological process | GO:0010975 | 443 | 8 | 18204 | 50 |
NTRK2,CTNNA2,MACF1,SYNE1,CAMK2G,DGKG,GFAP,NTRK3 |
2.792e-05 | -10.49 | Ig_I-set | interpro domains | IPR013098 | 132 | 5 | 18521 | 50 |
NTRK3,LSAMP,NTM,NTRK2,KALRN |
2.908e-05 | -10.45 | bone | COSMIC cancer mutations | bone | 8157 | 38 | 16828 | 49 |
LRP1B,GPC5,ADCY2,NDRG2,ERBB4,NRXN1,SLC4A4,NPAS3,LSAMP,CAMK2G,NTRK2,SOX5,PSD2,CTNND2,ATP1A2,TNC,DGKG,FMN2,RYR3,NTRK3,DTNA,NEBL,NRG3,SFXN5,TRPM3,GLIS3,NKAIN3,DCLK2,MACF1,GPM6A,NAV2,RORA,KALRN,ABLIM1,HPSE2,SORBS1,SYNE1,PARD3 |
2.973e-05 | -10.42 | lymphoid_neoplasm | COSMIC cancer mutations | lymphoid_neoplasm | 12233 | 47 | 16828 | 49 |
PITPNC1,MGAT4C,KALRN,DCLK2,PARD3,MSI2,SYNE1,DTNA,PRKCA,NTM,RYR3,RPS6KA2,FMN2,DGKG,NKAIN3,SFXN5,GLIS3,NRG3,CAMK2G,ATP1A2,PSD2,GPC5,LRP1B,ADCY2,NRXN1,SLC4A4,ERBB4,HPSE2,ABLIM1,RORA,MACF1,GPM6A,NAV2,SLC1A2,SORBS1,RFX4,NEBL,NTRK3,TRPM3,GFAP,SOX5,NTRK2,TNC,CTNND2,CDH20,LSAMP,NPAS3 |
2.978e-05 | -10.42 | salivary_gland-parotid-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | salivary_gland-parotid-carcinoma-adenoid_cystic_carcinoma | 561 | 9 | 16828 | 49 |
SYNE1,ERBB4,LRP1B,PRKCA,NTRK3,RYR3,CAMK2G,RPS6KA2,NTRK2 |
2.991e-05 | -10.42 | cell differentiation | biological process | GO:0030154 | 3645 | 23 | 18204 | 50 |
NDRG2,TNC,KALRN,NAV2,SYNE1,MSI2,NTRK2,NTM,ERBB4,CAMK2G,DGKG,GFAP,FMN2,DCLK2,RORA,NRXN1,CTNND2,CTNNA2,NEBL,GPM6A,PARD3,NTRK3,SOX5 |
3.032e-05 | -10.40 | cellular developmental process | biological process | GO:0048869 | 3648 | 23 | 18204 | 50 |
NDRG2,DCLK2,FMN2,TNC,KALRN,NRXN1,RORA,CTNND2,NAV2,SYNE1,CTNNA2,NTRK2,MSI2,NTM,NEBL,NTRK3,GPM6A,PARD3,CAMK2G,ERBB4,SOX5,GFAP,DGKG |
3.042e-05 | -10.40 | PROTEIN_KINASE_ATP | prosite domains | PS00107 | 377 | 8 | 12186 | 41 |
RPS6KA2,ERBB4,NTRK2,DCLK2,CAMK2G,NTRK3,PRKCA,KALRN |
3.055e-05 | -10.40 | I-set | pfam domains | PF07679 | 132 | 5 | 17795 | 49 |
NTRK2,NTRK3,KALRN,NTM,LSAMP |
3.248e-05 | -10.33 | SLC6A15 (solute carrier family 6 member 15) | protein interactions | 55117 | 143 | 5 | 19454 | 50 |
RPS6KA2,SFXN5,NTRK2,PARD3,NTRK3 |
3.322e-05 | -10.31 | SHC1 events in ERBB2 signaling | REACTOME pathways | R-HSA-1250196 | 22 | 3 | 10285 | 30 |
PRKCA,NRG3,ERBB4 |
3.354e-05 | -10.30 | NTKRECEPTOR | prints domains | PR01939 | 3 | 2 | 5227 | 18 |
NTRK3,NTRK2 |
3.484e-05 | -10.26 | OCLN (occludin) | protein interactions | 100506658 | 495 | 8 | 19454 | 50 |
PARD3,MACF1,FMN2,NTRK2,RPS6KA2,DTNA,ABLIM1,PRKCA |
3.600e-05 | -10.23 | Spectrin_repeat | interpro domains | IPR002017 | 24 | 3 | 18521 | 50 |
KALRN,SYNE1,MACF1 |
3.762e-05 | -10.19 | parotid | COSMIC cancer mutations | parotid | 578 | 9 | 16828 | 49 |
SYNE1,ERBB4,PRKCA,NTRK3,RYR3,RPS6KA2,CAMK2G,NTRK2,LRP1B |
3.813e-05 | -10.17 | Spectrin | pfam domains | PF00435 | 24 | 3 | 17795 | 49 |
MACF1,KALRN,SYNE1 |
3.961e-05 | -10.14 | Prot_kinase_dom | interpro domains | IPR000719 | 480 | 8 | 18521 | 50 |
NTRK3,ERBB4,RPS6KA2,PRKCA,CAMK2G,DCLK2,NTRK2,KALRN |
3.991e-05 | -10.13 | head development | biological process | GO:0060322 | 774 | 10 | 18204 | 50 |
NDRG2,SLC1A2,NTRK2,CTNNA2,RFX4,RORA,ERBB4,DCLK2,ATP1A2,NRG3 |
4.550e-05 | -10.00 | Htt (huntingtin) | protein interactions | 15194 | 77 | 4 | 19454 | 50 |
GPM6A,NTM,GFAP,LSAMP |
4.687e-05 | -9.97 | lung-carcinoma-small_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-small_cell_carcinoma | 9908 | 42 | 16828 | 49 |
NEBL,DTNA,RFX4,RYR3,NTRK3,NTM,PRKCA,DGKG,FMN2,RPS6KA2,NKAIN3,TRPM3,NRG3,HPSE2,PITPNC1,MGAT4C,ABLIM1,KALRN,RORA,NAV2,GPM6A,MACF1,DCLK2,SLC14A1,PARD3,MSI2,SYNE1,SORBS1,NDRG2,LRP1B,GPC5,CDH20,SLC4A4,NPAS3,NRXN1,ERBB4,SOX5,NTRK2,CAMK2G,TNC,ATP1A2,CTNND2 |
4.765e-05 | -9.95 | small_cell_carcinoma | COSMIC cancer mutations | small_cell_carcinoma | 9913 | 42 | 16828 | 49 |
ERBB4,SLC4A4,NPAS3,NRXN1,CDH20,GPC5,LRP1B,NDRG2,TNC,ATP1A2,CTNND2,NTRK2,CAMK2G,SOX5,NKAIN3,NRG3,TRPM3,NEBL,RFX4,DTNA,DGKG,FMN2,RPS6KA2,NTRK3,RYR3,PRKCA,NTM,MSI2,SLC14A1,PARD3,SORBS1,SYNE1,MGAT4C,ABLIM1,HPSE2,PITPNC1,GPM6A,NAV2,MACF1,DCLK2,KALRN,RORA |
4.784e-05 | -9.95 | Signalling by NGF | REACTOME pathways | R-HSA-166520 | 477 | 8 | 10285 | 30 |
NTRK2,KALRN,ERBB4,RPS6KA2,NRG3,PRKCA,ADCY2,CAMK2G |
4.933e-05 | -9.92 | Nuclear signaling by ERBB4 | REACTOME pathways | R-HSA-1251985 | 25 | 3 | 10285 | 30 |
NRG3,ERBB4,GFAP |
5.002e-05 | -9.90 | LRRC7 (leucine rich repeat containing 7) | protein interactions | 57554 | 28 | 3 | 19454 | 50 |
CAMK2G,ERBB4,CTNND2 |
5.429e-05 | -9.82 | skin-head_neck-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-head_neck-malignant_melanoma-superficial_spreading | 923 | 11 | 16828 | 49 |
TNC,ERBB4,SORBS1,SYNE1,CTNND2,LRP1B,ADCY2,MGAT4C,MACF1,KALRN,NTRK3 |
5.570e-05 | -9.80 | cell development | biological process | GO:0048468 | 2236 | 17 | 18204 | 50 |
DGKG,GFAP,ERBB4,PARD3,GPM6A,NEBL,NTM,MSI2,NTRK2,CTNNA2,CTNND2,RORA,KALRN,NRXN1,TNC,FMN2,DCLK2 |
6.620e-05 | -9.62 | skin-arm-malignant_melanoma | COSMIC cancer mutations | skin-arm-malignant_melanoma | 1308 | 13 | 16828 | 49 |
KALRN,MACF1,NAV2,SYNE1,SORBS1,ATP1A2,NTM,PRKCA,LRP1B,TRPM3,SLC4A4,NPAS3,ERBB4 |
6.710e-05 | -9.61 | bronchioloalveolar_adenocarcinoma | COSMIC cancer mutations | bronchioloalveolar_adenocarcinoma | 778 | 10 | 16828 | 49 |
ADCY2,SOX5,NTRK3,PRKCA,CAMK2G,DCLK2,RPS6KA2,NTRK2,CTNND2,ERBB4 |
6.710e-05 | -9.61 | lung-carcinoma-bronchioloalveolar_adenocarcinoma | COSMIC cancer mutations | lung-carcinoma-bronchioloalveolar_adenocarcinoma | 778 | 10 | 16828 | 49 |
CTNND2,ERBB4,ADCY2,SOX5,NTRK3,PRKCA,RPS6KA2,DCLK2,NTRK2,CAMK2G |
7.140e-05 | -9.55 | Spectrin/alpha-actinin | interpro domains | IPR018159 | 30 | 3 | 18521 | 50 |
KALRN,SYNE1,MACF1 |
7.147e-05 | -9.55 | neurotrophin receptor activity | molecular function | GO:0005030 | 5 | 2 | 18094 | 49 |
NTRK3,NTRK2 |
7.242e-05 | -9.53 | Kinase-like_dom_sf | interpro domains | IPR011009 | 523 | 8 | 18521 | 50 |
DCLK2,NTRK2,KALRN,CAMK2G,ERBB4,PRKCA,RPS6KA2,NTRK3 |
7.268e-05 | -9.53 | regulation of plasma membrane bounded cell projection organization | biological process | GO:0120035 | 666 | 9 | 18204 | 50 |
NTRK2,CTNNA2,SYNE1,MACF1,CAMK2G,DGKG,GFAP,GPM6A,NTRK3 |
7.355e-05 | -9.52 | D-aspartate import across plasma membrane | biological process | GO:0070779 | 5 | 2 | 18204 | 50 |
GFAP,SLC1A2 |
7.355e-05 | -9.52 | D-aspartate transmembrane transport | biological process | GO:0070777 | 5 | 2 | 18204 | 50 |
GFAP,SLC1A2 |
7.377e-05 | -9.51 | testis-germ_cell_tumour-non_seminoma | COSMIC cancer mutations | testis-germ_cell_tumour-non_seminoma | 487 | 8 | 16828 | 49 |
ERBB4,MACF1,CAMK2G,NTRK2,RPS6KA2,DCLK2,NTRK3,PRKCA |
7.654e-05 | -9.48 | upper_aerodigestive_tract-larynx-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-larynx-carcinoma-squamous_cell_carcinoma | 1946 | 16 | 16828 | 49 |
MGAT4C,HPSE2,MACF1,GPM6A,RORA,SOX5,SYNE1,LRP1B,NEBL,FMN2,NTRK3,RYR3,ERBB4,NRXN1,SLC4A4,NPAS3 |
7.670e-05 | -9.48 | synapse | cellular component | GO:0045202 | 1473 | 13 | 19108 | 50 |
PSD2,RPS6KA2,KALRN,NTRK2,SYNE1,DTNA,ATP1A2,CTNND2,NRG3,ERBB4,GPM6A,SLC1A2,NRXN1 |
7.695e-05 | -9.47 | skin-scalp-malignant_melanoma | COSMIC cancer mutations | skin-scalp-malignant_melanoma | 634 | 9 | 16828 | 49 |
NEBL,NTM,CAMK2G,RPS6KA2,FMN2,TNC,SYNE1,ERBB4,SORBS1 |
7.750e-05 | -9.47 | larynx | COSMIC cancer mutations | larynx | 1948 | 16 | 16828 | 49 |
NRXN1,SLC4A4,NPAS3,ERBB4,NTRK3,RYR3,FMN2,LRP1B,NEBL,SYNE1,RORA,SOX5,MACF1,GPM6A,HPSE2,MGAT4C |
7.919e-05 | -9.44 | arm | COSMIC cancer mutations | arm | 1331 | 13 | 16828 | 49 |
PRKCA,NTM,LRP1B,ERBB4,TRPM3,NPAS3,SLC4A4,MACF1,NAV2,KALRN,SORBS1,SYNE1,ATP1A2 |
7.923e-05 | -9.44 | non_seminoma | COSMIC cancer mutations | non_seminoma | 492 | 8 | 16828 | 49 |
ERBB4,CAMK2G,RPS6KA2,NTRK2,DCLK2,MACF1,NTRK3,PRKCA |
7.933e-05 | -9.44 | mast_cell_neoplasm | COSMIC cancer mutations | mast_cell_neoplasm | 248 | 6 | 16828 | 49 |
GPC5,ADCY2,HPSE2,NRG3,ERBB4,NPAS3 |
7.933e-05 | -9.44 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-mast_cell_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-mast_cell_neoplasm | 248 | 6 | 16828 | 49 |
NPAS3,ERBB4,NRG3,HPSE2,GPC5,ADCY2 |
8.096e-05 | -9.42 | phosphotransferase activity, alcohol group as acceptor | molecular function | GO:0016773 | 686 | 9 | 18094 | 49 |
NTRK2,RPS6KA2,NTRK3,CAMK2G,DGKG,DCLK2,KALRN,PRKCA,ERBB4 |
8.117e-05 | -9.42 | skin-trunk-malignant_melanoma | COSMIC cancer mutations | skin-trunk-malignant_melanoma | 2647 | 19 | 16828 | 49 |
HPSE2,MGAT4C,KALRN,SOX5,ATP1A2,SLC14A1,TNC,PARD3,SYNE1,CTNND2,LRP1B,CDH20,NEBL,RYR3,RPS6KA2,LSAMP,NRXN1,NRG3,ERBB4 |
8.255e-05 | -9.40 | NTM (neurotrimin) | protein interactions | 50863 | 33 | 3 | 19454 | 50 |
LSAMP,NTM,GPM6A |
8.559e-05 | -9.37 | plasma membrane region | cellular component | GO:0098590 | 1278 | 12 | 19108 | 50 |
SLC4A4,SLC1A2,GPM6A,ERBB4,NRXN1,PARD3,ATP1A2,SYNE1,SORBS1,MACF1,PSD2,SLC14A1 |
8.670e-05 | -9.35 | papillary_renal_cell_carcinoma | COSMIC cancer mutations | papillary_renal_cell_carcinoma | 6364 | 32 | 16828 | 49 |
CTNND2,PSD2,ATP1A2,SOX5,CAMK2G,NTRK2,SLC4A4,NRXN1,ERBB4,ADCY2,GPC5,LRP1B,SYNE1,PARD3,RORA,KALRN,NAV2,MACF1,DCLK2,HPSE2,PITPNC1,ABLIM1,TRPM3,NRG3,NTRK3,RYR3,NTM,PRKCA,FMN2,DGKG,RPS6KA2,RFX4 |
8.670e-05 | -9.35 | kidney-carcinoma-papillary_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-papillary_renal_cell_carcinoma | 6364 | 32 | 16828 | 49 |
TRPM3,NRG3,RFX4,PRKCA,NTM,RYR3,NTRK3,RPS6KA2,DGKG,FMN2,PARD3,SYNE1,PITPNC1,HPSE2,ABLIM1,RORA,KALRN,MACF1,DCLK2,NAV2,NRXN1,SLC4A4,ERBB4,GPC5,LRP1B,ADCY2,ATP1A2,PSD2,CTNND2,SOX5,NTRK2,CAMK2G |
8.705e-05 | -9.35 | urinary_tract-bladder-carcinoma-transitional_cell_carcinoma | COSMIC cancer mutations | urinary_tract-bladder-carcinoma-transitional_cell_carcinoma | 6040 | 31 | 16828 | 49 |
FMN2,DGKG,DTNA,RFX4,NEBL,TRPM3,SFXN5,GLIS3,NRG3,KALRN,MACF1,NAV2,GPM6A,HPSE2,ABLIM1,MGAT4C,SYNE1,SORBS1,PARD3,CDH20,LRP1B,GPC5,ADCY2,NRXN1,SLC4A4,ERBB4,NTRK2,CAMK2G,PSD2,ATP1A2,TNC |
8.767e-05 | -9.34 | transitional_cell_carcinoma | COSMIC cancer mutations | transitional_cell_carcinoma | 6042 | 31 | 16828 | 49 |
NEBL,RFX4,DTNA,DGKG,FMN2,NRG3,GLIS3,SFXN5,TRPM3,MGAT4C,ABLIM1,HPSE2,NAV2,GPM6A,MACF1,KALRN,PARD3,SORBS1,SYNE1,ADCY2,GPC5,LRP1B,CDH20,ERBB4,SLC4A4,NRXN1,NTRK2,CAMK2G,TNC,ATP1A2,PSD2 |
8.816e-05 | -9.34 | regulation of cell projection organization | biological process | GO:0031344 | 683 | 9 | 18204 | 50 |
MACF1,SYNE1,CTNNA2,NTRK2,NTRK3,GPM6A,GFAP,DGKG,CAMK2G |
9.721e-05 | -9.24 | NGF signalling via TRKA from the plasma membrane | REACTOME pathways | R-HSA-187037 | 387 | 7 | 10285 | 30 |
NRG3,RPS6KA2,ERBB4,NTRK2,CAMK2G,ADCY2,PRKCA |
1.011e-04 | -9.20 | PRNP (prion protein (Kanno blood group)) | protein interactions | 5621 | 1118 | 11 | 19454 | 50 |
GPM6A,SORBS1,CAMK2G,MACF1,TNC,ATP1A2,ABLIM1,TRPM3,SLC4A4,MSI2,LSAMP |
1.101e-04 | -9.11 | ERBB4-ERBB4 signaling pathway | biological process | GO:0038138 | 6 | 2 | 18204 | 50 |
NRG3,ERBB4 |
1.101e-04 | -9.11 | D-amino acid transport | biological process | GO:0042940 | 6 | 2 | 18204 | 50 |
SLC1A2,GFAP |
1.108e-04 | -9.11 | ovary-carcinoma-clear_cell_carcinoma | COSMIC cancer mutations | ovary-carcinoma-clear_cell_carcinoma | 665 | 9 | 16828 | 49 |
ERBB4,NDRG2,LRP1B,NTRK3,PRKCA,RPS6KA2,DCLK2,NTRK2,CAMK2G |
1.118e-04 | -9.10 | pancreas-carcinoma-adenocarcinoma | COSMIC cancer mutations | pancreas-carcinoma-adenocarcinoma | 517 | 8 | 16828 | 49 |
LRP1B,GPC5,NEBL,HPSE2,MACF1,DCLK2,TNC,SYNE1 |
1.123e-04 | -9.09 | skin-mucosal-malignant_melanoma | COSMIC cancer mutations | skin-mucosal-malignant_melanoma | 2009 | 16 | 16828 | 49 |
PSD2,SYNE1,CTNND2,SORBS1,ATP1A2,PARD3,TNC,RORA,NAV2,ABLIM1,MGAT4C,ERBB4,NRG3,FMN2,LRP1B,NEBL |
1.123e-04 | -9.09 | mucosal | COSMIC cancer mutations | mucosal | 2009 | 16 | 16828 | 49 |
RORA,NAV2,ABLIM1,MGAT4C,SYNE1,PSD2,CTNND2,SORBS1,ATP1A2,PARD3,TNC,FMN2,LRP1B,NEBL,NRG3,ERBB4 |
1.136e-04 | -9.08 | haematopoietic_neoplasm | COSMIC cancer mutations | haematopoietic_neoplasm | 11082 | 44 | 16828 | 49 |
NKAIN3,GLIS3,SFXN5,NRG3,DTNA,RYR3,PRKCA,NTM,DGKG,FMN2,RPS6KA2,PARD3,SLC14A1,MSI2,SYNE1,KALRN,DCLK2,SLC4A4,NRXN1,ERBB4,ADCY2,GPC5,LRP1B,ATP1A2,PSD2,CAMK2G,GFAP,TRPM3,NEBL,RFX4,NTRK3,SLC1A2,HPSE2,ABLIM1,RORA,NAV2,MACF1,LSAMP,NPAS3,CDH20,TNC,CTNND2,SOX5,NTRK2 |
1.160e-04 | -9.06 | clear_cell_carcinoma | COSMIC cancer mutations | clear_cell_carcinoma | 669 | 9 | 16828 | 49 |
ERBB4,NDRG2,LRP1B,NTRK3,PRKCA,DCLK2,CAMK2G,NTRK2,RPS6KA2 |
1.166e-04 | -9.06 | CDH1 (cadherin 1) | protein interactions | 999 | 757 | 9 | 19454 | 50 |
NAV2,NDRG2,CTNND2,ABLIM1,NEBL,PARD3,MACF1,SORBS1,CTNNA2 |
1.167e-04 | -9.06 | Transferase(Phosphotransferase) domain 1 | gene3d domains | 1.10.510.10 | 490 | 8 | 14470 | 45 |
CAMK2G,RPS6KA2,DCLK2,NTRK2,KALRN,ERBB4,NTRK3,PRKCA |
1.174e-04 | -9.05 | forebrain development | biological process | GO:0030900 | 408 | 7 | 18204 | 50 |
NTRK2,SLC1A2,RFX4,ERBB4,ATP1A2,DCLK2,NRG3 |
1.179e-04 | -9.05 | cell adhesion molecule binding | molecular function | GO:0050839 | 560 | 8 | 18094 | 49 |
CTNND2,GFAP,NRXN1,CTNNA2,CDH20,PRKCA,TNC,MACF1 |
1.219e-04 | -9.01 | tibia | COSMIC cancer mutations | tibia | 836 | 10 | 16828 | 49 |
TRPM3,PSD2,CTNND2,LSAMP,NKAIN3,MACF1,GPM6A,NDRG2,ABLIM1,LRP1B |
1.293e-04 | -8.95 | adherens junction | cellular component | GO:0005912 | 188 | 5 | 19108 | 50 |
SORBS1,CTNND2,PARD3,CDH20,CTNNA2 |
1.367e-04 | -8.90 | follicular_lymphoma | COSMIC cancer mutations | follicular_lymphoma | 1209 | 12 | 16828 | 49 |
HPSE2,SOX5,RORA,PARD3,CTNND2,ADCY2,GPC5,LRP1B,PRKCA,NKAIN3,LSAMP,NRG3 |
1.394e-04 | -8.88 | Gastric acid secretion | KEGG pathways | hsa04971 | 75 | 4 | 7161 | 26 |
ATP1A2,ADCY2,CAMK2G,PRKCA |
1.394e-04 | -8.88 | Gastric acid secretion | KEGG pathways | ko04971 | 75 | 4 | 7161 | 26 |
ATP1A2,ADCY2,PRKCA,CAMK2G |
1.426e-04 | -8.86 | kinase activity | molecular function | GO:0016301 | 739 | 9 | 18094 | 49 |
ERBB4,PRKCA,KALRN,CAMK2G,NTRK2,RPS6KA2,NTRK3,DCLK2,DGKG |
1.446e-04 | -8.84 | phosphorylation | biological process | GO:0016310 | 729 | 9 | 18204 | 50 |
KALRN,DGKG,CAMK2G,ERBB4,NTRK3,DCLK2,PRKCA,NTRK2,RPS6KA2 |
1.449e-04 | -8.84 | protein kinase activity | molecular function | GO:0004672 | 577 | 8 | 18094 | 49 |
CAMK2G,NTRK3,NTRK2,RPS6KA2,DCLK2,ERBB4,KALRN,PRKCA |
1.476e-04 | -8.82 | DZIP1 (DAZ interacting zinc finger protein 1) | protein interactions | 22873 | 40 | 3 | 19454 | 50 |
CAMK2G,NTRK2,PARD3 |
1.476e-04 | -8.82 | SHC2 (SHC adaptor protein 2) | protein interactions | 25759 | 40 | 3 | 19454 | 50 |
ERBB4,NTRK2,NTRK3 |
1.566e-04 | -8.76 | actin binding | molecular function | GO:0003779 | 434 | 7 | 18094 | 49 |
SYNE1,NEBL,CTNNA2,SORBS1,MACF1,FMN2,ABLIM1 |
1.597e-04 | -8.74 | SPEC | smart domains | SM00150 | 29 | 3 | 9717 | 36 |
SYNE1,MACF1,KALRN |
1.598e-04 | -8.74 | stomach-carcinoma-diffuse_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-diffuse_adenocarcinoma | 4383 | 25 | 16828 | 49 |
MGAT4C,ABLIM1,NAV2,GPM6A,MACF1,KALRN,PARD3,SYNE1,RFX4,DTNA,FMN2,DGKG,RYR3,NTRK3,NRG3,GLIS3,TRPM3,SOX5,TNC,ATP1A2,CTNND2,PSD2,ADCY2,LRP1B,ERBB4 |
1.598e-04 | -8.74 | diffuse_adenocarcinoma | COSMIC cancer mutations | diffuse_adenocarcinoma | 4383 | 25 | 16828 | 49 |
TNC,ATP1A2,CTNND2,PSD2,SOX5,ERBB4,ADCY2,LRP1B,PARD3,SYNE1,MGAT4C,ABLIM1,KALRN,GPM6A,NAV2,MACF1,GLIS3,TRPM3,NRG3,RFX4,DTNA,NTRK3,RYR3,FMN2,DGKG |
1.608e-04 | -8.74 | kidney-Wilms_tumour | COSMIC cancer mutations | kidney-Wilms_tumour | 545 | 8 | 16828 | 49 |
ERBB4,PRKCA,NTRK3,CAMK2G,NTRK2,RPS6KA2,DCLK2,FMN2 |
1.628e-04 | -8.72 | Wilms_tumour | COSMIC cancer mutations | Wilms_tumour | 546 | 8 | 16828 | 49 |
ERBB4,FMN2,CAMK2G,NTRK2,RPS6KA2,DCLK2,NTRK3,PRKCA |
1.658e-04 | -8.70 | PROTEIN_KINASE_DOM | prosite domains | PS50011 | 480 | 8 | 12186 | 41 |
KALRN,PRKCA,NTRK3,CAMK2G,DCLK2,NTRK2,ERBB4,RPS6KA2 |
1.706e-04 | -8.68 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_leukaemia | 2081 | 16 | 16828 | 49 |
ATP1A2,SYNE1,KALRN,SOX5,CAMK2G,NTRK2,DCLK2,GFAP,SLC4A4,ERBB4,LRP1B,DTNA,ADCY2,PRKCA,NTRK3,RPS6KA2 |
1.716e-04 | -8.67 | - | gene3d domains | 1.20.58.60 | 35 | 3 | 14470 | 45 |
SYNE1,MACF1,KALRN |
1.762e-04 | -8.64 | pancreas-carcinoid-endocrine_tumour | COSMIC cancer mutations | pancreas-carcinoid-endocrine_tumour | 7250 | 34 | 16828 | 49 |
SOX5,NTRK2,ATP1A2,TNC,PSD2,CTNND2,CDH20,GPC5,LRP1B,ADCY2,LSAMP,SLC4A4,ERBB4,HPSE2,ABLIM1,RORA,KALRN,MACF1,GPM6A,NAV2,PARD3,SYNE1,SLC1A2,RFX4,NEBL,PRKCA,RYR3,NTRK3,FMN2,DGKG,NKAIN3,SFXN5,GLIS3,NRG3 |
1.795e-04 | -8.63 | LHB (luteinizing hormone subunit beta) | protein interactions | 3972 | 8 | 2 | 19454 | 50 |
NTM,GFAP |
1.843e-04 | -8.60 | lung-left_upper_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-left_upper_lobe-carcinoma-adenocarcinoma | 556 | 8 | 16828 | 49 |
ERBB4,SYNE1,SLC4A4,CTNND2,LRP1B,ADCY2,NTRK2,RYR3 |
1.870e-04 | -8.58 | membrane | cellular component | GO:0016020 | 9220 | 37 | 19108 | 50 |
CAMK2G,NTRK3,MACF1,PRKCA,RYR3,SLC14A1,FMN2,SYNE1,CTNNA2,GPC5,DTNA,HPSE2,CTNND2,CDH20,PARD3,NTM,TNC,GPM6A,ERBB4,SFXN5,SLC4A4,SLC1A2,LSAMP,GFAP,PSD2,MGAT4C,ADCY2,NTRK2,KALRN,ATP1A2,SORBS1,NRG3,DGKG,TRPM3,NKAIN3,NRXN1,LRP1B |
1.889e-04 | -8.57 | left_upper_lobe | COSMIC cancer mutations | left_upper_lobe | 558 | 8 | 16828 | 49 |
ERBB4,SLC4A4,CTNND2,SYNE1,NTRK2,RYR3,ADCY2,LRP1B |
1.891e-04 | -8.57 | skin-extremity-malignant_melanoma | COSMIC cancer mutations | skin-extremity-malignant_melanoma | 1875 | 15 | 16828 | 49 |
PITPNC1,HPSE2,NTRK2,PARD3,TNC,SYNE1,CDH20,LRP1B,NEBL,ADCY2,NTRK3,RYR3,DGKG,FMN2,ERBB4 |
1.902e-04 | -8.57 | extremity | COSMIC cancer mutations | extremity | 1876 | 15 | 16828 | 49 |
ERBB4,RYR3,NTRK3,DGKG,FMN2,ADCY2,NEBL,CDH20,LRP1B,SYNE1,TNC,PARD3,NTRK2,HPSE2,PITPNC1 |
1.943e-04 | -8.55 | anatomical structure morphogenesis | biological process | GO:0009653 | 2225 | 16 | 18204 | 50 |
CTNND2,CTNNA2,NTRK2,CDH20,NEBL,PARD3,GPM6A,ERBB4,SOX5,ABLIM1,PRKCA,NRG3,TNC,NRXN1,KALRN,RORA |
1.964e-04 | -8.54 | SH2D1A (SH2 domain containing 1A) | protein interactions | 4068 | 44 | 3 | 19454 | 50 |
ERBB4,CAMK2G,LRP1B |
1.996e-04 | -8.52 | beta-catenin binding | molecular function | GO:0008013 | 107 | 4 | 18094 | 49 |
RORA,CTNND2,CTNNA2,CDH20 |
2.037e-04 | -8.50 | cell adhesion | biological process | GO:0007155 | 942 | 10 | 18204 | 50 |
SORBS1,CDH20,PRKCA,LSAMP,CTNNA2,CTNND2,NRXN1,TNC,PARD3,NTM |
2.048e-04 | -8.49 | ERBB4 signaling pathway | biological process | GO:0038130 | 8 | 2 | 18204 | 50 |
NRG3,ERBB4 |
2.226e-04 | -8.41 | g-Secretase Mediated ErbB4 Signalling Pathway | SMPDB pathways | SMP0089975 | 7 | 2 | 1369 | 5 |
PRKCA,ERBB4 |
2.254e-04 | -8.40 | Gastrin-CREB signalling pathway via PKC and MAPK | REACTOME pathways | R-HSA-881907 | 443 | 7 | 10285 | 30 |
RPS6KA2,KALRN,ERBB4,NRG3,CAMK2G,PRKCA,DGKG |
2.265e-04 | -8.39 | ErbB signaling pathway | KEGG pathways | ko04012 | 85 | 4 | 7161 | 26 |
PRKCA,CAMK2G,ERBB4,NRG3 |
2.265e-04 | -8.39 | Insulin secretion | KEGG pathways | hsa04911 | 85 | 4 | 7161 | 26 |
PRKCA,CAMK2G,ATP1A2,ADCY2 |
2.265e-04 | -8.39 | ErbB signaling pathway | KEGG pathways | hsa04012 | 85 | 4 | 7161 | 26 |
NRG3,ERBB4,CAMK2G,PRKCA |
2.302e-04 | -8.38 | chromophobe_renal_cell_carcinoma | COSMIC cancer mutations | chromophobe_renal_cell_carcinoma | 430 | 7 | 16828 | 49 |
RPS6KA2,NTRK2,DCLK2,CAMK2G,PRKCA,NTRK3,ERBB4 |
2.302e-04 | -8.38 | kidney-carcinoma-chromophobe_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-chromophobe_renal_cell_carcinoma | 430 | 7 | 16828 | 49 |
DCLK2,NTRK2,RPS6KA2,CAMK2G,PRKCA,NTRK3,ERBB4 |
2.304e-04 | -8.38 | NEGR1 (neuronal growth regulator 1) | protein interactions | 257194 | 9 | 2 | 19454 | 50 |
LSAMP,NTM |
2.304e-04 | -8.38 | LSAMP (limbic system associated membrane protein) | protein interactions | 4045 | 9 | 2 | 19454 | 50 |
NTM,LSAMP |
2.305e-04 | -8.38 | testis | COSMIC cancer mutations | testis | 733 | 9 | 16828 | 49 |
ERBB4,SYNE1,RPS6KA2,NTRK2,CAMK2G,MACF1,DCLK2,NTRK3,PRKCA |
2.323e-04 | -8.37 | GFAP (glial fibrillary acidic protein) | protein interactions | 2670 | 217 | 5 | 19454 | 50 |
NKAIN3,RORA,ABLIM1,PRKCA,GFAP |
2.353e-04 | -8.35 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia | 10418 | 42 | 16828 | 49 |
LSAMP,SLC4A4,NPAS3,NRXN1,ERBB4,ADCY2,LRP1B,GPC5,CDH20,TNC,ATP1A2,CTNND2,PSD2,SOX5,NTRK2,CAMK2G,NKAIN3,GFAP,GLIS3,TRPM3,SFXN5,NRG3,NEBL,RFX4,NTRK3,RYR3,NTM,PRKCA,DGKG,FMN2,RPS6KA2,PARD3,SLC14A1,MSI2,SYNE1,SLC1A2,HPSE2,ABLIM1,RORA,KALRN,NAV2,MACF1 |
2.353e-04 | -8.35 | acute_myeloid_leukaemia | COSMIC cancer mutations | acute_myeloid_leukaemia | 10418 | 42 | 16828 | 49 |
MSI2,PARD3,SLC14A1,SLC1A2,SYNE1,ABLIM1,HPSE2,MACF1,NAV2,RORA,KALRN,NKAIN3,NRG3,TRPM3,SFXN5,GFAP,GLIS3,RFX4,NEBL,RPS6KA2,DGKG,FMN2,NTM,PRKCA,RYR3,NTRK3,ATP1A2,TNC,PSD2,CTNND2,CAMK2G,NTRK2,SOX5,LSAMP,ERBB4,NRXN1,SLC4A4,NPAS3,CDH20,GPC5,LRP1B,ADCY2 |
2.443e-04 | -8.32 | central_nervous_system-cerebellum-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-cerebellum-glioma-astrocytoma_Grade_I | 105 | 4 | 16828 | 49 |
LRP1B,GPC5,PARD3,NRG3 |
2.501e-04 | -8.29 | postsynapse | cellular component | GO:0098794 | 646 | 8 | 19108 | 50 |
CTNND2,ATP1A2,ERBB4,SYNE1,GPM6A,NTRK2,KALRN,PSD2 |
2.555e-04 | -8.27 | Signaling by ERBB4 | REACTOME pathways | R-HSA-1236394 | 43 | 3 | 10285 | 30 |
GFAP,NRG3,ERBB4 |
2.584e-04 | -8.26 | actin filament binding | molecular function | GO:0051015 | 211 | 5 | 18094 | 49 |
ABLIM1,SYNE1,NEBL,CTNNA2,MACF1 |
2.601e-04 | -8.25 | acral_lentiginous | COSMIC cancer mutations | acral_lentiginous | 745 | 9 | 16828 | 49 |
LRP1B,CDH20,MACF1,KALRN,TNC,PARD3,NRG3,ERBB4,SYNE1 |
2.608e-04 | -8.25 | axon | cellular component | GO:0030424 | 650 | 8 | 19108 | 50 |
PARD3,NTRK3,NTRK2,DTNA,CTNNA2,SLC1A2,NDRG2,GPM6A |
2.823e-04 | -8.17 | Salivary secretion | KEGG pathways | hsa04970 | 90 | 4 | 7161 | 26 |
RYR3,PRKCA,ATP1A2,ADCY2 |
2.823e-04 | -8.17 | Salivary secretion | KEGG pathways | ko04970 | 90 | 4 | 7161 | 26 |
PRKCA,RYR3,ADCY2,ATP1A2 |
2.889e-04 | -8.15 | synapse organization | biological process | GO:0050808 | 333 | 6 | 18204 | 50 |
CTNND2,GPM6A,NRG3,NRXN1,TNC,ERBB4 |
2.926e-04 | -8.14 | Non-integrin membrane-ECM interactions | REACTOME pathways | R-HSA-3000171 | 45 | 3 | 10285 | 30 |
PRKCA,NRXN1,TNC |
2.977e-04 | -8.12 | ovary-carcinoma | COSMIC cancer mutations | ovary-carcinoma | 933 | 10 | 16828 | 49 |
ATP1A2,SYNE1,ERBB4,PRKCA,NTRK3,MACF1,DCLK2,CAMK2G,RPS6KA2,NTRK2 |
2.978e-04 | -8.12 | VANGL1 (VANGL planar cell polarity protein 1) | protein interactions | 81839 | 229 | 5 | 19454 | 50 |
NTRK2,PARD3,NTRK3,RPS6KA2,ERBB4 |
3.069e-04 | -8.09 | synapse assembly | biological process | GO:0007416 | 118 | 4 | 18204 | 50 |
NRXN1,ERBB4,GPM6A,NRG3 |
3.104e-04 | -8.08 | breast-carcinoma-lobular_carcinoma | COSMIC cancer mutations | breast-carcinoma-lobular_carcinoma | 763 | 9 | 16828 | 49 |
DCLK2,RPS6KA2,CAMK2G,NTRK2,PRKCA,NTRK3,LRP1B,CDH20,ERBB4 |
3.104e-04 | -8.08 | lobular_carcinoma | COSMIC cancer mutations | lobular_carcinoma | 763 | 9 | 16828 | 49 |
ERBB4,DCLK2,CAMK2G,NTRK2,RPS6KA2,NTRK3,PRKCA,CDH20,LRP1B |
3.162e-04 | -8.06 | EPB41L4A (erythrocyte membrane protein band 4.1 like 4A) | protein interactions | 64097 | 127 | 4 | 19454 | 50 |
PARD3,MACF1,DTNA,ABLIM1 |
3.188e-04 | -8.05 | neurotrophin binding | molecular function | GO:0043121 | 10 | 2 | 18094 | 49 |
NTRK2,NTRK3 |
3.212e-04 | -8.04 | acute_lymphoblastic_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_leukaemia | 2197 | 16 | 16828 | 49 |
GFAP,SLC4A4,ERBB4,ADCY2,LRP1B,DTNA,NTRK3,PRKCA,RPS6KA2,ATP1A2,SYNE1,SOX5,KALRN,DCLK2,NTRK2,CAMK2G |
3.231e-04 | -8.04 | SH2B2 (SH2B adaptor protein 2) | protein interactions | 10603 | 52 | 3 | 19454 | 50 |
SORBS1,ERBB4,NTRK2 |
3.267e-04 | -8.03 | YES1 (YES proto-oncogene 1, Src family tyrosine kinase) | protein interactions | 7525 | 364 | 6 | 19454 | 50 |
GFAP,CAMK2G,ERBB4,RPS6KA2,SLC14A1,MSI2 |
3.281e-04 | -8.02 | neuronal action potential propagation | biological process | GO:0019227 | 10 | 2 | 18204 | 50 |
ATP1A2,NTRK2 |
3.281e-04 | -8.02 | action potential propagation | biological process | GO:0098870 | 10 | 2 | 18204 | 50 |
ATP1A2,NTRK2 |
3.289e-04 | -8.02 | ovary-carcinoma-mucinous_carcinoma | COSMIC cancer mutations | ovary-carcinoma-mucinous_carcinoma | 456 | 7 | 16828 | 49 |
ERBB4,DCLK2,NTRK2,RPS6KA2,CAMK2G,PRKCA,NTRK3 |
3.377e-04 | -7.99 | mucinous_carcinoma | COSMIC cancer mutations | mucinous_carcinoma | 458 | 7 | 16828 | 49 |
ERBB4,PRKCA,NTRK3,RPS6KA2,NTRK2,CAMK2G,DCLK2 |
3.468e-04 | -7.97 | stomach-carcinoma-mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | COSMIC cancer mutations | stomach-carcinoma-mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | 951 | 10 | 16828 | 49 |
TNC,PARD3,SLC1A2,TRPM3,SYNE1,GPC5,LRP1B,FMN2,MACF1,NTRK3 |
3.468e-04 | -7.97 | mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | COSMIC cancer mutations | mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | 951 | 10 | 16828 | 49 |
FMN2,MACF1,NTRK3,LRP1B,GPC5,SLC1A2,SYNE1,TRPM3,PARD3,TNC |
3.474e-04 | -7.96 | Pancreatic secretion | KEGG pathways | hsa04972 | 95 | 4 | 7161 | 26 |
ADCY2,ATP1A2,PRKCA,SLC4A4 |
3.474e-04 | -7.96 | Pancreatic secretion | KEGG pathways | ko04972 | 95 | 4 | 7161 | 26 |
ADCY2,ATP1A2,PRKCA,SLC4A4 |
3.508e-04 | -7.96 | ADCY5 (adenylate cyclase 5) | protein interactions | 111 | 11 | 2 | 19454 | 50 |
PRKCA,ADCY2 |
3.613e-04 | -7.93 | SYNM (synemin) | protein interactions | 23336 | 54 | 3 | 19454 | 50 |
DTNA,ERBB4,GFAP |
3.617e-04 | -7.92 | Circadian entrainment | KEGG pathways | hsa04713 | 96 | 4 | 7161 | 26 |
PRKCA,CAMK2G,RYR3,ADCY2 |
3.617e-04 | -7.92 | Circadian entrainment | KEGG pathways | ko04713 | 96 | 4 | 7161 | 26 |
RYR3,PRKCA,CAMK2G,ADCY2 |
3.636e-04 | -7.92 | interstitial matrix | cellular component | GO:0005614 | 11 | 2 | 19108 | 50 |
TNC,NAV2 |
3.648e-04 | -7.92 | PI3K events in ERBB4 signaling | REACTOME pathways | R-HSA-1250342 | 10 | 2 | 10285 | 30 |
ERBB4,NRG3 |
3.653e-04 | -7.91 | ovary-carcinoma-endometrioid_carcinoma | COSMIC cancer mutations | ovary-carcinoma-endometrioid_carcinoma | 464 | 7 | 16828 | 49 |
ERBB4,DCLK2,NTRK2,RPS6KA2,CAMK2G,PRKCA,NTRK3 |
3.700e-04 | -7.90 | Transmission across Chemical Synapses | REACTOME pathways | R-HSA-112315 | 217 | 5 | 10285 | 30 |
SLC1A2,CAMK2G,ADCY2,PRKCA,RPS6KA2 |
3.766e-04 | -7.88 | soft_tissue | COSMIC cancer mutations | soft_tissue | 5828 | 29 | 16828 | 49 |
LSAMP,ERBB4,NPAS3,ADCY2,LRP1B,CDH20,GPC5,TNC,CTNND2,NTRK2,CAMK2G,SOX5,NKAIN3,NRG3,GLIS3,TRPM3,NEBL,FMN2,RYR3,NTRK3,PARD3,SORBS1,SLC1A2,SYNE1,HPSE2,NAV2,GPM6A,MACF1,RORA |
3.847e-04 | -7.86 | actin cytoskeleton | cellular component | GO:0015629 | 520 | 7 | 19108 | 50 |
MACF1,KALRN,FMN2,ABLIM1,CTNNA2,NEBL,SORBS1 |
3.868e-04 | -7.86 | Tyr_kinase_rcpt_2_CS | interpro domains | IPR002011 | 11 | 2 | 18521 | 50 |
NTRK3,NTRK2 |
4.170e-04 | -7.78 | Calcium signaling pathway | KEGG pathways | hsa04020 | 181 | 5 | 7161 | 26 |
ADCY2,ERBB4,RYR3,CAMK2G,PRKCA |
4.170e-04 | -7.78 | Calcium signaling pathway | KEGG pathways | ko04020 | 181 | 5 | 7161 | 26 |
ERBB4,ADCY2,CAMK2G,PRKCA,RYR3 |
4.216e-04 | -7.77 | ATP binding | molecular function | GO:0005524 | 1467 | 12 | 18094 | 49 |
ADCY2,ERBB4,PRKCA,KALRN,DCLK2,DGKG,RPS6KA2,NTRK2,NTRK3,CAMK2G,ATP1A2,NAV2 |
4.244e-04 | -7.76 | Signaling by ERBB2 | REACTOME pathways | R-HSA-1227986 | 51 | 3 | 10285 | 30 |
NRG3,ERBB4,PRKCA |
4.352e-04 | -7.74 | Neuronal System | REACTOME pathways | R-HSA-112316 | 349 | 6 | 10285 | 30 |
CAMK2G,SLC1A2,NRXN1,ADCY2,PRKCA,RPS6KA2 |
4.698e-04 | -7.66 | amino acid transport | biological process | GO:0006865 | 132 | 4 | 18204 | 50 |
GFAP,SFXN5,SLC1A2,NTRK2 |
4.781e-04 | -7.65 | stomach-adenocarcinoma | COSMIC cancer mutations | stomach-adenocarcinoma | 4101 | 23 | 16828 | 49 |
TNC,PARD3,ATP1A2,CTNND2,SYNE1,PSD2,SLC1A2,MGAT4C,ABLIM1,KALRN,RORA,NAV2,MACF1,SLC4A4,NRG3,ERBB4,NEBL,RFX4,GPC5,LRP1B,CDH20,PRKCA,FMN2 |
5.164e-04 | -7.57 | testis-germ_cell_tumour-seminoma | COSMIC cancer mutations | testis-germ_cell_tumour-seminoma | 648 | 8 | 16828 | 49 |
SYNE1,ERBB4,NTRK3,PRKCA,DCLK2,CAMK2G,NTRK2,RPS6KA2 |
5.231e-04 | -7.56 | large_intestine-caecum-adenoma | COSMIC cancer mutations | large_intestine-caecum-adenoma | 229 | 5 | 16828 | 49 |
KALRN,CTNND2,ERBB4,HPSE2,LRP1B |
5.245e-04 | -7.55 | signaling | biological process | GO:0023052 | 4968 | 25 | 18204 | 50 |
RPS6KA2,PRKCA,DCLK2,ATP1A2,FMN2,NRG3,NRXN1,RORA,CTNND2,ADCY2,PITPNC1,NTRK3,DTNA,PARD3,MACF1,RYR3,SORBS1,NDRG2,KALRN,TNC,SLC1A2,NTRK2,DGKG,CAMK2G,ERBB4 |
5.403e-04 | -7.52 | Transmembrane transport of small molecules | REACTOME pathways | R-HSA-382551 | 677 | 8 | 10285 | 30 |
CAMK2G,SLC1A2,ADCY2,TRPM3,ATP1A2,SLC4A4,SLC14A1,RYR3 |
5.522e-04 | -7.50 | neuron projection development | biological process | GO:0031175 | 693 | 8 | 18204 | 50 |
GPM6A,PARD3,NRXN1,KALRN,GFAP,TNC,CTNNA2,CTNND2 |
5.545e-04 | -7.50 | breast-carcinoma-ductolobular_carcinoma | COSMIC cancer mutations | breast-carcinoma-ductolobular_carcinoma | 1619 | 13 | 16828 | 49 |
CDH20,DTNA,NDRG2,FMN2,DGKG,NTRK3,ABLIM1,MACF1,KALRN,RORA,SORBS1,SYNE1,CTNND2 |
5.545e-04 | -7.50 | ductolobular_carcinoma | COSMIC cancer mutations | ductolobular_carcinoma | 1619 | 13 | 16828 | 49 |
NDRG2,CDH20,DTNA,NTRK3,DGKG,FMN2,SYNE1,CTNND2,SORBS1,ABLIM1,RORA,KALRN,MACF1 |
5.566e-04 | -7.49 | ovary-carcinoma-serous_carcinoma | COSMIC cancer mutations | ovary-carcinoma-serous_carcinoma | 10710 | 42 | 16828 | 49 |
HPSE2,MGAT4C,KALRN,RORA,NAV2,DCLK2,MACF1,PARD3,MSI2,SYNE1,SORBS1,SLC1A2,NEBL,DTNA,RYR3,NTRK3,NTM,PRKCA,FMN2,DGKG,RPS6KA2,GLIS3,GFAP,SFXN5,TRPM3,NRG3,SOX5,NTRK2,CAMK2G,TNC,ATP1A2,CTNND2,PSD2,ADCY2,GPC5,CDH20,LRP1B,LSAMP,SLC4A4,NPAS3,NRXN1,ERBB4 |
5.593e-04 | -7.49 | Ion homeostasis | REACTOME pathways | R-HSA-5578775 | 56 | 3 | 10285 | 30 |
CAMK2G,ATP1A2,RYR3 |
5.739e-04 | -7.46 | cell body | cellular component | GO:0044297 | 556 | 7 | 19108 | 50 |
PSD2,GPM6A,ATP1A2,SLC1A2,CTNND2,NRXN1,GFAP |
5.776e-04 | -7.46 | CHAT (choline O-acetyltransferase) | protein interactions | 1103 | 14 | 2 | 19454 | 50 |
CAMK2G,PRKCA |
5.849e-04 | -7.44 | lung-carcinoid-endocrine_tumour | COSMIC cancer mutations | lung-carcinoid-endocrine_tumour | 502 | 7 | 16828 | 49 |
ERBB4,RPS6KA2,CAMK2G,NTRK2,DCLK2,PRKCA,NTRK3 |
5.959e-04 | -7.43 | RECEPTOR_TYR_KIN_II | prosite domains | PS00239 | 11 | 2 | 12186 | 41 |
NTRK2,NTRK3 |
6.017e-04 | -7.42 | cell communication | biological process | GO:0007154 | 5010 | 25 | 18204 | 50 |
MACF1,RYR3,SORBS1,NDRG2,KALRN,TNC,NTRK2,SLC1A2,DGKG,CAMK2G,ERBB4,RPS6KA2,PRKCA,DCLK2,ATP1A2,FMN2,NRG3,NRXN1,RORA,CTNND2,ADCY2,PITPNC1,NTRK3,PARD3,DTNA |
6.096e-04 | -7.40 | adenyl ribonucleotide binding | molecular function | GO:0032559 | 1528 | 12 | 18094 | 49 |
KALRN,PRKCA,ERBB4,ADCY2,NAV2,ATP1A2,CAMK2G,NTRK2,NTRK3,RPS6KA2,DGKG,DCLK2 |
6.144e-04 | -7.39 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm | 7307 | 33 | 16828 | 49 |
NKAIN3,GLIS3,SFXN5,NRG3,NEBL,RFX4,RYR3,NTRK3,PRKCA,DGKG,FMN2,PARD3,SYNE1,SLC1A2,HPSE2,MGAT4C,ABLIM1,RORA,KALRN,GPM6A,NAV2,MACF1,LSAMP,ERBB4,ADCY2,GPC5,LRP1B,CDH20,TNC,CTNND2,PSD2,SOX5,NTRK2 |
6.239e-04 | -7.38 | nasopharyngeal_carcinoma | COSMIC cancer mutations | nasopharyngeal_carcinoma | 1425 | 12 | 16828 | 49 |
RFX4,PRKCA,RPS6KA2,FMN2,SFXN5,SLC4A4,PITPNC1,NTRK2,ATP1A2,SYNE1,CTNND2,SLC1A2 |
6.239e-04 | -7.38 | upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma | 1425 | 12 | 16828 | 49 |
CTNND2,SYNE1,SLC1A2,ATP1A2,NTRK2,PITPNC1,SLC4A4,SFXN5,PRKCA,FMN2,RPS6KA2,RFX4 |
6.257e-04 | -7.38 | transferase activity, transferring phosphorus-containing groups | molecular function | GO:0016772 | 903 | 9 | 18094 | 49 |
ERBB4,PRKCA,KALRN,NTRK3,NTRK2,RPS6KA2,CAMK2G,DCLK2,DGKG |
6.276e-04 | -7.37 | lung-carcinoid-endocrine_tumour-atypical | COSMIC cancer mutations | lung-carcinoid-endocrine_tumour-atypical | 508 | 7 | 16828 | 49 |
ERBB4,CAMK2G,RPS6KA2,NTRK2,DCLK2,NTRK3,PRKCA |
6.289e-04 | -7.37 | ERBB2 Activates PTK6 Signaling | REACTOME pathways | R-HSA-8847993 | 13 | 2 | 10285 | 30 |
ERBB4,NRG3 |
6.309e-04 | -7.37 | transmembrane receptor protein tyrosine kinase activity | molecular function | GO:0004714 | 62 | 3 | 18094 | 49 |
ERBB4,NTRK3,NTRK2 |
6.588e-04 | -7.33 | sodium ion export across plasma membrane | biological process | GO:0036376 | 14 | 2 | 18204 | 50 |
SLC4A4,ATP1A2 |
6.635e-04 | -7.32 | FLOT2 (flotillin 2) | protein interactions | 2319 | 273 | 5 | 19454 | 50 |
RPS6KA2,SLC14A1,SOX5,PARD3,NTRK2 |
6.805e-04 | -7.29 | atypical | COSMIC cancer mutations | atypical | 515 | 7 | 16828 | 49 |
ERBB4,NTRK3,PRKCA,NTRK2,CAMK2G,RPS6KA2,DCLK2 |
6.853e-04 | -7.29 | hairy_cell_leukaemia | COSMIC cancer mutations | hairy_cell_leukaemia | 1440 | 12 | 16828 | 49 |
NRXN1,RFX4,LRP1B,CDH20,NEBL,RYR3,NTRK3,FMN2,SYNE1,CTNND2,MACF1,NAV2 |
6.853e-04 | -7.29 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-hairy_cell_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-hairy_cell_leukaemia | 1440 | 12 | 16828 | 49 |
CTNND2,SYNE1,NAV2,MACF1,NRXN1,NTRK3,RYR3,FMN2,NEBL,LRP1B,CDH20,RFX4 |
6.938e-04 | -7.27 | endometrium-carcinoma-serous_carcinoma | COSMIC cancer mutations | endometrium-carcinoma-serous_carcinoma | 1442 | 12 | 16828 | 49 |
LSAMP,SLC4A4,NRXN1,TRPM3,GPC5,LRP1B,FMN2,RYR3,PARD3,SORBS1,CTNND2,SYNE1 |
7.080e-04 | -7.25 | astrocytoma_Grade_I | COSMIC cancer mutations | astrocytoma_Grade_I | 139 | 4 | 16828 | 49 |
LRP1B,GPC5,PARD3,NRG3 |
7.324e-04 | -7.22 | SHC1 events in ERBB4 signaling | REACTOME pathways | R-HSA-1250347 | 14 | 2 | 10285 | 30 |
NRG3,ERBB4 |
7.385e-04 | -7.21 | DTNBP1 (dystrobrevin binding protein 1) | protein interactions | 84062 | 159 | 4 | 19454 | 50 |
KALRN,MACF1,SYNE1,DTNA |
7.640e-04 | -7.18 | central_nervous_system-brain-glioma-oligodendroglioma_Grade_III | COSMIC cancer mutations | central_nervous_system-brain-glioma-oligodendroglioma_Grade_III | 249 | 5 | 16828 | 49 |
MGAT4C,GLIS3,SYNE1,NAV2,MACF1 |
7.849e-04 | -7.15 | germ_cell_tumour | COSMIC cancer mutations | germ_cell_tumour | 867 | 9 | 16828 | 49 |
NTRK2,CAMK2G,MACF1,RPS6KA2,DCLK2,NTRK3,PRKCA,ERBB4,SYNE1 |
7.919e-04 | -7.14 | DSCAM (DS cell adhesion molecule) | protein interactions | 1826 | 162 | 4 | 19454 | 50 |
SYNE1,GFAP,MACF1,KALRN |
8.014e-04 | -7.13 | Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | REACTOME pathways | R-HSA-112314 | 146 | 4 | 10285 | 30 |
PRKCA,ADCY2,CAMK2G,RPS6KA2 |
8.081e-04 | -7.12 | skin-subungual-malignant_melanoma-acral_lentiginous | COSMIC cancer mutations | skin-subungual-malignant_melanoma-acral_lentiginous | 144 | 4 | 16828 | 49 |
MACF1,SYNE1,CDH20,LRP1B |
8.168e-04 | -7.11 | Neurotrophin signaling pathway | KEGG pathways | hsa04722 | 119 | 4 | 7161 | 26 |
NTRK3,CAMK2G,NTRK2,RPS6KA2 |
8.168e-04 | -7.11 | Neurotrophin signaling pathway | KEGG pathways | ko04722 | 119 | 4 | 7161 | 26 |
NTRK3,CAMK2G,RPS6KA2,NTRK2 |
8.177e-04 | -7.11 | salivary_gland-carcinoma | COSMIC cancer mutations | salivary_gland-carcinoma | 383 | 6 | 16828 | 49 |
NTRK3,PRKCA,RPS6KA2,ERBB4,NTRK2,CAMK2G |
8.177e-04 | -7.11 | upper_aerodigestive_tract-mouth-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma-adenoid_cystic_carcinoma | 383 | 6 | 16828 | 49 |
NTRK3,PRKCA,RPS6KA2,ERBB4,CAMK2G,NTRK2 |
8.177e-04 | -7.11 | upper_aerodigestive_tract-carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-carcinoma | 383 | 6 | 16828 | 49 |
NTRK3,PRKCA,CAMK2G,RPS6KA2,NTRK2,ERBB4 |
8.177e-04 | -7.11 | upper_aerodigestive_tract-lymph_node-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-lymph_node-carcinoma-adenoid_cystic_carcinoma | 383 | 6 | 16828 | 49 |
ERBB4,NTRK2,RPS6KA2,CAMK2G,PRKCA,NTRK3 |
8.177e-04 | -7.11 | upper_aerodigestive_tract-head_neck-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-head_neck-carcinoma-adenoid_cystic_carcinoma | 383 | 6 | 16828 | 49 |
ERBB4,CAMK2G,RPS6KA2,NTRK2,NTRK3,PRKCA |
8.251e-04 | -7.10 | Axon guidance | REACTOME pathways | R-HSA-422475 | 549 | 7 | 10285 | 30 |
ERBB4,RPS6KA2,KALRN,NRG3,ABLIM1,PRKCA,CAMK2G |
8.304e-04 | -7.09 | CH | pfam domains | PF00307 | 67 | 3 | 17795 | 49 |
SYNE1,NAV2,MACF1 |
8.309e-04 | -7.09 | PARD3 (par-3 family cell polarity regulator) | protein interactions | 56288 | 287 | 5 | 19454 | 50 |
DTNA,SORBS1,NTRK2,PARD3,NTRK3 |
8.435e-04 | -7.08 | ERBB2 Regulates Cell Motility | REACTOME pathways | R-HSA-6785631 | 15 | 2 | 10285 | 30 |
ERBB4,NRG3 |
8.567e-04 | -7.06 | seminoma | COSMIC cancer mutations | seminoma | 700 | 8 | 16828 | 49 |
CAMK2G,RPS6KA2,NTRK2,DCLK2,NTRK3,PRKCA,ERBB4,SYNE1 |
8.587e-04 | -7.06 | ErbB Signaling Pathway | WikiPathways | WP673 | 54 | 3 | 5310 | 19 |
ERBB4,PRKCA,NRG3 |
8.657e-04 | -7.05 | asymmetric cell division | biological process | GO:0008356 | 16 | 2 | 18204 | 50 |
SOX5,PARD3 |
8.727e-04 | -7.04 | subungual | COSMIC cancer mutations | subungual | 147 | 4 | 16828 | 49 |
MACF1,SYNE1,LRP1B,CDH20 |
8.771e-04 | -7.04 | oesophagus-carcinoma | COSMIC cancer mutations | oesophagus-carcinoma | 4269 | 23 | 16828 | 49 |
LRP1B,RFX4,CDH20,ADCY2,NTM,RYR3,NTRK3,RPS6KA2,FMN2,TRPM3,SLC4A4,NRG3,HPSE2,KALRN,SOX5,MACF1,NTRK2,GPM6A,PARD3,SYNE1,PSD2,CTNND2,SORBS1 |
8.793e-04 | -7.04 | YWHAG (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma) | protein interactions | 7532 | 1211 | 10 | 19454 | 50 |
CAMK2G,MACF1,SORBS1,PARD3,ABLIM1,PITPNC1,PRKCA,FMN2,DCLK2,NAV2 |
9.010e-04 | -7.01 | upper_aerodigestive_tract-pharynx-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-pharynx-carcinoma-squamous_cell_carcinoma | 1485 | 12 | 16828 | 49 |
SORBS1,SYNE1,SLC14A1,MACF1,NRG3,NPAS3,DGKG,FMN2,RYR3,GPC5,DTNA,LRP1B |
9.072e-04 | -7.01 | prostate | COSMIC cancer mutations | prostate | 13883 | 48 | 16828 | 49 |
HPSE2,ABLIM1,RORA,NAV2,GPM6A,MACF1,SORBS1,SLC1A2,NEBL,RFX4,NTRK3,GFAP,TRPM3,SOX5,NTRK2,TNC,CTNND2,CDH20,LSAMP,NPAS3,PITPNC1,MGAT4C,KALRN,DCLK2,SLC14A1,PARD3,MSI2,SYNE1,DTNA,RYR3,NTM,PRKCA,FMN2,DGKG,RPS6KA2,NKAIN3,GLIS3,SFXN5,NRG3,ATP1A2,PSD2,NDRG2,ADCY2,GPC5,LRP1B,SLC4A4,NRXN1,ERBB4 |
9.623e-04 | -6.95 | GRB2 events in ERBB2 signaling | REACTOME pathways | R-HSA-1963640 | 16 | 2 | 10285 | 30 |
ERBB4,NRG3 |
9.623e-04 | -6.95 | PI3K events in ERBB2 signaling | REACTOME pathways | R-HSA-1963642 | 16 | 2 | 10285 | 30 |
ERBB4,NRG3 |
9.689e-04 | -6.94 | presynaptic membrane | cellular component | GO:0042734 | 168 | 4 | 19108 | 50 |
ERBB4,GPM6A,SLC1A2,NRXN1 |
9.965e-04 | -6.91 | plasma membrane bounded cell projection organization | biological process | GO:0120036 | 1152 | 10 | 18204 | 50 |
TNC,NRXN1,GFAP,KALRN,PARD3,GPM6A,ABLIM1,CTNND2,RFX4,CTNNA2 |
1.008e-03 | -6.90 | CDC37 (cell division cycle 37, HSP90 cochaperone) | protein interactions | 11140 | 623 | 7 | 19454 | 50 |
RPS6KA2,PRKCA,GFAP,CAMK2G,NTRK3,NTRK2,DCLK2 |
1.022e-03 | -6.89 | ADGRL2 (adhesion G protein-coupled receptor L2) | protein interactions | 23266 | 77 | 3 | 19454 | 50 |
NTRK2,PARD3,RPS6KA2 |
1.025e-03 | -6.88 | adenyl nucleotide binding | molecular function | GO:0030554 | 1620 | 12 | 18094 | 49 |
ATP1A2,NAV2,DGKG,DCLK2,CAMK2G,RPS6KA2,NTRK3,NTRK2,PRKCA,KALRN,ERBB4,ADCY2 |
1.049e-03 | -6.86 | animal organ development | biological process | GO:0048513 | 2846 | 17 | 18204 | 50 |
SLC1A2,NTRK2,SYNE1,CTNNA2,SOX5,ERBB4,NTRK3,GPM6A,NEBL,ABLIM1,NDRG2,RFX4,RORA,TNC,DCLK2,ATP1A2,NRG3 |
1.055e-03 | -6.85 | SLC4A7 (solute carrier family 4 member 7) | protein interactions | 9497 | 175 | 4 | 19454 | 50 |
NTRK3,SLC4A4,NTRK2,RPS6KA2 |
1.057e-03 | -6.85 | dendritic spine | cellular component | GO:0043197 | 172 | 4 | 19108 | 50 |
SYNE1,GPM6A,ATP1A2,NTRK2 |
1.077e-03 | -6.83 | RRAD (RRAD, Ras related glycolysis inhibitor and calcium channel regulator) | protein interactions | 6236 | 19 | 2 | 19454 | 50 |
PRKCA,CAMK2G |
1.080e-03 | -6.83 | cell surface receptor protein tyrosine kinase signaling pathway | biological process | GO:0007169 | 428 | 6 | 18204 | 50 |
NTRK3,NRG3,SORBS1,KALRN,NTRK2,ERBB4 |
1.088e-03 | -6.82 | dendrite | cellular component | GO:0030425 | 620 | 7 | 19108 | 50 |
PSD2,ADCY2,NTRK2,GPM6A,SYNE1,ATP1A2,CTNND2 |
1.104e-03 | -6.81 | neuron spine | cellular component | GO:0044309 | 174 | 4 | 19108 | 50 |
ATP1A2,GPM6A,SYNE1,NTRK2 |
1.108e-03 | -6.80 | dendritic tree | cellular component | GO:0097447 | 622 | 7 | 19108 | 50 |
CTNND2,NTRK2,ADCY2,ATP1A2,GPM6A,SYNE1,PSD2 |
1.115e-03 | -6.80 | astrocyte projection | cellular component | GO:0097449 | 19 | 2 | 19108 | 50 |
SLC1A2,GFAP |
1.124e-03 | -6.79 | ERBB4 (erb-b2 receptor tyrosine kinase 4) | protein interactions | 2066 | 178 | 4 | 19454 | 50 |
NTRK2,KALRN,ERBB4,NRG3 |
1.127e-03 | -6.79 | extrinsic component of membrane | cellular component | GO:0019898 | 175 | 4 | 19108 | 50 |
KALRN,CDH20,CTNNA2,DTNA |
1.155e-03 | -6.76 | AFDN (afadin, adherens junction formation factor) | protein interactions | 4301 | 309 | 5 | 19454 | 50 |
MACF1,SORBS1,DTNA,PARD3,NRXN1 |
1.172e-03 | -6.75 | C11orf52 (chromosome 11 open reading frame 52) | protein interactions | 91894 | 310 | 5 | 19454 | 50 |
FMN2,PARD3,ABLIM1,DTNA,MACF1 |
1.181e-03 | -6.74 | metal ion transmembrane transporter activity | molecular function | GO:0046873 | 442 | 6 | 18094 | 49 |
TRPM3,GPM6A,SLC4A4,RYR3,ATP1A2,SLC1A2 |
1.194e-03 | -6.73 | PDZD2 (PDZ domain containing 2) | protein interactions | 23037 | 20 | 2 | 19454 | 50 |
CTNND2,NRXN1 |
1.194e-03 | -6.73 | DOK5 (docking protein 5) | protein interactions | 55816 | 20 | 2 | 19454 | 50 |
NTRK2,NTRK3 |
1.209e-03 | -6.72 | serous_carcinoma | COSMIC cancer mutations | serous_carcinoma | 10987 | 42 | 16828 | 49 |
HPSE2,MGAT4C,KALRN,RORA,DCLK2,MACF1,NAV2,PARD3,MSI2,SYNE1,SLC1A2,SORBS1,DTNA,NEBL,NTM,PRKCA,NTRK3,RYR3,RPS6KA2,DGKG,FMN2,TRPM3,SFXN5,GLIS3,GFAP,NRG3,SOX5,CAMK2G,NTRK2,ATP1A2,TNC,PSD2,CTNND2,GPC5,LRP1B,CDH20,ADCY2,LSAMP,NRXN1,SLC4A4,NPAS3,ERBB4 |
1.222e-03 | -6.71 | KIF20A (kinesin family member 20A) | protein interactions | 10112 | 1044 | 9 | 19454 | 50 |
MACF1,PARD3,GFAP,NEBL,ABLIM1,SYNE1,RORA,NAV2,MSI2 |
1.227e-03 | -6.70 | regulation of neurotransmitter uptake | biological process | GO:0051580 | 19 | 2 | 18204 | 50 |
ATP1A2,GFAP |
1.250e-03 | -6.68 | central_nervous_system-brain-glioma-oligodendroglioma_Grade_II | COSMIC cancer mutations | central_nervous_system-brain-glioma-oligodendroglioma_Grade_II | 73 | 3 | 16828 | 49 |
NAV2,MACF1,SYNE1 |
1.261e-03 | -6.68 | regulation of ERK1 and ERK2 cascade | biological process | GO:0070372 | 295 | 5 | 18204 | 50 |
NTRK3,PRKCA,ERBB4,NDRG2,NTRK2 |
1.283e-03 | -6.66 | dicarboxylic acid transport | biological process | GO:0006835 | 78 | 3 | 18204 | 50 |
SLC1A2,NTRK2,GFAP |
1.300e-03 | -6.65 | bone-femur-chondrosarcoma | COSMIC cancer mutations | bone-femur-chondrosarcoma | 419 | 6 | 16828 | 49 |
LRP1B,ADCY2,HPSE2,NAV2,PSD2,SLC4A4 |
1.301e-03 | -6.64 | oligodendroglioma_Grade_II | COSMIC cancer mutations | oligodendroglioma_Grade_II | 74 | 3 | 16828 | 49 |
SYNE1,NAV2,MACF1 |
1.314e-03 | -6.63 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 748 | 8 | 16828 | 49 |
NEBL,LRP1B,DTNA,NTRK2,SOX5,PARD3,CTNND2,SYNE1 |
1.314e-03 | -6.63 | Tyr_kinase_cat_dom | interpro domains | IPR020635 | 80 | 3 | 18521 | 50 |
NTRK3,NTRK2,ERBB4 |
1.318e-03 | -6.63 | SHC4 (SHC adaptor protein 4) | protein interactions | 399694 | 21 | 2 | 19454 | 50 |
ERBB4,NTRK2 |
1.318e-03 | -6.63 | TENM1 (teneurin transmembrane protein 1) | protein interactions | 10178 | 21 | 2 | 19454 | 50 |
MACF1,SORBS1 |
1.359e-03 | -6.60 | cell projection organization | biological process | GO:0030030 | 1200 | 10 | 18204 | 50 |
CTNNA2,RFX4,CTNND2,ABLIM1,GPM6A,PARD3,KALRN,GFAP,NRXN1,TNC |
1.361e-03 | -6.60 | aspartate transmembrane transport | biological process | GO:0015810 | 20 | 2 | 18204 | 50 |
GFAP,SLC1A2 |
1.362e-03 | -6.60 | CH_dom | interpro domains | IPR001715 | 81 | 3 | 18521 | 50 |
SYNE1,MACF1,NAV2 |
1.373e-03 | -6.59 | transmembrane receptor protein kinase activity | molecular function | GO:0019199 | 81 | 3 | 18094 | 49 |
ERBB4,NTRK3,NTRK2 |
1.379e-03 | -6.59 | adrenal_cortical_carcinoma | COSMIC cancer mutations | adrenal_cortical_carcinoma | 2256 | 15 | 16828 | 49 |
TRPM3,NRG3,LRP1B,RFX4,NTRK3,FMN2,DGKG,ATP1A2,TNC,SYNE1,CTNND2,SLC1A2,HPSE2,SOX5,NTRK2 |
1.407e-03 | -6.57 | FAM171A1 (family with sequence similarity 171 member A1) | protein interactions | 221061 | 86 | 3 | 19454 | 50 |
NTRK2,PARD3,NTRK3 |
1.411e-03 | -6.56 | CH_dom_sf | interpro domains | IPR036872 | 82 | 3 | 18521 | 50 |
SYNE1,MACF1,NAV2 |
1.414e-03 | -6.56 | Ser/Thr_kinase_AS | interpro domains | IPR008271 | 308 | 5 | 18521 | 50 |
CAMK2G,KALRN,DCLK2,PRKCA,RPS6KA2 |
1.427e-03 | -6.55 | somatodendritic compartment | cellular component | GO:0036477 | 842 | 8 | 19108 | 50 |
PSD2,ADCY2,NTRK2,GPM6A,SYNE1,ATP1A2,CTNND2,NRXN1 |
1.455e-03 | -6.53 | PLCG2 (phospholipase C gamma 2) | protein interactions | 5336 | 87 | 3 | 19454 | 50 |
ERBB4,PRKCA,NTRK3 |
1.481e-03 | -6.52 | stress fiber | cellular component | GO:0001725 | 86 | 3 | 19108 | 50 |
ABLIM1,NEBL,SORBS1 |
1.481e-03 | -6.52 | contractile actin filament bundle | cellular component | GO:0097517 | 86 | 3 | 19108 | 50 |
SORBS1,NEBL,ABLIM1 |
1.506e-03 | -6.50 | thyroid-carcinoma-medullary_carcinoma | COSMIC cancer mutations | thyroid-carcinoma-medullary_carcinoma | 290 | 5 | 16828 | 49 |
SLC1A2,NRG3,GFAP,NTRK3,KALRN |
1.506e-03 | -6.50 | medullary_carcinoma | COSMIC cancer mutations | medullary_carcinoma | 290 | 5 | 16828 | 49 |
SLC1A2,NRG3,KALRN,GFAP,NTRK3 |
1.513e-03 | -6.49 | Syndecan interactions | REACTOME pathways | R-HSA-3000170 | 20 | 2 | 10285 | 30 |
TNC,PRKCA |
1.530e-03 | -6.48 | urinary_tract-bladder-carcinoma | COSMIC cancer mutations | urinary_tract-bladder-carcinoma | 14050 | 48 | 16828 | 49 |
TNC,CTNND2,NTRK2,SOX5,LSAMP,NPAS3,CDH20,SORBS1,SLC1A2,ABLIM1,HPSE2,GPM6A,NAV2,MACF1,RORA,GFAP,TRPM3,NEBL,RFX4,NTRK3,ATP1A2,PSD2,CAMK2G,ERBB4,SLC4A4,NRXN1,ADCY2,LRP1B,GPC5,NDRG2,MSI2,PARD3,SLC14A1,SYNE1,MGAT4C,PITPNC1,DCLK2,KALRN,NRG3,GLIS3,SFXN5,DTNA,FMN2,DGKG,RPS6KA2,RYR3,PRKCA,NTM |
1.537e-03 | -6.48 | cellular component organization | biological process | GO:0016043 | 5636 | 26 | 18204 | 50 |
CDH20,PITPNC1,CTNNA2,CTNND2,TRPM3,GPM6A,PARD3,NEBL,PRKCA,ABLIM1,RFX4,NRXN1,DCLK2,FMN2,NRG3,SLC1A2,HPSE2,SYNE1,NAV2,GFAP,ERBB4,SORBS1,MACF1,RYR3,KALRN,TNC |
1.548e-03 | -6.47 | SFN (stratifin) | protein interactions | 2810 | 671 | 7 | 19454 | 50 |
NAV2,PARD3,FMN2,NTRK3,SORBS1,MACF1,ABLIM1 |
1.578e-03 | -6.45 | YWHAH (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta) | protein interactions | 7533 | 1083 | 9 | 19454 | 50 |
PARD3,SORBS1,MACF1,CAMK2G,NAV2,DCLK2,FMN2,PITPNC1,ABLIM1 |
1.582e-03 | -6.45 | TIMM10B (translocase of inner mitochondrial membrane 10B) | protein interactions | 26515 | 23 | 2 | 19454 | 50 |
MSI2,HPSE2 |
1.621e-03 | -6.42 | phosphate-containing compound metabolic process | biological process | GO:0006796 | 1681 | 12 | 18204 | 50 |
DCLK2,NTRK3,ATP1A2,CAMK2G,ERBB4,KALRN,RORA,DGKG,RPS6KA2,NTRK2,PRKCA,ADCY2 |
1.632e-03 | -6.42 | cellular response to organic cyclic compound | biological process | GO:0071407 | 464 | 6 | 18204 | 50 |
TNC,RORA,ATP1A2,SLC1A2,ADCY2,RYR3 |
1.648e-03 | -6.41 | stomach-carcinoma | COSMIC cancer mutations | stomach-carcinoma | 439 | 6 | 16828 | 49 |
NTRK3,PRKCA,NTRK2,RPS6KA2,CAMK2G,ERBB4 |
1.655e-03 | -6.40 | TRIO (trio Rho guanine nucleotide exchange factor) | protein interactions | 7204 | 91 | 3 | 19454 | 50 |
NAV2,PARD3,NTRK3 |
1.662e-03 | -6.40 | Adrenergic signaling in cardiomyocytes | KEGG pathways | hsa04261 | 144 | 4 | 7161 | 26 |
CAMK2G,PRKCA,ADCY2,ATP1A2 |
1.662e-03 | -6.40 | Adrenergic signaling in cardiomyocytes | KEGG pathways | ko04261 | 144 | 4 | 7161 | 26 |
CAMK2G,PRKCA,ADCY2,ATP1A2 |
1.669e-03 | -6.40 | HS-GAG degradation | REACTOME pathways | R-HSA-2024096 | 21 | 2 | 10285 | 30 |
HPSE2,GPC5 |
1.698e-03 | -6.38 | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-virilizing_syndrome_producing | COSMIC cancer mutations | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-virilizing_syndrome_producing | 298 | 5 | 16828 | 49 |
CTNND2,FMN2,TNC,ATP1A2,LRP1B |
1.700e-03 | -6.38 | transport across blood-brain barrier | biological process | GO:0150104 | 86 | 3 | 18204 | 50 |
SLC4A4,SLC1A2,ATP1A2 |
1.700e-03 | -6.38 | vascular transport | biological process | GO:0010232 | 86 | 3 | 18204 | 50 |
ATP1A2,SLC1A2,SLC4A4 |
1.715e-03 | -6.37 | human chr17q24.2 | chromosome location | human chr17q24.2 | 32 | 2 | 26134 | 50 |
PRKCA,PITPNC1 |
1.723e-03 | -6.36 | RASGRF1 (Ras protein specific guanine nucleotide releasing factor 1) | protein interactions | 5923 | 24 | 2 | 19454 | 50 |
NTRK3,NTRK2 |
1.743e-03 | -6.35 | Actinin_actin-bd_CS | interpro domains | IPR001589 | 23 | 2 | 18521 | 50 |
MACF1,SYNE1 |
1.745e-03 | -6.35 | Long-term potentiation | KEGG pathways | hsa04720 | 67 | 3 | 7161 | 26 |
RPS6KA2,PRKCA,CAMK2G |
1.745e-03 | -6.35 | Long-term potentiation | KEGG pathways | ko04720 | 67 | 3 | 7161 | 26 |
RPS6KA2,CAMK2G,PRKCA |
1.745e-03 | -6.35 | Calcium Regulation in the Cardiac Cell | WikiPathways | WP536 | 151 | 4 | 5310 | 19 |
RYR3,CAMK2G,PRKCA,ADCY2 |
1.797e-03 | -6.32 | actomyosin | cellular component | GO:0042641 | 92 | 3 | 19108 | 50 |
SORBS1,ABLIM1,NEBL |
1.817e-03 | -6.31 | GRIN1 (glutamate ionotropic receptor NMDA type subunit 1) | protein interactions | 2902 | 94 | 3 | 19454 | 50 |
NTRK2,CAMK2G,PRKCA |
1.821e-03 | -6.31 | CH | smart domains | SM00033 | 66 | 3 | 9717 | 36 |
SYNE1,MACF1,NAV2 |
1.826e-03 | -6.31 | oligodendroglioma_Grade_III | COSMIC cancer mutations | oligodendroglioma_Grade_III | 303 | 5 | 16828 | 49 |
MGAT4C,SYNE1,GLIS3,MACF1,NAV2 |
1.829e-03 | -6.30 | bone-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 6023 | 28 | 16828 | 49 |
PARD3,SYNE1,ABLIM1,NAV2,DCLK2,MACF1,KALRN,RORA,NKAIN3,NRG3,GLIS3,TRPM3,NEBL,DTNA,DGKG,RYR3,NTRK3,TNC,ATP1A2,CTNND2,CAMK2G,NTRK2,SOX5,ERBB4,NPAS3,SLC4A4,ADCY2,LRP1B |
1.848e-03 | -6.29 | chondrosarcoma | COSMIC cancer mutations | chondrosarcoma | 1181 | 10 | 16828 | 49 |
NDRG2,HPSE2,LRP1B,ADCY2,KALRN,NAV2,LSAMP,PSD2,SLC4A4,ERBB4 |
1.848e-03 | -6.29 | phosphorus metabolic process | biological process | GO:0006793 | 1707 | 12 | 18204 | 50 |
DGKG,CAMK2G,ERBB4,NTRK3,ADCY2,NTRK2,KALRN,RORA,DCLK2,ATP1A2,PRKCA,RPS6KA2 |
1.854e-03 | -6.29 | bladder | COSMIC cancer mutations | bladder | 14112 | 48 | 16828 | 49 |
PSD2,ATP1A2,CAMK2G,ERBB4,SLC4A4,NRXN1,ADCY2,LRP1B,GPC5,NDRG2,SYNE1,MSI2,PARD3,SLC14A1,DCLK2,KALRN,MGAT4C,PITPNC1,NRG3,GLIS3,SFXN5,FMN2,DGKG,RPS6KA2,RYR3,NTM,PRKCA,DTNA,CTNND2,TNC,NTRK2,SOX5,NPAS3,LSAMP,CDH20,SORBS1,SLC1A2,NAV2,GPM6A,MACF1,RORA,ABLIM1,HPSE2,GFAP,TRPM3,NTRK3,NEBL,RFX4 |
1.854e-03 | -6.29 | urinary_tract | COSMIC cancer mutations | urinary_tract | 14112 | 48 | 16828 | 49 |
TRPM3,GFAP,RFX4,NEBL,NTRK3,SLC1A2,SORBS1,ABLIM1,HPSE2,MACF1,GPM6A,NAV2,RORA,LSAMP,NPAS3,CDH20,TNC,CTNND2,NTRK2,SOX5,NRG3,SFXN5,GLIS3,DTNA,RPS6KA2,DGKG,FMN2,PRKCA,NTM,RYR3,MSI2,PARD3,SLC14A1,SYNE1,MGAT4C,PITPNC1,DCLK2,KALRN,ERBB4,NRXN1,SLC4A4,LRP1B,GPC5,ADCY2,NDRG2,ATP1A2,PSD2,CAMK2G |
1.870e-03 | -6.28 | DGKD (diacylglycerol kinase delta) | protein interactions | 8527 | 25 | 2 | 19454 | 50 |
PRKCA,DGKG |
1.884e-03 | -6.27 | Calponin-like domain | gene3d domains | 1.10.418.10 | 79 | 3 | 14470 | 45 |
SYNE1,MACF1,NAV2 |
1.913e-03 | -6.26 | human chr4q31.23-q31.3 | chromosome location | human chr4q31.23-q31.3 | 1 | 1 | 26134 | 50 |
DCLK2 |
1.913e-03 | -6.26 | human chr9q21.12-q21.13 | chromosome location | human chr9q21.12-q21.13 | 1 | 1 | 26134 | 50 |
TRPM3 |
1.913e-03 | -6.26 | human chr10p11.22-p11.21 | chromosome location | human chr10p11.22-p11.21 | 1 | 1 | 26134 | 50 |
PARD3 |
1.913e-03 | -6.26 | human chr2q22.1-q22.2 | chromosome location | human chr2q22.1-q22.2 | 1 | 1 | 26134 | 50 |
LRP1B |
1.913e-03 | -6.26 | human chr12q21.31-q21.32 | chromosome location | human chr12q21.31-q21.32 | 1 | 1 | 26134 | 50 |
MGAT4C |
1.913e-03 | -6.26 | human chr3q21.1-q21.2 | chromosome location | human chr3q21.1-q21.2 | 1 | 1 | 26134 | 50 |
KALRN |
1.913e-03 | -6.26 | human chr3q27.2-q27.3 | chromosome location | human chr3q27.2-q27.3 | 1 | 1 | 26134 | 50 |
DGKG |
1.913e-03 | -6.26 | human chr15q13.3-q14 | chromosome location | human chr15q13.3-q14 | 1 | 1 | 26134 | 50 |
RYR3 |
1.957e-03 | -6.24 | bone-femur-other-chondroblastoma | COSMIC cancer mutations | bone-femur-other-chondroblastoma | 183 | 4 | 16828 | 49 |
RYR3,NRG3,LRP1B,GPC5 |
1.972e-03 | -6.23 | cellular component assembly | biological process | GO:0022607 | 2472 | 15 | 18204 | 50 |
ERBB4,TRPM3,NEBL,PARD3,GPM6A,SLC1A2,CDH20,NRXN1,NRG3,FMN2,ABLIM1,SORBS1,PRKCA,RFX4,RYR3 |
1.984e-03 | -6.22 | breast-carcinoma-ductal_carcinoma | COSMIC cancer mutations | breast-carcinoma-ductal_carcinoma | 14824 | 49 | 16828 | 49 |
LRP1B,GPC5,ADCY2,NDRG2,ERBB4,NRXN1,SLC4A4,CAMK2G,PSD2,ATP1A2,RPS6KA2,DGKG,FMN2,NTM,PRKCA,RYR3,DTNA,NRG3,SFXN5,GLIS3,NKAIN3,DCLK2,KALRN,MGAT4C,PITPNC1,SYNE1,MSI2,SLC14A1,PARD3,CDH20,NPAS3,LSAMP,NTRK2,SOX5,CTNND2,TNC,NTRK3,RFX4,NEBL,TRPM3,GFAP,MACF1,GPM6A,NAV2,RORA,ABLIM1,HPSE2,SLC1A2,SORBS1 |
1.987e-03 | -6.22 | carbohydrate derivative binding | molecular function | GO:0097367 | 2251 | 14 | 18094 | 49 |
HPSE2,DCLK2,DGKG,NTRK2,RPS6KA2,NTRK3,CAMK2G,ATP1A2,NAV2,ADCY2,TNC,ERBB4,KALRN,PRKCA |
1.998e-03 | -6.22 | SHC1 (SHC adaptor protein 1) | protein interactions | 6464 | 350 | 5 | 19454 | 50 |
NTRK3,NTRK2,GFAP,PRKCA,ERBB4 |
2.023e-03 | -6.20 | NTF3 (neurotrophin 3) | protein interactions | 4908 | 26 | 2 | 19454 | 50 |
NTRK2,NTRK3 |
2.027e-03 | -6.20 | Oxytocin signaling pathway | KEGG pathways | hsa04921 | 152 | 4 | 7161 | 26 |
ADCY2,RYR3,PRKCA,CAMK2G |
2.027e-03 | -6.20 | Oxytocin signaling pathway | KEGG pathways | ko04921 | 152 | 4 | 7161 | 26 |
PRKCA,CAMK2G,RYR3,ADCY2 |
2.030e-03 | -6.20 | actin filament bundle | cellular component | GO:0032432 | 96 | 3 | 19108 | 50 |
SORBS1,NEBL,ABLIM1 |
2.042e-03 | -6.19 | femur | COSMIC cancer mutations | femur | 1197 | 10 | 16828 | 49 |
LRP1B,GPC5,ADCY2,HPSE2,FMN2,NAV2,RYR3,NRG3,PSD2,SLC4A4 |
2.062e-03 | -6.18 | neuron projection morphogenesis | biological process | GO:0048812 | 486 | 6 | 18204 | 50 |
PARD3,GPM6A,KALRN,NRXN1,CTNNA2,CTNND2 |
2.062e-03 | -6.18 | Bile secretion | KEGG pathways | hsa04976 | 71 | 3 | 7161 | 26 |
ADCY2,ATP1A2,SLC4A4 |
2.062e-03 | -6.18 | Bile secretion | KEGG pathways | ko04976 | 71 | 3 | 7161 | 26 |
ADCY2,ATP1A2,SLC4A4 |
2.063e-03 | -6.18 | Myometrial Relaxation and Contraction Pathways | WikiPathways | WP289 | 158 | 4 | 5310 | 19 |
CAMK2G,RYR3,ADCY2,PRKCA |
2.065e-03 | -6.18 | prostate-adenoma | COSMIC cancer mutations | prostate-adenoma | 1634 | 12 | 16828 | 49 |
NPAS3,TRPM3,ERBB4,PRKCA,NEBL,GPC5,LRP1B,SYNE1,PARD3,SOX5,DCLK2,MACF1 |
2.123e-03 | -6.16 | cell-cell junction | cellular component | GO:0005911 | 513 | 6 | 19108 | 50 |
PARD3,CDH20,ATP1A2,CTNNA2,SORBS1,CTNND2 |
2.147e-03 | -6.14 | Adherens junction | KEGG pathways | ko04520 | 72 | 3 | 7161 | 26 |
PARD3,SORBS1,CTNNA2 |
2.147e-03 | -6.14 | Adherens junction | KEGG pathways | hsa04520 | 72 | 3 | 7161 | 26 |
SORBS1,CTNNA2,PARD3 |
2.149e-03 | -6.14 | central_nervous_system-brain-glioma-astrocytoma_Grade_III | COSMIC cancer mutations | central_nervous_system-brain-glioma-astrocytoma_Grade_III | 1419 | 11 | 16828 | 49 |
PRKCA,RYR3,NAV2,HPSE2,LRP1B,GPC5,ADCY2,TRPM3,ERBB4,NRG3,PARD3 |
2.152e-03 | -6.14 | Tyr_kinase_AS | interpro domains | IPR008266 | 95 | 3 | 18521 | 50 |
NTRK3,NTRK2,ERBB4 |
2.154e-03 | -6.14 | positive regulation of ERK1 and ERK2 cascade | biological process | GO:0070374 | 199 | 4 | 18204 | 50 |
NTRK3,PRKCA,ERBB4,NTRK2 |
2.171e-03 | -6.13 | plasma membrane bounded cell projection morphogenesis | biological process | GO:0120039 | 491 | 6 | 18204 | 50 |
KALRN,NRXN1,CTNND2,PARD3,CTNNA2,GPM6A |
2.177e-03 | -6.13 | large_intestine-colon-carcinoma | COSMIC cancer mutations | large_intestine-colon-carcinoma | 2612 | 16 | 16828 | 49 |
NRXN1,TRPM3,NRG3,NTRK3,FMN2,GPC5,LRP1B,ADCY2,SYNE1,PSD2,TNC,PARD3,RORA,KALRN,MACF1,NAV2 |
2.178e-03 | -6.13 | CXADR (CXADR Ig-like cell adhesion molecule) | protein interactions | 1525 | 357 | 5 | 19454 | 50 |
PARD3,NEBL,RPS6KA2,SORBS1,MACF1 |
2.181e-03 | -6.13 | KCNJ12 (potassium inwardly rectifying channel subfamily J member 12) | protein interactions | 3768 | 27 | 2 | 19454 | 50 |
ABLIM1,DTNA |
2.185e-03 | -6.13 | LYN (LYN proto-oncogene, Src family tyrosine kinase) | protein interactions | 4067 | 713 | 7 | 19454 | 50 |
ABLIM1,DTNA,ERBB4,MSI2,FMN2,MACF1,PARD3 |
2.200e-03 | -6.12 | EZR (ezrin) | protein interactions | 7430 | 526 | 6 | 19454 | 50 |
DTNA,NEBL,ABLIM1,PRKCA,SORBS1,MACF1 |
2.230e-03 | -6.11 | PRKCG (protein kinase C gamma) | protein interactions | 5582 | 101 | 3 | 19454 | 50 |
GFAP,PRKCA,PARD3 |
2.238e-03 | -6.10 | modulation of chemical synaptic transmission | biological process | GO:0050804 | 494 | 6 | 18204 | 50 |
NRXN1,GFAP,NTRK2,SYNE1,ATP1A2,NRG3 |
2.261e-03 | -6.09 | regulation of trans-synaptic signaling | biological process | GO:0099177 | 495 | 6 | 18204 | 50 |
NTRK2,SYNE1,GFAP,NRXN1,NRG3,ATP1A2 |
2.281e-03 | -6.08 | extrinsic component of plasma membrane | cellular component | GO:0019897 | 100 | 3 | 19108 | 50 |
CDH20,CTNNA2,DTNA |
2.284e-03 | -6.08 | cell projection morphogenesis | biological process | GO:0048858 | 496 | 6 | 18204 | 50 |
KALRN,NRXN1,PARD3,GPM6A,CTNNA2,CTNND2 |
2.285e-03 | -6.08 | skin-upper_back-malignant_melanoma | COSMIC cancer mutations | skin-upper_back-malignant_melanoma | 319 | 5 | 16828 | 49 |
GPC5,SYNE1,KALRN,MACF1,ERBB4 |
2.302e-03 | -6.07 | Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 7434 | 32 | 16828 | 49 |
ABLIM1,DCLK2,MACF1,NAV2,RORA,KALRN,PARD3,SORBS1,SYNE1,DTNA,NEBL,DGKG,FMN2,RYR3,NTRK3,NKAIN3,NRG3,TRPM3,GLIS3,NTRK2,CAMK2G,SOX5,ATP1A2,TNC,PSD2,CTNND2,LRP1B,ADCY2,ERBB4,NRXN1,SLC4A4,NPAS3 |
2.304e-03 | -6.07 | C4-dicarboxylate transport | biological process | GO:0015740 | 26 | 2 | 18204 | 50 |
GFAP,SLC1A2 |
2.322e-03 | -6.07 | adrenal_gland | COSMIC cancer mutations | adrenal_gland | 2628 | 16 | 16828 | 49 |
NRG3,TRPM3,RFX4,LRP1B,ADCY2,DGKG,FMN2,NTRK3,ATP1A2,TNC,SLC1A2,SYNE1,CTNND2,HPSE2,NTRK2,SOX5 |
2.322e-03 | -6.07 | Thyroid hormone synthesis | KEGG pathways | hsa04918 | 74 | 3 | 7161 | 26 |
PRKCA,ATP1A2,ADCY2 |
2.322e-03 | -6.07 | Thyroid hormone synthesis | KEGG pathways | ko04918 | 74 | 3 | 7161 | 26 |
PRKCA,ATP1A2,ADCY2 |
2.348e-03 | -6.05 | virilizing_syndrome_producing | COSMIC cancer mutations | virilizing_syndrome_producing | 321 | 5 | 16828 | 49 |
FMN2,CTNND2,LRP1B,ATP1A2,TNC |
2.362e-03 | -6.05 | skin-head_neck-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-head_neck-carcinoma-squamous_cell_carcinoma | 14191 | 48 | 16828 | 49 |
DCLK2,KALRN,MGAT4C,PITPNC1,SYNE1,PARD3,SLC14A1,DGKG,FMN2,RPS6KA2,RYR3,NTM,PRKCA,DTNA,NRG3,GLIS3,SFXN5,NKAIN3,CAMK2G,PSD2,ATP1A2,ADCY2,GPC5,LRP1B,NDRG2,ERBB4,SLC4A4,NRXN1,GPM6A,NAV2,MACF1,RORA,ABLIM1,HPSE2,SORBS1,SLC1A2,NTRK3,NEBL,RFX4,GFAP,TRPM3,NTRK2,SOX5,CTNND2,TNC,CDH20,NPAS3,LSAMP |
2.412e-03 | -6.03 | haematopoietic_and_lymphoid_tissue-spleen-lymphoid_neoplasm-marginal_zone_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-spleen-lymphoid_neoplasm-marginal_zone_lymphoma | 323 | 5 | 16828 | 49 |
LRP1B,ADCY2,NTM,SYNE1,SORBS1 |
2.484e-03 | -6.00 | protein kinase C-activating G protein-coupled receptor signaling pathway | biological process | GO:0007205 | 27 | 2 | 18204 | 50 |
DGKG,PARD3 |
2.495e-03 | -5.99 | LRRNT | pfam domains | PF01462 | 27 | 2 | 17795 | 49 |
NTRK2,NTRK3 |
2.514e-03 | -5.99 | CH | prosite domains | PS50021 | 81 | 3 | 12186 | 41 |
SYNE1,NAV2,MACF1 |
2.559e-03 | -5.97 | USP6NL (USP6 N-terminal like) | protein interactions | 9712 | 106 | 3 | 19454 | 50 |
PARD3,NTRK3,NTRK2 |
2.570e-03 | -5.96 | App (amyloid beta precursor protein) | protein interactions | 100689222 | 1 | 1 | 19454 | 50 |
LRP1B |
2.570e-03 | -5.96 | Sytl1 (synaptotagmin-like 1) | protein interactions | 269589 | 1 | 1 | 19454 | 50 |
NRXN1 |
2.570e-03 | -5.96 | Isl1 (ISL1 transcription factor, LIM/homeodomain) | protein interactions | 16392 | 1 | 1 | 19454 | 50 |
GLIS3 |
2.570e-03 | -5.96 | Itga7 (integrin subunit alpha 7) | protein interactions | 81008 | 1 | 1 | 19454 | 50 |
TNC |
2.570e-03 | -5.96 | Bdnf (brain derived neurotrophic factor) | protein interactions | 12064 | 1 | 1 | 19454 | 50 |
NTRK2 |
2.570e-03 | -5.96 | TAS2R20 (taste 2 receptor member 20) | protein interactions | 259295 | 1 | 1 | 19454 | 50 |
PRKCA |
2.570e-03 | -5.96 | IML3 (Iml3p) | protein interactions | 852404 | 1 | 1 | 19454 | 50 |
GFAP |
2.570e-03 | -5.96 | Hipk3 (homeodomain interacting protein kinase 3) | protein interactions | 15259 | 1 | 1 | 19454 | 50 |
GLIS3 |
2.570e-03 | -5.96 | Agtrap (angiotensin II, type I receptor-associated protein) | protein interactions | 11610 | 1 | 1 | 19454 | 50 |
PITPNC1 |
2.570e-03 | -5.96 | fbxw7.L (F-box and WD repeat domain containing 7 L homeolog) | protein interactions | 734230 | 1 | 1 | 19454 | 50 |
PRKCA |
2.570e-03 | -5.96 | Dynlt1 (dynein light chain Tctex-type 1) | protein interactions | 83462 | 1 | 1 | 19454 | 50 |
NTRK2 |
2.573e-03 | -5.96 | cell morphogenesis | biological process | GO:0000902 | 687 | 7 | 18204 | 50 |
GPM6A,PARD3,NRXN1,KALRN,CTNNA2,CTNND2,CDH20 |
2.577e-03 | -5.96 | upper_back | COSMIC cancer mutations | upper_back | 328 | 5 | 16828 | 49 |
ERBB4,MACF1,KALRN,SYNE1,GPC5 |
2.584e-03 | -5.96 | purine ribonucleoside triphosphate binding | molecular function | GO:0035639 | 1804 | 12 | 18094 | 49 |
ERBB4,KALRN,PRKCA,ADCY2,NAV2,ATP1A2,RPS6KA2,NTRK2,NTRK3,CAMK2G,DCLK2,DGKG |
2.585e-03 | -5.96 | Pkinase | pfam domains | PF00069 | 347 | 5 | 17795 | 49 |
PRKCA,KALRN,DCLK2,RPS6KA2,CAMK2G |
2.603e-03 | -5.95 | MAPRE3 (microtubule associated protein RP/EB family member 3) | protein interactions | 22924 | 224 | 4 | 19454 | 50 |
NAV2,MACF1,ABLIM1,GPM6A |
2.628e-03 | -5.94 | EFR3A (EFR3 homolog A) | protein interactions | 23167 | 107 | 3 | 19454 | 50 |
NTRK3,PARD3,RPS6KA2 |
2.672e-03 | -5.92 | ACTININ_1 | prosite domains | PS00019 | 23 | 2 | 12186 | 41 |
SYNE1,MACF1 |
2.672e-03 | -5.92 | ACTININ_2 | prosite domains | PS00020 | 23 | 2 | 12186 | 41 |
SYNE1,MACF1 |
2.681e-03 | -5.92 | marginal_zone_lymphoma | COSMIC cancer mutations | marginal_zone_lymphoma | 331 | 5 | 16828 | 49 |
NTM,SYNE1,SORBS1,LRP1B,ADCY2 |
2.688e-03 | -5.92 | PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2) | protein interactions | 5296 | 226 | 4 | 19454 | 50 |
ERBB4,RPS6KA2,NTRK3,NTRK2 |
2.698e-03 | -5.92 | FKBP1A (FKBP prolyl isomerase 1A) | protein interactions | 2280 | 108 | 3 | 19454 | 50 |
ERBB4,RYR3,MSI2 |
2.700e-03 | -5.91 | SORBS1_SH3_2 | interpro domains | IPR035611 | 1 | 1 | 18521 | 50 |
SORBS1 |
2.700e-03 | -5.91 | Nebulette_SH3 | interpro domains | IPR035631 | 1 | 1 | 18521 | 50 |
NEBL |
2.700e-03 | -5.91 | RSK3_STKc | interpro domains | IPR042766 | 1 | 1 | 18521 | 50 |
RPS6KA2 |
2.700e-03 | -5.91 | SORBS1_SH3_1 | interpro domains | IPR035610 | 1 | 1 | 18521 | 50 |
SORBS1 |
2.700e-03 | -5.91 | NTRK2 | interpro domains | IPR020455 | 1 | 1 | 18521 | 50 |
NTRK2 |
2.700e-03 | -5.91 | C1_DGKgamma_rpt2 | interpro domains | IPR047475 | 1 | 1 | 18521 | 50 |
DGKG |
2.700e-03 | -5.91 | NTRK3 | interpro domains | IPR020446 | 1 | 1 | 18521 | 50 |
NTRK3 |
2.700e-03 | -5.91 | cPKC_alpha | interpro domains | IPR034663 | 1 | 1 | 18521 | 50 |
PRKCA |
2.700e-03 | -5.91 | SORBS1_SH3 | interpro domains | IPR035606 | 1 | 1 | 18521 | 50 |
SORBS1 |
2.700e-03 | -5.91 | CH_SYNE1_rpt1 | interpro domains | IPR047290 | 1 | 1 | 18521 | 50 |
SYNE1 |
2.700e-03 | -5.91 | CH_SYNE1_rpt2 | interpro domains | IPR047291 | 1 | 1 | 18521 | 50 |
SYNE1 |
2.708e-03 | -5.91 | brain-derived neurotrophic factor receptor activity | molecular function | GO:0060175 | 1 | 1 | 18094 | 49 |
NTRK2 |
2.709e-03 | -5.91 | large_intestine-caecum-carcinoma-adenocarcinoma | COSMIC cancer mutations | large_intestine-caecum-carcinoma-adenocarcinoma | 14236 | 48 | 16828 | 49 |
TNC,CTNND2,NTRK2,SOX5,LSAMP,NPAS3,CDH20,SORBS1,SLC1A2,ABLIM1,HPSE2,NAV2,GPM6A,MACF1,RORA,GFAP,TRPM3,NEBL,RFX4,NTRK3,ATP1A2,PSD2,CAMK2G,ERBB4,SLC4A4,NRXN1,ADCY2,GPC5,LRP1B,NDRG2,SLC14A1,PARD3,SYNE1,MGAT4C,PITPNC1,DCLK2,KALRN,NKAIN3,NRG3,GLIS3,SFXN5,DTNA,FMN2,DGKG,RPS6KA2,RYR3,NTM,PRKCA |
2.747e-03 | -5.90 | homologous chromosome movement towards spindle pole in meiosis I anaphase | biological process | GO:0051758 | 1 | 1 | 18204 | 50 |
FMN2 |
2.747e-03 | -5.90 | regulation of nucleus organization | biological process | GO:1903353 | 1 | 1 | 18204 | 50 |
SYNE1 |
2.747e-03 | -5.90 | directional guidance of interneurons involved in migration from the subpallium to the cortex | biological process | GO:0021840 | 1 | 1 | 18204 | 50 |
NRG3 |
2.747e-03 | -5.90 | trans-synaptic signaling by neuropeptide, modulating synaptic transmission | biological process | GO:0099551 | 1 | 1 | 18204 | 50 |
NTRK2 |
2.747e-03 | -5.90 | positive regulation of angiotensin-activated signaling pathway | biological process | GO:0110063 | 1 | 1 | 18204 | 50 |
PRKCA |
2.747e-03 | -5.90 | negative regulation of calcium:sodium antiporter activity | biological process | GO:1903280 | 1 | 1 | 18204 | 50 |
ATP1A2 |
2.747e-03 | -5.90 | olfactory cortex development | biological process | GO:0021989 | 1 | 1 | 18204 | 50 |
ATP1A2 |
2.747e-03 | -5.90 | trans-synaptic signaling by neuropeptide | biological process | GO:0099540 | 1 | 1 | 18204 | 50 |
NTRK2 |
2.747e-03 | -5.90 | chemorepulsion involved in interneuron migration from the subpallium to the cortex | biological process | GO:0021842 | 1 | 1 | 18204 | 50 |
NRG3 |
2.749e-03 | -5.90 | Muscle contraction | REACTOME pathways | R-HSA-397014 | 204 | 4 | 10285 | 30 |
ATP1A2,CAMK2G,RYR3,SORBS1 |
2.777e-03 | -5.89 | cellular component organization or biogenesis | biological process | GO:0071840 | 5850 | 26 | 18204 | 50 |
SLC1A2,HPSE2,SYNE1,NAV2,ERBB4,GFAP,SORBS1,MACF1,RYR3,TNC,KALRN,PITPNC1,CDH20,CTNND2,CTNNA2,TRPM3,NEBL,GPM6A,PARD3,ABLIM1,PRKCA,RFX4,NRXN1,NRG3,DCLK2,FMN2 |
2.809e-03 | -5.87 | caecum | COSMIC cancer mutations | caecum | 14248 | 48 | 16828 | 49 |
LSAMP,NPAS3,CDH20,TNC,CTNND2,NTRK2,SOX5,TRPM3,GFAP,RFX4,NEBL,NTRK3,SLC1A2,SORBS1,ABLIM1,HPSE2,MACF1,NAV2,GPM6A,RORA,ERBB4,NRXN1,SLC4A4,GPC5,LRP1B,ADCY2,NDRG2,ATP1A2,PSD2,CAMK2G,NKAIN3,NRG3,SFXN5,GLIS3,DTNA,RPS6KA2,FMN2,DGKG,PRKCA,NTM,RYR3,SLC14A1,PARD3,SYNE1,MGAT4C,PITPNC1,DCLK2,KALRN |
2.862e-03 | -5.86 | ACTB (actin beta) | protein interactions | 60 | 958 | 8 | 19454 | 50 |
SFXN5,MACF1,SORBS1,FMN2,PRKCA,ABLIM1,NEBL,DTNA |
2.863e-03 | -5.86 | neurotrophin signaling pathway | biological process | GO:0038179 | 29 | 2 | 18204 | 50 |
NTRK3,NTRK2 |
2.863e-03 | -5.86 | peripheral nervous system axon ensheathment | biological process | GO:0032292 | 29 | 2 | 18204 | 50 |
PARD3,NTRK2 |
2.863e-03 | -5.86 | myelination in peripheral nervous system | biological process | GO:0022011 | 29 | 2 | 18204 | 50 |
PARD3,NTRK2 |
2.870e-03 | -5.85 | SH2D1B (SH2 domain containing 1B) | protein interactions | 117157 | 31 | 2 | 19454 | 50 |
ABLIM1,ERBB4 |
2.870e-03 | -5.85 | AVPR1B (arginine vasopressin receptor 1B) | protein interactions | 553 | 31 | 2 | 19454 | 50 |
FMN2,PRKCA |
2.870e-03 | -5.85 | SH2B1 (SH2B adaptor protein 1) | protein interactions | 25970 | 31 | 2 | 19454 | 50 |
NTRK2,ERBB4 |
2.888e-03 | -5.85 | protein serine kinase activity | molecular function | GO:0106310 | 362 | 5 | 18094 | 49 |
DCLK2,PRKCA,KALRN,CAMK2G,RPS6KA2 |
2.909e-03 | -5.84 | lung-carcinoma-large_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-large_cell_carcinoma | 849 | 8 | 16828 | 49 |
ERBB4,SYNE1,CAMK2G,DCLK2,RPS6KA2,NTRK2,PRKCA,NTRK3 |
2.909e-03 | -5.84 | large_cell_carcinoma | COSMIC cancer mutations | large_cell_carcinoma | 849 | 8 | 16828 | 49 |
SYNE1,ERBB4,NTRK3,PRKCA,NTRK2,DCLK2,CAMK2G,RPS6KA2 |
2.933e-03 | -5.83 | central_nervous_system-brainstem-glioma | COSMIC cancer mutations | central_nervous_system-brainstem-glioma | 338 | 5 | 16828 | 49 |
HPSE2,TNC,LRP1B,GPC5,ERBB4 |
2.934e-03 | -5.83 | inorganic molecular entity transmembrane transporter activity | molecular function | GO:0015318 | 714 | 7 | 18094 | 49 |
GPM6A,SLC14A1,TRPM3,SLC4A4,SLC1A2,ATP1A2,RYR3 |
2.966e-03 | -5.82 | CaM pathway | REACTOME pathways | R-HSA-111997 | 28 | 2 | 10285 | 30 |
ADCY2,PRKCA |
2.966e-03 | -5.82 | Calmodulin induced events | REACTOME pathways | R-HSA-111933 | 28 | 2 | 10285 | 30 |
ADCY2,PRKCA |
2.973e-03 | -5.82 | catenin complex | cellular component | GO:0016342 | 31 | 2 | 19108 | 50 |
CDH20,CTNNA2 |
2.991e-03 | -5.81 | EDA (ectodysplasin A) | protein interactions | 1896 | 112 | 3 | 19454 | 50 |
RPS6KA2,GPM6A,ERBB4 |
2.993e-03 | -5.81 | YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta) | protein interactions | 7529 | 965 | 8 | 19454 | 50 |
DCLK2,NAV2,PITPNC1,ABLIM1,PARD3,MACF1,CAMK2G,SORBS1 |
3.000e-03 | -5.81 | Ion channel transport | REACTOME pathways | R-HSA-983712 | 209 | 4 | 10285 | 30 |
RYR3,CAMK2G,ATP1A2,TRPM3 |
3.005e-03 | -5.81 | SH3_domain | interpro domains | IPR001452 | 222 | 4 | 18521 | 50 |
KALRN,MACF1,NEBL,SORBS1 |
3.057e-03 | -5.79 | GRIA4 (glutamate ionotropic receptor AMPA type subunit 4) | protein interactions | 2893 | 32 | 2 | 19454 | 50 |
PRKCA,CAMK2G |
3.060e-03 | -5.79 | Proximal tubule bicarbonate reclamation | KEGG pathways | ko04964 | 23 | 2 | 7161 | 26 |
ATP1A2,SLC4A4 |
3.060e-03 | -5.79 | Proximal tubule bicarbonate reclamation | KEGG pathways | hsa04964 | 23 | 2 | 7161 | 26 |
SLC4A4,ATP1A2 |
3.062e-03 | -5.79 | neuron projection regeneration | biological process | GO:0031102 | 30 | 2 | 18204 | 50 |
TNC,GFAP |
3.062e-03 | -5.79 | neurotransmitter uptake | biological process | GO:0001504 | 30 | 2 | 18204 | 50 |
SLC1A2,ATP1A2 |
3.093e-03 | -5.78 | MARK3 (microtubule affinity regulating kinase 3) | protein interactions | 4140 | 235 | 4 | 19454 | 50 |
DTNA,MACF1,NTRK2,PARD3 |
3.110e-03 | -5.77 | - | gene3d domains | 6.10.250.880 | 1 | 1 | 14470 | 45 |
ERBB4 |
3.112e-03 | -5.77 | Aldosterone synthesis and secretion | KEGG pathways | hsa04925 | 82 | 3 | 7161 | 26 |
ADCY2,PRKCA,CAMK2G |
3.112e-03 | -5.77 | Aldosterone synthesis and secretion | KEGG pathways | ko04925 | 82 | 3 | 7161 | 26 |
PRKCA,CAMK2G,ADCY2 |
3.155e-03 | -5.76 | TyrKc | smart domains | SM00219 | 80 | 3 | 9717 | 36 |
NTRK3,ERBB4,NTRK2 |
3.180e-03 | -5.75 | CREB phosphorylation through the activation of Ras | REACTOME pathways | R-HSA-442742 | 29 | 2 | 10285 | 30 |
RPS6KA2,CAMK2G |
3.188e-03 | -5.75 | CAMK2A (calcium/calmodulin dependent protein kinase II alpha) | protein interactions | 815 | 237 | 4 | 19454 | 50 |
GPM6A,CAMK2G,GFAP,SOX5 |
3.204e-03 | -5.74 | cervix-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | cervix-carcinoma-squamous_cell_carcinoma | 11789 | 43 | 16828 | 49 |
PSD2,ATP1A2,ADCY2,GPC5,LRP1B,SLC4A4,NRXN1,ERBB4,KALRN,DCLK2,PITPNC1,MGAT4C,SYNE1,PARD3,RYR3,PRKCA,NTM,DGKG,FMN2,RPS6KA2,DTNA,GLIS3,SFXN5,NRG3,SOX5,NTRK2,CTNND2,TNC,CDH20,NPAS3,LSAMP,RORA,NAV2,GPM6A,MACF1,HPSE2,ABLIM1,SORBS1,SLC1A2,NTRK3,NEBL,RFX4,TRPM3 |
3.212e-03 | -5.74 | Downstream signal transduction | REACTOME pathways | R-HSA-186763 | 352 | 5 | 10285 | 30 |
ERBB4,NRG3,ADCY2,PRKCA,CAMK2G |
3.222e-03 | -5.74 | CDH2 (cadherin 2) | protein interactions | 1000 | 115 | 3 | 19454 | 50 |
CTNND2,PARD3,NTRK3 |
3.237e-03 | -5.73 | cervix | COSMIC cancer mutations | cervix | 11793 | 43 | 16828 | 49 |
PARD3,SORBS1,SLC1A2,SYNE1,MGAT4C,ABLIM1,HPSE2,PITPNC1,NAV2,GPM6A,MACF1,DCLK2,KALRN,RORA,NRG3,GLIS3,SFXN5,TRPM3,NEBL,DTNA,RFX4,DGKG,FMN2,RPS6KA2,RYR3,NTRK3,NTM,PRKCA,TNC,ATP1A2,CTNND2,PSD2,NTRK2,SOX5,LSAMP,ERBB4,NPAS3,SLC4A4,NRXN1,ADCY2,LRP1B,GPC5,CDH20 |
3.314e-03 | -5.71 | Axon guidance | KEGG pathways | hsa04360 | 174 | 4 | 7161 | 26 |
ABLIM1,PRKCA,CAMK2G,PARD3 |
3.314e-03 | -5.71 | Axon guidance | KEGG pathways | ko04360 | 174 | 4 | 7161 | 26 |
ABLIM1,PRKCA,CAMK2G,PARD3 |
3.372e-03 | -5.69 | DAP12 signaling | REACTOME pathways | R-HSA-2424491 | 356 | 5 | 10285 | 30 |
PRKCA,ADCY2,CAMK2G,ERBB4,NRG3 |
3.375e-03 | -5.69 | cell migration | biological process | GO:0016477 | 921 | 8 | 18204 | 50 |
CTNNA2,CDH20,NTRK2,FMN2,GPM6A,NRG3,ERBB4,GPC5 |
3.385e-03 | -5.69 | ERBIN (erbb2 interacting protein) | protein interactions | 55914 | 241 | 4 | 19454 | 50 |
CTNND2,NTRK2,NTRK3,PARD3 |
3.401e-03 | -5.68 | Ca-dependent events | REACTOME pathways | R-HSA-111996 | 30 | 2 | 10285 | 30 |
ADCY2,PRKCA |
3.401e-03 | -5.68 | Downregulation of ERBB2 signaling | REACTOME pathways | R-HSA-8863795 | 30 | 2 | 10285 | 30 |
NRG3,ERBB4 |
3.404e-03 | -5.68 | cellular response to endogenous stimulus | biological process | GO:0071495 | 1135 | 9 | 18204 | 50 |
SORBS1,SLC1A2,NTRK2,RYR3,SOX5,ERBB4,TNC,NTRK3,ATP1A2 |
3.444e-03 | -5.67 | NTKRECEPTOR3 | prints domains | PR01942 | 1 | 1 | 5227 | 18 |
NTRK3 |
3.444e-03 | -5.67 | NTKRECEPTOR2 | prints domains | PR01941 | 1 | 1 | 5227 | 18 |
NTRK2 |
3.501e-03 | -5.65 | purine ribonucleotide binding | molecular function | GO:0032555 | 1871 | 12 | 18094 | 49 |
KALRN,PRKCA,ERBB4,ADCY2,NAV2,ATP1A2,CAMK2G,NTRK2,NTRK3,RPS6KA2,DGKG,DCLK2 |
3.519e-03 | -5.65 | EGF-like_dom | interpro domains | IPR000742 | 232 | 4 | 18521 | 50 |
TNC,LRP1B,NRG3,NRXN1 |
3.549e-03 | -5.64 | PROTEIN_KINASE_ST | prosite domains | PS00108 | 308 | 5 | 12186 | 41 |
PRKCA,RPS6KA2,KALRN,DCLK2,CAMK2G |
3.590e-03 | -5.63 | SCRIB (scribble planar cell polarity protein) | protein interactions | 23513 | 245 | 4 | 19454 | 50 |
PARD3,NTRK3,PRKCA,RPS6KA2 |
3.619e-03 | -5.62 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-NK-T_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-NK-T_cell_lymphoma | 217 | 4 | 16828 | 49 |
RFX4,DTNA,MGAT4C,NAV2 |
3.621e-03 | -5.62 | meninges | COSMIC cancer mutations | meninges | 514 | 6 | 16828 | 49 |
RPS6KA2,NAV2,FMN2,NTRK3,RYR3,SYNE1 |
3.621e-03 | -5.62 | meningioma | COSMIC cancer mutations | meningioma | 514 | 6 | 16828 | 49 |
RPS6KA2,NAV2,FMN2,RYR3,NTRK3,SYNE1 |
3.650e-03 | -5.61 | lower_third | COSMIC cancer mutations | lower_third | 7961 | 33 | 16828 | 49 |
NRG3,TRPM3,RPS6KA2,FMN2,DGKG,PRKCA,RYR3,NTRK3,NEBL,SORBS1,SYNE1,PARD3,MACF1,DCLK2,NAV2,KALRN,RORA,MGAT4C,HPSE2,ERBB4,NRXN1,SLC4A4,NPAS3,GPC5,CDH20,LRP1B,ADCY2,PSD2,CTNND2,ATP1A2,TNC,NTRK2,SOX5 |
3.697e-03 | -5.60 | response to auditory stimulus | biological process | GO:0010996 | 33 | 2 | 18204 | 50 |
ATP1A2,NRXN1 |
3.705e-03 | -5.60 | DELLA | smart domains | SM01129 | 1 | 1 | 9717 | 36 |
MACF1 |
3.709e-03 | -5.60 | Signaling by EGFR | REACTOME pathways | R-HSA-177929 | 364 | 5 | 10285 | 30 |
NRG3,ERBB4,CAMK2G,ADCY2,PRKCA |
3.771e-03 | -5.58 | ribonucleotide binding | molecular function | GO:0032553 | 1888 | 12 | 18094 | 49 |
ERBB4,PRKCA,KALRN,ADCY2,ATP1A2,NAV2,DCLK2,DGKG,NTRK2,RPS6KA2,NTRK3,CAMK2G |
3.792e-03 | -5.57 | Pkinase_C | interpro domains | IPR017892 | 34 | 2 | 18521 | 50 |
PRKCA,RPS6KA2 |
3.803e-03 | -5.57 | anion binding | molecular function | GO:0043168 | 2412 | 14 | 18094 | 49 |
ADCY2,PITPNC1,KALRN,PRKCA,ERBB4,RPS6KA2,NTRK2,NTRK3,CAMK2G,PARD3,DGKG,DCLK2,NAV2,ATP1A2 |
3.833e-03 | -5.56 | PROTEIN_KINASE_TYR | prosite domains | PS00109 | 94 | 3 | 12186 | 41 |
ERBB4,NTRK2,NTRK3 |
3.833e-03 | -5.56 | synaptic membrane | cellular component | GO:0097060 | 400 | 5 | 19108 | 50 |
ERBB4,SYNE1,GPM6A,SLC1A2,NRXN1 |
3.857e-03 | -5.56 | SLC5A5 (solute carrier family 5 member 5) | protein interactions | 6528 | 36 | 2 | 19454 | 50 |
SFXN5,CAMK2G |
3.864e-03 | -5.56 | Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity | REACTOME pathways | R-HSA-399721 | 32 | 2 | 10285 | 30 |
CAMK2G,PRKCA |
3.864e-03 | -5.56 | Trafficking of AMPA receptors | REACTOME pathways | R-HSA-399719 | 32 | 2 | 10285 | 30 |
PRKCA,CAMK2G |
3.908e-03 | -5.54 | monoatomic ion transmembrane transporter activity | molecular function | GO:0015075 | 752 | 7 | 18094 | 49 |
SFXN5,TRPM3,GPM6A,SLC4A4,SLC1A2,RYR3,ATP1A2 |
3.910e-03 | -5.54 | calcium channel activity | molecular function | GO:0005262 | 117 | 3 | 18094 | 49 |
GPM6A,TRPM3,RYR3 |
3.912e-03 | -5.54 | Ig_sub2 | interpro domains | IPR003598 | 239 | 4 | 18521 | 50 |
LSAMP,NTM,NTRK2,KALRN |
3.930e-03 | -5.54 | oesophagus-lower_third-carcinoma-adenocarcinoma | COSMIC cancer mutations | oesophagus-lower_third-carcinoma-adenocarcinoma | 6302 | 28 | 16828 | 49 |
SYNE1,SORBS1,PARD3,RORA,KALRN,MACF1,MGAT4C,TRPM3,NRG3,PRKCA,RYR3,NTRK3,RPS6KA2,FMN2,DGKG,NEBL,PSD2,CTNND2,TNC,SOX5,NTRK2,NRXN1,NPAS3,ERBB4,CDH20,GPC5,LRP1B,ADCY2 |
3.939e-03 | -5.54 | Pkinase_C | pfam domains | PF00433 | 34 | 2 | 17795 | 49 |
RPS6KA2,PRKCA |
3.969e-03 | -5.53 | NCK2 (NCK adaptor protein 2) | protein interactions | 8440 | 252 | 4 | 19454 | 50 |
ERBB4,SORBS1,NTRK2,NTRK3 |
4.024e-03 | -5.52 | DAP12 interactions | REACTOME pathways | R-HSA-2172127 | 371 | 5 | 10285 | 30 |
ADCY2,PRKCA,CAMK2G,NRG3,ERBB4 |
4.032e-03 | -5.51 | haematopoietic_and_lymphoid_tissue | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue | 14368 | 48 | 16828 | 49 |
GLIS3,SFXN5,NRG3,NKAIN3,RYR3,PRKCA,NTM,DGKG,FMN2,RPS6KA2,DTNA,SYNE1,PARD3,SLC14A1,MSI2,KALRN,DCLK2,PITPNC1,MGAT4C,SLC4A4,NRXN1,ERBB4,ADCY2,GPC5,LRP1B,PSD2,ATP1A2,CAMK2G,GFAP,TRPM3,NTRK3,NEBL,RFX4,SORBS1,SLC1A2,RORA,GPM6A,NAV2,MACF1,HPSE2,ABLIM1,NPAS3,LSAMP,CDH20,CTNND2,TNC,SOX5,NTRK2 |
4.071e-03 | -5.50 | PRRG4 (proline rich and Gla domain 4) | protein interactions | 79056 | 37 | 2 | 19454 | 50 |
ERBB4,NEBL |
4.071e-03 | -5.50 | MAGI2 (membrane associated guanylate kinase, WW and PDZ domain containing 2) | protein interactions | 9863 | 37 | 2 | 19454 | 50 |
CTNND2,ERBB4 |
4.102e-03 | -5.50 | Ig_sub | interpro domains | IPR003599 | 394 | 5 | 18521 | 50 |
KALRN,NTRK2,NTM,LSAMP,NTRK3 |
4.112e-03 | -5.49 | FYN (FYN proto-oncogene, Src family tyrosine kinase) | protein interactions | 2534 | 414 | 5 | 19454 | 50 |
KALRN,NTRK2,RPS6KA2,CTNND2,ERBB4 |
4.117e-03 | -5.49 | NK-T_cell_lymphoma | COSMIC cancer mutations | NK-T_cell_lymphoma | 225 | 4 | 16828 | 49 |
DTNA,RFX4,MGAT4C,NAV2 |
4.128e-03 | -5.49 | EGF_3 | prosite domains | PS50026 | 196 | 4 | 12186 | 41 |
NRG3,TNC,NRXN1,LRP1B |
4.140e-03 | -5.49 | salivary_gland-submandibular-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | salivary_gland-submandibular-carcinoma-adenoid_cystic_carcinoma | 33 | 2 | 16828 | 49 |
LRP1B,NAV2 |
4.151e-03 | -5.48 | astrocytoma_Grade_III | COSMIC cancer mutations | astrocytoma_Grade_III | 1544 | 11 | 16828 | 49 |
RYR3,PRKCA,NAV2,HPSE2,ADCY2,GPC5,LRP1B,TRPM3,ERBB4,NRG3,PARD3 |
4.215e-03 | -5.47 | glial cell projection | cellular component | GO:0097386 | 37 | 2 | 19108 | 50 |
GFAP,SLC1A2 |
4.251e-03 | -5.46 | TYRKINASE | prints domains | PR00109 | 98 | 3 | 5227 | 18 |
NTRK3,NTRK2,ERBB4 |
4.255e-03 | -5.46 | PDLIM7 (PDZ and LIM domain 7) | protein interactions | 9260 | 257 | 4 | 19454 | 50 |
ABLIM1,PRKCA,GFAP,PARD3 |
4.261e-03 | -5.46 | Signaling by PDGF | REACTOME pathways | R-HSA-186797 | 376 | 5 | 10285 | 30 |
ERBB4,NRG3,ADCY2,PRKCA,CAMK2G |
4.268e-03 | -5.46 | proteoglycan binding | molecular function | GO:0043394 | 36 | 2 | 18094 | 49 |
TNC,HPSE2 |
4.290e-03 | -5.45 | RORA (RAR related orphan receptor A) | protein interactions | 6095 | 38 | 2 | 19454 | 50 |
RORA,GFAP |
4.308e-03 | -5.45 | GnRH signaling pathway | KEGG pathways | hsa04912 | 92 | 3 | 7161 | 26 |
PRKCA,CAMK2G,ADCY2 |
4.308e-03 | -5.45 | GnRH signaling pathway | KEGG pathways | ko04912 | 92 | 3 | 7161 | 26 |
CAMK2G,PRKCA,ADCY2 |
4.335e-03 | -5.44 | kidney-other-neoplasm | COSMIC cancer mutations | kidney-other-neoplasm | 10653 | 40 | 16828 | 49 |
FMN2,DGKG,PRKCA,NTRK3,RYR3,DTNA,RFX4,NEBL,NRG3,SFXN5,TRPM3,GFAP,NKAIN3,MACF1,GPM6A,NAV2,KALRN,RORA,ABLIM1,MGAT4C,HPSE2,SLC1A2,SORBS1,SYNE1,PARD3,LRP1B,CDH20,GPC5,ADCY2,ERBB4,NRXN1,NPAS3,LSAMP,NTRK2,CAMK2G,SOX5,PSD2,CTNND2,ATP1A2,TNC |
4.344e-03 | -5.44 | glutamatergic synapse | cellular component | GO:0098978 | 412 | 5 | 19108 | 50 |
NRG3,SLC1A2,ERBB4,GPM6A,PSD2 |
4.354e-03 | -5.44 | DAG and IP3 signaling | REACTOME pathways | R-HSA-1489509 | 34 | 2 | 10285 | 30 |
ADCY2,PRKCA |
4.370e-03 | -5.43 | regulation of nervous system process | biological process | GO:0031644 | 120 | 3 | 18204 | 50 |
NRXN1,SYNE1,PARD3 |
4.370e-03 | -5.43 | striated muscle contraction | biological process | GO:0006941 | 120 | 3 | 18204 | 50 |
DTNA,RYR3,ATP1A2 |
4.448e-03 | -5.42 | central_nervous_system-brainstem-glioma-oligoastrocytoma_Grade_III | COSMIC cancer mutations | central_nervous_system-brainstem-glioma-oligoastrocytoma_Grade_III | 114 | 3 | 16828 | 49 |
SLC1A2,RYR3,SOX5 |
4.472e-03 | -5.41 | regulation of signaling | biological process | GO:0023051 | 3534 | 18 | 18204 | 50 |
SYNE1,PSD2,CTNND2,NTRK2,NTRK3,GFAP,DGKG,ERBB4,MACF1,SORBS1,PRKCA,NDRG2,ATP1A2,NRG3,KALRN,NRXN1,RORA,GPC5 |
4.494e-03 | -5.41 | DIRAS3 (DIRAS family GTPase 3) | protein interactions | 9077 | 261 | 4 | 19454 | 50 |
FMN2,PARD3,DTNA,MACF1 |
4.569e-03 | -5.39 | regulation of system process | biological process | GO:0044057 | 571 | 6 | 18204 | 50 |
CAMK2G,NRXN1,PARD3,ATP1A2,PRKCA,SYNE1 |
4.571e-03 | -5.39 | regulation of cell communication | biological process | GO:0010646 | 3541 | 18 | 18204 | 50 |
GPC5,NRXN1,KALRN,RORA,NRG3,ATP1A2,NDRG2,SORBS1,PRKCA,MACF1,ERBB4,GFAP,DGKG,NTRK3,NTRK2,PSD2,CTNND2,SYNE1 |
4.603e-03 | -5.38 | organic anion transport | biological process | GO:0015711 | 398 | 5 | 18204 | 50 |
SLC1A2,NTRK2,SFXN5,GFAP,SLC4A4 |
4.605e-03 | -5.38 | regulation of synapse organization | biological process | GO:0050807 | 246 | 4 | 18204 | 50 |
GPM6A,CTNNA2,NTRK2,NRXN1 |
4.631e-03 | -5.38 | positive regulation of glucose import | biological process | GO:0046326 | 37 | 2 | 18204 | 50 |
SLC1A2,SORBS1 |
4.723e-03 | -5.36 | transporter activity | molecular function | GO:0005215 | 1211 | 9 | 18094 | 49 |
PITPNC1,TRPM3,SLC14A1,GPM6A,SFXN5,RYR3,ATP1A2,SLC1A2,SLC4A4 |
4.740e-03 | -5.35 | cytoskeletal protein binding | molecular function | GO:0008092 | 989 | 8 | 18094 | 49 |
ABLIM1,CTNNA2,FMN2,NEBL,SYNE1,DCLK2,MACF1,SORBS1 |
4.816e-03 | -5.34 | gallbladder | COSMIC cancer mutations | gallbladder | 2821 | 16 | 16828 | 49 |
NKAIN3,TRPM3,SLC4A4,NRG3,ERBB4,LRP1B,RYR3,NTRK3,FMN2,TNC,PARD3,SYNE1,PSD2,CTNND2,PITPNC1,MACF1 |
4.816e-03 | -5.34 | biliary_tract-gallbladder-carcinoma-adenocarcinoma | COSMIC cancer mutations | biliary_tract-gallbladder-carcinoma-adenocarcinoma | 2821 | 16 | 16828 | 49 |
PSD2,SYNE1,CTNND2,PARD3,TNC,MACF1,PITPNC1,TRPM3,SLC4A4,ERBB4,NRG3,NKAIN3,RYR3,NTRK3,FMN2,LRP1B |
4.872e-03 | -5.32 | EGFR interacts with phospholipase C-gamma | REACTOME pathways | R-HSA-212718 | 36 | 2 | 10285 | 30 |
ADCY2,PRKCA |
4.872e-03 | -5.32 | PLC-gamma1 signalling | REACTOME pathways | R-HSA-167021 | 36 | 2 | 10285 | 30 |
ADCY2,PRKCA |
4.880e-03 | -5.32 | amino acid import across plasma membrane | biological process | GO:0089718 | 38 | 2 | 18204 | 50 |
SLC1A2,GFAP |
4.912e-03 | -5.32 | submandibular | COSMIC cancer mutations | submandibular | 36 | 2 | 16828 | 49 |
NAV2,LRP1B |
4.934e-03 | -5.31 | VCL (vinculin) | protein interactions | 7414 | 268 | 4 | 19454 | 50 |
MACF1,SORBS1,PRKCA,NEBL |
4.940e-03 | -5.31 | inorganic cation transmembrane transporter activity | molecular function | GO:0022890 | 589 | 6 | 18094 | 49 |
ATP1A2,RYR3,SLC1A2,GPM6A,TRPM3,SLC4A4 |
4.966e-03 | -5.31 | cellular component biogenesis | biological process | GO:0044085 | 2716 | 15 | 18204 | 50 |
CDH20,SLC1A2,GPM6A,PARD3,NEBL,TRPM3,ERBB4,RYR3,RFX4,SORBS1,PRKCA,ABLIM1,FMN2,NRG3,NRXN1 |
4.989e-03 | -5.30 | SH3 Domains | gene3d domains | 2.30.30.40 | 223 | 4 | 14470 | 45 |
NEBL,MACF1,KALRN,SORBS1 |
4.997e-03 | -5.30 | Inflammatory mediator regulation of TRP channels | KEGG pathways | hsa04750 | 97 | 3 | 7161 | 26 |
ADCY2,CAMK2G,PRKCA |
4.997e-03 | -5.30 | Inflammatory mediator regulation of TRP channels | KEGG pathways | ko04750 | 97 | 3 | 7161 | 26 |
PRKCA,CAMK2G,ADCY2 |
5.014e-03 | -5.30 | regulation of synapse structure or activity | biological process | GO:0050803 | 252 | 4 | 18204 | 50 |
NRXN1,NTRK2,GPM6A,CTNNA2 |
5.020e-03 | -5.29 | localization | biological process | GO:0051179 | 4474 | 21 | 18204 | 50 |
SFXN5,LRP1B,SLC14A1,SLC1A2,PITPNC1,NTRK2,SYNE1,SLC4A4,TRPM3,GFAP,ERBB4,CAMK2G,PARD3,GPM6A,RYR3,MACF1,NRXN1,KALRN,FMN2,ATP1A2,DCLK2 |
5.065e-03 | -5.29 | WDR6 (WD repeat domain 6) | protein interactions | 11180 | 270 | 4 | 19454 | 50 |
NTRK2,NTRK3,PARD3,RPS6KA2 |
5.094e-03 | -5.28 | SRC (SRC proto-oncogene, non-receptor tyrosine kinase) | protein interactions | 6714 | 624 | 6 | 19454 | 50 |
SORBS1,SLC14A1,ERBB4,PRKCA,GFAP,MSI2 |
5.118e-03 | -5.28 | cell-cell junction assembly | biological process | GO:0007043 | 127 | 3 | 18204 | 50 |
CDH20,PRKCA,PARD3 |
5.127e-03 | -5.27 | EF-hand-dom_pair | interpro domains | IPR011992 | 258 | 4 | 18521 | 50 |
MACF1,RYR3,DTNA,DGKG |
5.134e-03 | -5.27 | Grin2c (glutamate ionotropic receptor NMDA type subunit 2C) | protein interactions | 24411 | 2 | 1 | 19454 | 50 |
PRKCA |
5.134e-03 | -5.27 | Zmym2 (zinc finger, MYM-type 2) | protein interactions | 76007 | 2 | 1 | 19454 | 50 |
GLIS3 |
5.134e-03 | -5.27 | EST1 (Est1p) | protein interactions | 850934 | 2 | 1 | 19454 | 50 |
NAV2 |
5.134e-03 | -5.27 | Kdm4c (lysine (K)-specific demethylase 4C) | protein interactions | 76804 | 2 | 1 | 19454 | 50 |
GLIS3 |
5.134e-03 | -5.27 | numb (numb) | protein interactions | 34263 | 2 | 1 | 19454 | 50 |
PRKCA |
5.134e-03 | -5.27 | URA1 (dihydroorotate dehydrogenase) | protein interactions | 853664 | 2 | 1 | 19454 | 50 |
GFAP |
5.134e-03 | -5.27 | cdh11.S (cadherin 11 S homeolog) | protein interactions | 100337621 | 2 | 1 | 19454 | 50 |
ERBB4 |
5.134e-03 | -5.27 | cellular response to alkaloid | biological process | GO:0071312 | 39 | 2 | 18204 | 50 |
SLC1A2,RYR3 |
5.134e-03 | -5.27 | olfactory lobe development | biological process | GO:0021988 | 39 | 2 | 18204 | 50 |
ATP1A2,ERBB4 |
5.141e-03 | -5.27 | Post NMDA receptor activation events | REACTOME pathways | R-HSA-438064 | 37 | 2 | 10285 | 30 |
RPS6KA2,CAMK2G |
5.198e-03 | -5.26 | RDX (radixin) | protein interactions | 5962 | 272 | 4 | 19454 | 50 |
NTRK3,MACF1,ABLIM1,NEBL |
5.198e-03 | -5.26 | purine nucleotide binding | molecular function | GO:0017076 | 1964 | 12 | 18094 | 49 |
NAV2,ATP1A2,RPS6KA2,NTRK2,NTRK3,CAMK2G,DGKG,DCLK2,PRKCA,KALRN,ERBB4,ADCY2 |
5.220e-03 | -5.26 | GRIA2 (glutamate ionotropic receptor AMPA type subunit 2) | protein interactions | 2891 | 42 | 2 | 19454 | 50 |
PRKCA,GPM6A |
5.230e-03 | -5.25 | Laminin | gene3d domains | 2.10.25.10 | 226 | 4 | 14470 | 45 |
TNC,NRG3,NRXN1,LRP1B |
5.231e-03 | -5.25 | glial cell development | biological process | GO:0021782 | 128 | 3 | 18204 | 50 |
GFAP,NTRK2,PARD3 |
5.283e-03 | -5.24 | positive regulation of cell population proliferation | biological process | GO:0008284 | 992 | 8 | 18204 | 50 |
SYNE1,NTRK3,GFAP,PRKCA,NTRK2,HPSE2,TNC,ERBB4 |
5.328e-03 | -5.23 | establishment of localization | biological process | GO:0051234 | 3887 | 19 | 18204 | 50 |
PARD3,GPM6A,SLC4A4,TRPM3,GFAP,ERBB4,CAMK2G,LRP1B,SLC14A1,SFXN5,SLC1A2,NTRK2,PITPNC1,ATP1A2,FMN2,NRXN1,KALRN,RYR3,MACF1 |
5.356e-03 | -5.23 | lung-middle_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-middle_lobe-carcinoma-adenocarcinoma | 1368 | 10 | 16828 | 49 |
HPSE2,LRP1B,RYR3,NTRK3,MACF1,ATP1A2,SYNE1,TRPM3,CTNND2,ERBB4 |
5.373e-03 | -5.23 | positive regulation of multicellular organismal process | biological process | GO:0051240 | 1691 | 11 | 18204 | 50 |
PRKCA,NTRK2,SFXN5,MACF1,GFAP,NRXN1,SOX5,RORA,ERBB4,ATP1A2,PARD3 |
5.392e-03 | -5.22 | Par3/HAL_N | interpro domains | IPR021922 | 2 | 1 | 18521 | 50 |
PARD3 |
5.392e-03 | -5.22 | Glyco_hydro_79 | interpro domains | IPR005199 | 2 | 1 | 18521 | 50 |
HPSE2 |
5.392e-03 | -5.22 | Kalirin_TRIO_SH3_2 | interpro domains | IPR047053 | 2 | 1 | 18521 | 50 |
KALRN |
5.392e-03 | -5.22 | MSI_RRM2 | interpro domains | IPR034126 | 2 | 1 | 18521 | 50 |
MSI2 |
5.392e-03 | -5.22 | Distrobrevin | interpro domains | IPR017432 | 2 | 1 | 18521 | 50 |
DTNA |
5.392e-03 | -5.22 | Kalirin_TRIO_SH3_1 | interpro domains | IPR028570 | 2 | 1 | 18521 | 50 |
KALRN |
5.392e-03 | -5.22 | Kalirin_TRIO_PH_1 | interpro domains | IPR047054 | 2 | 1 | 18521 | 50 |
KALRN |
5.392e-03 | -5.22 | Anc-1/SYNE1/2-like | interpro domains | IPR039906 | 2 | 1 | 18521 | 50 |
SYNE1 |
5.392e-03 | -5.22 | Formin_Cappuccino_subfam | interpro domains | IPR001265 | 2 | 1 | 18521 | 50 |
FMN2 |
5.392e-03 | -5.22 | Urea_transporter | interpro domains | IPR004937 | 2 | 1 | 18521 | 50 |
SLC14A1 |
5.392e-03 | -5.22 | LRP1-like_beta_prop | interpro domains | IPR032485 | 2 | 1 | 18521 | 50 |
LRP1B |
5.395e-03 | -5.22 | cyclic purine nucleotide metabolic process | biological process | GO:0052652 | 40 | 2 | 18204 | 50 |
RORA,ADCY2 |
5.409e-03 | -5.22 | histone H3T6 kinase activity | molecular function | GO:0035403 | 2 | 1 | 18094 | 49 |
PRKCA |
5.409e-03 | -5.22 | heparanase activity | molecular function | GO:0030305 | 2 | 1 | 18094 | 49 |
HPSE2 |
5.409e-03 | -5.22 | calcium,diacylglycerol-dependent serine/threonine kinase activity | molecular function | GO:0004698 | 2 | 1 | 18094 | 49 |
PRKCA |
5.462e-03 | -5.21 | lung-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-carcinoma-adenocarcinoma | 15133 | 49 | 16828 | 49 |
NRG3,GLIS3,SFXN5,NKAIN3,DGKG,FMN2,RPS6KA2,RYR3,PRKCA,NTM,DTNA,SYNE1,MSI2,SLC14A1,PARD3,DCLK2,KALRN,MGAT4C,PITPNC1,ERBB4,SLC4A4,NRXN1,ADCY2,LRP1B,GPC5,NDRG2,PSD2,ATP1A2,CAMK2G,GFAP,TRPM3,NTRK3,NEBL,RFX4,SORBS1,SLC1A2,NAV2,GPM6A,MACF1,RORA,ABLIM1,HPSE2,NPAS3,LSAMP,CDH20,CTNND2,TNC,NTRK2,SOX5 |
5.466e-03 | -5.21 | C2CD4B (C2 calcium dependent domain containing 4B) | protein interactions | 388125 | 43 | 2 | 19454 | 50 |
MACF1,LRP1B |
5.486e-03 | -5.21 | mesenchymal-epithelial cell signaling involved in prostate gland development | biological process | GO:0060739 | 2 | 1 | 18204 | 50 |
TNC |
5.486e-03 | -5.21 | negative regulation of mini excitatory postsynaptic potential | biological process | GO:0061886 | 2 | 1 | 18204 | 50 |
SYNE1 |
5.486e-03 | -5.21 | positive regulation of dense core granule biogenesis | biological process | GO:2000707 | 2 | 1 | 18204 | 50 |
PRKCA |
5.486e-03 | -5.21 | establishment of planar polarity involved in nephron morphogenesis | biological process | GO:0072046 | 2 | 1 | 18204 | 50 |
ERBB4 |
5.493e-03 | -5.20 | PK_Tyr_Ser-Thr | pfam domains | PF07714 | 130 | 3 | 17795 | 49 |
NTRK2,NTRK3,ERBB4 |
5.500e-03 | -5.20 | Glyco_hydro_79n | pfam domains | PF03662 | 2 | 1 | 17795 | 49 |
HPSE2 |
5.500e-03 | -5.20 | DUF5050 | pfam domains | PF16472 | 2 | 1 | 17795 | 49 |
LRP1B |
5.500e-03 | -5.20 | Par3_HAL_N_term | pfam domains | PF12053 | 2 | 1 | 17795 | 49 |
PARD3 |
5.500e-03 | -5.20 | SH3-RhoG_link | pfam domains | PF16609 | 2 | 1 | 17795 | 49 |
KALRN |
5.500e-03 | -5.20 | UT | pfam domains | PF03253 | 2 | 1 | 17795 | 49 |
SLC14A1 |
5.547e-03 | -5.19 | Ser-Thr/Tyr_kinase_cat_dom | interpro domains | IPR001245 | 133 | 3 | 18521 | 50 |
NTRK2,ERBB4,NTRK3 |
5.595e-03 | -5.19 | Melanogenesis | KEGG pathways | ko04916 | 101 | 3 | 7161 | 26 |
ADCY2,PRKCA,CAMK2G |
5.595e-03 | -5.19 | Melanogenesis | KEGG pathways | hsa04916 | 101 | 3 | 7161 | 26 |
ADCY2,PRKCA,CAMK2G |
5.658e-03 | -5.17 | sarcoplasmic reticulum membrane | cellular component | GO:0033017 | 43 | 2 | 19108 | 50 |
CAMK2G,RYR3 |
5.662e-03 | -5.17 | cyclic nucleotide metabolic process | biological process | GO:0009187 | 41 | 2 | 18204 | 50 |
ADCY2,RORA |
5.696e-03 | -5.17 | ARHGAP32 (Rho GTPase activating protein 32) | protein interactions | 9743 | 141 | 3 | 19454 | 50 |
PARD3,NTRK3,NTRK2 |
5.696e-03 | -5.17 | LLGL1 (LLGL scribble cell polarity complex component 1) | protein interactions | 3996 | 141 | 3 | 19454 | 50 |
NTRK2,NTRK3,PARD3 |
5.734e-03 | -5.16 | transport | biological process | GO:0006810 | 3615 | 18 | 18204 | 50 |
MACF1,RYR3,ATP1A2,FMN2,KALRN,NRXN1,NTRK2,PITPNC1,SLC1A2,SFXN5,SLC14A1,LRP1B,GPM6A,TRPM3,GFAP,SLC4A4,CAMK2G,ERBB4 |
5.744e-03 | -5.16 | Proteoglycans in cancer | KEGG pathways | ko05205 | 203 | 4 | 7161 | 26 |
HPSE2,ERBB4,CAMK2G,PRKCA |
5.744e-03 | -5.16 | Proteoglycans in cancer | KEGG pathways | hsa05205 | 203 | 4 | 7161 | 26 |
CAMK2G,PRKCA,HPSE2,ERBB4 |
5.752e-03 | -5.16 | middle_lobe | COSMIC cancer mutations | middle_lobe | 1382 | 10 | 16828 | 49 |
MACF1,NTRK3,RYR3,LRP1B,HPSE2,ERBB4,TRPM3,SYNE1,CTNND2,ATP1A2 |
5.755e-03 | -5.16 | clear_cell_renal_cell_carcinoma | COSMIC cancer mutations | clear_cell_renal_cell_carcinoma | 13924 | 47 | 16828 | 49 |
TNC,CTNND2,NTRK2,SOX5,LSAMP,NPAS3,CDH20,SORBS1,SLC1A2,ABLIM1,HPSE2,NAV2,GPM6A,MACF1,RORA,GFAP,TRPM3,NEBL,NTRK3,ATP1A2,PSD2,CAMK2G,ERBB4,SLC4A4,NRXN1,ADCY2,LRP1B,GPC5,NDRG2,MSI2,SLC14A1,PARD3,SYNE1,MGAT4C,PITPNC1,DCLK2,KALRN,NKAIN3,NRG3,GLIS3,SFXN5,DTNA,DGKG,FMN2,RPS6KA2,RYR3,PRKCA |
5.755e-03 | -5.16 | kidney-carcinoma-clear_cell_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-clear_cell_renal_cell_carcinoma | 13924 | 47 | 16828 | 49 |
NTRK2,SOX5,TNC,CTNND2,CDH20,LSAMP,NPAS3,ABLIM1,HPSE2,NAV2,GPM6A,MACF1,RORA,SORBS1,SLC1A2,NEBL,NTRK3,GFAP,TRPM3,CAMK2G,ATP1A2,PSD2,ADCY2,LRP1B,GPC5,NDRG2,ERBB4,SLC4A4,NRXN1,MGAT4C,PITPNC1,DCLK2,KALRN,MSI2,PARD3,SLC14A1,SYNE1,DTNA,FMN2,DGKG,RPS6KA2,RYR3,PRKCA,NKAIN3,NRG3,GLIS3,SFXN5 |
5.766e-03 | -5.16 | axon development | biological process | GO:0061564 | 420 | 5 | 18204 | 50 |
TNC,NRXN1,KALRN,CTNNA2,PARD3 |
5.867e-03 | -5.14 | protein serine/threonine kinase activity | molecular function | GO:0004674 | 428 | 5 | 18094 | 49 |
RPS6KA2,CAMK2G,PRKCA,KALRN,DCLK2 |
5.935e-03 | -5.13 | Schwann cell development | biological process | GO:0014044 | 42 | 2 | 18204 | 50 |
PARD3,NTRK2 |
5.946e-03 | -5.13 | calcium ion transmembrane transporter activity | molecular function | GO:0015085 | 136 | 3 | 18094 | 49 |
TRPM3,GPM6A,RYR3 |
6.035e-03 | -5.11 | Ig-like_dom | interpro domains | IPR007110 | 432 | 5 | 18521 | 50 |
LSAMP,NTRK3,KALRN,NTRK2,NTM |
6.037e-03 | -5.11 | Calml3 (calmodulin-like 3) | protein interactions | 70405 | 144 | 3 | 19454 | 50 |
ABLIM1,CAMK2G,MACF1 |
6.090e-03 | -5.10 | monoatomic ion transmembrane transport | biological process | GO:0034220 | 804 | 7 | 18204 | 50 |
SLC4A4,TRPM3,GPM6A,ATP1A2,SFXN5,SLC1A2,RYR3 |
6.102e-03 | -5.10 | sarcolemma | cellular component | GO:0042383 | 142 | 3 | 19108 | 50 |
RYR3,ATP1A2,DTNA |
6.210e-03 | -5.08 | Vinculin, Vh2 four-helix bundle | gene3d domains | 1.20.120.810 | 2 | 1 | 14470 | 45 |
CTNNA2 |
6.210e-03 | -5.08 | - | gene3d domains | 6.20.350.10 | 2 | 1 | 14470 | 45 |
RYR3 |
6.272e-03 | -5.07 | DSCR9 (Down syndrome critical region 9) | protein interactions | 257203 | 146 | 3 | 19454 | 50 |
KALRN,SYNE1,MACF1 |
6.285e-03 | -5.07 | Activation of NMDA receptor upon glutamate binding and postsynaptic events | REACTOME pathways | R-HSA-442755 | 41 | 2 | 10285 | 30 |
RPS6KA2,CAMK2G |
6.345e-03 | -5.06 | VEGFR2 mediated cell proliferation | REACTOME pathways | R-HSA-5218921 | 258 | 4 | 10285 | 30 |
PRKCA,CAMK2G,ERBB4,NRG3 |
6.348e-03 | -5.06 | VASP (vasodilator stimulated phosphoprotein) | protein interactions | 7408 | 288 | 4 | 19454 | 50 |
FMN2,PARD3,SORBS1,NEBL |
6.405e-03 | -5.05 | SH3 | prosite domains | PS50002 | 222 | 4 | 12186 | 41 |
MACF1,NEBL,KALRN,SORBS1 |
6.420e-03 | -5.05 | trans-synaptic signaling | biological process | GO:0099537 | 431 | 5 | 18204 | 50 |
RPS6KA2,DTNA,NRXN1,NTRK2,SLC1A2 |
6.435e-03 | -5.05 | cytoskeleton organization | biological process | GO:0007010 | 1251 | 9 | 18204 | 50 |
ABLIM1,SORBS1,CTNNA2,MACF1,GFAP,NEBL,PARD3,FMN2,DCLK2 |
6.454e-03 | -5.04 | leg | COSMIC cancer mutations | leg | 969 | 8 | 16828 | 49 |
FMN2,NTRK3,NTM,NEBL,LRP1B,NRG3,SLC4A4,SYNE1 |
6.493e-03 | -5.04 | spleen | COSMIC cancer mutations | spleen | 408 | 5 | 16828 | 49 |
LRP1B,ADCY2,NTM,SYNE1,SORBS1 |
6.498e-03 | -5.04 | positive regulation of glucose transmembrane transport | biological process | GO:0010828 | 44 | 2 | 18204 | 50 |
SLC1A2,SORBS1 |
6.500e-03 | -5.04 | CNTN1 (contactin 1) | protein interactions | 1272 | 47 | 2 | 19454 | 50 |
TNC,GPM6A |
6.500e-03 | -5.04 | GRIA1 (glutamate ionotropic receptor AMPA type subunit 1) | protein interactions | 2890 | 47 | 2 | 19454 | 50 |
PRKCA,CAMK2G |
6.512e-03 | -5.03 | PKP4 (plakophilin 4) | protein interactions | 8502 | 148 | 3 | 19454 | 50 |
RPS6KA2,PARD3,NTRK3 |
6.698e-03 | -5.01 | protein tyrosine kinase activity | molecular function | GO:0004713 | 142 | 3 | 18094 | 49 |
ERBB4,NTRK2,NTRK3 |
6.702e-03 | -5.01 | neurotransmitter transport | biological process | GO:0006836 | 140 | 3 | 18204 | 50 |
ATP1A2,NRXN1,SLC1A2 |
6.772e-03 | -4.99 | PAM (peptidylglycine alpha-amidating monooxygenase) | protein interactions | 5066 | 48 | 2 | 19454 | 50 |
PRKCA,KALRN |
6.788e-03 | -4.99 | acidic amino acid transport | biological process | GO:0015800 | 45 | 2 | 18204 | 50 |
NTRK2,SLC1A2 |
6.817e-03 | -4.99 | monoatomic cation transmembrane transporter activity | molecular function | GO:0008324 | 630 | 6 | 18094 | 49 |
SLC4A4,TRPM3,GPM6A,SLC1A2,RYR3,ATP1A2 |
6.853e-03 | -4.98 | cell-cell signaling | biological process | GO:0007267 | 822 | 7 | 18204 | 50 |
TNC,CAMK2G,NRXN1,DTNA,NTRK2,SLC1A2,RPS6KA2 |
6.870e-03 | -4.98 | uveal_tract | COSMIC cancer mutations | uveal_tract | 587 | 6 | 16828 | 49 |
ADCY2,NTRK3,CTNND2,KALRN,TRPM3,MACF1 |
6.875e-03 | -4.98 | transmembrane transport | biological process | GO:0055085 | 1264 | 9 | 18204 | 50 |
RYR3,SLC14A1,SFXN5,SLC1A2,ATP1A2,GPM6A,SLC4A4,TRPM3,GFAP |
6.876e-03 | -4.98 | FORMIN | prints domains | PR00828 | 2 | 1 | 5227 | 18 |
FMN2 |
6.881e-03 | -4.98 | TNIK (TRAF2 and NCK interacting kinase) | protein interactions | 23043 | 151 | 3 | 19454 | 50 |
MACF1,SYNE1,NTRK3 |
6.881e-03 | -4.98 | NISCH (nischarin) | protein interactions | 11188 | 151 | 3 | 19454 | 50 |
NTRK2,NTRK3,RPS6KA2 |
6.919e-03 | -4.97 | membrane raft | cellular component | GO:0045121 | 290 | 4 | 19108 | 50 |
SLC1A2,ATP1A2,SORBS1,ADCY2 |
6.932e-03 | -4.97 | embryonal | COSMIC cancer mutations | embryonal | 2659 | 15 | 16828 | 49 |
GLIS3,NPAS3,TRPM3,ADCY2,LRP1B,RYR3,FMN2,TNC,CTNND2,SYNE1,SORBS1,RORA,NAV2,CAMK2G,MACF1 |
6.932e-03 | -4.97 | soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal | COSMIC cancer mutations | soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal | 2659 | 15 | 16828 | 49 |
NPAS3,GLIS3,TRPM3,FMN2,RYR3,ADCY2,LRP1B,SORBS1,CTNND2,SYNE1,TNC,NAV2,CAMK2G,MACF1,RORA |
6.994e-03 | -4.96 | intracellular signal transduction | biological process | GO:0035556 | 1505 | 10 | 18204 | 50 |
RYR3,RPS6KA2,ADCY2,PRKCA,DCLK2,ATP1A2,FMN2,NRG3,KALRN,DGKG |
7.007e-03 | -4.96 | STMN1 (stathmin 1) | protein interactions | 3925 | 152 | 3 | 19454 | 50 |
CAMK2G,PRKCA,DTNA |
7.086e-03 | -4.95 | membrane microdomain | cellular component | GO:0098857 | 292 | 4 | 19108 | 50 |
SORBS1,ADCY2,SLC1A2,ATP1A2 |
7.095e-03 | -4.95 | enzyme-linked receptor protein signaling pathway | biological process | GO:0007167 | 626 | 6 | 18204 | 50 |
NTRK2,SORBS1,NRG3,NTRK3,ERBB4,KALRN |
7.119e-03 | -4.94 | oligoastrocytoma_Grade_III | COSMIC cancer mutations | oligoastrocytoma_Grade_III | 263 | 4 | 16828 | 49 |
SYNE1,RYR3,SOX5,SLC1A2 |
7.191e-03 | -4.93 | cell morphogenesis involved in neuron differentiation | biological process | GO:0048667 | 443 | 5 | 18204 | 50 |
NRXN1,KALRN,PARD3,CTNNA2,CTNND2 |
7.213e-03 | -4.93 | skin-acral-malignant_melanoma | COSMIC cancer mutations | skin-acral-malignant_melanoma | 264 | 4 | 16828 | 49 |
CDH20,PARD3,FMN2,PSD2 |
7.330e-03 | -4.92 | C1GALT1 (core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1) | protein interactions | 56913 | 50 | 2 | 19454 | 50 |
SLC14A1,NTRK3 |
7.386e-03 | -4.91 | regulation of neuron migration | biological process | GO:2001222 | 47 | 2 | 18204 | 50 |
NRG3,CTNNA2 |
7.386e-03 | -4.91 | Schwann cell differentiation | biological process | GO:0014037 | 47 | 2 | 18204 | 50 |
NTRK2,PARD3 |
7.404e-03 | -4.91 | large_intestine-adenoma | COSMIC cancer mutations | large_intestine-adenoma | 266 | 4 | 16828 | 49 |
SOX5,RYR3,LRP1B,CDH20 |
7.436e-03 | -4.90 | RET signaling | REACTOME pathways | R-HSA-8853659 | 270 | 4 | 10285 | 30 |
ERBB4,NRG3,PRKCA,CAMK2G |
7.452e-03 | -4.90 | Cholinergic synapse | KEGG pathways | hsa04725 | 112 | 3 | 7161 | 26 |
CAMK2G,PRKCA,ADCY2 |
7.521e-03 | -4.89 | adult behavior | biological process | GO:0030534 | 146 | 3 | 18204 | 50 |
SLC1A2,NRXN1,ATP1A2 |
7.525e-03 | -4.89 | CEP19 (centrosomal protein 19) | protein interactions | 84984 | 156 | 3 | 19454 | 50 |
FMN2,PARD3,ABLIM1 |
7.585e-03 | -4.88 | oesophagus-lower_third-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-lower_third-carcinoma-squamous_cell_carcinoma | 3507 | 18 | 16828 | 49 |
HPSE2,DCLK2,MACF1,NAV2,ATP1A2,PARD3,SYNE1,CTNND2,GPC5,LRP1B,ADCY2,DGKG,FMN2,RYR3,ERBB4,TRPM3,SLC4A4,NPAS3 |
7.592e-03 | -4.88 | haematopoietic_and_lymphoid_tissue-small_intestine-lymphoid_neoplasm-enteropathy_type_T_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-small_intestine-lymphoid_neoplasm-enteropathy_type_T_cell_lymphoma | 45 | 2 | 16828 | 49 |
MGAT4C,MACF1 |
7.592e-03 | -4.88 | enteropathy_type_T_cell_lymphoma | COSMIC cancer mutations | enteropathy_type_T_cell_lymphoma | 45 | 2 | 16828 | 49 |
MGAT4C,MACF1 |
7.599e-03 | -4.88 | acral | COSMIC cancer mutations | acral | 268 | 4 | 16828 | 49 |
CDH20,PARD3,FMN2,PSD2 |
7.617e-03 | -4.88 | LINGO1 (leucine rich repeat and Ig domain containing 1) | protein interactions | 84894 | 51 | 2 | 19454 | 50 |
NTRK3,NTM |
7.617e-03 | -4.88 | FAM171B (family with sequence similarity 171 member B) | protein interactions | 165215 | 51 | 2 | 19454 | 50 |
NTRK2,PARD3 |
7.691e-03 | -4.87 | Spop (speckle-type BTB/POZ protein) | protein interactions | 20747 | 3 | 1 | 19454 | 50 |
GLIS3 |
7.691e-03 | -4.87 | NRG3 (neuregulin 3) | protein interactions | 10718 | 3 | 1 | 19454 | 50 |
ERBB4 |
7.691e-03 | -4.87 | QRFPR (pyroglutamylated RFamide peptide receptor) | protein interactions | 84109 | 3 | 1 | 19454 | 50 |
NTM |
7.691e-03 | -4.87 | BCO1 (beta-carotene oxygenase 1) | protein interactions | 53630 | 3 | 1 | 19454 | 50 |
ABLIM1 |
7.691e-03 | -4.87 | Lrrc7 (leucine rich repeat containing 7) | protein interactions | 117284 | 3 | 1 | 19454 | 50 |
CAMK2G |
7.691e-03 | -4.87 | Itgb1 (integrin subunit beta 1) | protein interactions | 24511 | 3 | 1 | 19454 | 50 |
TNC |
7.691e-03 | -4.87 | TULP1 (TUB like protein 1) | protein interactions | 7287 | 3 | 1 | 19454 | 50 |
NRXN1 |
7.691e-03 | -4.87 | Grm5 (glutamate metabotropic receptor 5) | protein interactions | 24418 | 3 | 1 | 19454 | 50 |
PRKCA |
7.746e-03 | -4.86 | cytoskeleton | cellular component | GO:0005856 | 2412 | 13 | 19108 | 50 |
PARD3,ABLIM1,NEBL,DGKG,GFAP,MACF1,KALRN,FMN2,PRKCA,DTNA,CTNNA2,SYNE1,SORBS1 |
7.782e-03 | -4.86 | signal transduction | biological process | GO:0007165 | 4637 | 21 | 18204 | 50 |
RPS6KA2,RYR3,MACF1,PRKCA,SORBS1,NDRG2,FMN2,ATP1A2,DCLK2,NRG3,RORA,KALRN,CTNND2,ADCY2,NTRK2,PITPNC1,PARD3,DTNA,NTRK3,DGKG,ERBB4 |
7.809e-03 | -4.85 | Aldosterone-regulated sodium reabsorption | KEGG pathways | hsa04960 | 37 | 2 | 7161 | 26 |
ATP1A2,PRKCA |
7.809e-03 | -4.85 | Aldosterone-regulated sodium reabsorption | KEGG pathways | ko04960 | 37 | 2 | 7161 | 26 |
ATP1A2,PRKCA |
7.825e-03 | -4.85 | Glutamatergic synapse | KEGG pathways | ko04724 | 114 | 3 | 7161 | 26 |
PRKCA,SLC1A2,ADCY2 |
7.825e-03 | -4.85 | Glutamatergic synapse | KEGG pathways | hsa04724 | 114 | 3 | 7161 | 26 |
SLC1A2,ADCY2,PRKCA |
7.830e-03 | -4.85 | alphav-beta3 integrin-PKCalpha complex | cellular component | GO:0035866 | 3 | 1 | 19108 | 50 |
PRKCA |
7.881e-03 | -4.84 | Syndecan-4-mediated signaling events | Pathway Interaction DB | syndecan_4_pathway | 31 | 2 | 2226 | 10 |
TNC,PRKCA |
7.909e-03 | -4.84 | SNAP91 (synaptosome associated protein 91) | protein interactions | 9892 | 52 | 2 | 19454 | 50 |
GPM6A,ERBB4 |
7.928e-03 | -4.84 | ABLIM1 (actin binding LIM protein 1) | protein interactions | 3983 | 159 | 3 | 19454 | 50 |
GFAP,NTRK3,NTRK2 |
7.964e-03 | -4.83 | Cardiac conduction | REACTOME pathways | R-HSA-5576891 | 142 | 3 | 10285 | 30 |
ATP1A2,CAMK2G,RYR3 |
7.984e-03 | -4.83 | eye | COSMIC cancer mutations | eye | 606 | 6 | 16828 | 49 |
MACF1,TRPM3,KALRN,NTRK3,CTNND2,ADCY2 |
8.007e-03 | -4.83 | modulation of excitatory postsynaptic potential | biological process | GO:0098815 | 49 | 2 | 18204 | 50 |
NRXN1,SYNE1 |
8.021e-03 | -4.83 | YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta) | protein interactions | 7534 | 1138 | 8 | 19454 | 50 |
SORBS1,CAMK2G,MACF1,PARD3,ABLIM1,PRKCA,PITPNC1,NAV2 |
8.021e-03 | -4.83 | skin-neck-malignant_melanoma | COSMIC cancer mutations | skin-neck-malignant_melanoma | 1223 | 9 | 16828 | 49 |
ADCY2,GPC5,LRP1B,TNC,ATP1A2,ERBB4,CTNND2,TRPM3,SYNE1 |
8.078e-03 | -4.82 | SoHo_dom | interpro domains | IPR003127 | 3 | 1 | 18521 | 50 |
SORBS1 |
8.078e-03 | -4.82 | SPRY3_RyR | interpro domains | IPR035762 | 3 | 1 | 18521 | 50 |
RYR3 |
8.078e-03 | -4.82 | Ryanodine_rcpt | interpro domains | IPR003032 | 3 | 1 | 18521 | 50 |
RYR3 |
8.078e-03 | -4.82 | Nav/unc-53 | interpro domains | IPR039041 | 3 | 1 | 18521 | 50 |
NAV2 |
8.078e-03 | -4.82 | NR_DBD_ROR | interpro domains | IPR044101 | 3 | 1 | 18521 | 50 |
RORA |
8.078e-03 | -4.82 | TM_ErbB1 | interpro domains | IPR049328 | 3 | 1 | 18521 | 50 |
ERBB4 |
8.078e-03 | -4.82 | Neuregulin | interpro domains | IPR040180 | 3 | 1 | 18521 | 50 |
NRG3 |
8.078e-03 | -4.82 | Ryanrecept_TM4-6 | interpro domains | IPR009460 | 3 | 1 | 18521 | 50 |
RYR3 |
8.078e-03 | -4.82 | Ryan_recept | interpro domains | IPR013333 | 3 | 1 | 18521 | 50 |
RYR3 |
8.078e-03 | -4.82 | AKAP6/CEP68 | interpro domains | IPR026696 | 3 | 1 | 18521 | 50 |
SYNE1 |
8.078e-03 | -4.82 | SPRY1_RyR | interpro domains | IPR035761 | 3 | 1 | 18521 | 50 |
RYR3 |
8.078e-03 | -4.82 | RYDR_Jsol | interpro domains | IPR048581 | 3 | 1 | 18521 | 50 |
RYR3 |
8.078e-03 | -4.82 | Protein_kinase_C_a/b/g | interpro domains | IPR014375 | 3 | 1 | 18521 | 50 |
PRKCA |
8.078e-03 | -4.82 | Myelin_PLP | interpro domains | IPR001614 | 3 | 1 | 18521 | 50 |
GPM6A |
8.078e-03 | -4.82 | SPRY2_RyR | interpro domains | IPR035764 | 3 | 1 | 18521 | 50 |
RYR3 |
8.078e-03 | -4.82 | Myelin_PLP_CS | interpro domains | IPR018237 | 3 | 1 | 18521 | 50 |
GPM6A |
8.078e-03 | -4.82 | Vinculin_CS | interpro domains | IPR000633 | 3 | 1 | 18521 | 50 |
CTNNA2 |
8.078e-03 | -4.82 | DAG_kinase_typeI_N | interpro domains | IPR029477 | 3 | 1 | 18521 | 50 |
DGKG |
8.078e-03 | -4.82 | DGK_typeI_N_sf | interpro domains | IPR038199 | 3 | 1 | 18521 | 50 |
DGKG |
8.078e-03 | -4.82 | ROR_rcpt | interpro domains | IPR003079 | 3 | 1 | 18521 | 50 |
RORA |
8.097e-03 | -4.82 | regulation of nervous system development | biological process | GO:0051960 | 456 | 5 | 18204 | 50 |
MACF1,PARD3,GFAP,NRXN1,NTRK2 |
8.103e-03 | -4.82 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity | molecular function | GO:0008454 | 3 | 1 | 18094 | 49 |
MGAT4C |
8.103e-03 | -4.82 | cysteine transmembrane transporter activity | molecular function | GO:0033229 | 3 | 1 | 18094 | 49 |
SLC1A2 |
8.103e-03 | -4.82 | epidermal growth factor receptor activity | molecular function | GO:0005006 | 3 | 1 | 18094 | 49 |
ERBB4 |
8.103e-03 | -4.82 | urea channel activity | molecular function | GO:0015265 | 3 | 1 | 18094 | 49 |
SLC14A1 |
8.103e-03 | -4.82 | neuregulin receptor activity | molecular function | GO:0038131 | 3 | 1 | 18094 | 49 |
ERBB4 |
8.196e-03 | -4.80 | PLC beta mediated events | REACTOME pathways | R-HSA-112043 | 47 | 2 | 10285 | 30 |
ADCY2,PRKCA |
8.206e-03 | -4.80 | GOLGA6A (golgin A6 family member A) | protein interactions | 342096 | 53 | 2 | 19454 | 50 |
GFAP,NEBL |
8.218e-03 | -4.80 | meiotic chromosome movement towards spindle pole | biological process | GO:0016344 | 3 | 1 | 18204 | 50 |
FMN2 |
8.218e-03 | -4.80 | trans-synaptic signaling by BDNF, modulating synaptic transmission | biological process | GO:0099183 | 3 | 1 | 18204 | 50 |
NTRK2 |
8.218e-03 | -4.80 | formin-nucleated actin cable assembly | biological process | GO:0070649 | 3 | 1 | 18204 | 50 |
FMN2 |
8.218e-03 | -4.80 | regulation of calcium:sodium antiporter activity | biological process | GO:1903279 | 3 | 1 | 18204 | 50 |
ATP1A2 |
8.218e-03 | -4.80 | central nervous system morphogenesis | biological process | GO:0021551 | 3 | 1 | 18204 | 50 |
ERBB4 |
8.218e-03 | -4.80 | regulation of platelet-derived growth factor production | biological process | GO:0090361 | 3 | 1 | 18204 | 50 |
NDRG2 |
8.218e-03 | -4.80 | regulation of dense core granule biogenesis | biological process | GO:2000705 | 3 | 1 | 18204 | 50 |
PRKCA |
8.218e-03 | -4.80 | formin-nucleated actin cable organization | biological process | GO:0110009 | 3 | 1 | 18204 | 50 |
FMN2 |
8.218e-03 | -4.80 | cysteine transport | biological process | GO:0042883 | 3 | 1 | 18204 | 50 |
SLC1A2 |
8.218e-03 | -4.80 | bud outgrowth involved in lung branching | biological process | GO:0060447 | 3 | 1 | 18204 | 50 |
TNC |
8.218e-03 | -4.80 | Schwann cell proliferation | biological process | GO:0014010 | 3 | 1 | 18204 | 50 |
GFAP |
8.218e-03 | -4.80 | cysteine transmembrane transport | biological process | GO:1903712 | 3 | 1 | 18204 | 50 |
SLC1A2 |
8.218e-03 | -4.80 | positive regulation of Schwann cell proliferation | biological process | GO:0010625 | 3 | 1 | 18204 | 50 |
GFAP |
8.218e-03 | -4.80 | radial glia guided migration of Purkinje cell | biological process | GO:0021942 | 3 | 1 | 18204 | 50 |
CTNNA2 |
8.218e-03 | -4.80 | vagus nerve development | biological process | GO:0021564 | 3 | 1 | 18204 | 50 |
NAV2 |
8.218e-03 | -4.80 | neuroligin clustering involved in postsynaptic membrane assembly | biological process | GO:0097118 | 3 | 1 | 18204 | 50 |
NRXN1 |
8.218e-03 | -4.80 | mammary placode formation | biological process | GO:0060596 | 3 | 1 | 18204 | 50 |
NRG3 |
8.218e-03 | -4.80 | cardiac muscle thin filament assembly | biological process | GO:0071691 | 3 | 1 | 18204 | 50 |
NEBL |
8.218e-03 | -4.80 | nuclear matrix anchoring at nuclear membrane | biological process | GO:0090292 | 3 | 1 | 18204 | 50 |
SYNE1 |
8.238e-03 | -4.80 | RyR | pfam domains | PF02026 | 3 | 1 | 17795 | 49 |
RYR3 |
8.238e-03 | -4.80 | Myelin_PLP | pfam domains | PF01275 | 3 | 1 | 17795 | 49 |
GPM6A |
8.238e-03 | -4.80 | RYDR_Jsol | pfam domains | PF21119 | 3 | 1 | 17795 | 49 |
RYR3 |
8.238e-03 | -4.80 | RR_TM4-6 | pfam domains | PF06459 | 3 | 1 | 17795 | 49 |
RYR3 |
8.238e-03 | -4.80 | DAG_kinase_N | pfam domains | PF14513 | 3 | 1 | 17795 | 49 |
DGKG |
8.238e-03 | -4.80 | SR_plectin_7 | pfam domains | PF21097 | 3 | 1 | 17795 | 49 |
MACF1 |
8.238e-03 | -4.80 | TM_ErbB1 | pfam domains | PF21314 | 3 | 1 | 17795 | 49 |
ERBB4 |
8.238e-03 | -4.80 | Sorb | pfam domains | PF02208 | 3 | 1 | 17795 | 49 |
SORBS1 |
8.317e-03 | -4.79 | synaptic signaling | biological process | GO:0099536 | 459 | 5 | 18204 | 50 |
RPS6KA2,DTNA,NTRK2,SLC1A2,NRXN1 |
8.327e-03 | -4.79 | cellular response to nerve growth factor stimulus | biological process | GO:1990090 | 50 | 2 | 18204 | 50 |
NTRK3,NTRK2 |
8.343e-03 | -4.79 | CCDC57 (coiled-coil domain containing 57) | protein interactions | 284001 | 162 | 3 | 19454 | 50 |
GFAP,ABLIM1,DCLK2 |
8.358e-03 | -4.78 | neck | COSMIC cancer mutations | neck | 1231 | 9 | 16828 | 49 |
ERBB4,CTNND2,TRPM3,SYNE1,TNC,ATP1A2,ADCY2,GPC5,LRP1B |
8.373e-03 | -4.78 | PRKCI (protein kinase C iota) | protein interactions | 5584 | 312 | 4 | 19454 | 50 |
PRKCA,NTRK3,PARD3,NTRK2 |
8.537e-03 | -4.76 | G alpha (z) signalling events | REACTOME pathways | R-HSA-418597 | 48 | 2 | 10285 | 30 |
PRKCA,ADCY2 |
8.537e-03 | -4.76 | G-protein mediated events | REACTOME pathways | R-HSA-112040 | 48 | 2 | 10285 | 30 |
ADCY2,PRKCA |
8.603e-03 | -4.76 | central_nervous_system-temporoparietal-glioma-astrocytoma_Grade_IV | COSMIC cancer mutations | central_nervous_system-temporoparietal-glioma-astrocytoma_Grade_IV | 48 | 2 | 16828 | 49 |
RYR3,PARD3 |
8.613e-03 | -4.75 | thyroid-carcinoma | COSMIC cancer mutations | thyroid-carcinoma | 4126 | 20 | 16828 | 49 |
GPC5,DTNA,LRP1B,ADCY2,RYR3,NTRK3,DGKG,LSAMP,TRPM3,NRXN1,GLIS3,ERBB4,SOX5,MACF1,NAV2,ATP1A2,PARD3,SYNE1,PSD2,CTNND2 |
8.617e-03 | -4.75 | regulation of membrane potential | biological process | GO:0042391 | 463 | 5 | 18204 | 50 |
SYNE1,ATP1A2,NRXN1,SLC4A4,NTRK2 |
8.627e-03 | -4.75 | LRBA (LPS responsive beige-like anchor protein) | protein interactions | 987 | 164 | 3 | 19454 | 50 |
MACF1,NTRK3,NTRK2 |
8.658e-03 | -4.75 | S_TKc | smart domains | SM00220 | 348 | 5 | 9717 | 36 |
KALRN,DCLK2,PRKCA,RPS6KA2,CAMK2G |
8.667e-03 | -4.75 | anchoring junction | cellular component | GO:0070161 | 902 | 7 | 19108 | 50 |
TNC,CDH20,PARD3,CTNNA2,ATP1A2,CTNND2,SORBS1 |
8.702e-03 | -4.74 | learning | biological process | GO:0007612 | 154 | 3 | 18204 | 50 |
ATP1A2,NRXN1,NTRK2 |
8.748e-03 | -4.74 | ZYX (zyxin) | protein interactions | 7791 | 316 | 4 | 19454 | 50 |
SORBS1,MACF1,NEBL,ABLIM1 |
8.771e-03 | -4.74 | positive regulation of nervous system development | biological process | GO:0051962 | 296 | 4 | 18204 | 50 |
MACF1,NTRK2,GFAP,NRXN1 |
8.814e-03 | -4.73 | PLCB1 (phospholipase C beta 1) | protein interactions | 23236 | 55 | 2 | 19454 | 50 |
PRKCA,PARD3 |
8.814e-03 | -4.73 | SYN1 (synapsin I) | protein interactions | 6853 | 55 | 2 | 19454 | 50 |
GPM6A,CAMK2G |
8.836e-03 | -4.73 | skin-back-malignant_melanoma | COSMIC cancer mutations | skin-back-malignant_melanoma | 280 | 4 | 16828 | 49 |
ERBB4,SYNE1,LRP1B,ATP1A2 |
8.841e-03 | -4.73 | neuronal cell body | cellular component | GO:0043025 | 489 | 5 | 19108 | 50 |
PSD2,GPM6A,ATP1A2,NRXN1,CTNND2 |
8.857e-03 | -4.73 | regeneration | biological process | GO:0031099 | 155 | 3 | 18204 | 50 |
ERBB4,TNC,GFAP |
8.869e-03 | -4.73 | mannosyl-glycoprotein N-acetylglucosaminyltransferases | BIOCYC pathways | META_PWY-7426 | 8 | 1 | 902 | 1 |
MGAT4C |
8.873e-03 | -4.72 | carboxylic acid transport | biological process | GO:0046942 | 297 | 4 | 18204 | 50 |
GFAP,SFXN5,SLC1A2,NTRK2 |
8.917e-03 | -4.72 | SCLT1 (sodium channel and clathrin linker 1) | protein interactions | 132320 | 166 | 3 | 19454 | 50 |
ATP1A2,NEBL,ABLIM1 |
8.972e-03 | -4.71 | sodium ion transmembrane transporter activity | molecular function | GO:0015081 | 158 | 3 | 18094 | 49 |
SLC4A4,SLC1A2,ATP1A2 |
8.972e-03 | -4.71 | integrin binding | molecular function | GO:0005178 | 158 | 3 | 18094 | 49 |
PRKCA,TNC,GFAP |
8.976e-03 | -4.71 | organic acid transport | biological process | GO:0015849 | 298 | 4 | 18204 | 50 |
GFAP,NTRK2,SLC1A2,SFXN5 |
8.982e-03 | -4.71 | response to nerve growth factor | biological process | GO:1990089 | 52 | 2 | 18204 | 50 |
NTRK3,NTRK2 |
9.008e-03 | -4.71 | Oocyte meiosis | KEGG pathways | ko04114 | 120 | 3 | 7161 | 26 |
CAMK2G,RPS6KA2,ADCY2 |
9.008e-03 | -4.71 | Oocyte meiosis | KEGG pathways | hsa04114 | 120 | 3 | 7161 | 26 |
ADCY2,CAMK2G,RPS6KA2 |
9.053e-03 | -4.70 | CTNNB1 (catenin beta 1) | protein interactions | 1499 | 926 | 7 | 19454 | 50 |
DTNA,CTNND2,PRKCA,NTRK3,CTNNA2,SORBS1,PARD3 |
9.125e-03 | -4.70 | L1CAM (L1 cell adhesion molecule) | protein interactions | 3897 | 56 | 2 | 19454 | 50 |
RPS6KA2,GPM6A |
9.156e-03 | -4.69 | ear | COSMIC cancer mutations | ear | 624 | 6 | 16828 | 49 |
RPS6KA2,MGAT4C,LRP1B,NPAS3,SLC14A1,TNC |
9.171e-03 | -4.69 | positive regulation of synaptic transmission | biological process | GO:0050806 | 157 | 3 | 18204 | 50 |
NTRK2,NRXN1,GFAP |
9.212e-03 | -4.69 | GAB1 (GRB2 associated binding protein 1) | protein interactions | 2549 | 168 | 3 | 19454 | 50 |
NTRK3,PARD3,NTRK2 |
9.231e-03 | -4.69 | ACTA1 (actin alpha 1, skeletal muscle) | protein interactions | 58 | 321 | 4 | 19454 | 50 |
DTNA,MACF1,PRKCA,SORBS1 |
9.295e-03 | -4.68 | MAPRE1 (microtubule associated protein RP/EB family member 1) | protein interactions | 22919 | 504 | 5 | 19454 | 50 |
NAV2,CAMK2G,MACF1,PRKCA,ABLIM1 |
9.301e-03 | -4.68 | - | gene3d domains | 1.10.490.160 | 3 | 1 | 14470 | 45 |
RYR3 |
9.301e-03 | -4.68 | - | gene3d domains | 6.10.250.2510 | 3 | 1 | 14470 | 45 |
CTNNA2 |
9.301e-03 | -4.68 | Diacylglycerol kinase alpha | gene3d domains | 1.10.238.110 | 3 | 1 | 14470 | 45 |
DGKG |
9.337e-03 | -4.67 | transmembrane transporter activity | molecular function | GO:0022857 | 1110 | 8 | 18094 | 49 |
SLC1A2,ATP1A2,RYR3,SLC4A4,SFXN5,GPM6A,SLC14A1,TRPM3 |
9.346e-03 | -4.67 | LRRNT | interpro domains | IPR000372 | 54 | 2 | 18521 | 50 |
NTRK2,NTRK3 |
9.361e-03 | -4.67 | PIAS2 (protein inhibitor of activated STAT 2) | protein interactions | 9063 | 169 | 3 | 19454 | 50 |
SOX5,NAV2,GFAP |
9.401e-03 | -4.67 | postsynaptic density | cellular component | GO:0014069 | 317 | 4 | 19108 | 50 |
ERBB4,KALRN,CTNND2,NTRK2 |
9.442e-03 | -4.66 | NXPH3 (neurexophilin 3) | protein interactions | 11248 | 57 | 2 | 19454 | 50 |
CTNNA2,NRXN1 |
9.520e-03 | -4.65 | MAPK family signaling cascades | REACTOME pathways | R-HSA-5683057 | 290 | 4 | 10285 | 30 |
CAMK2G,ERBB4,KALRN,NRG3 |
9.616e-03 | -4.64 | lung-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-squamous_cell_carcinoma | 14664 | 48 | 16828 | 49 |
NPAS3,LSAMP,CDH20,CTNND2,TNC,NTRK2,SOX5,TRPM3,GFAP,NTRK3,RFX4,NEBL,SLC1A2,SORBS1,MACF1,GPM6A,NAV2,RORA,ABLIM1,HPSE2,ERBB4,NRXN1,SLC4A4,GPC5,LRP1B,ADCY2,PSD2,ATP1A2,CAMK2G,NRG3,SFXN5,GLIS3,NKAIN3,RPS6KA2,DGKG,FMN2,NTM,PRKCA,RYR3,DTNA,SYNE1,MSI2,PARD3,SLC14A1,DCLK2,KALRN,MGAT4C,PITPNC1 |
9.665e-03 | -4.64 | PPFIBP1 (PPFIA binding protein 1) | protein interactions | 8496 | 171 | 3 | 19454 | 50 |
RPS6KA2,NTRK2,PARD3 |
9.682e-03 | -4.64 | AGC-kinase_C | interpro domains | IPR000961 | 55 | 2 | 18521 | 50 |
RPS6KA2,PRKCA |
9.703e-03 | -4.64 | C1_1 | pfam domains | PF00130 | 54 | 2 | 17795 | 49 |
PRKCA,DGKG |
9.714e-03 | -4.63 | cell motility | biological process | GO:0048870 | 1101 | 8 | 18204 | 50 |
CTNNA2,NTRK2,CDH20,NRG3,GPM6A,FMN2,ERBB4,GPC5 |
9.763e-03 | -4.63 | GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B) | protein interactions | 2904 | 58 | 2 | 19454 | 50 |
CAMK2G,PRKCA |
9.763e-03 | -4.63 | SNAP25 (synaptosome associated protein 25) | protein interactions | 6616 | 58 | 2 | 19454 | 50 |
GPM6A,PRKCA |
9.763e-03 | -4.63 | CILK1 (ciliogenesis associated kinase 1) | protein interactions | 22858 | 58 | 2 | 19454 | 50 |
CAMK2G,MSI2 |
9.770e-03 | -4.63 | regulation of response to stimulus | biological process | GO:0048583 | 4104 | 19 | 18204 | 50 |
MACF1,SORBS1,PRKCA,NDRG2,FMN2,KALRN,NRXN1,RORA,GPC5,TNC,SYNE1,CTNNA2,PSD2,CTNND2,NTRK2,NTRK3,DGKG,CAMK2G,ERBB4 |
9.774e-03 | -4.63 | nucleotide binding | molecular function | GO:0000166 | 2128 | 12 | 18094 | 49 |
NAV2,ATP1A2,CAMK2G,NTRK3,NTRK2,RPS6KA2,DCLK2,DGKG,ERBB4,KALRN,PRKCA,ADCY2 |
9.810e-03 | -4.62 | nucleoside phosphate binding | molecular function | GO:1901265 | 2129 | 12 | 18094 | 49 |
ATP1A2,NAV2,DGKG,DCLK2,RPS6KA2,NTRK3,NTRK2,CAMK2G,KALRN,PRKCA,ERBB4,ADCY2 |
9.833e-03 | -4.62 | APC (APC regulator of WNT signaling pathway) | protein interactions | 324 | 327 | 4 | 19454 | 50 |
PARD3,NAV2,SYNE1,MACF1 |
9.833e-03 | -4.62 | ROR2 (receptor tyrosine kinase like orphan receptor 2) | protein interactions | 4920 | 327 | 4 | 19454 | 50 |
RPS6KA2,DTNA,SORBS1,PARD3 |
9.942e-03 | -4.61 | EF-hand | gene3d domains | 1.10.238.10 | 272 | 4 | 14470 | 45 |
DGKG,RYR3,DTNA,MACF1 |
9.975e-03 | -4.61 | LSR (lipolysis stimulated lipoprotein receptor) | protein interactions | 51599 | 173 | 3 | 19454 | 50 |
NTRK2,PARD3,NTRK3 |
9.984e-03 | -4.61 | Developmental Biology | REACTOME pathways | R-HSA-1266738 | 1075 | 8 | 10285 | 30 |
NRG3,ABLIM1,ERBB4,KALRN,RPS6KA2,CTNNA2,PRKCA,CAMK2G |
1.006e-02 | -4.60 | MYELIN_PLP_1 | prosite domains | PS00575 | 3 | 1 | 12186 | 41 |
GPM6A |
1.006e-02 | -4.60 | MYELIN_PLP_2 | prosite domains | PS01004 | 3 | 1 | 12186 | 41 |
GPM6A |
1.006e-02 | -4.60 | SOHO | prosite domains | PS50831 | 3 | 1 | 12186 | 41 |
SORBS1 |
1.006e-02 | -4.60 | VINCULIN_1 | prosite domains | PS00663 | 3 | 1 | 12186 | 41 |
CTNNA2 |
1.009e-02 | -4.60 | HTATIP2 (HIV-1 Tat interactive protein 2) | protein interactions | 10553 | 59 | 2 | 19454 | 50 |
PRKCA,PITPNC1 |
1.009e-02 | -4.60 | ADAM17 (ADAM metallopeptidase domain 17) | protein interactions | 6868 | 59 | 2 | 19454 | 50 |
ERBB4,CAMK2G |
1.013e-02 | -4.59 | CDCA3 (cell division cycle associated 3) | protein interactions | 83461 | 174 | 3 | 19454 | 50 |
RPS6KA2,NTRK3,NTRK2 |
1.013e-02 | -4.59 | APPL1 (adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1) | protein interactions | 26060 | 174 | 3 | 19454 | 50 |
NTRK2,NTRK3,DTNA |
1.024e-02 | -4.58 | IGKV@ (immunoglobulin kappa variable cluster) | protein interactions | 3519 | 4 | 1 | 19454 | 50 |
LRP1B |
1.024e-02 | -4.58 | Pick1 (protein interacting with PRKCA 1) | protein interactions | 84591 | 4 | 1 | 19454 | 50 |
PRKCA |
1.024e-02 | -4.58 | AVPR1A (arginine vasopressin receptor 1A) | protein interactions | 552 | 4 | 1 | 19454 | 50 |
PRKCA |
1.024e-02 | -4.58 | CALML4 (calmodulin like 4) | protein interactions | 91860 | 4 | 1 | 19454 | 50 |
CAMK2G |
1.024e-02 | -4.58 | CCDC126 (coiled-coil domain containing 126) | protein interactions | 90693 | 4 | 1 | 19454 | 50 |
GPM6A |
1.024e-02 | -4.58 | Nme2 (NME/NM23 nucleoside diphosphate kinase 2) | protein interactions | 18103 | 4 | 1 | 19454 | 50 |
RORA |
1.024e-02 | -4.58 | Ngfr (nerve growth factor receptor) | protein interactions | 24596 | 4 | 1 | 19454 | 50 |
NTRK3 |
1.024e-02 | -4.58 | Dnaja1 (DnaJ heat shock protein family (Hsp40) member A1) | protein interactions | 15502 | 4 | 1 | 19454 | 50 |
GLIS3 |
1.029e-02 | -4.58 | PPP1R9B (protein phosphatase 1 regulatory subunit 9B) | protein interactions | 84687 | 175 | 3 | 19454 | 50 |
DCLK2,NAV2,RPS6KA2 |
1.030e-02 | -4.58 | RORNUCRECPTR | prints domains | PR01293 | 3 | 1 | 5227 | 18 |
RORA |
1.030e-02 | -4.58 | RYANODINER | prints domains | PR00795 | 3 | 1 | 5227 | 18 |
RYR3 |
1.030e-02 | -4.58 | MYELINPLP | prints domains | PR00214 | 3 | 1 | 5227 | 18 |
GPM6A |
1.040e-02 | -4.57 | export from cell | biological process | GO:0140352 | 485 | 5 | 18204 | 50 |
NTRK2,CAMK2G,NRXN1,SLC4A4,ATP1A2 |
1.042e-02 | -4.56 | F11R (F11 receptor) | protein interactions | 50848 | 60 | 2 | 19454 | 50 |
PRKCA,PARD3 |
1.043e-02 | -4.56 | internode region of axon | cellular component | GO:0033269 | 4 | 1 | 19108 | 50 |
PARD3 |
1.043e-02 | -4.56 | tenascin complex | cellular component | GO:0090733 | 4 | 1 | 19108 | 50 |
TNC |
1.049e-02 | -4.56 | import across plasma membrane | biological process | GO:0098739 | 165 | 3 | 18204 | 50 |
ATP1A2,GFAP,SLC1A2 |
1.071e-02 | -4.54 | Heparan sulfate/heparin (HS-GAG) metabolism | REACTOME pathways | R-HSA-1638091 | 54 | 2 | 10285 | 30 |
HPSE2,GPC5 |
1.072e-02 | -4.54 | visual behavior | biological process | GO:0007632 | 57 | 2 | 18204 | 50 |
ATP1A2,SLC1A2 |
1.076e-02 | -4.53 | AbLIM_anchor | interpro domains | IPR032402 | 4 | 1 | 18521 | 50 |
ABLIM1 |
1.076e-02 | -4.53 | TRPM_tetra | interpro domains | IPR032415 | 4 | 1 | 18521 | 50 |
TRPM3 |
1.076e-02 | -4.53 | RSK_N | interpro domains | IPR041906 | 4 | 1 | 18521 | 50 |
RPS6KA2 |
1.076e-02 | -4.53 | Tyr_kinase_EGF/ERB/XmrK_rcpt | interpro domains | IPR016245 | 4 | 1 | 18521 | 50 |
ERBB4 |
1.076e-02 | -4.53 | TRPM_tetra_sf | interpro domains | IPR037162 | 4 | 1 | 18521 | 50 |
TRPM3 |
1.076e-02 | -4.53 | KASH | interpro domains | IPR012315 | 4 | 1 | 18521 | 50 |
SYNE1 |
1.076e-02 | -4.53 | NDRG | interpro domains | IPR004142 | 4 | 1 | 18521 | 50 |
NDRG2 |
1.076e-02 | -4.53 | Alpha_catenin | interpro domains | IPR001033 | 4 | 1 | 18521 | 50 |
CTNNA2 |
1.076e-02 | -4.53 | Na/K-Atpase_Interacting | interpro domains | IPR008516 | 4 | 1 | 18521 | 50 |
NKAIN3 |
1.076e-02 | -4.53 | Desmoplakin_Spectrin-like | interpro domains | IPR041573 | 4 | 1 | 18521 | 50 |
MACF1 |
1.076e-02 | -4.53 | Glyco_transf_54 | interpro domains | IPR006759 | 4 | 1 | 18521 | 50 |
MGAT4C |
1.076e-02 | -4.53 | Nebulin_repeat | interpro domains | IPR000900 | 4 | 1 | 18521 | 50 |
NEBL |
1.076e-02 | -4.53 | Ca/CaM-dep_prot_kinase-assoc | interpro domains | IPR013543 | 4 | 1 | 18521 | 50 |
CAMK2G |
1.076e-02 | -4.53 | PCN-like_spectrin-like_rpt | interpro domains | IPR049538 | 4 | 1 | 18521 | 50 |
MACF1 |
1.077e-02 | -4.53 | KIDINS220 (kinase D interacting substrate 220) | protein interactions | 57498 | 178 | 3 | 19454 | 50 |
NTRK3,PARD3,NTRK2 |
1.079e-02 | -4.53 | citrate transmembrane transporter activity | molecular function | GO:0015137 | 4 | 1 | 18094 | 49 |
SFXN5 |
1.079e-02 | -4.53 | ryanodine-sensitive calcium-release channel activity | molecular function | GO:0005219 | 4 | 1 | 18094 | 49 |
RYR3 |
1.079e-02 | -4.53 | tricarboxylic acid transmembrane transporter activity | molecular function | GO:0015142 | 4 | 1 | 18094 | 49 |
SFXN5 |
1.079e-02 | -4.53 | brain-derived neurotrophic factor binding | molecular function | GO:0048403 | 4 | 1 | 18094 | 49 |
NTRK2 |
1.094e-02 | -4.52 | regulation of amino acid uptake involved in synaptic transmission | biological process | GO:0051941 | 4 | 1 | 18204 | 50 |
ATP1A2 |
1.094e-02 | -4.52 | response to glycoside | biological process | GO:1903416 | 4 | 1 | 18204 | 50 |
ATP1A2 |
1.094e-02 | -4.52 | trans-synaptic signaling by BDNF | biological process | GO:0099191 | 4 | 1 | 18204 | 50 |
NTRK2 |
1.094e-02 | -4.52 | regulation of angiotensin-activated signaling pathway | biological process | GO:0110061 | 4 | 1 | 18204 | 50 |
PRKCA |
1.094e-02 | -4.52 | regulation of glutamate uptake involved in transmission of nerve impulse | biological process | GO:0051946 | 4 | 1 | 18204 | 50 |
ATP1A2 |
1.094e-02 | -4.52 | positive regulation of mesenchymal stem cell differentiation | biological process | GO:2000741 | 4 | 1 | 18204 | 50 |
SOX5 |
1.094e-02 | -4.52 | regulation of mini excitatory postsynaptic potential | biological process | GO:0061884 | 4 | 1 | 18204 | 50 |
SYNE1 |
1.094e-02 | -4.52 | cardiac muscle tissue regeneration | biological process | GO:0061026 | 4 | 1 | 18204 | 50 |
ERBB4 |
1.094e-02 | -4.52 | nuclear matrix organization | biological process | GO:0043578 | 4 | 1 | 18204 | 50 |
SYNE1 |
1.094e-02 | -4.52 | desmosome assembly | biological process | GO:0002159 | 4 | 1 | 18204 | 50 |
PRKCA |
1.094e-02 | -4.52 | brain-derived neurotrophic factor receptor signaling pathway | biological process | GO:0031547 | 4 | 1 | 18204 | 50 |
NTRK2 |
1.094e-02 | -4.52 | negative regulation of protein kinase C signaling | biological process | GO:0090038 | 4 | 1 | 18204 | 50 |
DGKG |
1.094e-02 | -4.52 | regulation of systemic arterial blood pressure by baroreceptor feedback | biological process | GO:0003025 | 4 | 1 | 18204 | 50 |
NAV2 |
1.097e-02 | -4.51 | TRPM_tetra | pfam domains | PF16519 | 4 | 1 | 17795 | 49 |
TRPM3 |
1.097e-02 | -4.51 | AbLIM_anchor | pfam domains | PF16182 | 4 | 1 | 17795 | 49 |
ABLIM1 |
1.097e-02 | -4.51 | NKAIN | pfam domains | PF05640 | 4 | 1 | 17795 | 49 |
NKAIN3 |
1.097e-02 | -4.51 | Glyco_transf_54 | pfam domains | PF04666 | 4 | 1 | 17795 | 49 |
MGAT4C |
1.097e-02 | -4.51 | Spectrin_4 | pfam domains | PF21020 | 4 | 1 | 17795 | 49 |
MACF1 |
1.097e-02 | -4.51 | Spectrin_3 | pfam domains | PF21019 | 4 | 1 | 17795 | 49 |
MACF1 |
1.097e-02 | -4.51 | Nebulin | pfam domains | PF00880 | 4 | 1 | 17795 | 49 |
NEBL |
1.097e-02 | -4.51 | CaMKII_AD | pfam domains | PF08332 | 4 | 1 | 17795 | 49 |
CAMK2G |
1.097e-02 | -4.51 | Ndr | pfam domains | PF03096 | 4 | 1 | 17795 | 49 |
NDRG2 |
1.097e-02 | -4.51 | KASH | pfam domains | PF10541 | 4 | 1 | 17795 | 49 |
SYNE1 |
1.097e-02 | -4.51 | Spectrin_2 | pfam domains | PF18373 | 4 | 1 | 17795 | 49 |
MACF1 |
1.098e-02 | -4.51 | primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | primitive_neuroectodermal_tumour-medulloblastoma | 15350 | 49 | 16828 | 49 |
TRPM3,GFAP,RFX4,NEBL,NTRK3,SLC1A2,SORBS1,HPSE2,ABLIM1,RORA,MACF1,GPM6A,NAV2,LSAMP,NPAS3,CDH20,TNC,CTNND2,SOX5,NTRK2,NKAIN3,SFXN5,GLIS3,NRG3,DTNA,NTM,PRKCA,RYR3,RPS6KA2,DGKG,FMN2,SLC14A1,PARD3,MSI2,SYNE1,PITPNC1,MGAT4C,KALRN,DCLK2,NRXN1,SLC4A4,ERBB4,NDRG2,LRP1B,GPC5,ADCY2,ATP1A2,PSD2,CAMK2G |
1.107e-02 | -4.50 | Sorb | smart domains | SM00459 | 3 | 1 | 9717 | 36 |
SORBS1 |
1.107e-02 | -4.50 | PLP | smart domains | SM00002 | 3 | 1 | 9717 | 36 |
GPM6A |
1.110e-02 | -4.50 | ARHGAP29 (Rho GTPase activating protein 29) | protein interactions | 9411 | 62 | 2 | 19454 | 50 |
PARD3,CAMK2G |
1.110e-02 | -4.50 | PTPN13 (protein tyrosine phosphatase non-receptor type 13) | protein interactions | 5783 | 180 | 3 | 19454 | 50 |
NTRK3,PARD3,NTRK2 |
1.111e-02 | -4.50 | asymmetric synapse | cellular component | GO:0032279 | 333 | 4 | 19108 | 50 |
KALRN,CTNND2,NTRK2,ERBB4 |
1.118e-02 | -4.49 | parathyroid-carcinoma | COSMIC cancer mutations | parathyroid-carcinoma | 300 | 4 | 16828 | 49 |
RYR3,SYNE1,MACF1,GPC5 |
1.134e-02 | -4.48 | IGc2 | smart domains | SM00408 | 239 | 4 | 9717 | 36 |
NTM,LSAMP,NTRK2,KALRN |
1.138e-02 | -4.48 | head_neck | COSMIC cancer mutations | head_neck | 15361 | 49 | 16828 | 49 |
SOX5,NTRK2,CTNND2,TNC,CDH20,NPAS3,LSAMP,RORA,NAV2,GPM6A,MACF1,HPSE2,ABLIM1,SORBS1,SLC1A2,NTRK3,NEBL,RFX4,GFAP,TRPM3,CAMK2G,PSD2,ATP1A2,NDRG2,ADCY2,LRP1B,GPC5,SLC4A4,NRXN1,ERBB4,KALRN,DCLK2,PITPNC1,MGAT4C,SYNE1,PARD3,SLC14A1,MSI2,RYR3,PRKCA,NTM,DGKG,FMN2,RPS6KA2,DTNA,GLIS3,SFXN5,NRG3,NKAIN3 |
1.143e-02 | -4.47 | human chr14q13.1 | chromosome location | human chr14q13.1 | 6 | 1 | 26134 | 50 |
NPAS3 |
1.143e-02 | -4.47 | human chr4q34.2 | chromosome location | human chr4q34.2 | 6 | 1 | 26134 | 50 |
GPM6A |
1.144e-02 | -4.47 | PRPH (peripherin) | protein interactions | 5630 | 182 | 3 | 19454 | 50 |
GFAP,SORBS1,ABLIM1 |
1.144e-02 | -4.47 | PAG1 (phosphoprotein membrane anchor with glycosphingolipid microdomains 1) | protein interactions | 55824 | 63 | 2 | 19454 | 50 |
NTRK3,GFAP |
1.144e-02 | -4.47 | DCAF16 (DDB1 and CUL4 associated factor 16) | protein interactions | 54876 | 63 | 2 | 19454 | 50 |
DGKG,PSD2 |
1.145e-02 | -4.47 | protein localization to synapse | biological process | GO:0035418 | 59 | 2 | 18204 | 50 |
NRXN1,ERBB4 |
1.148e-02 | -4.47 | adrenal_cortical_adenoma | COSMIC cancer mutations | adrenal_cortical_adenoma | 161 | 3 | 16828 | 49 |
ADCY2,LRP1B,FMN2 |
1.162e-02 | -4.46 | Neurotransmitter uptake and Metabolism In Glial Cells | REACTOME pathways | R-HSA-112313 | 4 | 1 | 10285 | 30 |
SLC1A2 |
1.162e-02 | -4.46 | Astrocytic Glutamate-Glutamine Uptake And Metabolism | REACTOME pathways | R-HSA-210455 | 4 | 1 | 10285 | 30 |
SLC1A2 |
1.165e-02 | -4.45 | leading edge membrane | cellular component | GO:0031256 | 180 | 3 | 19108 | 50 |
PSD2,MACF1,SLC1A2 |
1.167e-02 | -4.45 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-peripheral_T_cell_lymphoma_unspecified | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-peripheral_T_cell_lymphoma_unspecified | 162 | 3 | 16828 | 49 |
MACF1,SYNE1,RYR3 |
1.171e-02 | -4.45 | organic substance transport | biological process | GO:0071702 | 1881 | 11 | 18204 | 50 |
FMN2,MACF1,SLC4A4,GFAP,CAMK2G,LRP1B,SLC14A1,SFXN5,SLC1A2,NTRK2,PITPNC1 |
1.179e-02 | -4.44 | SYNC (syncoilin, intermediate filament protein) | protein interactions | 81493 | 64 | 2 | 19454 | 50 |
DTNA,GFAP |
1.181e-02 | -4.44 | C1-like_sf | interpro domains | IPR046349 | 61 | 2 | 18521 | 50 |
PRKCA,DGKG |
1.182e-02 | -4.44 | regulation of glucose import | biological process | GO:0046324 | 60 | 2 | 18204 | 50 |
SLC1A2,SORBS1 |
1.182e-02 | -4.44 | export across plasma membrane | biological process | GO:0140115 | 60 | 2 | 18204 | 50 |
SLC4A4,ATP1A2 |
1.182e-02 | -4.44 | transmission of nerve impulse | biological process | GO:0019226 | 60 | 2 | 18204 | 50 |
NTRK2,ATP1A2 |
1.191e-02 | -4.43 | SLC3A2 (solute carrier family 3 member 2) | protein interactions | 6520 | 346 | 4 | 19454 | 50 |
PARD3,NTRK3,SLC1A2,RPS6KA2 |
1.195e-02 | -4.43 | ENTR1 (endosome associated trafficking regulator 1) | protein interactions | 10807 | 185 | 3 | 19454 | 50 |
PARD3,RPS6KA2,GFAP |
1.202e-02 | -4.42 | PTPN11 (protein tyrosine phosphatase non-receptor type 11) | protein interactions | 5781 | 347 | 4 | 19454 | 50 |
NTRK2,NTRK3,ERBB4,PRKCA |
1.204e-02 | -4.42 | protein phosphorylation | biological process | GO:0006468 | 503 | 5 | 18204 | 50 |
RPS6KA2,ERBB4,NTRK2,PRKCA,KALRN |
1.205e-02 | -4.42 | TRIM67 (tripartite motif containing 67) | protein interactions | 440730 | 4804 | 20 | 19454 | 50 |
SLC4A4,KALRN,GFAP,TNC,PARD3,CAMK2G,MACF1,CTNNA2,GPM6A,LSAMP,DCLK2,MSI2,PRKCA,CTNND2,PITPNC1,RPS6KA2,DTNA,SYNE1,ATP1A2,NTM |
1.209e-02 | -4.42 | kidney | COSMIC cancer mutations | kidney | 15380 | 49 | 16828 | 49 |
CAMK2G,ATP1A2,PSD2,NDRG2,GPC5,LRP1B,ADCY2,NRXN1,SLC4A4,ERBB4,PITPNC1,MGAT4C,KALRN,DCLK2,PARD3,SLC14A1,MSI2,SYNE1,DTNA,NTM,PRKCA,RYR3,RPS6KA2,DGKG,FMN2,NKAIN3,SFXN5,GLIS3,NRG3,SOX5,NTRK2,TNC,CTNND2,CDH20,LSAMP,NPAS3,HPSE2,ABLIM1,RORA,MACF1,NAV2,GPM6A,SLC1A2,SORBS1,RFX4,NEBL,NTRK3,TRPM3,GFAP |
1.216e-02 | -4.41 | parathyroid | COSMIC cancer mutations | parathyroid | 476 | 5 | 16828 | 49 |
GPC5,RYR3,SYNE1,GPM6A,MACF1 |
1.220e-02 | -4.41 | regulation of vascular endothelial growth factor production | biological process | GO:0010574 | 61 | 2 | 18204 | 50 |
NDRG2,RORA |
1.229e-02 | -4.40 | Ion transport by P-type ATPases | REACTOME pathways | R-HSA-936837 | 58 | 2 | 10285 | 30 |
ATP1A2,CAMK2G |
1.238e-02 | -4.39 | EPHA2 (EPH receptor A2) | protein interactions | 1969 | 350 | 4 | 19454 | 50 |
RPS6KA2,NTRK2,NTRK3,PARD3 |
1.238e-02 | -4.39 | TRPM, tetramerisation domain | gene3d domains | 1.20.5.1010 | 4 | 1 | 14470 | 45 |
TRPM3 |
1.238e-02 | -4.39 | - | gene3d domains | 1.20.58.1060 | 4 | 1 | 14470 | 45 |
MACF1 |
1.240e-02 | -4.39 | Endocrine and other factor-regulated calcium reabsorption | KEGG pathways | hsa04961 | 47 | 2 | 7161 | 26 |
PRKCA,ATP1A2 |
1.240e-02 | -4.39 | Endocrine and other factor-regulated calcium reabsorption | KEGG pathways | ko04961 | 47 | 2 | 7161 | 26 |
ATP1A2,PRKCA |
1.248e-02 | -4.38 | SNAP23 (synaptosome associated protein 23) | protein interactions | 8773 | 188 | 3 | 19454 | 50 |
PRKCA,RPS6KA2,PARD3 |
1.249e-02 | -4.38 | central nervous system neuron differentiation | biological process | GO:0021953 | 176 | 3 | 18204 | 50 |
NTRK2,RORA,DCLK2 |
1.249e-02 | -4.38 | back | COSMIC cancer mutations | back | 310 | 4 | 16828 | 49 |
LRP1B,ATP1A2,ERBB4,SYNE1 |
1.253e-02 | -4.38 | postsynaptic specialization | cellular component | GO:0099572 | 345 | 4 | 19108 | 50 |
ERBB4,CTNND2,NTRK2,KALRN |
1.262e-02 | -4.37 | Ig-like_fold | interpro domains | IPR013783 | 721 | 6 | 18521 | 50 |
LSAMP,NTRK3,NTRK2,NTM,KALRN,TNC |
1.266e-02 | -4.37 | peripheral_T_cell_lymphoma_unspecified | COSMIC cancer mutations | peripheral_T_cell_lymphoma_unspecified | 167 | 3 | 16828 | 49 |
RYR3,SYNE1,MACF1 |
1.271e-02 | -4.37 | cadherin binding | molecular function | GO:0045296 | 335 | 4 | 18094 | 49 |
CDH20,CTNNA2,CTNND2,MACF1 |
1.279e-02 | -4.36 | SUI2 (translation initiation factor eIF2 subunit alpha) | protein interactions | 853463 | 5 | 1 | 19454 | 50 |
PRKCA |
1.279e-02 | -4.36 | RFX4 (regulatory factor X4) | protein interactions | 5992 | 5 | 1 | 19454 | 50 |
RFX4 |
1.279e-02 | -4.36 | RVS161 (amphiphysin-like protein RVS161) | protein interactions | 850367 | 5 | 1 | 19454 | 50 |
GFAP |
1.279e-02 | -4.36 | SYT13 (synaptotagmin 13) | protein interactions | 57586 | 5 | 1 | 19454 | 50 |
NRXN1 |
1.279e-02 | -4.36 | CAMK2N2 (calcium/calmodulin dependent protein kinase II inhibitor 2) | protein interactions | 94032 | 5 | 1 | 19454 | 50 |
CAMK2G |
1.279e-02 | -4.36 | TRPM6 (transient receptor potential cation channel subfamily M member 6) | protein interactions | 140803 | 5 | 1 | 19454 | 50 |
TRPM3 |
1.279e-02 | -4.36 | GABRR2 (gamma-aminobutyric acid type A receptor subunit rho2) | protein interactions | 2570 | 5 | 1 | 19454 | 50 |
PRKCA |
1.279e-02 | -4.36 | SLC10A3 (solute carrier family 10 member 3) | protein interactions | 8273 | 5 | 1 | 19454 | 50 |
SORBS1 |
1.279e-02 | -4.36 | Wwp2 (WW domain containing E3 ubiquitin protein ligase 2) | protein interactions | 66894 | 5 | 1 | 19454 | 50 |
GLIS3 |
1.279e-02 | -4.36 | NRG2 (neuregulin 2) | protein interactions | 9542 | 5 | 1 | 19454 | 50 |
ERBB4 |
1.279e-02 | -4.36 | CFHR3 (complement factor H related 3) | protein interactions | 10878 | 5 | 1 | 19454 | 50 |
PRKCA |
1.279e-02 | -4.36 | DLX3 (distal-less homeobox 3) | protein interactions | 1747 | 5 | 1 | 19454 | 50 |
PRKCA |
1.287e-02 | -4.35 | PARD6A (par-6 family cell polarity regulator alpha) | protein interactions | 50855 | 67 | 2 | 19454 | 50 |
PRKCA,PARD3 |
1.287e-02 | -4.35 | SHC3 (SHC adaptor protein 3) | protein interactions | 53358 | 67 | 2 | 19454 | 50 |
NTRK2,ERBB4 |
1.300e-02 | -4.34 | functioning | COSMIC cancer mutations | functioning | 1803 | 11 | 16828 | 49 |
SYNE1,SLC1A2,SOX5,NTRK2,HPSE2,TRPM3,NRG3,NTRK3,DGKG,FMN2,RFX4 |
1.300e-02 | -4.34 | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-functioning | COSMIC cancer mutations | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-functioning | 1803 | 11 | 16828 | 49 |
NTRK3,SOX5,FMN2,DGKG,NTRK2,HPSE2,RFX4,TRPM3,SYNE1,SLC1A2,NRG3 |
1.302e-02 | -4.34 | calcium- and calmodulin-dependent protein kinase complex | cellular component | GO:0005954 | 5 | 1 | 19108 | 50 |
CAMK2G |
1.302e-02 | -4.34 | pancreas-carcinoma | COSMIC cancer mutations | pancreas-carcinoma | 14770 | 48 | 16828 | 49 |
SYNE1,SLC14A1,PARD3,MSI2,KALRN,DCLK2,PITPNC1,MGAT4C,SFXN5,GLIS3,NRG3,NKAIN3,NTM,PRKCA,RYR3,RPS6KA2,DGKG,FMN2,PSD2,ATP1A2,CAMK2G,NRXN1,SLC4A4,ERBB4,NDRG2,LRP1B,GPC5,ADCY2,SLC1A2,SORBS1,RORA,MACF1,NAV2,GPM6A,HPSE2,ABLIM1,TRPM3,GFAP,NTRK3,RFX4,NEBL,CTNND2,TNC,SOX5,NTRK2,NPAS3,LSAMP,CDH20 |
1.304e-02 | -4.34 | SH3_9 | pfam domains | PF14604 | 63 | 2 | 17795 | 49 |
NEBL,SORBS1 |
1.313e-02 | -4.33 | response to endogenous stimulus | biological process | GO:0009719 | 1402 | 9 | 18204 | 50 |
SOX5,ERBB4,TNC,NTRK3,ATP1A2,SORBS1,NTRK2,SLC1A2,RYR3 |
1.313e-02 | -4.33 | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-desmoplastic | COSMIC cancer mutations | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-desmoplastic | 14773 | 48 | 16828 | 49 |
GFAP,TRPM3,NEBL,RFX4,NTRK3,SORBS1,SLC1A2,ABLIM1,HPSE2,GPM6A,NAV2,MACF1,RORA,LSAMP,NPAS3,CDH20,TNC,CTNND2,NTRK2,SOX5,NRG3,GLIS3,SFXN5,DTNA,FMN2,DGKG,RPS6KA2,RYR3,PRKCA,NTM,MSI2,PARD3,SLC14A1,SYNE1,MGAT4C,PITPNC1,DCLK2,KALRN,ERBB4,SLC4A4,NRXN1,ADCY2,LRP1B,GPC5,NDRG2,ATP1A2,PSD2,CAMK2G |
1.313e-02 | -4.33 | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-classic | COSMIC cancer mutations | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-classic | 14773 | 48 | 16828 | 49 |
NTRK3,NEBL,RFX4,GFAP,TRPM3,RORA,GPM6A,NAV2,MACF1,HPSE2,ABLIM1,SORBS1,SLC1A2,CDH20,NPAS3,LSAMP,SOX5,NTRK2,CTNND2,TNC,RYR3,PRKCA,NTM,DGKG,FMN2,RPS6KA2,DTNA,GLIS3,SFXN5,NRG3,KALRN,DCLK2,PITPNC1,MGAT4C,SYNE1,PARD3,SLC14A1,MSI2,NDRG2,ADCY2,LRP1B,GPC5,SLC4A4,NRXN1,ERBB4,CAMK2G,PSD2,ATP1A2 |
1.313e-02 | -4.33 | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | COSMIC cancer mutations | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | 14773 | 48 | 16828 | 49 |
TNC,CTNND2,NTRK2,SOX5,LSAMP,NPAS3,CDH20,SORBS1,SLC1A2,ABLIM1,HPSE2,NAV2,GPM6A,MACF1,RORA,GFAP,TRPM3,NEBL,RFX4,NTRK3,ATP1A2,PSD2,CAMK2G,ERBB4,SLC4A4,NRXN1,ADCY2,LRP1B,GPC5,NDRG2,MSI2,SLC14A1,PARD3,SYNE1,MGAT4C,PITPNC1,DCLK2,KALRN,NRG3,GLIS3,SFXN5,DTNA,FMN2,DGKG,RPS6KA2,RYR3,NTM,PRKCA |
1.313e-02 | -4.33 | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma | 14773 | 48 | 16828 | 49 |
DCLK2,KALRN,MGAT4C,PITPNC1,SYNE1,MSI2,SLC14A1,PARD3,DGKG,FMN2,RPS6KA2,RYR3,PRKCA,NTM,DTNA,NRG3,GLIS3,SFXN5,CAMK2G,PSD2,ATP1A2,ADCY2,LRP1B,GPC5,NDRG2,ERBB4,SLC4A4,NRXN1,GPM6A,NAV2,MACF1,RORA,ABLIM1,HPSE2,SORBS1,SLC1A2,NTRK3,NEBL,RFX4,GFAP,TRPM3,NTRK2,SOX5,CTNND2,TNC,CDH20,NPAS3,LSAMP |
1.317e-02 | -4.33 | classic | COSMIC cancer mutations | classic | 14774 | 48 | 16828 | 49 |
SFXN5,GLIS3,NRG3,NTM,PRKCA,RYR3,RPS6KA2,DGKG,FMN2,DTNA,SYNE1,SLC14A1,PARD3,MSI2,KALRN,DCLK2,PITPNC1,MGAT4C,NRXN1,SLC4A4,ERBB4,NDRG2,LRP1B,GPC5,ADCY2,PSD2,ATP1A2,CAMK2G,TRPM3,GFAP,NTRK3,RFX4,NEBL,SLC1A2,SORBS1,RORA,MACF1,GPM6A,NAV2,HPSE2,ABLIM1,NPAS3,LSAMP,CDH20,CTNND2,TNC,SOX5,NTRK2 |
1.324e-02 | -4.32 | SHROOM3 (shroom family member 3) | protein interactions | 57619 | 68 | 2 | 19454 | 50 |
PARD3,RPS6KA2 |
1.324e-02 | -4.32 | PLCH1 (phospholipase C eta 1) | protein interactions | 23007 | 68 | 2 | 19454 | 50 |
NTRK2,PARD3 |
1.324e-02 | -4.32 | circulatory system development | biological process | GO:0072359 | 933 | 7 | 18204 | 50 |
NTRK3,NEBL,RORA,ERBB4,SYNE1,PRKCA,NTRK2 |
1.328e-02 | -4.32 | env (Envelope surface glycoprotein gp160, precursor) | protein interactions | 155971 | 1501 | 9 | 19454 | 50 |
CTNNA2,SLC1A2,MGAT4C,TNC,PRKCA,GFAP,NTRK3,ADCY2,NTRK2 |
1.332e-02 | -4.32 | medulla | COSMIC cancer mutations | medulla | 14778 | 48 | 16828 | 49 |
RORA,MACF1,NAV2,GPM6A,HPSE2,ABLIM1,SLC1A2,SORBS1,NTRK3,RFX4,NEBL,TRPM3,GFAP,SOX5,NTRK2,CTNND2,TNC,CDH20,NPAS3,LSAMP,KALRN,DCLK2,PITPNC1,MGAT4C,SYNE1,PARD3,SLC14A1,MSI2,NTM,PRKCA,RYR3,RPS6KA2,FMN2,DGKG,DTNA,SFXN5,GLIS3,NRG3,CAMK2G,PSD2,ATP1A2,NDRG2,LRP1B,GPC5,ADCY2,NRXN1,SLC4A4,ERBB4 |
1.336e-02 | -4.32 | desmoplastic | COSMIC cancer mutations | desmoplastic | 14779 | 48 | 16828 | 49 |
NTRK3,RFX4,NEBL,TRPM3,GFAP,MACF1,GPM6A,NAV2,RORA,ABLIM1,HPSE2,SLC1A2,SORBS1,CDH20,NPAS3,LSAMP,NTRK2,SOX5,CTNND2,TNC,RPS6KA2,FMN2,DGKG,NTM,PRKCA,RYR3,DTNA,NRG3,SFXN5,GLIS3,DCLK2,KALRN,MGAT4C,PITPNC1,SYNE1,MSI2,SLC14A1,PARD3,LRP1B,GPC5,ADCY2,NDRG2,ERBB4,NRXN1,SLC4A4,CAMK2G,PSD2,ATP1A2 |
1.337e-02 | -4.31 | dendrite morphogenesis | biological process | GO:0048813 | 64 | 2 | 18204 | 50 |
CTNND2,CTNNA2 |
1.337e-02 | -4.31 | actin filament bundle assembly | biological process | GO:0051017 | 64 | 2 | 18204 | 50 |
SORBS1,FMN2 |
1.339e-02 | -4.31 | prostate-carcinoma-adenocarcinoma | COSMIC cancer mutations | prostate-carcinoma-adenocarcinoma | 12379 | 43 | 16828 | 49 |
SYNE1,SORBS1,SLC1A2,SLC14A1,PARD3,KALRN,RORA,GPM6A,NAV2,MACF1,HPSE2,PITPNC1,MGAT4C,ABLIM1,GLIS3,GFAP,SFXN5,TRPM3,NRG3,NKAIN3,NTRK3,RYR3,PRKCA,NTM,DGKG,FMN2,NEBL,RFX4,CTNND2,PSD2,TNC,ATP1A2,SOX5,NTRK2,NPAS3,NRXN1,ERBB4,LSAMP,NDRG2,ADCY2,GPC5,CDH20,LRP1B |
1.339e-02 | -4.31 | KASH | prosite domains | PS51049 | 4 | 1 | 12186 | 41 |
SYNE1 |
1.339e-02 | -4.31 | NEBULIN | prosite domains | PS51216 | 4 | 1 | 12186 | 41 |
NEBL |
1.342e-02 | -4.31 | salivary_gland-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | salivary_gland-carcinoma-adenoid_cystic_carcinoma | 488 | 5 | 16828 | 49 |
SYNE1,RORA,CTNND2,RYR3,MGAT4C |
1.343e-02 | -4.31 | Na/HCO3_transpt | interpro domains | IPR003024 | 5 | 1 | 18521 | 50 |
SLC4A4 |
1.343e-02 | -4.31 | PI_transfer | interpro domains | IPR001666 | 5 | 1 | 18521 | 50 |
PITPNC1 |
1.343e-02 | -4.31 | Vinculin/catenin | interpro domains | IPR006077 | 5 | 1 | 18521 | 50 |
CTNNA2 |
1.343e-02 | -4.31 | EGF_Tenascin | interpro domains | IPR041161 | 5 | 1 | 18521 | 50 |
TNC |
1.343e-02 | -4.31 | Mtc | interpro domains | IPR004686 | 5 | 1 | 18521 | 50 |
SFXN5 |
1.346e-02 | -4.31 | cell-cell junction organization | biological process | GO:0045216 | 181 | 3 | 18204 | 50 |
PRKCA,CDH20,PARD3 |
1.347e-02 | -4.31 | glutamate:sodium symporter activity | molecular function | GO:0015501 | 5 | 1 | 18094 | 49 |
SLC1A2 |
1.347e-02 | -4.31 | high-affinity L-glutamate transmembrane transporter activity | molecular function | GO:0005314 | 5 | 1 | 18094 | 49 |
SLC1A2 |
1.347e-02 | -4.31 | neuroligin family protein binding | molecular function | GO:0097109 | 5 | 1 | 18094 | 49 |
NRXN1 |
1.347e-02 | -4.31 | cytoskeleton-nuclear membrane anchor activity | molecular function | GO:0140444 | 5 | 1 | 18094 | 49 |
SYNE1 |
1.347e-02 | -4.31 | syndecan binding | molecular function | GO:0045545 | 5 | 1 | 18094 | 49 |
TNC |
1.354e-02 | -4.30 | GRB2 (growth factor receptor bound protein 2) | protein interactions | 2885 | 769 | 6 | 19454 | 50 |
MSI2,NTRK3,NTRK2,SLC1A2,GFAP,ERBB4 |
1.363e-02 | -4.30 | temporoparietal | COSMIC cancer mutations | temporoparietal | 61 | 2 | 16828 | 49 |
RYR3,PARD3 |
1.363e-02 | -4.30 | central_nervous_system-cerebrum-glioma-astrocytoma_Grade_IV | COSMIC cancer mutations | central_nervous_system-cerebrum-glioma-astrocytoma_Grade_IV | 61 | 2 | 16828 | 49 |
LRP1B,SYNE1 |
1.366e-02 | -4.29 | stem cell differentiation | biological process | GO:0048863 | 182 | 3 | 18204 | 50 |
GPM6A,ERBB4,MSI2 |
1.366e-02 | -4.29 | cellular response to prostaglandin D stimulus | biological process | GO:0071799 | 5 | 1 | 18204 | 50 |
TNC |
1.366e-02 | -4.29 | glossopharyngeal nerve development | biological process | GO:0021563 | 5 | 1 | 18204 | 50 |
NAV2 |
1.366e-02 | -4.29 | synaptic signaling via neuropeptide | biological process | GO:0099538 | 5 | 1 | 18204 | 50 |
NTRK2 |
1.366e-02 | -4.29 | citrate transport | biological process | GO:0015746 | 5 | 1 | 18204 | 50 |
SFXN5 |
1.366e-02 | -4.29 | gephyrin clustering involved in postsynaptic density assembly | biological process | GO:0097116 | 5 | 1 | 18204 | 50 |
NRXN1 |
1.366e-02 | -4.29 | amygdala development | biological process | GO:0021764 | 5 | 1 | 18204 | 50 |
ATP1A2 |
1.366e-02 | -4.29 | tricarboxylic acid transport | biological process | GO:0006842 | 5 | 1 | 18204 | 50 |
SFXN5 |
1.366e-02 | -4.29 | polar body extrusion after meiotic divisions | biological process | GO:0040038 | 5 | 1 | 18204 | 50 |
FMN2 |
1.366e-02 | -4.29 | ERBB2-ERBB4 signaling pathway | biological process | GO:0038135 | 5 | 1 | 18204 | 50 |
ERBB4 |
1.366e-02 | -4.29 | response to prostaglandin D | biological process | GO:0071798 | 5 | 1 | 18204 | 50 |
TNC |
1.367e-02 | -4.29 | neoplasm | COSMIC cancer mutations | neoplasm | 14787 | 48 | 16828 | 49 |
CAMK2G,ATP1A2,PSD2,NDRG2,ADCY2,GPC5,LRP1B,SLC4A4,NRXN1,ERBB4,MGAT4C,KALRN,DCLK2,SLC14A1,PARD3,MSI2,SYNE1,DTNA,RYR3,PRKCA,NTM,DGKG,FMN2,RPS6KA2,NKAIN3,GLIS3,SFXN5,NRG3,SOX5,NTRK2,TNC,CTNND2,CDH20,LSAMP,NPAS3,HPSE2,ABLIM1,RORA,NAV2,GPM6A,MACF1,SORBS1,SLC1A2,NEBL,RFX4,NTRK3,GFAP,TRPM3 |
1.369e-02 | -4.29 | Vinculin | pfam domains | PF01044 | 5 | 1 | 17795 | 49 |
CTNNA2 |
1.369e-02 | -4.29 | IP_trans | pfam domains | PF02121 | 5 | 1 | 17795 | 49 |
PITPNC1 |
1.369e-02 | -4.29 | EGF_Tenascin | pfam domains | PF18720 | 5 | 1 | 17795 | 49 |
TNC |
1.369e-02 | -4.29 | SFXNs | pfam domains | PF03820 | 5 | 1 | 17795 | 49 |
SFXN5 |
1.369e-02 | -4.29 | main axon | cellular component | GO:0044304 | 68 | 2 | 19108 | 50 |
PARD3,SLC1A2 |
1.371e-02 | -4.29 | ALPHACATENIN | prints domains | PR00805 | 4 | 1 | 5227 | 18 |
CTNNA2 |
1.372e-02 | -4.29 | PE/DAG-bd | interpro domains | IPR002219 | 66 | 2 | 18521 | 50 |
DGKG,PRKCA |
1.377e-02 | -4.29 | positive regulation of synapse assembly | biological process | GO:0051965 | 65 | 2 | 18204 | 50 |
NRXN1,NTRK2 |
1.377e-02 | -4.29 | long-term synaptic potentiation | biological process | GO:0060291 | 65 | 2 | 18204 | 50 |
GFAP,NTRK2 |
1.386e-02 | -4.28 | regulation of carbohydrate metabolic process | biological process | GO:0006109 | 183 | 3 | 18204 | 50 |
SORBS1,RORA,SLC4A4 |
1.387e-02 | -4.28 | primary_central_nervous_system_lymphoma | COSMIC cancer mutations | primary_central_nervous_system_lymphoma | 683 | 6 | 16828 | 49 |
LRP1B,MACF1,PARD3,NRG3,NRXN1,SYNE1 |
1.387e-02 | -4.28 | haematopoietic_and_lymphoid_tissue-central_nervous_system-lymphoid_neoplasm-primary_central_nervous_system_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-central_nervous_system-lymphoid_neoplasm-primary_central_nervous_system_lymphoma | 683 | 6 | 16828 | 49 |
SYNE1,NRXN1,NRG3,MACF1,PARD3,LRP1B |
1.398e-02 | -4.27 | skin-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-carcinoma-squamous_cell_carcinoma | 493 | 5 | 16828 | 49 |
LRP1B,SYNE1,NTRK3,ERBB4,NTRK2 |
1.399e-02 | -4.27 | NGFR (nerve growth factor receptor) | protein interactions | 4804 | 70 | 2 | 19454 | 50 |
NTRK2,NTRK3 |
1.399e-02 | -4.27 | PCDH20 (protocadherin 20) | protein interactions | 64881 | 70 | 2 | 19454 | 50 |
CTNNA2,MGAT4C |
1.403e-02 | -4.27 | bone-extraskeletal-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-extraskeletal-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 891 | 7 | 16828 | 49 |
ATP1A2,SYNE1,PSD2,NPAS3,ABLIM1,DGKG,NAV2 |
1.407e-02 | -4.26 | S_TK_X | smart domains | SM00133 | 49 | 2 | 9717 | 36 |
PRKCA,RPS6KA2 |
1.408e-02 | -4.26 | IG_LIKE | prosite domains | PS50835 | 430 | 5 | 12186 | 41 |
NTRK3,LSAMP,NTRK2,NTM,KALRN |
1.414e-02 | -4.26 | PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3) | protein interactions | 8503 | 197 | 3 | 19454 | 50 |
NTRK2,ERBB4,NEBL |
1.414e-02 | -4.26 | FBXO25 (F-box protein 25) | protein interactions | 26260 | 197 | 3 | 19454 | 50 |
ATP1A2,GFAP,PRKCA |
1.418e-02 | -4.26 | ERBB signaling pathway | biological process | GO:0038127 | 66 | 2 | 18204 | 50 |
ERBB4,NRG3 |
1.424e-02 | -4.25 | EGF | pfam domains | PF00008 | 66 | 2 | 17795 | 49 |
NRXN1,LRP1B |
1.427e-02 | -4.25 | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | biological process | GO:0051897 | 185 | 3 | 18204 | 50 |
NTRK3,NTRK2,ERBB4 |
1.427e-02 | -4.25 | response to growth factor | biological process | GO:0070848 | 525 | 5 | 18204 | 50 |
NTRK3,SOX5,TNC,ERBB4,NTRK2 |
1.430e-02 | -4.25 | IG | smart domains | SM00409 | 394 | 5 | 9717 | 36 |
LSAMP,NTM,NTRK2,NTRK3,KALRN |
1.437e-02 | -4.24 | AKR7L (aldo-keto reductase family 7 like (gene/pseudogene)) | protein interactions | 246181 | 71 | 2 | 19454 | 50 |
MACF1,PARD3 |
1.450e-02 | -4.23 | NGF-independant TRKA activation | REACTOME pathways | R-HSA-187024 | 5 | 1 | 10285 | 30 |
NTRK2 |
1.450e-02 | -4.23 | Disinhibition of SNARE formation | REACTOME pathways | R-HSA-114516 | 5 | 1 | 10285 | 30 |
PRKCA |
1.455e-02 | -4.23 | Activation of PKC Through G Protein-Coupled Receptor | SMPDB pathways | SMP0000749 | 4 | 1 | 1369 | 5 |
PRKCA |
1.465e-02 | -4.22 | AGC_KINASE_CTER | prosite domains | PS51285 | 55 | 2 | 12186 | 41 |
RPS6KA2,PRKCA |
1.474e-02 | -4.22 | NEBU | smart domains | SM00227 | 4 | 1 | 9717 | 36 |
NEBL |
1.474e-02 | -4.22 | KASH | smart domains | SM01249 | 4 | 1 | 9717 | 36 |
SYNE1 |
1.476e-02 | -4.22 | Ppp1cb (protein phosphatase 1 catalytic subunit beta) | protein interactions | 19046 | 72 | 2 | 19454 | 50 |
ABLIM1,PARD3 |
1.476e-02 | -4.22 | VEGFA-VEGFR2 Pathway | REACTOME pathways | R-HSA-4420097 | 330 | 4 | 10285 | 30 |
CAMK2G,PRKCA,NRG3,ERBB4 |
1.491e-02 | -4.21 | DBN1 (drebrin 1) | protein interactions | 1627 | 370 | 4 | 19454 | 50 |
ABLIM1,PRKCA,CAMK2G,SOX5 |
1.501e-02 | -4.20 | actin filament bundle organization | biological process | GO:0061572 | 68 | 2 | 18204 | 50 |
FMN2,SORBS1 |
1.501e-02 | -4.20 | extraskeletal | COSMIC cancer mutations | extraskeletal | 903 | 7 | 16828 | 49 |
DGKG,NAV2,ABLIM1,SYNE1,PSD2,NPAS3,ATP1A2 |
1.503e-02 | -4.20 | Phospholipase D signaling pathway | KEGG pathways | ko04072 | 145 | 3 | 7161 | 26 |
DGKG,ADCY2,PRKCA |
1.503e-02 | -4.20 | Phospholipase D signaling pathway | KEGG pathways | hsa04072 | 145 | 3 | 7161 | 26 |
PRKCA,DGKG,ADCY2 |
1.512e-02 | -4.19 | neuron to neuron synapse | cellular component | GO:0098984 | 365 | 4 | 19108 | 50 |
ERBB4,CTNND2,NTRK2,KALRN |
1.520e-02 | -4.19 | skin-scalp-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-scalp-carcinoma-squamous_cell_carcinoma | 1596 | 10 | 16828 | 49 |
SYNE1,NRXN1,GFAP,SLC4A4,ATP1A2,LSAMP,MACF1,RORA,SOX5,GPC5 |
1.527e-02 | -4.18 | Constitutive Signaling by Aberrant PI3K in Cancer | REACTOME pathways | R-HSA-2219530 | 65 | 2 | 10285 | 30 |
ERBB4,NRG3 |
1.532e-02 | -4.18 | SMOC2 (SPARC related modular calcium binding 2) | protein interactions | 64094 | 6 | 1 | 19454 | 50 |
TNC |
1.532e-02 | -4.18 | SOX1 (SRY-box transcription factor 1) | protein interactions | 6656 | 6 | 1 | 19454 | 50 |
SOX5 |
1.532e-02 | -4.18 | SLC12A5 (solute carrier family 12 member 5) | protein interactions | 57468 | 6 | 1 | 19454 | 50 |
GPM6A |
1.532e-02 | -4.18 | LBX2 (ladybird homeobox 2) | protein interactions | 85474 | 6 | 1 | 19454 | 50 |
GFAP |
1.532e-02 | -4.18 | Zbtb2 (zinc finger and BTB domain containing 2) | protein interactions | 381990 | 6 | 1 | 19454 | 50 |
SORBS1 |
1.532e-02 | -4.18 | CIBAR2 (CBY1 interacting BAR domain containing 2) | protein interactions | 339145 | 6 | 1 | 19454 | 50 |
CAMK2G |
1.532e-02 | -4.18 | DRP2 (dystrophin related protein 2) | protein interactions | 1821 | 6 | 1 | 19454 | 50 |
DTNA |
1.532e-02 | -4.18 | Csnk1d (casein kinase 1, delta) | protein interactions | 64462 | 6 | 1 | 19454 | 50 |
PRKCA |
1.532e-02 | -4.18 | Itch (itchy, E3 ubiquitin protein ligase) | protein interactions | 16396 | 6 | 1 | 19454 | 50 |
GLIS3 |
1.532e-02 | -4.18 | NRG4 (neuregulin 4) | protein interactions | 145957 | 6 | 1 | 19454 | 50 |
ERBB4 |
1.532e-02 | -4.18 | CYRIA (CYFIP related Rac1 interactor A) | protein interactions | 81553 | 6 | 1 | 19454 | 50 |
GPM6A |
1.532e-02 | -4.18 | SYTL3 (synaptotagmin like 3) | protein interactions | 94120 | 6 | 1 | 19454 | 50 |
NRXN1 |
1.532e-02 | -4.18 | Tiam2 (T cell lymphoma invasion and metastasis 2) | protein interactions | 24001 | 6 | 1 | 19454 | 50 |
DTNA |
1.532e-02 | -4.18 | ARMS2 (age-related maculopathy susceptibility 2) | protein interactions | 387715 | 6 | 1 | 19454 | 50 |
PRKCA |
1.532e-02 | -4.18 | SOX11 (SRY-box transcription factor 11) | protein interactions | 6664 | 6 | 1 | 19454 | 50 |
SOX5 |
1.532e-02 | -4.18 | ADCY1 (adenylate cyclase 1) | protein interactions | 107 | 6 | 1 | 19454 | 50 |
ADCY2 |
1.535e-02 | -4.18 | Immunoglobulin | interpro domains | IPR013151 | 70 | 2 | 18521 | 50 |
NTM,NTRK3 |
1.539e-02 | -4.17 | skin-ankle-malignant_melanoma-acral_lentiginous | COSMIC cancer mutations | skin-ankle-malignant_melanoma-acral_lentiginous | 330 | 4 | 16828 | 49 |
KALRN,ERBB4,NRG3,PARD3 |
1.541e-02 | -4.17 | GJA1 (gap junction protein alpha 1) | protein interactions | 2697 | 572 | 5 | 19454 | 50 |
ERBB4,MACF1,PRKCA,DTNA,PARD3 |
1.546e-02 | -4.17 | - | gene3d domains | 6.10.140.620 | 5 | 1 | 14470 | 45 |
CAMK2G |
1.549e-02 | -4.17 | skin-ear-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-ear-carcinoma-squamous_cell_carcinoma | 506 | 5 | 16828 | 49 |
SLC14A1,TNC,MGAT4C,NPAS3,RPS6KA2 |
1.550e-02 | -4.17 | LIM | pfam domains | PF00412 | 69 | 2 | 17795 | 49 |
NEBL,ABLIM1 |
1.552e-02 | -4.17 | CASK (calcium/calmodulin dependent serine protein kinase) | protein interactions | 8573 | 204 | 3 | 19454 | 50 |
NRXN1,ABLIM1,DTNA |
1.554e-02 | -4.16 | TEC (tec protein tyrosine kinase) | protein interactions | 7006 | 74 | 2 | 19454 | 50 |
MSI2,ERBB4 |
1.555e-02 | -4.16 | heterocyclic compound binding | molecular function | GO:1901363 | 2263 | 12 | 18094 | 49 |
DCLK2,DGKG,NTRK3,RPS6KA2,NTRK2,CAMK2G,ATP1A2,NAV2,ADCY2,ERBB4,PRKCA,KALRN |
1.560e-02 | -4.16 | PAR polarity complex | cellular component | GO:0120157 | 6 | 1 | 19108 | 50 |
PARD3 |
1.561e-02 | -4.16 | monoatomic ion transport | biological process | GO:0006811 | 964 | 7 | 18204 | 50 |
GPM6A,ATP1A2,TRPM3,SLC4A4,RYR3,SLC1A2,SFXN5 |
1.576e-02 | -4.15 | Znf_LIM | interpro domains | IPR001781 | 71 | 2 | 18521 | 50 |
NEBL,ABLIM1 |
1.578e-02 | -4.15 | ion binding | molecular function | GO:0043167 | 6007 | 24 | 18094 | 49 |
NRXN1,ERBB4,KALRN,MACF1,CAMK2G,NTRK2,RPS6KA2,DCLK2,DGKG,PARD3,NAV2,SLC1A2,RYR3,ATP1A2,ADCY2,LRP1B,PITPNC1,MGAT4C,PRKCA,GLIS3,ABLIM1,NTRK3,RORA,DTNA |
1.584e-02 | -4.15 | Signaling by SCF-KIT | REACTOME pathways | R-HSA-1433557 | 337 | 4 | 10285 | 30 |
PRKCA,CAMK2G,NRG3,ERBB4 |
1.586e-02 | -4.14 | membrane protein complex | cellular component | GO:0098796 | 1261 | 8 | 19108 | 50 |
SORBS1,ATP1A2,SLC1A2,CTNNA2,SYNE1,PRKCA,RYR3,CDH20 |
1.592e-02 | -4.14 | cellular process | biological process | GO:0009987 | 14996 | 47 | 18204 | 50 |
NRG3,ATP1A2,RORA,RFX4,RPS6KA2,ABLIM1,PRKCA,GPM6A,SOX5,LSAMP,ADCY2,CDH20,TNC,GPC5,RYR3,MACF1,NDRG2,CAMK2G,SLC4A4,GFAP,NAV2,SYNE1,MSI2,HPSE2,SFXN5,SLC1A2,NTRK2,FMN2,DCLK2,NRXN1,NEBL,DTNA,PARD3,NTRK3,TRPM3,CTNND2,CTNNA2,SLC14A1,PITPNC1,KALRN,SORBS1,NTM,MGAT4C,ERBB4,DGKG,GLIS3,LRP1B |
1.592e-02 | -4.14 | ig | pfam domains | PF00047 | 70 | 2 | 17795 | 49 |
NTM,NTRK3 |
1.594e-02 | -4.14 | UNC5B (unc-5 netrin receptor B) | protein interactions | 219699 | 75 | 2 | 19454 | 50 |
NTRK3,PARD3 |
1.599e-02 | -4.14 | Signaling by VEGF | REACTOME pathways | R-HSA-194138 | 338 | 4 | 10285 | 30 |
NRG3,ERBB4,PRKCA,CAMK2G |
1.600e-02 | -4.13 | other | COSMIC cancer mutations | other | 14843 | 48 | 16828 | 49 |
NPAS3,LSAMP,CDH20,CTNND2,TNC,NTRK2,SOX5,TRPM3,GFAP,NTRK3,RFX4,NEBL,SLC1A2,SORBS1,MACF1,NAV2,GPM6A,RORA,ABLIM1,HPSE2,ERBB4,NRXN1,SLC4A4,GPC5,LRP1B,ADCY2,NDRG2,PSD2,ATP1A2,CAMK2G,NRG3,SFXN5,GLIS3,NKAIN3,RPS6KA2,DGKG,FMN2,PRKCA,NTM,RYR3,DTNA,SYNE1,MSI2,SLC14A1,PARD3,DCLK2,KALRN,MGAT4C |
1.609e-02 | -4.13 | G3BP1 (G3BP stress granule assembly factor 1) | protein interactions | 10146 | 799 | 6 | 19454 | 50 |
CTNNA2,SYNE1,SORBS1,MACF1,MSI2,SOX5 |
1.609e-02 | -4.13 | RyR/IP3R_RIH_dom_sf | interpro domains | IPR035910 | 6 | 1 | 18521 | 50 |
RYR3 |
1.609e-02 | -4.13 | PH_dom-spectrin-type | interpro domains | IPR001605 | 6 | 1 | 18521 | 50 |
PSD2 |
1.609e-02 | -4.13 | GAR_dom_sf | interpro domains | IPR036534 | 6 | 1 | 18521 | 50 |
MACF1 |
1.609e-02 | -4.13 | Glypican | interpro domains | IPR001863 | 6 | 1 | 18521 | 50 |
GPC5 |
1.609e-02 | -4.13 | Adcy_conserved_dom | interpro domains | IPR009398 | 6 | 1 | 18521 | 50 |
ADCY2 |
1.609e-02 | -4.13 | Ribosomal_S6_kinase_II | interpro domains | IPR016239 | 6 | 1 | 18521 | 50 |
RPS6KA2 |
1.609e-02 | -4.13 | P-type_ATPase_IIC | interpro domains | IPR005775 | 6 | 1 | 18521 | 50 |
ATP1A2 |
1.609e-02 | -4.13 | GLI-like | interpro domains | IPR043359 | 6 | 1 | 18521 | 50 |
GLIS3 |
1.609e-02 | -4.13 | EF-hand_dom_typ1 | interpro domains | IPR015153 | 6 | 1 | 18521 | 50 |
DTNA |
1.609e-02 | -4.13 | Ins145_P3_rcpt | interpro domains | IPR014821 | 6 | 1 | 18521 | 50 |
RYR3 |
1.609e-02 | -4.13 | Glypican_CS | interpro domains | IPR019803 | 6 | 1 | 18521 | 50 |
GPC5 |
1.609e-02 | -4.13 | EF-hand_dom_typ2 | interpro domains | IPR015154 | 6 | 1 | 18521 | 50 |
DTNA |
1.609e-02 | -4.13 | Ryanodine_IP3_receptor | interpro domains | IPR015925 | 6 | 1 | 18521 | 50 |
RYR3 |
1.609e-02 | -4.13 | RIH_assoc-dom | interpro domains | IPR013662 | 6 | 1 | 18521 | 50 |
RYR3 |
1.609e-02 | -4.13 | Desmoplakin_SH3 | interpro domains | IPR041615 | 6 | 1 | 18521 | 50 |
MACF1 |
1.609e-02 | -4.13 | GAR_dom | interpro domains | IPR003108 | 6 | 1 | 18521 | 50 |
MACF1 |
1.609e-02 | -4.13 | Syndecan/Neurexin_dom | interpro domains | IPR027789 | 6 | 1 | 18521 | 50 |
NRXN1 |
1.609e-02 | -4.13 | GF_recep_IV | interpro domains | IPR032778 | 6 | 1 | 18521 | 50 |
ERBB4 |
1.609e-02 | -4.13 | RIH_dom | interpro domains | IPR000699 | 6 | 1 | 18521 | 50 |
RYR3 |
1.609e-02 | -4.13 | large_cell | COSMIC cancer mutations | large_cell | 14845 | 48 | 16828 | 49 |
LRP1B,GPC5,ADCY2,NDRG2,ERBB4,NRXN1,SLC4A4,CAMK2G,PSD2,ATP1A2,RPS6KA2,FMN2,DGKG,PRKCA,NTM,RYR3,DTNA,NRG3,SFXN5,GLIS3,DCLK2,KALRN,MGAT4C,PITPNC1,SYNE1,MSI2,SLC14A1,PARD3,CDH20,NPAS3,LSAMP,NTRK2,SOX5,CTNND2,TNC,NTRK3,RFX4,NEBL,TRPM3,GFAP,MACF1,GPM6A,NAV2,RORA,ABLIM1,HPSE2,SLC1A2,SORBS1 |
1.614e-02 | -4.13 | sodium:bicarbonate symporter activity | molecular function | GO:0008510 | 6 | 1 | 18094 | 49 |
SLC4A4 |
1.614e-02 | -4.13 | steroid hormone binding | molecular function | GO:1990239 | 6 | 1 | 18094 | 49 |
ATP1A2 |
1.614e-02 | -4.13 | calcium-induced calcium release activity | molecular function | GO:0048763 | 6 | 1 | 18094 | 49 |
RYR3 |
1.615e-02 | -4.13 | organelle organization | biological process | GO:0006996 | 3091 | 15 | 18204 | 50 |
DCLK2,FMN2,NRXN1,MACF1,RFX4,SORBS1,PRKCA,ABLIM1,PARD3,NEBL,GFAP,ERBB4,SYNE1,NAV2,CTNNA2 |
1.617e-02 | -4.12 | Signaling by PTK6 | REACTOME pathways | R-HSA-8848021 | 67 | 2 | 10285 | 30 |
NRG3,ERBB4 |
1.619e-02 | -4.12 | presynapse | cellular component | GO:0098793 | 569 | 5 | 19108 | 50 |
NTRK2,NRXN1,ERBB4,GPM6A,SLC1A2 |
1.621e-02 | -4.12 | ZF_DAG_PE_1 | prosite domains | PS00479 | 58 | 2 | 12186 | 41 |
DGKG,PRKCA |
1.628e-02 | -4.12 | cerebrum | COSMIC cancer mutations | cerebrum | 67 | 2 | 16828 | 49 |
SYNE1,LRP1B |
1.628e-02 | -4.12 | haematopoietic_and_lymphoid_tissue-soft_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-soft_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 67 | 2 | 16828 | 49 |
SYNE1,LRP1B |
1.635e-02 | -4.11 | RAPGEF6 (Rap guanine nucleotide exchange factor 6) | protein interactions | 51735 | 76 | 2 | 19454 | 50 |
PARD3,NTRK3 |
1.637e-02 | -4.11 | asymmetric neuroblast division | biological process | GO:0055059 | 6 | 1 | 18204 | 50 |
SOX5 |
1.637e-02 | -4.11 | vascular associated smooth muscle cell proliferation | biological process | GO:1990874 | 6 | 1 | 18204 | 50 |
NDRG2 |
1.637e-02 | -4.11 | positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway | biological process | GO:0106071 | 6 | 1 | 18204 | 50 |
PRKCA |
1.637e-02 | -4.11 | establishment of meiotic spindle localization | biological process | GO:0051295 | 6 | 1 | 18204 | 50 |
FMN2 |
1.637e-02 | -4.11 | postsynaptic density protein 95 clustering | biological process | GO:0097119 | 6 | 1 | 18204 | 50 |
NRXN1 |
1.637e-02 | -4.11 | L-aspartate import across plasma membrane | biological process | GO:0140009 | 6 | 1 | 18204 | 50 |
SLC1A2 |
1.637e-02 | -4.11 | vocal learning | biological process | GO:0042297 | 6 | 1 | 18204 | 50 |
NRXN1 |
1.637e-02 | -4.11 | imitative learning | biological process | GO:0098596 | 6 | 1 | 18204 | 50 |
NRXN1 |
1.637e-02 | -4.11 | mammary gland formation | biological process | GO:0060592 | 6 | 1 | 18204 | 50 |
NRG3 |
1.641e-02 | -4.11 | Ins145_P3_rec | pfam domains | PF08709 | 6 | 1 | 17795 | 49 |
RYR3 |
1.641e-02 | -4.11 | GAS2 | pfam domains | PF02187 | 6 | 1 | 17795 | 49 |
MACF1 |
1.641e-02 | -4.11 | Plectin | pfam domains | PF00681 | 6 | 1 | 17795 | 49 |
MACF1 |
1.641e-02 | -4.11 | GF_recep_IV | pfam domains | PF14843 | 6 | 1 | 17795 | 49 |
ERBB4 |
1.641e-02 | -4.11 | EF-hand_2 | pfam domains | PF09068 | 6 | 1 | 17795 | 49 |
DTNA |
1.641e-02 | -4.11 | RIH_assoc | pfam domains | PF08454 | 6 | 1 | 17795 | 49 |
RYR3 |
1.641e-02 | -4.11 | Glypican | pfam domains | PF01153 | 6 | 1 | 17795 | 49 |
GPC5 |
1.641e-02 | -4.11 | Syndecan | pfam domains | PF01034 | 6 | 1 | 17795 | 49 |
NRXN1 |
1.641e-02 | -4.11 | EF-hand_3 | pfam domains | PF09069 | 6 | 1 | 17795 | 49 |
DTNA |
1.641e-02 | -4.11 | Adcy_cons_dom | pfam domains | PF06327 | 6 | 1 | 17795 | 49 |
ADCY2 |
1.641e-02 | -4.11 | RYDR_ITPR | pfam domains | PF01365 | 6 | 1 | 17795 | 49 |
RYR3 |
1.641e-02 | -4.11 | SH3_10 | pfam domains | PF17902 | 6 | 1 | 17795 | 49 |
MACF1 |
1.675e-02 | -4.09 | ABI1 (abl interactor 1) | protein interactions | 10006 | 210 | 3 | 19454 | 50 |
SORBS1,RPS6KA2,NTRK3 |
1.687e-02 | -4.08 | - | gene3d domains | 3.30.60.20 | 64 | 2 | 14470 | 45 |
DGKG,PRKCA |
1.691e-02 | -4.08 | sarcoplasmic reticulum | cellular component | GO:0016529 | 76 | 2 | 19108 | 50 |
RYR3,CAMK2G |
1.693e-02 | -4.08 | LRRNT | smart domains | SM00013 | 54 | 2 | 9717 | 36 |
NTRK3,NTRK2 |
1.711e-02 | -4.07 | NAHCO3TRSPRT | prints domains | PR01232 | 5 | 1 | 5227 | 18 |
SLC4A4 |
1.711e-02 | -4.07 | PITRANSFER | prints domains | PR00391 | 5 | 1 | 5227 | 18 |
PITPNC1 |
1.711e-02 | -4.07 | positive regulation of cell projection organization | biological process | GO:0031346 | 361 | 4 | 18204 | 50 |
GPM6A,NTRK3,MACF1,NTRK2 |
1.716e-02 | -4.07 | MARCKS (myristoylated alanine rich protein kinase C substrate) | protein interactions | 4082 | 588 | 5 | 19454 | 50 |
DTNA,RPS6KA2,ABLIM1,PRKCA,MACF1 |
1.717e-02 | -4.06 | ANKRD40 (ankyrin repeat domain 40) | protein interactions | 91369 | 78 | 2 | 19454 | 50 |
MSI2,SOX5 |
1.717e-02 | -4.06 | ATOH1 (atonal bHLH transcription factor 1) | protein interactions | 474 | 78 | 2 | 19454 | 50 |
GFAP,MACF1 |
1.722e-02 | -4.06 | regulation of signal transduction | biological process | GO:0009966 | 3114 | 15 | 18204 | 50 |
GPC5,KALRN,NRXN1,RORA,MACF1,NDRG2,SORBS1,PRKCA,NTRK3,ERBB4,DGKG,CTNND2,PSD2,SYNE1,NTRK2 |
1.738e-02 | -4.05 | RSK activation | REACTOME pathways | R-HSA-444257 | 6 | 1 | 10285 | 30 |
RPS6KA2 |
1.738e-02 | -4.05 | Activation of TRKA receptors | REACTOME pathways | R-HSA-187015 | 6 | 1 | 10285 | 30 |
NTRK2 |
1.739e-02 | -4.05 | NUMB (NUMB endocytic adaptor protein) | protein interactions | 8650 | 213 | 3 | 19454 | 50 |
PARD3,NTRK3,PRKCA |
1.759e-02 | -4.04 | KRTAP3-2 (keratin associated protein 3-2) | protein interactions | 83897 | 79 | 2 | 19454 | 50 |
NTM,GFAP |
1.761e-02 | -4.04 | DLG1 (discs large MAGUK scaffold protein 1) | protein interactions | 1739 | 214 | 3 | 19454 | 50 |
PARD3,NTRK3,ERBB4 |
1.761e-02 | -4.04 | NCK1 (NCK adaptor protein 1) | protein interactions | 4690 | 214 | 3 | 19454 | 50 |
ERBB4,NTRK3,NTRK2 |
1.765e-02 | -4.04 | animal organ morphogenesis | biological process | GO:0009887 | 988 | 7 | 18204 | 50 |
CTNNA2,ABLIM1,NTRK2,NRG3,SOX5,ERBB4,TNC |
1.786e-02 | -4.03 | Smurf1 (SMAD specific E3 ubiquitin protein ligase 1) | protein interactions | 75788 | 7 | 1 | 19454 | 50 |
GLIS3 |
1.786e-02 | -4.03 | Nde1 (nudE neurodevelopment protein 1) | protein interactions | 67203 | 7 | 1 | 19454 | 50 |
SYNE1 |
1.786e-02 | -4.03 | ABCC12 (ATP binding cassette subfamily C member 12) | protein interactions | 94160 | 7 | 1 | 19454 | 50 |
NPAS3 |
1.790e-02 | -4.02 | axonogenesis | biological process | GO:0007409 | 366 | 4 | 18204 | 50 |
PARD3,CTNNA2,NRXN1,KALRN |
1.801e-02 | -4.02 | GJB1 (gap junction protein beta 1) | protein interactions | 2705 | 80 | 2 | 19454 | 50 |
MSI2,PRKCA |
1.804e-02 | -4.01 | ATP2B1 (ATPase plasma membrane Ca2+ transporting 1) | protein interactions | 490 | 216 | 3 | 19454 | 50 |
PRKCA,NTRK2,PARD3 |
1.815e-02 | -4.01 | Corticotropin Activation of Cortisol Production | SMPDB pathways | SMP0000310 | 5 | 1 | 1369 | 5 |
ADCY2 |
1.815e-02 | -4.01 | Ion Channel and Phorbal Esters Signaling Pathway | SMPDB pathways | SMP0090032 | 5 | 1 | 1369 | 5 |
PRKCA |
1.818e-02 | -4.01 | dendritic spine head | cellular component | GO:0044327 | 7 | 1 | 19108 | 50 |
SYNE1 |
1.835e-02 | -4.00 | PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1) | protein interactions | 5295 | 394 | 4 | 19454 | 50 |
NTRK3,NTRK2,RPS6KA2,ERBB4 |
1.843e-02 | -3.99 | FAM135A (family with sequence similarity 135 member A) | protein interactions | 57579 | 81 | 2 | 19454 | 50 |
NTRK2,NTRK3 |
1.852e-02 | -3.99 | Gas2-like domain | gene3d domains | 3.30.920.20 | 6 | 1 | 14470 | 45 |
MACF1 |
1.852e-02 | -3.99 | Plakin repeat | gene3d domains | 3.90.1290.10 | 6 | 1 | 14470 | 45 |
MACF1 |
1.852e-02 | -3.99 | IP3 receptor type 1 binding core, RIH domain | gene3d domains | 1.25.10.30 | 6 | 1 | 14470 | 45 |
RYR3 |
1.855e-02 | -3.99 | Insulin Signaling | WikiPathways | WP481 | 161 | 3 | 5310 | 19 |
SORBS1,PRKCA,RPS6KA2 |
1.865e-02 | -3.98 | cortisol_producing | COSMIC cancer mutations | cortisol_producing | 72 | 2 | 16828 | 49 |
FMN2,LRP1B |
1.865e-02 | -3.98 | adrenal_gland-adrenal_gland-adrenal_cortical_adenoma-cortisol_producing | COSMIC cancer mutations | adrenal_gland-adrenal_gland-adrenal_cortical_adenoma-cortisol_producing | 72 | 2 | 16828 | 49 |
LRP1B,FMN2 |
1.871e-02 | -3.98 | TRIM29 (tripartite motif containing 29) | protein interactions | 23650 | 219 | 3 | 19454 | 50 |
NKAIN3,SYNE1,PRKCA |
1.871e-02 | -3.98 | positive regulation of biological process | biological process | GO:0048518 | 6326 | 25 | 18204 | 50 |
NPAS3,PARD3,GPM6A,NTRK3,SOX5,RPS6KA2,RFX4,PRKCA,FMN2,ATP1A2,RORA,NRXN1,SYNE1,SFXN5,HPSE2,NTRK2,SLC1A2,SLC4A4,GFAP,GLIS3,ERBB4,MACF1,SORBS1,TNC,GPC5 |
1.872e-02 | -3.98 | calcium ion transmembrane transport | biological process | GO:0070588 | 205 | 3 | 18204 | 50 |
TRPM3,RYR3,GPM6A |
1.875e-02 | -3.98 | Plakin_repeat_sf | interpro domains | IPR035915 | 7 | 1 | 18521 | 50 |
MACF1 |
1.875e-02 | -3.98 | Na-dicarboxylate_symporter | interpro domains | IPR001991 | 7 | 1 | 18521 | 50 |
SLC1A2 |
1.875e-02 | -3.98 | Furin-like_Cys-rich_dom | interpro domains | IPR006211 | 7 | 1 | 18521 | 50 |
ERBB4 |
1.875e-02 | -3.98 | Na-dicarboxylate_symporter_CS | interpro domains | IPR018107 | 7 | 1 | 18521 | 50 |
SLC1A2 |
1.875e-02 | -3.98 | Rcpt_L-dom | interpro domains | IPR000494 | 7 | 1 | 18521 | 50 |
ERBB4 |
1.875e-02 | -3.98 | Ammonium/urea_transptr | interpro domains | IPR029020 | 7 | 1 | 18521 | 50 |
SLC14A1 |
1.875e-02 | -3.98 | Na:dicarbo_symporter_sf | interpro domains | IPR036458 | 7 | 1 | 18521 | 50 |
SLC1A2 |
1.875e-02 | -3.98 | Alpha-catenin/vinculin-like_sf | interpro domains | IPR036723 | 7 | 1 | 18521 | 50 |
CTNNA2 |
1.875e-02 | -3.98 | Plectin_repeat | interpro domains | IPR001101 | 7 | 1 | 18521 | 50 |
MACF1 |
1.875e-02 | -3.98 | Intermed_filament_DNA-bd | interpro domains | IPR006821 | 7 | 1 | 18521 | 50 |
GFAP |
1.875e-02 | -3.98 | Plakophilin/d_Catenin | interpro domains | IPR028435 | 7 | 1 | 18521 | 50 |
CTNND2 |
1.875e-02 | -3.98 | Rcpt_L-dom_sf | interpro domains | IPR036941 | 7 | 1 | 18521 | 50 |
ERBB4 |
1.881e-02 | -3.97 | calcium-dependent protein serine/threonine phosphatase activity | molecular function | GO:0004723 | 7 | 1 | 18094 | 49 |
CAMK2G |
1.881e-02 | -3.97 | P-type sodium transporter activity | molecular function | GO:0008554 | 7 | 1 | 18094 | 49 |
ATP1A2 |
1.881e-02 | -3.97 | P-type sodium:potassium-exchanging transporter activity | molecular function | GO:0005391 | 7 | 1 | 18094 | 49 |
ATP1A2 |
1.881e-02 | -3.97 | phosphatidic acid transfer activity | molecular function | GO:1990050 | 7 | 1 | 18094 | 49 |
PITPNC1 |
1.881e-02 | -3.97 | ribosomal protein S6 kinase activity | molecular function | GO:0004711 | 7 | 1 | 18094 | 49 |
RPS6KA2 |
1.895e-02 | -3.97 | ZF_DAG_PE_2 | prosite domains | PS50081 | 63 | 2 | 12186 | 41 |
PRKCA,DGKG |
1.897e-02 | -3.96 | human chr9p24.2 | chromosome location | human chr9p24.2 | 10 | 1 | 26134 | 50 |
GLIS3 |
1.898e-02 | -3.96 | regulation of synaptic transmission, glutamatergic | biological process | GO:0051966 | 77 | 2 | 18204 | 50 |
ATP1A2,NRXN1 |
1.898e-02 | -3.96 | neural retina development | biological process | GO:0003407 | 77 | 2 | 18204 | 50 |
GPM6A,NTRK2 |
1.898e-02 | -3.96 | positive regulation of axonogenesis | biological process | GO:0050772 | 77 | 2 | 18204 | 50 |
MACF1,NTRK2 |
1.907e-02 | -3.96 | negative regulation of Arp2/3 complex-mediated actin nucleation | biological process | GO:0034316 | 7 | 1 | 18204 | 50 |
CTNNA2 |
1.907e-02 | -3.96 | parallel actin filament bundle assembly | biological process | GO:0030046 | 7 | 1 | 18204 | 50 |
FMN2 |
1.907e-02 | -3.96 | observational learning | biological process | GO:0098597 | 7 | 1 | 18204 | 50 |
NRXN1 |
1.907e-02 | -3.96 | cellular response to magnesium ion | biological process | GO:0071286 | 7 | 1 | 18204 | 50 |
RYR3 |
1.907e-02 | -3.96 | peripheral nervous system axon regeneration | biological process | GO:0014012 | 7 | 1 | 18204 | 50 |
TNC |
1.907e-02 | -3.96 | chromosome movement towards spindle pole | biological process | GO:0051305 | 7 | 1 | 18204 | 50 |
FMN2 |
1.907e-02 | -3.96 | interneuron migration from the subpallium to the cortex | biological process | GO:0021830 | 7 | 1 | 18204 | 50 |
NRG3 |
1.912e-02 | -3.96 | Furin-like | pfam domains | PF00757 | 7 | 1 | 17795 | 49 |
ERBB4 |
1.912e-02 | -3.96 | Recep_L_domain | pfam domains | PF01030 | 7 | 1 | 17795 | 49 |
ERBB4 |
1.912e-02 | -3.96 | SDF | pfam domains | PF00375 | 7 | 1 | 17795 | 49 |
SLC1A2 |
1.912e-02 | -3.96 | Filament_head | pfam domains | PF04732 | 7 | 1 | 17795 | 49 |
GFAP |
1.930e-02 | -3.95 | ARHGEF10 (Rho guanine nucleotide exchange factor 10) | protein interactions | 9639 | 83 | 2 | 19454 | 50 |
NTRK3,NTRK2 |
1.930e-02 | -3.95 | SYT1 (synaptotagmin 1) | protein interactions | 6857 | 83 | 2 | 19454 | 50 |
GPM6A,NRXN1 |
1.937e-02 | -3.94 | sarcomere | cellular component | GO:0030017 | 218 | 3 | 19108 | 50 |
NEBL,SYNE1,RYR3 |
1.939e-02 | -3.94 | PKP2 (plakophilin 2) | protein interactions | 5318 | 222 | 3 | 19454 | 50 |
PARD3,NTRK3,NTRK2 |
1.939e-02 | -3.94 | PSEN1 (presenilin 1) | protein interactions | 5663 | 222 | 3 | 19454 | 50 |
GFAP,CTNND2,DTNA |
1.939e-02 | -3.94 | YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta) | protein interactions | 10971 | 1076 | 7 | 19454 | 50 |
PARD3,SORBS1,MACF1,NAV2,DCLK2,PRKCA,ABLIM1 |
1.944e-02 | -3.94 | regulation of glucose transmembrane transport | biological process | GO:0010827 | 78 | 2 | 18204 | 50 |
SLC1A2,SORBS1 |
1.944e-02 | -3.94 | positive regulation of carbohydrate metabolic process | biological process | GO:0045913 | 78 | 2 | 18204 | 50 |
SLC4A4,SORBS1 |
1.954e-02 | -3.94 | SH3-like_dom_sf | interpro domains | IPR036028 | 212 | 3 | 18521 | 50 |
NEBL,SORBS1,KALRN |
1.974e-02 | -3.93 | PSEN2 (presenilin 2) | protein interactions | 5664 | 84 | 2 | 19454 | 50 |
GFAP,CTNND2 |
1.976e-02 | -3.92 | regulation of localization | biological process | GO:0032879 | 2028 | 11 | 18204 | 50 |
GPC5,CAMK2G,ERBB4,GFAP,DCLK2,ATP1A2,SLC1A2,SORBS1,NKAIN3,SYNE1,RYR3 |
1.985e-02 | -3.92 | PLEKHA5 (pleckstrin homology domain containing A5) | protein interactions | 54477 | 224 | 3 | 19454 | 50 |
RPS6KA2,NTRK3,PARD3 |
1.985e-02 | -3.92 | solute:sodium symporter activity | molecular function | GO:0015370 | 80 | 2 | 18094 | 49 |
SLC4A4,SLC1A2 |
1.989e-02 | -3.92 | plasma membrane protein complex | cellular component | GO:0098797 | 600 | 5 | 19108 | 50 |
SORBS1,PRKCA,CDH20,ATP1A2,CTNNA2 |
1.996e-02 | -3.91 | caveola | cellular component | GO:0005901 | 83 | 2 | 19108 | 50 |
SORBS1,ATP1A2 |
2.002e-02 | -3.91 | GLYPICAN | prosite domains | PS01207 | 6 | 1 | 12186 | 41 |
GPC5 |
2.002e-02 | -3.91 | GAR | prosite domains | PS51460 | 6 | 1 | 12186 | 41 |
MACF1 |
2.018e-02 | -3.90 | CREM (cAMP responsive element modulator) | protein interactions | 1390 | 85 | 2 | 19454 | 50 |
CAMK2G,PRKCA |
2.021e-02 | -3.90 | stomach-carcinoma-mixed_adenosquamous_carcinoma | COSMIC cancer mutations | stomach-carcinoma-mixed_adenosquamous_carcinoma | 7 | 1 | 16828 | 49 |
NTRK3 |
2.025e-02 | -3.90 | CREB phosphorylation | REACTOME pathways | R-HSA-199920 | 7 | 1 | 10285 | 30 |
RPS6KA2 |
2.038e-02 | -3.89 | CD163 (CD163 molecule) | protein interactions | 9332 | 8 | 1 | 19454 | 50 |
PRKCA |
2.038e-02 | -3.89 | NKAIN3 (sodium/potassium transporting ATPase interacting 3) | protein interactions | 286183 | 8 | 1 | 19454 | 50 |
GFAP |
2.038e-02 | -3.89 | Prkca (protein kinase C, alpha) | protein interactions | 24680 | 8 | 1 | 19454 | 50 |
PRKCA |
2.038e-02 | -3.89 | Marcks (myristoylated alanine rich protein kinase C substrate) | protein interactions | 17118 | 8 | 1 | 19454 | 50 |
PRKCA |
2.038e-02 | -3.89 | UBALD2 (UBA like domain containing 2) | protein interactions | 283991 | 8 | 1 | 19454 | 50 |
GFAP |
2.038e-02 | -3.89 | INSM1 (INSM transcriptional repressor 1) | protein interactions | 3642 | 8 | 1 | 19454 | 50 |
SORBS1 |
2.049e-02 | -3.89 | SPECTRINPH | prints domains | PR00683 | 6 | 1 | 5227 | 18 |
PSD2 |
2.051e-02 | -3.89 | EGF_1 | prosite domains | PS00022 | 174 | 3 | 12186 | 41 |
TNC,NRG3,LRP1B |
2.055e-02 | -3.88 | PRKCD (protein kinase C delta) | protein interactions | 5580 | 227 | 3 | 19454 | 50 |
CAMK2G,MACF1,PRKCA |
2.063e-02 | -3.88 | SYNJ1 (synaptojanin 1) | protein interactions | 8867 | 86 | 2 | 19454 | 50 |
SORBS1,GPM6A |
2.069e-02 | -3.88 | protein binding | molecular function | GO:0005515 | 13983 | 44 | 18094 | 49 |
NRG3,ABLIM1,RFX4,GPC5,LRP1B,CTNND2,ADCY2,PITPNC1,GLIS3,SOX5,SYNE1,PRKCA,NPAS3,TNC,FMN2,CAMK2G,GFAP,RYR3,ATP1A2,MSI2,KALRN,SORBS1,MACF1,NTRK3,SFXN5,HPSE2,RORA,DTNA,NDRG2,NEBL,NTM,RPS6KA2,NTRK2,GPM6A,PARD3,DCLK2,CTNNA2,CDH20,NAV2,SLC4A4,LSAMP,SLC1A2,NRXN1,ERBB4 |
2.073e-02 | -3.88 | NOTCH2 (notch receptor 2) | protein interactions | 4853 | 409 | 4 | 19454 | 50 |
NTRK3,PARD3,NTRK2,RPS6KA2 |
2.075e-02 | -3.88 | zonula adherens | cellular component | GO:0005915 | 8 | 1 | 19108 | 50 |
SORBS1 |
2.101e-02 | -3.86 | EF_hand_dom | interpro domains | IPR002048 | 218 | 3 | 18521 | 50 |
MACF1,RYR3,DGKG |
2.103e-02 | -3.86 | YKT6 (YKT6 v-SNARE homolog) | protein interactions | 10652 | 229 | 3 | 19454 | 50 |
NTRK3,GPM6A,RPS6KA2 |
2.103e-02 | -3.86 | PCNT (pericentrin) | protein interactions | 5116 | 229 | 3 | 19454 | 50 |
KALRN,MACF1,SYNE1 |
2.106e-02 | -3.86 | eye-uveal_tract-malignant_melanoma-spindle | COSMIC cancer mutations | eye-uveal_tract-malignant_melanoma-spindle | 363 | 4 | 16828 | 49 |
CTNND2,KALRN,TRPM3,MACF1 |
2.115e-02 | -3.86 | Cys-rich_flank_reg_C | interpro domains | IPR000483 | 83 | 2 | 18521 | 50 |
NTRK3,NTRK2 |
2.126e-02 | -3.85 | skin-leg-malignant_melanoma | COSMIC cancer mutations | skin-leg-malignant_melanoma | 549 | 5 | 16828 | 49 |
LRP1B,NEBL,NRG3,SYNE1,NTRK3 |
2.127e-02 | -3.85 | DST (dystonin) | protein interactions | 667 | 230 | 3 | 19454 | 50 |
ATP1A2,NTRK2,PARD3 |
2.140e-02 | -3.84 | PH_9 | interpro domains | IPR041681 | 8 | 1 | 18521 | 50 |
PSD2 |
2.140e-02 | -3.84 | RFX-like | interpro domains | IPR039779 | 8 | 1 | 18521 | 50 |
RFX4 |
2.140e-02 | -3.84 | Plakin | interpro domains | IPR043197 | 8 | 1 | 18521 | 50 |
MACF1 |
2.140e-02 | -3.84 | AC_N | interpro domains | IPR032628 | 8 | 1 | 18521 | 50 |
ADCY2 |
2.140e-02 | -3.84 | Villin_headpiece | interpro domains | IPR003128 | 8 | 1 | 18521 | 50 |
ABLIM1 |
2.140e-02 | -3.84 | TRPM_SLOG | interpro domains | IPR041491 | 8 | 1 | 18521 | 50 |
TRPM3 |
2.140e-02 | -3.84 | Adcy | interpro domains | IPR030672 | 8 | 1 | 18521 | 50 |
ADCY2 |
2.140e-02 | -3.84 | Villin_headpiece_dom_sf | interpro domains | IPR036886 | 8 | 1 | 18521 | 50 |
ABLIM1 |
2.140e-02 | -3.84 | positive regulation of cellular process | biological process | GO:0048522 | 5719 | 23 | 18204 | 50 |
SYNE1,NTRK2,SLC1A2,HPSE2,NPAS3,NTRK3,PARD3,GPM6A,ERBB4,GFAP,SOX5,GLIS3,SLC4A4,RFX4,MACF1,RPS6KA2,SORBS1,PRKCA,FMN2,GPC5,TNC,NRXN1,RORA |
2.146e-02 | -3.84 | sodium ion binding | molecular function | GO:0031402 | 8 | 1 | 18094 | 49 |
ATP1A2 |
2.146e-02 | -3.84 | urea transmembrane transporter activity | molecular function | GO:0015204 | 8 | 1 | 18094 | 49 |
SLC14A1 |
2.146e-02 | -3.84 | P-type potassium transmembrane transporter activity | molecular function | GO:0008556 | 8 | 1 | 18094 | 49 |
ATP1A2 |
2.153e-02 | -3.84 | TIMP3 (TIMP metallopeptidase inhibitor 3) | protein interactions | 7078 | 88 | 2 | 19454 | 50 |
LRP1B,NTRK3 |
2.157e-02 | -3.84 | Sodium:dicarboxylate symporter | gene3d domains | 1.10.3860.10 | 7 | 1 | 14470 | 45 |
SLC1A2 |
2.157e-02 | -3.84 | Receptor L-domain | gene3d domains | 3.80.20.20 | 7 | 1 | 14470 | 45 |
ERBB4 |
2.157e-02 | -3.84 | Ammonium transporter AmtB like domains | gene3d domains | 1.10.3430.10 | 7 | 1 | 14470 | 45 |
SLC14A1 |
2.161e-02 | -3.83 | Cysteine Rich Protein | gene3d domains | 2.10.110.10 | 73 | 2 | 14470 | 45 |
NEBL,ABLIM1 |
2.172e-02 | -3.83 | regulation of cell junction assembly | biological process | GO:1901888 | 217 | 3 | 18204 | 50 |
NTRK2,NRXN1,MACF1 |
2.175e-02 | -3.83 | CTNND1 (catenin delta 1) | protein interactions | 1500 | 232 | 3 | 19454 | 50 |
NTRK3,PARD3,RPS6KA2 |
2.175e-02 | -3.83 | Dopamine Activation of Neurological Reward System | SMPDB pathways | SMP0000308 | 6 | 1 | 1369 | 5 |
ADCY2 |
2.175e-02 | -3.83 | Phospholipase C Signaling Pathway | SMPDB pathways | SMP0063783 | 6 | 1 | 1369 | 5 |
PRKCA |
2.175e-02 | -3.83 | Intracellular Signalling Through PGD2 receptor and Prostaglandin D2 | SMPDB pathways | SMP0000343 | 6 | 1 | 1369 | 5 |
ADCY2 |
2.177e-02 | -3.83 | cell proliferation in hindbrain | biological process | GO:0021534 | 8 | 1 | 18204 | 50 |
RORA |
2.177e-02 | -3.83 | smooth muscle cell proliferation | biological process | GO:0048659 | 8 | 1 | 18204 | 50 |
NDRG2 |
2.177e-02 | -3.83 | regulation of chaperone-mediated autophagy | biological process | GO:1904714 | 8 | 1 | 18204 | 50 |
GFAP |
2.177e-02 | -3.83 | cerebellar granule cell precursor proliferation | biological process | GO:0021930 | 8 | 1 | 18204 | 50 |
RORA |
2.177e-02 | -3.83 | regulation of synapse structural plasticity | biological process | GO:0051823 | 8 | 1 | 18204 | 50 |
CTNNA2 |
2.177e-02 | -3.83 | meiotic cytokinesis | biological process | GO:0033206 | 8 | 1 | 18204 | 50 |
FMN2 |
2.177e-02 | -3.83 | mitotic nuclear membrane disassembly | biological process | GO:0007077 | 8 | 1 | 18204 | 50 |
PRKCA |
2.177e-02 | -3.83 | regulation of L-glutamate import across plasma membrane | biological process | GO:0002036 | 8 | 1 | 18204 | 50 |
ATP1A2 |
2.177e-02 | -3.83 | cell proliferation in external granule layer | biological process | GO:0021924 | 8 | 1 | 18204 | 50 |
RORA |
2.182e-02 | -3.82 | DCX | pfam domains | PF03607 | 8 | 1 | 17795 | 49 |
DCLK2 |
2.182e-02 | -3.82 | PH_9 | pfam domains | PF15410 | 8 | 1 | 17795 | 49 |
PSD2 |
2.182e-02 | -3.82 | VHP | pfam domains | PF02209 | 8 | 1 | 17795 | 49 |
ABLIM1 |
2.182e-02 | -3.82 | LSDAT_euk | pfam domains | PF18139 | 8 | 1 | 17795 | 49 |
TRPM3 |
2.182e-02 | -3.82 | AC_N | pfam domains | PF16214 | 8 | 1 | 17795 | 49 |
ADCY2 |
2.186e-02 | -3.82 | skin-upper_arm-malignant_melanoma | COSMIC cancer mutations | skin-upper_arm-malignant_melanoma | 553 | 5 | 16828 | 49 |
LRP1B,SYNE1,SLC4A4,ERBB4,FMN2 |
2.194e-02 | -3.82 | regulation of cell population proliferation | biological process | GO:0042127 | 1790 | 10 | 18204 | 50 |
GFAP,TNC,ERBB4,NTRK3,PRKCA,NDRG2,NTRK2,HPSE2,SYNE1,RPS6KA2 |
2.197e-02 | -3.82 | receptor complex | cellular component | GO:0043235 | 409 | 4 | 19108 | 50 |
NTRK3,ERBB4,NTRK2,LRP1B |
2.199e-02 | -3.82 | PEA15 (proliferation and apoptosis adaptor protein 15) | protein interactions | 8682 | 89 | 2 | 19454 | 50 |
CAMK2G,PRKCA |
2.203e-02 | -3.82 | GAS2 | smart domains | SM00243 | 6 | 1 | 9717 | 36 |
MACF1 |
2.210e-02 | -3.81 | response to stimulus | biological process | GO:0050896 | 7803 | 29 | 18204 | 50 |
PITPNC1,ADCY2,CTNND2,CTNNA2,SOX5,GPM6A,DTNA,PARD3,NTRK3,PRKCA,RPS6KA2,RORA,NRXN1,NRG3,FMN2,ATP1A2,DCLK2,NTRK2,SLC1A2,SYNE1,ERBB4,DGKG,GFAP,NDRG2,SORBS1,RYR3,MACF1,TNC,KALRN |
2.215e-02 | -3.81 | Endothelins | Pathway Interaction DB | endothelinpathway | 53 | 2 | 2226 | 10 |
PRKCA,ADCY2 |
2.224e-02 | -3.81 | glial cell differentiation | biological process | GO:0010001 | 219 | 3 | 18204 | 50 |
NTRK2,GFAP,PARD3 |
2.226e-02 | -3.80 | Glioma | KEGG pathways | ko05214 | 64 | 2 | 7161 | 26 |
PRKCA,CAMK2G |
2.226e-02 | -3.80 | Glioma | KEGG pathways | hsa05214 | 64 | 2 | 7161 | 26 |
CAMK2G,PRKCA |
2.233e-02 | -3.80 | regulation of sodium ion transport | biological process | GO:0002028 | 84 | 2 | 18204 | 50 |
NKAIN3,ATP1A2 |
2.233e-02 | -3.80 | stem cell development | biological process | GO:0048864 | 84 | 2 | 18204 | 50 |
ERBB4,MSI2 |
2.233e-02 | -3.80 | peripheral nervous system development | biological process | GO:0007422 | 84 | 2 | 18204 | 50 |
NTRK2,PARD3 |
2.246e-02 | -3.80 | CTDSPL (CTD small phosphatase like) | protein interactions | 10217 | 90 | 2 | 19454 | 50 |
FMN2,DTNA |
2.250e-02 | -3.79 | response to mechanical stimulus | biological process | GO:0009612 | 220 | 3 | 18204 | 50 |
ATP1A2,NRXN1,TNC |
2.272e-02 | -3.78 | human chr6q25.2 | chromosome location | human chr6q25.2 | 12 | 1 | 26134 | 50 |
SYNE1 |
2.290e-02 | -3.78 | MUC4 (mucin 4, cell surface associated) | protein interactions | 4585 | 9 | 1 | 19454 | 50 |
ERBB4 |
2.290e-02 | -3.78 | LSB3 (Lsb3p) | protein interactions | 850580 | 9 | 1 | 19454 | 50 |
GFAP |
2.290e-02 | -3.78 | MMP19 (matrix metallopeptidase 19) | protein interactions | 4327 | 9 | 1 | 19454 | 50 |
SYNE1 |
2.290e-02 | -3.78 | CAMK2N1 (calcium/calmodulin dependent protein kinase II inhibitor 1) | protein interactions | 55450 | 9 | 1 | 19454 | 50 |
CAMK2G |
2.290e-02 | -3.78 | Tyw3 (tRNA-yW synthesizing protein 3 homolog (S. cerevisiae)) | protein interactions | 209584 | 9 | 1 | 19454 | 50 |
CTNNA2 |
2.290e-02 | -3.78 | NRXN2 (neurexin 2) | protein interactions | 9379 | 9 | 1 | 19454 | 50 |
MACF1 |
2.290e-02 | -3.78 | SCTR (secretin receptor) | protein interactions | 6344 | 9 | 1 | 19454 | 50 |
PRKCA |
2.292e-02 | -3.78 | PTPN21 (protein tyrosine phosphatase non-receptor type 21) | protein interactions | 11099 | 91 | 2 | 19454 | 50 |
NRG3,ERBB4 |
2.292e-02 | -3.78 | THUMPD3 (THUMP domain containing 3) | protein interactions | 25917 | 91 | 2 | 19454 | 50 |
RPS6KA2,CTNND2 |
2.292e-02 | -3.78 | DGUOK (deoxyguanosine kinase) | protein interactions | 1716 | 91 | 2 | 19454 | 50 |
GPM6A,NTM |
2.299e-02 | -3.77 | CLU (clusterin) | protein interactions | 1191 | 237 | 3 | 19454 | 50 |
LRP1B,NTRK3,TNC |
2.306e-02 | -3.77 | stomach-carcinoma-papillary_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-papillary_adenocarcinoma | 8 | 1 | 16828 | 49 |
NTRK3 |
2.306e-02 | -3.77 | papillary_adenocarcinoma | COSMIC cancer mutations | papillary_adenocarcinoma | 8 | 1 | 16828 | 49 |
NTRK3 |
2.311e-02 | -3.77 | Release of Hh-Np from the secreting cell | REACTOME pathways | R-HSA-5362798 | 8 | 1 | 10285 | 30 |
GPC5 |
2.311e-02 | -3.77 | Downregulation of ERBB4 signaling | REACTOME pathways | R-HSA-1253288 | 8 | 1 | 10285 | 30 |
ERBB4 |
2.311e-02 | -3.77 | HuR (ELAVL1) binds and stabilizes mRNA | REACTOME pathways | R-HSA-450520 | 8 | 1 | 10285 | 30 |
PRKCA |
2.318e-02 | -3.76 | skin-leg-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-leg-malignant_melanoma-superficial_spreading | 210 | 3 | 16828 | 49 |
NTM,SLC4A4,LRP1B |
2.331e-02 | -3.76 | Immunoglobulins | gene3d domains | 2.60.40.10 | 721 | 6 | 14470 | 45 |
NTRK2,LSAMP,NTRK3,NTM,TNC,KALRN |
2.331e-02 | -3.76 | flotillin complex | cellular component | GO:0016600 | 9 | 1 | 19108 | 50 |
SORBS1 |
2.331e-02 | -3.76 | astrocyte end-foot | cellular component | GO:0097450 | 9 | 1 | 19108 | 50 |
GFAP |
2.332e-02 | -3.76 | NA_DICARBOXYL_SYMP_1 | prosite domains | PS00713 | 7 | 1 | 12186 | 41 |
SLC1A2 |
2.332e-02 | -3.76 | NA_DICARBOXYL_SYMP_2 | prosite domains | PS00714 | 7 | 1 | 12186 | 41 |
SLC1A2 |
2.333e-02 | -3.76 | small molecule binding | molecular function | GO:0036094 | 6197 | 24 | 18094 | 49 |
NAV2,RYR3,ATP1A2,SLC1A2,RPS6KA2,NTRK2,CAMK2G,PARD3,DCLK2,DGKG,ERBB4,KALRN,MACF1,NRXN1,RORA,DTNA,NTRK3,ABLIM1,GLIS3,PRKCA,LRP1B,ADCY2,MGAT4C,PITPNC1 |
2.334e-02 | -3.76 | central nervous system neuron development | biological process | GO:0021954 | 86 | 2 | 18204 | 50 |
DCLK2,NTRK2 |
2.334e-02 | -3.76 | protein localization to cell junction | biological process | GO:1902414 | 86 | 2 | 18204 | 50 |
NRXN1,ERBB4 |
2.361e-02 | -3.75 | regulation of biological quality | biological process | GO:0065008 | 2936 | 14 | 18204 | 50 |
ATP1A2,NRXN1,MACF1,PRKCA,GPM6A,CAMK2G,ERBB4,GFAP,DGKG,SLC4A4,SYNE1,NAV2,CTNNA2,NTRK2 |
2.371e-02 | -3.74 | LIM_DOMAIN_1 | prosite domains | PS00478 | 71 | 2 | 12186 | 41 |
ABLIM1,NEBL |
2.371e-02 | -3.74 | LIM_DOMAIN_2 | prosite domains | PS50023 | 71 | 2 | 12186 | 41 |
ABLIM1,NEBL |
2.380e-02 | -3.74 | bone-fibula-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-fibula-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 377 | 4 | 16828 | 49 |
NRXN1,SYNE1,TRPM3,MACF1 |
2.387e-02 | -3.74 | EDTRNSPORT | prints domains | PR00173 | 7 | 1 | 5227 | 18 |
SLC1A2 |
2.398e-02 | -3.73 | C1 | smart domains | SM00109 | 65 | 2 | 9717 | 36 |
PRKCA,DGKG |
2.404e-02 | -3.73 | Band3_cytoplasmic_dom | interpro domains | IPR013769 | 9 | 1 | 18521 | 50 |
SLC4A4 |
2.404e-02 | -3.73 | DNA-bd_RFX | interpro domains | IPR003150 | 9 | 1 | 18521 | 50 |
RFX4 |
2.404e-02 | -3.73 | Doublecortin_dom | interpro domains | IPR003533 | 9 | 1 | 18521 | 50 |
DCLK2 |
2.412e-02 | -3.72 | calcium-dependent protein serine/threonine kinase activity | molecular function | GO:0009931 | 9 | 1 | 18094 | 49 |
PRKCA |
2.427e-02 | -3.72 | DSG2 (desmoglein 2) | protein interactions | 1829 | 242 | 3 | 19454 | 50 |
PARD3,NTRK3,RPS6KA2 |
2.435e-02 | -3.72 | WWC1 (WW and C2 domain containing 1) | protein interactions | 23286 | 94 | 2 | 19454 | 50 |
ABLIM1,PRKCA |
2.436e-02 | -3.71 | positive regulation of peptidyl-serine phosphorylation | biological process | GO:0033138 | 88 | 2 | 18204 | 50 |
NTRK3,NTRK2 |
2.446e-02 | -3.71 | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | biological process | GO:0014808 | 9 | 1 | 18204 | 50 |
RYR3 |
2.446e-02 | -3.71 | mesenchymal-epithelial cell signaling | biological process | GO:0060638 | 9 | 1 | 18204 | 50 |
TNC |
2.446e-02 | -3.71 | negative regulation of actin nucleation | biological process | GO:0051126 | 9 | 1 | 18204 | 50 |
CTNNA2 |
2.446e-02 | -3.71 | hindbrain radial glia guided cell migration | biological process | GO:0021932 | 9 | 1 | 18204 | 50 |
CTNNA2 |
2.446e-02 | -3.71 | positive regulation of synapse maturation | biological process | GO:0090129 | 9 | 1 | 18204 | 50 |
NRXN1 |
2.446e-02 | -3.71 | negative regulation of striated muscle contraction | biological process | GO:0045988 | 9 | 1 | 18204 | 50 |
ATP1A2 |
2.452e-02 | -3.71 | Band_3_cyto | pfam domains | PF07565 | 9 | 1 | 17795 | 49 |
SLC4A4 |
2.452e-02 | -3.71 | RFX_DNA_binding | pfam domains | PF02257 | 9 | 1 | 17795 | 49 |
RFX4 |
2.458e-02 | -3.71 | Neurotrophic factor-mediated Trk receptor signaling | Pathway Interaction DB | trkrpathway | 56 | 2 | 2226 | 10 |
NTRK3,NTRK2 |
2.461e-02 | -3.70 | myofibril | cellular component | GO:0030016 | 239 | 3 | 19108 | 50 |
RYR3,NEBL,SYNE1 |
2.462e-02 | -3.70 | Villin headpiece domain | gene3d domains | 1.10.950.10 | 8 | 1 | 14470 | 45 |
ABLIM1 |
2.483e-02 | -3.70 | MPP7 (MAGUK p55 scaffold protein 7) | protein interactions | 143098 | 95 | 2 | 19454 | 50 |
RPS6KA2,NTRK3 |
2.494e-02 | -3.69 | Amphetamine addiction | KEGG pathways | ko05031 | 68 | 2 | 7161 | 26 |
PRKCA,CAMK2G |
2.494e-02 | -3.69 | Amphetamine addiction | KEGG pathways | hsa05031 | 68 | 2 | 7161 | 26 |
CAMK2G,PRKCA |
2.501e-02 | -3.69 | regulation of cell migration | biological process | GO:0030334 | 1061 | 7 | 18204 | 50 |
ERBB4,TNC,NRG3,NTRK3,PRKCA,CTNNA2,MACF1 |
2.514e-02 | -3.68 | intermediate filament cytoskeleton | cellular component | GO:0045111 | 241 | 3 | 19108 | 50 |
GFAP,MACF1,DTNA |
2.528e-02 | -3.68 | Opioid Signalling | REACTOME pathways | R-HSA-111885 | 85 | 2 | 10285 | 30 |
ADCY2,PRKCA |
2.532e-02 | -3.68 | SOCS2 (suppressor of cytokine signaling 2) | protein interactions | 8835 | 96 | 2 | 19454 | 50 |
NTRK2,ERBB4 |
2.534e-02 | -3.68 | Vasopressin Regulation of Water Homeostasis | SMPDB pathways | SMP0000322 | 7 | 1 | 1369 | 5 |
ADCY2 |
2.541e-02 | -3.67 | EREG (epiregulin) | protein interactions | 2069 | 10 | 1 | 19454 | 50 |
ERBB4 |
2.541e-02 | -3.67 | DOA4 (ubiquitin-specific protease DOA4) | protein interactions | 851641 | 10 | 1 | 19454 | 50 |
NAV2 |
2.541e-02 | -3.67 | CALB2 (calbindin 2) | protein interactions | 794 | 10 | 1 | 19454 | 50 |
GPM6A |
2.541e-02 | -3.67 | TNP1 (transition protein 1) | protein interactions | 7141 | 10 | 1 | 19454 | 50 |
PRKCA |
2.541e-02 | -3.67 | SLC8A2 (solute carrier family 8 member A2) | protein interactions | 6543 | 10 | 1 | 19454 | 50 |
GPM6A |
2.541e-02 | -3.67 | CHRDL1 (chordin like 1) | protein interactions | 91851 | 10 | 1 | 19454 | 50 |
LRP1B |
2.541e-02 | -3.67 | AXDND1 (axonemal dynein light chain domain containing 1) | protein interactions | 126859 | 10 | 1 | 19454 | 50 |
SYNE1 |
2.541e-02 | -3.67 | GSG1 (germ cell associated 1) | protein interactions | 83445 | 10 | 1 | 19454 | 50 |
PITPNC1 |
2.541e-02 | -3.67 | PPY (pancreatic polypeptide) | protein interactions | 5539 | 10 | 1 | 19454 | 50 |
PRKCA |
2.541e-02 | -3.67 | PTPRT (protein tyrosine phosphatase receptor type T) | protein interactions | 11122 | 10 | 1 | 19454 | 50 |
ERBB4 |
2.541e-02 | -3.67 | Vbp1 (von Hippel-Lindau binding protein 1) | protein interactions | 22327 | 10 | 1 | 19454 | 50 |
ABLIM1 |
2.541e-02 | -3.67 | ZNF563 (zinc finger protein 563) | protein interactions | 147837 | 10 | 1 | 19454 | 50 |
LRP1B |
2.541e-02 | -3.67 | Smurf2 (SMAD specific E3 ubiquitin protein ligase 2) | protein interactions | 66313 | 10 | 1 | 19454 | 50 |
GLIS3 |
2.544e-02 | -3.67 | cell leading edge | cellular component | GO:0031252 | 428 | 4 | 19108 | 50 |
SLC1A2,MACF1,ABLIM1,PSD2 |
2.546e-02 | -3.67 | regulation of biological process | biological process | GO:0050789 | 12079 | 40 | 18204 | 50 |
ERBB4,CAMK2G,SLC4A4,DGKG,GLIS3,GFAP,PSD2,SYNE1,HPSE2,MSI2,SFXN5,NTRK2,SLC1A2,TNC,GPC5,KALRN,NKAIN3,RYR3,MACF1,NDRG2,SORBS1,PARD3,DTNA,GPM6A,NTRK3,SOX5,CTNND2,CTNNA2,PITPNC1,NPAS3,ADCY2,NRG3,FMN2,ATP1A2,DCLK2,RORA,NRXN1,RFX4,RPS6KA2,PRKCA |
2.566e-02 | -3.66 | PLEC | smart domains | SM00250 | 7 | 1 | 9717 | 36 |
MACF1 |
2.568e-02 | -3.66 | spindle | COSMIC cancer mutations | spindle | 386 | 4 | 16828 | 49 |
MACF1,CTNND2,TRPM3,KALRN |
2.579e-02 | -3.66 | biological regulation | biological process | GO:0065007 | 12501 | 41 | 18204 | 50 |
KALRN,TNC,GPC5,RYR3,MACF1,NKAIN3,SORBS1,NDRG2,SLC4A4,DGKG,GFAP,GLIS3,ERBB4,CAMK2G,SYNE1,NAV2,PSD2,SFXN5,MSI2,HPSE2,SLC1A2,NTRK2,FMN2,ATP1A2,DCLK2,NRG3,RORA,NRXN1,RPS6KA2,RFX4,PRKCA,DTNA,GPM6A,PARD3,NTRK3,SOX5,CTNNA2,CTNND2,NPAS3,ADCY2,PITPNC1 |
2.581e-02 | -3.66 | STXBP3 (syntaxin binding protein 3) | protein interactions | 6814 | 97 | 2 | 19454 | 50 |
RPS6KA2,PRKCA |
2.581e-02 | -3.66 | BTG3 (BTG anti-proliferation factor 3) | protein interactions | 10950 | 97 | 2 | 19454 | 50 |
SYNE1,DCLK2 |
2.581e-02 | -3.66 | LIN7C (lin-7 homolog C, crumbs cell polarity complex component) | protein interactions | 55327 | 97 | 2 | 19454 | 50 |
NTRK3,ABLIM1 |
2.581e-02 | -3.66 | PLCB3 (phospholipase C beta 3) | protein interactions | 5331 | 97 | 2 | 19454 | 50 |
CAMK2G,PARD3 |
2.585e-02 | -3.66 | ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase) | protein interactions | 25 | 248 | 3 | 19454 | 50 |
ERBB4,CTNND2,SORBS1 |
2.589e-02 | -3.65 | fibula | COSMIC cancer mutations | fibula | 387 | 4 | 16828 | 49 |
MACF1,SYNE1,TRPM3,NRXN1 |
2.596e-02 | -3.65 | EGFR Transactivation by Gastrin | REACTOME pathways | R-HSA-2179392 | 9 | 1 | 10285 | 30 |
PRKCA |
2.612e-02 | -3.65 | GAN (gigaxonin) | protein interactions | 8139 | 249 | 3 | 19454 | 50 |
CTNNA2,SYNE1,GFAP |
2.612e-02 | -3.65 | MYO1B (myosin IB) | protein interactions | 4430 | 249 | 3 | 19454 | 50 |
CAMK2G,PARD3,NTRK3 |
2.617e-02 | -3.64 | sarcoplasm | cellular component | GO:0016528 | 96 | 2 | 19108 | 50 |
CAMK2G,RYR3 |
2.621e-02 | -3.64 | oesophagus-carcinoma-adenocarcinoma | COSMIC cancer mutations | oesophagus-carcinoma-adenocarcinoma | 13112 | 44 | 16828 | 49 |
ATP1A2,TNC,PSD2,CTNND2,SOX5,CAMK2G,NTRK2,LSAMP,NRXN1,NPAS3,SLC4A4,ERBB4,NDRG2,GPC5,CDH20,LRP1B,ADCY2,PARD3,SYNE1,SLC1A2,SORBS1,HPSE2,MGAT4C,RORA,KALRN,DCLK2,MACF1,NAV2,GPM6A,NKAIN3,TRPM3,SFXN5,GLIS3,GFAP,NRG3,RFX4,NEBL,NTM,PRKCA,RYR3,NTRK3,RPS6KA2,DGKG,FMN2 |
2.631e-02 | -3.64 | MB21D2 (Mab-21 domain containing 2) | protein interactions | 151963 | 98 | 2 | 19454 | 50 |
NTRK3,NTRK2 |
2.631e-02 | -3.64 | FRAS1 (Fraser extracellular matrix complex subunit 1) | protein interactions | 80144 | 98 | 2 | 19454 | 50 |
MGAT4C,HPSE2 |
2.631e-02 | -3.64 | DNAAF2 (dynein axonemal assembly factor 2) | protein interactions | 55172 | 98 | 2 | 19454 | 50 |
GPM6A,LSAMP |
2.639e-02 | -3.63 | PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | REACTOME pathways | R-HSA-6811558 | 87 | 2 | 10285 | 30 |
NRG3,ERBB4 |
2.645e-02 | -3.63 | protein tetramerization | biological process | GO:0051262 | 92 | 2 | 18204 | 50 |
RYR3,TRPM3 |
2.646e-02 | -3.63 | human chr2p16.3 | chromosome location | human chr2p16.3 | 14 | 1 | 26134 | 50 |
NRXN1 |
2.646e-02 | -3.63 | human chr2p13.2 | chromosome location | human chr2p13.2 | 14 | 1 | 26134 | 50 |
SFXN5 |
2.646e-02 | -3.63 | human chr9q33.1 | chromosome location | human chr9q33.1 | 14 | 1 | 26134 | 50 |
TNC |
2.654e-02 | -3.63 | upper_arm | COSMIC cancer mutations | upper_arm | 582 | 5 | 16828 | 49 |
LRP1B,FMN2,ERBB4,SLC4A4,SYNE1 |
2.661e-02 | -3.63 | HP | prosite domains | PS51089 | 8 | 1 | 12186 | 41 |
ABLIM1 |
2.668e-02 | -3.62 | HCO3_transpt-like_TM_dom | interpro domains | IPR011531 | 10 | 1 | 18521 | 50 |
SLC4A4 |
2.668e-02 | -3.62 | Diacylglycerol_kin_accessory | interpro domains | IPR000756 | 10 | 1 | 18521 | 50 |
DGKG |
2.668e-02 | -3.62 | HCO3_transpt_euk | interpro domains | IPR003020 | 10 | 1 | 18521 | 50 |
SLC4A4 |
2.668e-02 | -3.62 | DGK | interpro domains | IPR037607 | 10 | 1 | 18521 | 50 |
DGKG |
2.668e-02 | -3.62 | MIR_motif | interpro domains | IPR016093 | 10 | 1 | 18521 | 50 |
RYR3 |
2.668e-02 | -3.62 | PTrfase/Anion_transptr | interpro domains | IPR016152 | 10 | 1 | 18521 | 50 |
SLC4A4 |
2.668e-02 | -3.62 | PAS_fold_3 | interpro domains | IPR013655 | 10 | 1 | 18521 | 50 |
NPAS3 |
2.668e-02 | -3.62 | Doublecortin_dom_sf | interpro domains | IPR036572 | 10 | 1 | 18521 | 50 |
DCLK2 |
2.668e-02 | -3.62 | MIR_dom_sf | interpro domains | IPR036300 | 10 | 1 | 18521 | 50 |
RYR3 |
2.676e-02 | -3.62 | phosphatidylinositol transfer activity | molecular function | GO:0008526 | 10 | 1 | 18094 | 49 |
PITPNC1 |
2.676e-02 | -3.62 | calcium-dependent protein kinase activity | molecular function | GO:0010857 | 10 | 1 | 18094 | 49 |
PRKCA |
2.676e-02 | -3.62 | inorganic cation transmembrane transport | biological process | GO:0098662 | 618 | 5 | 18204 | 50 |
RYR3,GPM6A,ATP1A2,TRPM3,SLC4A4 |
2.678e-02 | -3.62 | YWHAE (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon) | protein interactions | 7531 | 1150 | 7 | 19454 | 50 |
ABLIM1,DCLK2,NAV2,MACF1,CAMK2G,SORBS1,PARD3 |
2.678e-02 | -3.62 | HSP90AA1 (heat shock protein 90 alpha family class A member 1) | protein interactions | 3320 | 1150 | 7 | 19454 | 50 |
DCLK2,NTRK3,NTRK2,PRKCA,ERBB4,CAMK2G,RPS6KA2 |
2.690e-02 | -3.62 | chemical synaptic transmission | biological process | GO:0007268 | 415 | 4 | 18204 | 50 |
NRXN1,SLC1A2,RPS6KA2,DTNA |
2.690e-02 | -3.62 | anterograde trans-synaptic signaling | biological process | GO:0098916 | 415 | 4 | 18204 | 50 |
NRXN1,SLC1A2,DTNA,RPS6KA2 |
2.693e-02 | -3.61 | behavior | biological process | GO:0007610 | 619 | 5 | 18204 | 50 |
NAV2,ATP1A2,SLC1A2,NTRK2,NRXN1 |
2.699e-02 | -3.61 | intermediate filament cytoskeleton organization | biological process | GO:0045104 | 93 | 2 | 18204 | 50 |
MACF1,GFAP |
2.714e-02 | -3.61 | mitochondrial fragmentation involved in apoptotic process | biological process | GO:0043653 | 10 | 1 | 18204 | 50 |
ERBB4 |
2.714e-02 | -3.61 | desmosome organization | biological process | GO:0002934 | 10 | 1 | 18204 | 50 |
PRKCA |
2.714e-02 | -3.61 | learned vocalization behavior or vocal learning | biological process | GO:0098598 | 10 | 1 | 18204 | 50 |
NRXN1 |
2.714e-02 | -3.61 | urea transmembrane transport | biological process | GO:0071918 | 10 | 1 | 18204 | 50 |
SLC14A1 |
2.714e-02 | -3.61 | substrate-independent telencephalic tangential migration | biological process | GO:0021826 | 10 | 1 | 18204 | 50 |
NRG3 |
2.714e-02 | -3.61 | negative regulation of glial cell apoptotic process | biological process | GO:0034351 | 10 | 1 | 18204 | 50 |
PRKCA |
2.714e-02 | -3.61 | postsynaptic membrane assembly | biological process | GO:0097104 | 10 | 1 | 18204 | 50 |
NRXN1 |
2.714e-02 | -3.61 | trans-synaptic signaling, modulating synaptic transmission | biological process | GO:0099550 | 10 | 1 | 18204 | 50 |
NTRK2 |
2.714e-02 | -3.61 | substrate-independent telencephalic tangential interneuron migration | biological process | GO:0021843 | 10 | 1 | 18204 | 50 |
NRG3 |
2.714e-02 | -3.61 | cAMP biosynthetic process | biological process | GO:0006171 | 10 | 1 | 18204 | 50 |
ADCY2 |
2.714e-02 | -3.61 | cellular response to cocaine | biological process | GO:0071314 | 10 | 1 | 18204 | 50 |
SLC1A2 |
2.714e-02 | -3.61 | release of sequestered calcium ion into cytosol by endoplasmic reticulum | biological process | GO:1903514 | 10 | 1 | 18204 | 50 |
RYR3 |
2.714e-02 | -3.61 | cellular response to brain-derived neurotrophic factor stimulus | biological process | GO:1990416 | 10 | 1 | 18204 | 50 |
NTRK2 |
2.714e-02 | -3.61 | positive regulation of lipopolysaccharide-mediated signaling pathway | biological process | GO:0031666 | 10 | 1 | 18204 | 50 |
PRKCA |
2.714e-02 | -3.61 | retinal rod cell development | biological process | GO:0046548 | 10 | 1 | 18204 | 50 |
NTRK2 |
2.714e-02 | -3.61 | establishment of centrosome localization | biological process | GO:0051660 | 10 | 1 | 18204 | 50 |
PARD3 |
2.714e-02 | -3.61 | postsynaptic density assembly | biological process | GO:0097107 | 10 | 1 | 18204 | 50 |
NRXN1 |
2.714e-02 | -3.61 | regulation of mesenchymal stem cell differentiation | biological process | GO:2000739 | 10 | 1 | 18204 | 50 |
SOX5 |
2.719e-02 | -3.60 | EGF-type_Asp/Asn_hydroxyl_site | interpro domains | IPR000152 | 95 | 2 | 18521 | 50 |
LRP1B,NRXN1 |
2.719e-02 | -3.60 | response to organic cyclic compound | biological process | GO:0014070 | 843 | 6 | 18204 | 50 |
TNC,RORA,ATP1A2,SLC1A2,ADCY2,RYR3 |
2.720e-02 | -3.60 | DAGK_acc | pfam domains | PF00609 | 10 | 1 | 17795 | 49 |
DGKG |
2.720e-02 | -3.60 | MIR | pfam domains | PF02815 | 10 | 1 | 17795 | 49 |
RYR3 |
2.720e-02 | -3.60 | PAS_3 | pfam domains | PF08447 | 10 | 1 | 17795 | 49 |
NPAS3 |
2.720e-02 | -3.60 | HCO3_cotransp | pfam domains | PF00955 | 10 | 1 | 17795 | 49 |
SLC4A4 |
2.721e-02 | -3.60 | PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1) | protein interactions | 5562 | 253 | 3 | 19454 | 50 |
RPS6KA2,NTRK3,SLC4A4 |
2.731e-02 | -3.60 | APBA1 (amyloid beta precursor protein binding family A member 1) | protein interactions | 320 | 100 | 2 | 19454 | 50 |
ABLIM1,NRXN1 |
2.731e-02 | -3.60 | ATP4A (ATPase H+/K+ transporting subunit alpha) | protein interactions | 495 | 100 | 2 | 19454 | 50 |
ATP1A2,GPM6A |
2.731e-02 | -3.60 | NDFIP1 (Nedd4 family interacting protein 1) | protein interactions | 80762 | 100 | 2 | 19454 | 50 |
NTRK3,NTRK2 |
2.734e-02 | -3.60 | contractile muscle fiber | cellular component | GO:0043292 | 249 | 3 | 19108 | 50 |
RYR3,SYNE1,NEBL |
2.752e-02 | -3.59 | intermediate filament-based process | biological process | GO:0045103 | 94 | 2 | 18204 | 50 |
MACF1,GFAP |
2.756e-02 | -3.59 | muscle contraction | biological process | GO:0006936 | 238 | 3 | 18204 | 50 |
ATP1A2,RYR3,DTNA |
2.765e-02 | -3.59 | Doublecortin domain | gene3d domains | 3.10.20.230 | 9 | 1 | 14470 | 45 |
DCLK2 |
2.781e-02 | -3.58 | MYLK (myosin light chain kinase) | protein interactions | 4638 | 101 | 2 | 19454 | 50 |
CAMK2G,PRKCA |
2.781e-02 | -3.58 | FAM171A2 (family with sequence similarity 171 member A2) | protein interactions | 284069 | 101 | 2 | 19454 | 50 |
NTRK3,NTRK2 |
2.792e-02 | -3.58 | Batf3 (basic leucine zipper transcription factor, ATF-like 3) | protein interactions | 381319 | 11 | 1 | 19454 | 50 |
MACF1 |
2.792e-02 | -3.58 | SYTL1 (synaptotagmin like 1) | protein interactions | 84958 | 11 | 1 | 19454 | 50 |
NRXN1 |
2.792e-02 | -3.58 | Cobll1 (Cobl-like 1) | protein interactions | 319876 | 11 | 1 | 19454 | 50 |
ABLIM1 |
2.792e-02 | -3.58 | SYN3 (synapsin III) | protein interactions | 8224 | 11 | 1 | 19454 | 50 |
GPM6A |
2.792e-02 | -3.58 | Wipi2 (WD repeat domain, phosphoinositide interacting 2) | protein interactions | 74781 | 11 | 1 | 19454 | 50 |
MACF1 |
2.792e-02 | -3.58 | TMEM53 (transmembrane protein 53) | protein interactions | 79639 | 11 | 1 | 19454 | 50 |
PRKCA |
2.792e-02 | -3.58 | ITPKA (inositol-trisphosphate 3-kinase A) | protein interactions | 3706 | 11 | 1 | 19454 | 50 |
PRKCA |
2.792e-02 | -3.58 | AQP5 (aquaporin 5) | protein interactions | 362 | 11 | 1 | 19454 | 50 |
ATP1A2 |
2.795e-02 | -3.58 | lipid binding | molecular function | GO:0008289 | 861 | 6 | 18094 | 49 |
PSD2,PARD3,DGKG,PITPNC1,RORA,ATP1A2 |
2.804e-02 | -3.57 | ovary-other-neoplasm | COSMIC cancer mutations | ovary-other-neoplasm | 12717 | 43 | 16828 | 49 |
ATP1A2,PSD2,SLC4A4,ERBB4,NDRG2,ADCY2,GPC5,LRP1B,PARD3,MSI2,SYNE1,MGAT4C,KALRN,DCLK2,NKAIN3,GLIS3,SFXN5,NRG3,RYR3,NTM,PRKCA,DGKG,FMN2,RPS6KA2,TNC,CTNND2,SOX5,NTRK2,LSAMP,CDH20,SORBS1,SLC1A2,HPSE2,ABLIM1,RORA,GPM6A,NAV2,MACF1,GFAP,TRPM3,NEBL,RFX4,NTRK3 |
2.807e-02 | -3.57 | cardiac muscle cell differentiation | biological process | GO:0055007 | 95 | 2 | 18204 | 50 |
SYNE1,NEBL |
2.811e-02 | -3.57 | PI3K/AKT Signaling in Cancer | REACTOME pathways | R-HSA-2219528 | 90 | 2 | 10285 | 30 |
ERBB4,NRG3 |
2.826e-02 | -3.57 | LIM | smart domains | SM00132 | 71 | 2 | 9717 | 36 |
NEBL,ABLIM1 |
2.831e-02 | -3.56 | ankle | COSMIC cancer mutations | ankle | 398 | 4 | 16828 | 49 |
ERBB4,NRG3,KALRN,PARD3 |
2.832e-02 | -3.56 | human chr8q12.3 | chromosome location | human chr8q12.3 | 15 | 1 | 26134 | 50 |
NKAIN3 |
2.832e-02 | -3.56 | human chr10p12.31 | chromosome location | human chr10p12.31 | 15 | 1 | 26134 | 50 |
NEBL |
2.832e-02 | -3.56 | human chr18q12.3 | chromosome location | human chr18q12.3 | 15 | 1 | 26134 | 50 |
SLC14A1 |
2.832e-02 | -3.56 | GRAP2 (GRB2 related adaptor protein 2) | protein interactions | 9402 | 102 | 2 | 19454 | 50 |
GFAP,ERBB4 |
2.832e-02 | -3.56 | KRTAP6-1 (keratin associated protein 6-1) | protein interactions | 337966 | 102 | 2 | 19454 | 50 |
CAMK2G,GLIS3 |
2.842e-02 | -3.56 | perisynaptic extracellular matrix | cellular component | GO:0098966 | 11 | 1 | 19108 | 50 |
TNC |
2.842e-02 | -3.56 | nuclear membrane microtubule tethering complex | cellular component | GO:0106094 | 11 | 1 | 19108 | 50 |
SYNE1 |
2.842e-02 | -3.56 | nuclear membrane protein complex | cellular component | GO:0106083 | 11 | 1 | 19108 | 50 |
SYNE1 |
2.842e-02 | -3.56 | meiotic nuclear membrane microtubule tethering complex | cellular component | GO:0034993 | 11 | 1 | 19108 | 50 |
SYNE1 |
2.842e-02 | -3.56 | microtubule organizing center attachment site | cellular component | GO:0034992 | 11 | 1 | 19108 | 50 |
SYNE1 |
2.860e-02 | -3.55 | PLCG1 (phospholipase C gamma 1) | protein interactions | 5335 | 258 | 3 | 19454 | 50 |
NTRK3,NTRK2,ERBB4 |
2.862e-02 | -3.55 | regulation of muscle adaptation | biological process | GO:0043502 | 96 | 2 | 18204 | 50 |
PRKCA,CAMK2G |
2.865e-02 | -3.55 | HER-positive_carcinoma | COSMIC cancer mutations | HER-positive_carcinoma | 2025 | 11 | 16828 | 49 |
RORA,NTRK2,ABLIM1,TNC,MSI2,NTRK3,PRKCA,RPS6KA2,GPC5,ERBB4,NRG3 |
2.865e-02 | -3.55 | breast-carcinoma-HER-positive_carcinoma | COSMIC cancer mutations | breast-carcinoma-HER-positive_carcinoma | 2025 | 11 | 16828 | 49 |
TNC,MSI2,ERBB4,NRG3,ABLIM1,GPC5,PRKCA,RORA,NTRK3,NTRK2,RPS6KA2 |
2.875e-02 | -3.55 | ruffle membrane | cellular component | GO:0032587 | 101 | 2 | 19108 | 50 |
PSD2,MACF1 |
2.876e-02 | -3.55 | metal ion transport | biological process | GO:0030001 | 630 | 5 | 18204 | 50 |
SLC4A4,TRPM3,ATP1A2,RYR3,GPM6A |
2.880e-02 | -3.55 | Bicarbonate transporters | REACTOME pathways | R-HSA-425381 | 10 | 1 | 10285 | 30 |
SLC4A4 |
2.880e-02 | -3.55 | Adenylate cyclase activating pathway | REACTOME pathways | R-HSA-170660 | 10 | 1 | 10285 | 30 |
ADCY2 |
2.880e-02 | -3.55 | Acetylcholine regulates insulin secretion | REACTOME pathways | R-HSA-399997 | 10 | 1 | 10285 | 30 |
PRKCA |
2.881e-02 | -3.55 | upper_aerodigestive_tract-head_neck-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-head_neck-carcinoma-squamous_cell_carcinoma | 9263 | 34 | 16828 | 49 |
ADCY2,CDH20,GPC5,LRP1B,ERBB4,SLC4A4,LSAMP,CAMK2G,NTRK2,SOX5,CTNND2,TNC,ATP1A2,FMN2,DGKG,RPS6KA2,RYR3,NTRK3,PRKCA,NEBL,GLIS3,TRPM3,NKAIN3,NAV2,MACF1,DCLK2,KALRN,RORA,MGAT4C,HPSE2,PITPNC1,SORBS1,SYNE1,MSI2 |
2.884e-02 | -3.55 | ZDHHC5 (zinc finger DHHC-type palmitoyltransferase 5) | protein interactions | 25921 | 103 | 2 | 19454 | 50 |
PARD3,NTRK2 |
2.884e-02 | -3.55 | PLEKHA1 (pleckstrin homology domain containing A1) | protein interactions | 59338 | 103 | 2 | 19454 | 50 |
PARD3,NTRK3 |
2.885e-02 | -3.55 | adrenal_gland-adrenal_gland-adrenal_cortical_adenoma-aldosterone_producing | COSMIC cancer mutations | adrenal_gland-adrenal_gland-adrenal_cortical_adenoma-aldosterone_producing | 91 | 2 | 16828 | 49 |
LRP1B,ADCY2 |
2.889e-02 | -3.54 | Signaling by GPCR | REACTOME pathways | R-HSA-372790 | 1299 | 8 | 10285 | 30 |
RPS6KA2,KALRN,ERBB4,NRG3,CAMK2G,ADCY2,PRKCA,DGKG |
2.892e-02 | -3.54 | Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin | SMPDB pathways | SMP0000354 | 8 | 1 | 1369 | 5 |
ADCY2 |
2.917e-02 | -3.53 | amino acid transmembrane transport | biological process | GO:0003333 | 97 | 2 | 18204 | 50 |
SLC1A2,GFAP |
2.927e-02 | -3.53 | VHP | smart domains | SM00153 | 8 | 1 | 9717 | 36 |
ABLIM1 |
2.927e-02 | -3.53 | Post-translational modification: synthesis of GPI-anchored proteins | REACTOME pathways | R-HSA-163125 | 92 | 2 | 10285 | 30 |
LSAMP,NTM |
2.929e-02 | -3.53 | EF-hand_7 | pfam domains | PF13499 | 97 | 2 | 17795 | 49 |
DGKG,MACF1 |
2.935e-02 | -3.53 | tat (Tat) | protein interactions | 155871 | 1718 | 9 | 19454 | 50 |
RYR3,ADCY2,PRKCA,GFAP,SLC14A1,TNC,CAMK2G,SORBS1,SLC1A2 |
2.936e-02 | -3.53 | HUNK (hormonally up-regulated Neu-associated kinase) | protein interactions | 30811 | 104 | 2 | 19454 | 50 |
SORBS1,ABLIM1 |
2.936e-02 | -3.53 | CDH5 (cadherin 5) | protein interactions | 1003 | 104 | 2 | 19454 | 50 |
PRKCA,CTNNA2 |
2.940e-02 | -3.53 | acetylcholine receptor binding | molecular function | GO:0033130 | 11 | 1 | 18094 | 49 |
NRXN1 |
2.940e-02 | -3.53 | sulfur amino acid transmembrane transporter activity | molecular function | GO:0000099 | 11 | 1 | 18094 | 49 |
SLC1A2 |
2.940e-02 | -3.53 | ATP-dependent diacylglycerol kinase activity | molecular function | GO:0004143 | 11 | 1 | 18094 | 49 |
DGKG |
2.940e-02 | -3.53 | histone H3 kinase activity | molecular function | GO:0140996 | 11 | 1 | 18094 | 49 |
PRKCA |
2.964e-02 | -3.52 | basolateral plasma membrane | cellular component | GO:0016323 | 257 | 3 | 19108 | 50 |
SLC4A4,ERBB4,SLC14A1 |
2.971e-02 | -3.52 | response to abiotic stimulus | biological process | GO:0009628 | 1100 | 7 | 18204 | 50 |
SLC1A2,SYNE1,RORA,NRXN1,TNC,FMN2,ATP1A2 |
2.980e-02 | -3.51 | monoatomic cation transmembrane transport | biological process | GO:0098655 | 636 | 5 | 18204 | 50 |
TRPM3,SLC4A4,GPM6A,RYR3,ATP1A2 |
2.981e-02 | -3.51 | glutamate secretion | biological process | GO:0014047 | 11 | 1 | 18204 | 50 |
NTRK2 |
2.981e-02 | -3.51 | regulation of Schwann cell proliferation | biological process | GO:0010624 | 11 | 1 | 18204 | 50 |
GFAP |
2.981e-02 | -3.51 | L-ascorbic acid metabolic process | biological process | GO:0019852 | 11 | 1 | 18204 | 50 |
ATP1A2 |
2.981e-02 | -3.51 | ectodermal placode morphogenesis | biological process | GO:0071697 | 11 | 1 | 18204 | 50 |
NRG3 |
2.981e-02 | -3.51 | cellular response to caffeine | biological process | GO:0071313 | 11 | 1 | 18204 | 50 |
RYR3 |
2.981e-02 | -3.51 | ectodermal placode formation | biological process | GO:0060788 | 11 | 1 | 18204 | 50 |
NRG3 |
2.981e-02 | -3.51 | lactone metabolic process | biological process | GO:1901334 | 11 | 1 | 18204 | 50 |
ATP1A2 |
2.981e-02 | -3.51 | pyramidal neuron development | biological process | GO:0021860 | 11 | 1 | 18204 | 50 |
DCLK2 |
2.981e-02 | -3.51 | Bergmann glial cell differentiation | biological process | GO:0060020 | 11 | 1 | 18204 | 50 |
GFAP |
2.981e-02 | -3.51 | negative regulation of mesenchymal cell apoptotic process | biological process | GO:2001054 | 11 | 1 | 18204 | 50 |
SYNE1 |
2.981e-02 | -3.51 | L-glutamate import across plasma membrane | biological process | GO:0098712 | 11 | 1 | 18204 | 50 |
SLC1A2 |
2.981e-02 | -3.51 | L-aspartate transmembrane transport | biological process | GO:0070778 | 11 | 1 | 18204 | 50 |
SLC1A2 |
2.981e-02 | -3.51 | negative regulation of excitatory postsynaptic potential | biological process | GO:0090394 | 11 | 1 | 18204 | 50 |
SYNE1 |
2.981e-02 | -3.51 | lipid phosphorylation | biological process | GO:0046834 | 11 | 1 | 18204 | 50 |
DGKG |
2.981e-02 | -3.51 | negative regulation of neuron migration | biological process | GO:2001223 | 11 | 1 | 18204 | 50 |
NRG3 |
2.981e-02 | -3.51 | establishment or maintenance of transmembrane electrochemical gradient | biological process | GO:0010248 | 11 | 1 | 18204 | 50 |
ATP1A2 |
2.988e-02 | -3.51 | GLB1 (galactosidase beta 1) | protein interactions | 2720 | 105 | 2 | 19454 | 50 |
SFXN5,RPS6KA2 |
2.989e-02 | -3.51 | DC | prosite domains | PS50309 | 9 | 1 | 12186 | 41 |
DCLK2 |
2.989e-02 | -3.51 | RFX_DBD | prosite domains | PS51526 | 9 | 1 | 12186 | 41 |
RFX4 |
2.999e-02 | -3.51 | positive regulation of neurogenesis | biological process | GO:0050769 | 246 | 3 | 18204 | 50 |
GFAP,NTRK2,MACF1 |
3.003e-02 | -3.51 | aldosterone_producing | COSMIC cancer mutations | aldosterone_producing | 93 | 2 | 16828 | 49 |
ADCY2,LRP1B |
3.019e-02 | -3.50 | EGF | smart domains | SM00181 | 184 | 3 | 9717 | 36 |
NRXN1,TNC,LRP1B |
3.028e-02 | -3.50 | regulation of neurotransmitter transport | biological process | GO:0051588 | 99 | 2 | 18204 | 50 |
ATP1A2,GFAP |
3.034e-02 | -3.50 | response to wounding | biological process | GO:0009611 | 431 | 4 | 18204 | 50 |
MACF1,TNC,SLC1A2,DGKG |
3.040e-02 | -3.49 | NSD1 (nuclear receptor binding SET domain protein 1) | protein interactions | 64324 | 106 | 2 | 19454 | 50 |
NTRK3,RORA |
3.042e-02 | -3.49 | XK (X-linked Kx blood group antigen, Kell and VPS13A binding protein) | protein interactions | 7504 | 12 | 1 | 19454 | 50 |
PRKCA |
3.042e-02 | -3.49 | PTPN20 (protein tyrosine phosphatase non-receptor type 20) | protein interactions | 26095 | 12 | 1 | 19454 | 50 |
ERBB4 |
3.042e-02 | -3.49 | NTF4 (neurotrophin 4) | protein interactions | 4909 | 12 | 1 | 19454 | 50 |
NTRK2 |
3.042e-02 | -3.49 | INTS4P2 (integrator complex subunit 4 pseudogene 2) | protein interactions | 644619 | 12 | 1 | 19454 | 50 |
GFAP |
3.042e-02 | -3.49 | MYBPHL (myosin binding protein H like) | protein interactions | 343263 | 12 | 1 | 19454 | 50 |
GFAP |
3.042e-02 | -3.49 | Ctnnbl1 (catenin, beta like 1) | protein interactions | 66642 | 12 | 1 | 19454 | 50 |
PRKCA |
3.042e-02 | -3.49 | SMIM20 (small integral membrane protein 20) | protein interactions | 389203 | 12 | 1 | 19454 | 50 |
ERBB4 |
3.042e-02 | -3.49 | CDHR2 (cadherin related family member 2) | protein interactions | 54825 | 12 | 1 | 19454 | 50 |
RPS6KA2 |
3.042e-02 | -3.49 | CA4 (carbonic anhydrase 4) | protein interactions | 762 | 12 | 1 | 19454 | 50 |
SLC4A4 |
3.042e-02 | -3.49 | PROK2 (prokineticin 2) | protein interactions | 60675 | 12 | 1 | 19454 | 50 |
LRP1B |
3.042e-02 | -3.49 | ART4 (ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)) | protein interactions | 420 | 12 | 1 | 19454 | 50 |
GPM6A |
3.042e-02 | -3.49 | Pard6b (par-6 family cell polarity regulator beta) | protein interactions | 58220 | 12 | 1 | 19454 | 50 |
PARD3 |
3.046e-02 | -3.49 | Negative regulation of the PI3K/AKT network | REACTOME pathways | R-HSA-199418 | 94 | 2 | 10285 | 30 |
NRG3,ERBB4 |
3.059e-02 | -3.49 | NAKATPASE | prints domains | PR00121 | 9 | 1 | 5227 | 18 |
ATP1A2 |
3.068e-02 | -3.48 | Helical hairpin bin | gene3d domains | 1.10.287.570 | 10 | 1 | 14470 | 45 |
SLC4A4 |
3.085e-02 | -3.48 | response to alkaloid | biological process | GO:0043279 | 100 | 2 | 18204 | 50 |
RYR3,SLC1A2 |
3.085e-02 | -3.48 | regulation of dendrite development | biological process | GO:0050773 | 100 | 2 | 18204 | 50 |
SYNE1,DGKG |
3.093e-02 | -3.48 | regulation of muscle system process | biological process | GO:0090257 | 249 | 3 | 18204 | 50 |
PRKCA,CAMK2G,ATP1A2 |
3.093e-02 | -3.48 | APLP2 (amyloid beta precursor like protein 2) | protein interactions | 334 | 107 | 2 | 19454 | 50 |
PRKCA,HPSE2 |
3.096e-02 | -3.48 | sodium:potassium-exchanging ATPase complex | cellular component | GO:0005890 | 12 | 1 | 19108 | 50 |
ATP1A2 |
3.096e-02 | -3.48 | synapse-associated extracellular matrix | cellular component | GO:0099535 | 12 | 1 | 19108 | 50 |
TNC |
3.104e-02 | -3.47 | regulation of cellular component organization | biological process | GO:0051128 | 2455 | 12 | 18204 | 50 |
CTNNA2,SYNE1,MACF1,NTRK2,NRG3,GPM6A,NTRK3,TNC,CAMK2G,DGKG,GFAP,NRXN1 |
3.123e-02 | -3.47 | haemangiopericytic | COSMIC cancer mutations | haemangiopericytic | 95 | 2 | 16828 | 49 |
RYR3,SYNE1 |
3.123e-02 | -3.47 | meninges-meningioma-haemangiopericytic | COSMIC cancer mutations | meninges-meningioma-haemangiopericytic | 95 | 2 | 16828 | 49 |
SYNE1,RYR3 |
3.142e-02 | -3.46 | regulation of glucose metabolic process | biological process | GO:0010906 | 101 | 2 | 18204 | 50 |
RORA,SORBS1 |
3.147e-02 | -3.46 | CLASP1 (cytoplasmic linker associated protein 1) | protein interactions | 23332 | 108 | 2 | 19454 | 50 |
DCLK2,MACF1 |
3.147e-02 | -3.46 | ALDH3B1 (aldehyde dehydrogenase 3 family member B1) | protein interactions | 221 | 108 | 2 | 19454 | 50 |
GFAP,FMN2 |
3.149e-02 | -3.46 | PFN1 (profilin 1) | protein interactions | 5216 | 466 | 4 | 19454 | 50 |
CAMK2G,MACF1,ABLIM1,FMN2 |
3.157e-02 | -3.46 | calcium ion transport | biological process | GO:0006816 | 251 | 3 | 18204 | 50 |
TRPM3,RYR3,GPM6A |
3.158e-02 | -3.46 | stomach-carcinoma-tubular_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-tubular_adenocarcinoma | 11 | 1 | 16828 | 49 |
NTRK3 |
3.158e-02 | -3.46 | tubular_adenocarcinoma | COSMIC cancer mutations | tubular_adenocarcinoma | 11 | 1 | 16828 | 49 |
NTRK3 |
3.167e-02 | -3.45 | large_intestine-colon | COSMIC cancer mutations | large_intestine-colon | 1291 | 8 | 16828 | 49 |
SYNE1,ERBB4,TNC,KALRN,NAV2,FMN2,ADCY2,LRP1B |
3.177e-02 | -3.45 | EV release from cardiac cells and their functional effects | WikiPathways | WP3297 | 9 | 1 | 5310 | 19 |
ERBB4 |
3.200e-02 | -3.44 | PRR20A (proline rich 20A) | protein interactions | 122183 | 109 | 2 | 19454 | 50 |
SOX5,TRPM3 |
3.200e-02 | -3.44 | NOS1AP (nitric oxide synthase 1 adaptor protein) | protein interactions | 9722 | 109 | 2 | 19454 | 50 |
NTRK2,NTRK3 |
3.200e-02 | -3.44 | SIPA1L3 (signal induced proliferation associated 1 like 3) | protein interactions | 23094 | 109 | 2 | 19454 | 50 |
PARD3,GFAP |
3.203e-02 | -3.44 | adenylate cyclase binding | molecular function | GO:0008179 | 12 | 1 | 18094 | 49 |
ADCY2 |
3.204e-02 | -3.44 | human chr9q21.33 | chromosome location | human chr9q21.33 | 17 | 1 | 26134 | 50 |
NTRK2 |
3.222e-02 | -3.44 | Heparan sulfate degradation | KEGG pathways | M00078 | 9 | 1 | 7161 | 26 |
HPSE2 |
3.222e-02 | -3.44 | Heparan sulfate degradation | KEGG pathways | hsa_M00078 | 9 | 1 | 7161 | 26 |
HPSE2 |
3.233e-02 | -3.43 | SH3DOMAIN | prints domains | PR00452 | 83 | 2 | 5227 | 18 |
SORBS1,NEBL |
3.248e-02 | -3.43 | auditory behavior | biological process | GO:0031223 | 12 | 1 | 18204 | 50 |
NRXN1 |
3.248e-02 | -3.43 | nuclear membrane disassembly | biological process | GO:0051081 | 12 | 1 | 18204 | 50 |
PRKCA |
3.248e-02 | -3.43 | sulfur amino acid transport | biological process | GO:0000101 | 12 | 1 | 18204 | 50 |
SLC1A2 |
3.248e-02 | -3.43 | urea transport | biological process | GO:0015840 | 12 | 1 | 18204 | 50 |
SLC14A1 |
3.248e-02 | -3.43 | regulation of glial cell apoptotic process | biological process | GO:0034350 | 12 | 1 | 18204 | 50 |
PRKCA |
3.249e-02 | -3.43 | Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone | SMPDB pathways | SMP0000333 | 9 | 1 | 1369 | 5 |
ADCY2 |
3.249e-02 | -3.43 | Intracellular Signalling Through Histamine H2 Receptor and Histamine | SMPDB pathways | SMP0000335 | 9 | 1 | 1369 | 5 |
ADCY2 |
3.249e-02 | -3.43 | Excitatory Neural Signalling Through 5-HTR 7 and Serotonin | SMPDB pathways | SMP0000311 | 9 | 1 | 1369 | 5 |
ADCY2 |
3.249e-02 | -3.43 | Excitatory Neural Signalling Through 5-HTR 6 and Serotonin | SMPDB pathways | SMP0000312 | 9 | 1 | 1369 | 5 |
ADCY2 |
3.249e-02 | -3.43 | Excitatory Neural Signalling Through 5-HTR 4 and Serotonin | SMPDB pathways | SMP0000309 | 9 | 1 | 1369 | 5 |
ADCY2 |
3.249e-02 | -3.43 | Nitric Oxide Signaling Pathway | SMPDB pathways | SMP0063777 | 9 | 1 | 1369 | 5 |
PRKCA |
3.262e-02 | -3.42 | regulation of cell motility | biological process | GO:2000145 | 1122 | 7 | 18204 | 50 |
NTRK3,NRG3,TNC,ERBB4,CTNNA2,MACF1,PRKCA |
3.287e-02 | -3.42 | DCX | smart domains | SM00537 | 9 | 1 | 9717 | 36 |
DCLK2 |
3.291e-02 | -3.41 | NCAN (neurocan) | protein interactions | 1463 | 13 | 1 | 19454 | 50 |
TNC |
3.291e-02 | -3.41 | KCNQ2 (potassium voltage-gated channel subfamily Q member 2) | protein interactions | 3785 | 13 | 1 | 19454 | 50 |
PRKCA |
3.291e-02 | -3.41 | IL23R (interleukin 23 receptor) | protein interactions | 149233 | 13 | 1 | 19454 | 50 |
PRKCA |
3.291e-02 | -3.41 | NPR2 (natriuretic peptide receptor 2) | protein interactions | 4882 | 13 | 1 | 19454 | 50 |
CAMK2G |
3.291e-02 | -3.41 | TBCC (tubulin folding cofactor C) | protein interactions | 6903 | 13 | 1 | 19454 | 50 |
NTM |
3.291e-02 | -3.41 | MYO16 (myosin XVI) | protein interactions | 23026 | 13 | 1 | 19454 | 50 |
NRXN1 |
3.291e-02 | -3.41 | RAB3C (RAB3C, member RAS oncogene family) | protein interactions | 115827 | 13 | 1 | 19454 | 50 |
GPM6A |
3.291e-02 | -3.41 | RNASE4 (ribonuclease A family member 4) | protein interactions | 6038 | 13 | 1 | 19454 | 50 |
LRP1B |
3.291e-02 | -3.41 | JAM2 (junctional adhesion molecule 2) | protein interactions | 58494 | 13 | 1 | 19454 | 50 |
PARD3 |
3.315e-02 | -3.41 | MIR | prosite domains | PS50919 | 10 | 1 | 12186 | 41 |
RYR3 |
3.318e-02 | -3.41 | protein complex oligomerization | biological process | GO:0051259 | 256 | 3 | 18204 | 50 |
SLC1A2,TRPM3,RYR3 |
3.350e-02 | -3.40 | cytoplasmic side of lysosomal membrane | cellular component | GO:0098574 | 13 | 1 | 19108 | 50 |
GFAP |
3.373e-02 | -3.39 | neural precursor cell proliferation | biological process | GO:0061351 | 105 | 2 | 18204 | 50 |
RORA,SOX5 |
3.373e-02 | -3.39 | cellular response to alcohol | biological process | GO:0097306 | 105 | 2 | 18204 | 50 |
TNC,ADCY2 |
3.373e-02 | -3.39 | gland morphogenesis | biological process | GO:0022612 | 105 | 2 | 18204 | 50 |
TNC,NRG3 |
3.373e-02 | -3.39 | response to interleukin-1 | biological process | GO:0070555 | 105 | 2 | 18204 | 50 |
RORA,PRKCA |
3.377e-02 | -3.39 | SHC1 events in EGFR signaling | REACTOME pathways | R-HSA-180336 | 245 | 3 | 10285 | 30 |
ERBB4,NRG3,CAMK2G |
3.377e-02 | -3.39 | SOS-mediated signalling | REACTOME pathways | R-HSA-112412 | 245 | 3 | 10285 | 30 |
NRG3,ERBB4,CAMK2G |
3.377e-02 | -3.39 | GRB2 events in EGFR signaling | REACTOME pathways | R-HSA-179812 | 245 | 3 | 10285 | 30 |
CAMK2G,ERBB4,NRG3 |
3.377e-02 | -3.39 | RAF/MAP kinase cascade | REACTOME pathways | R-HSA-5673001 | 245 | 3 | 10285 | 30 |
NRG3,ERBB4,CAMK2G |
3.389e-02 | -3.38 | human chr18q21.33 | chromosome location | human chr18q21.33 | 18 | 1 | 26134 | 50 |
CDH20 |
3.392e-02 | -3.38 | cAMP signaling pathway | KEGG pathways | ko04024 | 198 | 3 | 7161 | 26 |
CAMK2G,ADCY2,ATP1A2 |
3.392e-02 | -3.38 | cAMP signaling pathway | KEGG pathways | hsa04024 | 198 | 3 | 7161 | 26 |
CAMK2G,ATP1A2,ADCY2 |
3.394e-02 | -3.38 | HCO3TRNSPORT | prints domains | PR01231 | 10 | 1 | 5227 | 18 |
SLC4A4 |
3.402e-02 | -3.38 | steroid binding | molecular function | GO:0005496 | 107 | 2 | 18094 | 49 |
ATP1A2,RORA |
3.418e-02 | -3.38 | GFI1B (growth factor independent 1B transcriptional repressor) | protein interactions | 8328 | 113 | 2 | 19454 | 50 |
KALRN,DTNA |
3.418e-02 | -3.38 | KIRREL1 (kirre like nephrin family adhesion molecule 1) | protein interactions | 55243 | 113 | 2 | 19454 | 50 |
RPS6KA2,PARD3 |
3.432e-02 | -3.37 | cellular response to ketone | biological process | GO:1901655 | 106 | 2 | 18204 | 50 |
TNC,ADCY2 |
3.446e-02 | -3.37 | Defective EXT2 causes exostoses 2 | REACTOME pathways | R-HSA-3656237 | 12 | 1 | 10285 | 30 |
GPC5 |
3.446e-02 | -3.37 | Defective EXT1 causes exostoses 1, TRPS2 and CHDS | REACTOME pathways | R-HSA-3656253 | 12 | 1 | 10285 | 30 |
GPC5 |
3.451e-02 | -3.37 | EGF_2 | prosite domains | PS01186 | 213 | 3 | 12186 | 41 |
TNC,LRP1B,NRG3 |
3.455e-02 | -3.37 | distal axon | cellular component | GO:0150034 | 273 | 3 | 19108 | 50 |
GPM6A,NDRG2,NTRK2 |
3.457e-02 | -3.36 | TJP2 (tight junction protein 2) | protein interactions | 9414 | 278 | 3 | 19454 | 50 |
NEBL,SORBS1,PARD3 |
3.465e-02 | -3.36 | potassium ion binding | molecular function | GO:0030955 | 13 | 1 | 18094 | 49 |
ATP1A2 |
3.465e-02 | -3.36 | monoatomic cation:bicarbonate symporter activity | molecular function | GO:0140410 | 13 | 1 | 18094 | 49 |
SLC4A4 |
3.475e-02 | -3.36 | Visual phototransduction | REACTOME pathways | R-HSA-2187338 | 101 | 2 | 10285 | 30 |
GPC5,PRKCA |
3.500e-02 | -3.35 | Ion_trans_dom | interpro domains | IPR005821 | 109 | 2 | 18521 | 50 |
TRPM3,RYR3 |
3.505e-02 | -3.35 | cellular response to stimulus | biological process | GO:0051716 | 6307 | 24 | 18204 | 50 |
RORA,DCLK2,ATP1A2,FMN2,NRG3,PRKCA,RPS6KA2,NTRK3,DTNA,PARD3,ADCY2,PITPNC1,CTNND2,KALRN,TNC,SORBS1,NDRG2,MACF1,RYR3,GFAP,DGKG,ERBB4,SLC1A2,NTRK2 |
3.514e-02 | -3.35 | membrane disassembly | biological process | GO:0030397 | 13 | 1 | 18204 | 50 |
PRKCA |
3.514e-02 | -3.35 | cellular response to vitamin D | biological process | GO:0071305 | 13 | 1 | 18204 | 50 |
TNC |
3.514e-02 | -3.35 | cerebellar Purkinje cell differentiation | biological process | GO:0021702 | 13 | 1 | 18204 | 50 |
RORA |
3.514e-02 | -3.35 | regulation of respiratory gaseous exchange by nervous system process | biological process | GO:0002087 | 13 | 1 | 18204 | 50 |
ATP1A2 |
3.514e-02 | -3.35 | T-helper 17 cell differentiation | biological process | GO:0072539 | 13 | 1 | 18204 | 50 |
RORA |
3.514e-02 | -3.35 | nervous system process involved in regulation of systemic arterial blood pressure | biological process | GO:0001976 | 13 | 1 | 18204 | 50 |
NAV2 |
3.514e-02 | -3.35 | ectodermal placode development | biological process | GO:0071696 | 13 | 1 | 18204 | 50 |
NRG3 |
3.514e-02 | -3.35 | postsynaptic specialization assembly | biological process | GO:0098698 | 13 | 1 | 18204 | 50 |
NRXN1 |
3.514e-02 | -3.35 | prepulse inhibition | biological process | GO:0060134 | 13 | 1 | 18204 | 50 |
CTNNA2 |
3.514e-02 | -3.35 | negative regulation of cytosolic calcium ion concentration | biological process | GO:0051481 | 13 | 1 | 18204 | 50 |
ATP1A2 |
3.514e-02 | -3.35 | olfactory bulb interneuron differentiation | biological process | GO:0021889 | 13 | 1 | 18204 | 50 |
ERBB4 |
3.519e-02 | -3.35 | ARMS-mediated activation | REACTOME pathways | R-HSA-170984 | 249 | 3 | 10285 | 30 |
CAMK2G,NRG3,ERBB4 |
3.519e-02 | -3.35 | Signalling to p38 via RIT and RIN | REACTOME pathways | R-HSA-187706 | 249 | 3 | 10285 | 30 |
ERBB4,NRG3,CAMK2G |
3.522e-02 | -3.35 | Ldl_recept_b | pfam domains | PF00058 | 13 | 1 | 17795 | 49 |
LRP1B |
3.530e-02 | -3.34 | SMAD7 (SMAD family member 7) | protein interactions | 4092 | 115 | 2 | 19454 | 50 |
PARD3,SOX5 |
3.530e-02 | -3.34 | DTNA (dystrobrevin alpha) | protein interactions | 1837 | 115 | 2 | 19454 | 50 |
PARD3,NTRK2 |
3.533e-02 | -3.34 | EF_HAND_2 | prosite domains | PS50222 | 215 | 3 | 12186 | 41 |
RYR3,DGKG,MACF1 |
3.540e-02 | -3.34 | SYT5 (synaptotagmin 5) | protein interactions | 6861 | 14 | 1 | 19454 | 50 |
NRXN1 |
3.540e-02 | -3.34 | BOD1L2 (biorientation of chromosomes in cell division 1 like 2) | protein interactions | 284257 | 14 | 1 | 19454 | 50 |
FMN2 |
3.540e-02 | -3.34 | TPSAB1 (tryptase alpha/beta 1) | protein interactions | 7177 | 14 | 1 | 19454 | 50 |
CAMK2G |
3.540e-02 | -3.34 | RSPO1 (R-spondin 1) | protein interactions | 284654 | 14 | 1 | 19454 | 50 |
LRP1B |
3.540e-02 | -3.34 | CFAP58 (cilia and flagella associated protein 58) | protein interactions | 159686 | 14 | 1 | 19454 | 50 |
NAV2 |
3.540e-02 | -3.34 | CABS1 (calcium binding protein, spermatid associated 1) | protein interactions | 85438 | 14 | 1 | 19454 | 50 |
GFAP |
3.540e-02 | -3.34 | DACT2 (dishevelled binding antagonist of beta catenin 2) | protein interactions | 168002 | 14 | 1 | 19454 | 50 |
CAMK2G |
3.540e-02 | -3.34 | TAS2R7 (taste 2 receptor member 7) | protein interactions | 50837 | 14 | 1 | 19454 | 50 |
PRKCA |
3.540e-02 | -3.34 | ABTB1 (ankyrin repeat and BTB domain containing 1) | protein interactions | 80325 | 14 | 1 | 19454 | 50 |
NTRK3 |
3.540e-02 | -3.34 | Nedd4 (neural precursor cell expressed, developmentally down-regulated 4) | protein interactions | 17999 | 14 | 1 | 19454 | 50 |
GLIS3 |
3.540e-02 | -3.34 | SH3YL1 (SH3 and SYLF domain containing 1) | protein interactions | 26751 | 14 | 1 | 19454 | 50 |
GFAP |
3.540e-02 | -3.34 | SLC1A2 (solute carrier family 1 member 2) | protein interactions | 6506 | 14 | 1 | 19454 | 50 |
SLC1A2 |
3.540e-02 | -3.34 | PLXNA4 (plexin A4) | protein interactions | 91584 | 14 | 1 | 19454 | 50 |
GPM6A |
3.540e-02 | -3.34 | Asap1 (ArfGAP with SH3 domain, ankyrin repeat and PH domain1) | protein interactions | 13196 | 14 | 1 | 19454 | 50 |
MACF1 |
3.554e-02 | -3.34 | Frs2-mediated activation | REACTOME pathways | R-HSA-170968 | 250 | 3 | 10285 | 30 |
CAMK2G,NRG3,ERBB4 |
3.569e-02 | -3.33 | DYNLL1 (dynein light chain LC8-type 1) | protein interactions | 8655 | 485 | 4 | 19454 | 50 |
NTRK3,PARD3,NTRK2,CAMK2G |
3.574e-02 | -3.33 | human chr5p15.2 | chromosome location | human chr5p15.2 | 19 | 1 | 26134 | 50 |
CTNND2 |
3.574e-02 | -3.33 | human chr11q25 | chromosome location | human chr11q25 | 19 | 1 | 26134 | 50 |
NTM |
3.574e-02 | -3.33 | human chr15q25.3 | chromosome location | human chr15q25.3 | 19 | 1 | 26134 | 50 |
NTRK3 |
3.578e-02 | -3.33 | structural constituent of cytoskeleton | molecular function | GO:0005200 | 110 | 2 | 18094 | 49 |
GFAP,CTNNA2 |
3.589e-02 | -3.33 | plasma membrane raft | cellular component | GO:0044853 | 114 | 2 | 19108 | 50 |
SORBS1,ATP1A2 |
3.590e-02 | -3.33 | MAPK1/MAPK3 signaling | REACTOME pathways | R-HSA-5684996 | 251 | 3 | 10285 | 30 |
CAMK2G,NRG3,ERBB4 |
3.592e-02 | -3.33 | regulation of MAPK cascade | biological process | GO:0043408 | 669 | 5 | 18204 | 50 |
ERBB4,NDRG2,NTRK2,PRKCA,NTRK3 |
3.592e-02 | -3.33 | organic anion transmembrane transporter activity | molecular function | GO:0008514 | 268 | 3 | 18094 | 49 |
SLC4A4,SFXN5,SLC1A2 |
3.605e-02 | -3.32 | Intracellular Signalling Through LHCGR Receptor and Luteinizing Hormone/Choriogonadotropin | SMPDB pathways | SMP0000338 | 10 | 1 | 1369 | 5 |
ADCY2 |
3.612e-02 | -3.32 | postsynapse organization | biological process | GO:0099173 | 109 | 2 | 18204 | 50 |
CTNND2,NRXN1 |
3.617e-02 | -3.32 | small_intestine | COSMIC cancer mutations | small_intestine | 250 | 3 | 16828 | 49 |
NTRK3,MACF1,MGAT4C |
3.623e-02 | -3.32 | regulation of cellular process | biological process | GO:0050794 | 11468 | 38 | 18204 | 50 |
RYR3,MACF1,NDRG2,SORBS1,TNC,GPC5,KALRN,PSD2,SYNE1,MSI2,HPSE2,NTRK2,SLC1A2,ERBB4,CAMK2G,SLC4A4,DGKG,GFAP,GLIS3,RFX4,RPS6KA2,PRKCA,NRG3,ATP1A2,FMN2,DCLK2,RORA,NRXN1,CTNND2,CTNNA2,PITPNC1,NPAS3,ADCY2,DTNA,GPM6A,PARD3,NTRK3,SOX5 |
3.627e-02 | -3.32 | Prolonged ERK activation events | REACTOME pathways | R-HSA-169893 | 252 | 3 | 10285 | 30 |
CAMK2G,NRG3,ERBB4 |
3.627e-02 | -3.32 | Ion_trans | pfam domains | PF00520 | 109 | 2 | 17795 | 49 |
TRPM3,RYR3 |
3.645e-02 | -3.31 | MIR | smart domains | SM00472 | 10 | 1 | 9717 | 36 |
RYR3 |
3.645e-02 | -3.31 | DAGKa | smart domains | SM00045 | 10 | 1 | 9717 | 36 |
DGKG |
3.647e-02 | -3.31 | Dppa3 (developmental pluripotency-associated 3) | protein interactions | 73708 | 284 | 3 | 19454 | 50 |
CAMK2G,MSI2,ATP1A2 |
3.663e-02 | -3.31 | Signaling by Leptin | REACTOME pathways | R-HSA-2586552 | 253 | 3 | 10285 | 30 |
ERBB4,NRG3,CAMK2G |
3.666e-02 | -3.31 | Stimuli-sensing channels | REACTOME pathways | R-HSA-2672351 | 104 | 2 | 10285 | 30 |
RYR3,TRPM3 |
3.668e-02 | -3.31 | CAV1 (caveolin 1) | protein interactions | 857 | 719 | 5 | 19454 | 50 |
DTNA,RPS6KA2,MACF1,FMN2,PARD3 |
3.670e-02 | -3.30 | - | gene3d domains | 3.10.450.50 | 12 | 1 | 14470 | 45 |
CAMK2G |
3.670e-02 | -3.30 | Alpha-catenin/vinculin-like | gene3d domains | 1.20.120.230 | 12 | 1 | 14470 | 45 |
CTNNA2 |
3.670e-02 | -3.30 | positive regulation of cell development | biological process | GO:0010720 | 458 | 4 | 18204 | 50 |
NTRK2,GFAP,PRKCA,MACF1 |
3.672e-02 | -3.30 | positive regulation of cell junction assembly | biological process | GO:1901890 | 110 | 2 | 18204 | 50 |
NRXN1,NTRK2 |
3.673e-02 | -3.30 | calcium ion binding | molecular function | GO:0005509 | 683 | 5 | 18094 | 49 |
LRP1B,MACF1,DGKG,NRXN1,RYR3 |
3.699e-02 | -3.30 | SIPA1L2 (signal induced proliferation associated 1 like 2) | protein interactions | 57568 | 118 | 2 | 19454 | 50 |
GFAP,PARD3 |
3.699e-02 | -3.30 | DNM1 (dynamin 1) | protein interactions | 1759 | 118 | 2 | 19454 | 50 |
GPM6A,PRKCA |
3.715e-02 | -3.29 | regulation of multicellular organismal process | biological process | GO:0051239 | 3113 | 14 | 18204 | 50 |
RORA,NRXN1,ATP1A2,PRKCA,NDRG2,MACF1,GFAP,SOX5,ERBB4,CAMK2G,PARD3,SFXN5,NTRK2,SYNE1 |
3.715e-02 | -3.29 | Neurexin-like | interpro domains | IPR003585 | 14 | 1 | 18521 | 50 |
NRXN1 |
3.715e-02 | -3.29 | LDLR_classB_rpt | interpro domains | IPR000033 | 14 | 1 | 18521 | 50 |
LRP1B |
3.719e-02 | -3.29 | stomach-carcinoma-adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-adenocarcinoma | 15150 | 48 | 16828 | 49 |
CAMK2G,ATP1A2,PSD2,NDRG2,ADCY2,LRP1B,GPC5,SLC4A4,NRXN1,ERBB4,PITPNC1,MGAT4C,KALRN,DCLK2,SLC14A1,PARD3,MSI2,SYNE1,DTNA,RYR3,PRKCA,NTM,DGKG,FMN2,RPS6KA2,GLIS3,SFXN5,NRG3,SOX5,NTRK2,TNC,CTNND2,CDH20,LSAMP,NPAS3,HPSE2,ABLIM1,RORA,GPM6A,NAV2,MACF1,SORBS1,SLC1A2,NEBL,RFX4,NTRK3,GFAP,TRPM3 |
3.721e-02 | -3.29 | stomach-carcinoma-mucinous_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-mucinous_adenocarcinoma | 13 | 1 | 16828 | 49 |
NTRK3 |
3.721e-02 | -3.29 | mucinous_adenocarcinoma | COSMIC cancer mutations | mucinous_adenocarcinoma | 13 | 1 | 16828 | 49 |
NTRK3 |
3.727e-02 | -3.29 | microtubule minus-end binding | molecular function | GO:0051011 | 14 | 1 | 18094 | 49 |
MACF1 |
3.727e-02 | -3.29 | L-glutamate transmembrane transporter activity | molecular function | GO:0005313 | 14 | 1 | 18094 | 49 |
SLC1A2 |
3.736e-02 | -3.29 | Interleukin receptor SHC signaling | REACTOME pathways | R-HSA-912526 | 255 | 3 | 10285 | 30 |
ERBB4,NRG3,CAMK2G |
3.744e-02 | -3.29 | protein localization | biological process | GO:0008104 | 1954 | 10 | 18204 | 50 |
DCLK2,FMN2,PARD3,CAMK2G,ERBB4,NRXN1,GFAP,MACF1,SYNE1,LRP1B |
3.745e-02 | -3.28 | HSPA1B (heat shock protein family A (Hsp70) member 1B) | protein interactions | 3304 | 287 | 3 | 19454 | 50 |
NDRG2,NTRK3,NTRK2 |
3.756e-02 | -3.28 | ANKRD26 (ankyrin repeat domain containing 26) | protein interactions | 22852 | 119 | 2 | 19454 | 50 |
NTRK2,PARD3 |
3.765e-02 | -3.28 | LRRCT | smart domains | SM00082 | 83 | 2 | 9717 | 36 |
NTRK2,NTRK3 |
3.771e-02 | -3.28 | protein localization to membrane | biological process | GO:0072657 | 462 | 4 | 18204 | 50 |
PARD3,MACF1,ERBB4,NRXN1 |
3.773e-02 | -3.28 | Signalling to RAS | REACTOME pathways | R-HSA-167044 | 256 | 3 | 10285 | 30 |
ERBB4,NRG3,CAMK2G |
3.775e-02 | -3.28 | skin-malignant_melanoma | COSMIC cancer mutations | skin-malignant_melanoma | 15741 | 49 | 16828 | 49 |
TNC,CTNND2,NTRK2,SOX5,LSAMP,NPAS3,CDH20,SORBS1,SLC1A2,ABLIM1,HPSE2,GPM6A,NAV2,MACF1,RORA,GFAP,TRPM3,NEBL,RFX4,NTRK3,ATP1A2,PSD2,CAMK2G,ERBB4,SLC4A4,NRXN1,ADCY2,LRP1B,GPC5,NDRG2,MSI2,SLC14A1,PARD3,SYNE1,MGAT4C,PITPNC1,DCLK2,KALRN,NKAIN3,NRG3,GLIS3,SFXN5,DTNA,DGKG,FMN2,RPS6KA2,RYR3,NTM,PRKCA |
3.779e-02 | -3.28 | regulation of mesenchymal cell apoptotic process | biological process | GO:2001053 | 14 | 1 | 18204 | 50 |
SYNE1 |
3.779e-02 | -3.28 | negative regulation of sodium ion transmembrane transporter activity | biological process | GO:2000650 | 14 | 1 | 18204 | 50 |
ATP1A2 |
3.779e-02 | -3.28 | protein localization to postsynaptic specialization membrane | biological process | GO:0099633 | 14 | 1 | 18204 | 50 |
ERBB4 |
3.779e-02 | -3.28 | cellular response to purine-containing compound | biological process | GO:0071415 | 14 | 1 | 18204 | 50 |
RYR3 |
3.779e-02 | -3.28 | neurotransmitter receptor localization to postsynaptic specialization membrane | biological process | GO:0099645 | 14 | 1 | 18204 | 50 |
ERBB4 |
3.779e-02 | -3.28 | relaxation of cardiac muscle | biological process | GO:0055119 | 14 | 1 | 18204 | 50 |
ATP1A2 |
3.779e-02 | -3.28 | regulation of skeletal muscle adaptation | biological process | GO:0014733 | 14 | 1 | 18204 | 50 |
CAMK2G |
3.779e-02 | -3.28 | response to forskolin | biological process | GO:1904321 | 14 | 1 | 18204 | 50 |
ADCY2 |
3.779e-02 | -3.28 | glutathione biosynthetic process | biological process | GO:0006750 | 14 | 1 | 18204 | 50 |
SLC1A2 |
3.779e-02 | -3.28 | mechanosensory behavior | biological process | GO:0007638 | 14 | 1 | 18204 | 50 |
NRXN1 |
3.779e-02 | -3.28 | cellular response to forskolin | biological process | GO:1904322 | 14 | 1 | 18204 | 50 |
ADCY2 |
3.788e-02 | -3.27 | PCSK1N (proprotein convertase subtilisin/kexin type 1 inhibitor) | protein interactions | 27344 | 15 | 1 | 19454 | 50 |
MGAT4C |
3.788e-02 | -3.27 | OGG1 (8-oxoguanine DNA glycosylase) | protein interactions | 4968 | 15 | 1 | 19454 | 50 |
PRKCA |
3.788e-02 | -3.27 | DEFB123 (defensin beta 123) | protein interactions | 245936 | 15 | 1 | 19454 | 50 |
LRP1B |
3.788e-02 | -3.27 | OLFM3 (olfactomedin 3) | protein interactions | 118427 | 15 | 1 | 19454 | 50 |
LRP1B |
3.788e-02 | -3.27 | TAFA5 (TAFA chemokine like family member 5) | protein interactions | 25817 | 15 | 1 | 19454 | 50 |
NEBL |
3.788e-02 | -3.27 | TIAM2 (TIAM Rac1 associated GEF 2) | protein interactions | 26230 | 15 | 1 | 19454 | 50 |
PARD3 |
3.788e-02 | -3.27 | FN3K (fructosamine 3 kinase) | protein interactions | 64122 | 15 | 1 | 19454 | 50 |
PRKCA |
3.788e-02 | -3.27 | ENTPD5 (ectonucleoside triphosphate diphosphohydrolase 5 (inactive)) | protein interactions | 957 | 15 | 1 | 19454 | 50 |
PRKCA |
3.788e-02 | -3.27 | ADRA1B (adrenoceptor alpha 1B) | protein interactions | 147 | 15 | 1 | 19454 | 50 |
PRKCA |
3.788e-02 | -3.27 | GRM7 (glutamate metabotropic receptor 7) | protein interactions | 2917 | 15 | 1 | 19454 | 50 |
PRKCA |
3.788e-02 | -3.27 | XIRP1 (xin actin binding repeat containing 1) | protein interactions | 165904 | 15 | 1 | 19454 | 50 |
NEBL |
3.794e-02 | -3.27 | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | biological process | GO:0051896 | 270 | 3 | 18204 | 50 |
NTRK3,NTRK2,ERBB4 |
3.797e-02 | -3.27 | active monoatomic ion transmembrane transporter activity | molecular function | GO:0022853 | 274 | 3 | 18094 | 49 |
SLC1A2,ATP1A2,SLC4A4 |
3.810e-02 | -3.27 | CEP128 (centrosomal protein 128) | protein interactions | 145508 | 289 | 3 | 19454 | 50 |
NEBL,ABLIM1,SORBS1 |
3.814e-02 | -3.27 | IBTK (inhibitor of Bruton tyrosine kinase) | protein interactions | 25998 | 120 | 2 | 19454 | 50 |
RPS6KA2,PRKCA |
3.824e-02 | -3.26 | SH3 | smart domains | SM00326 | 202 | 3 | 9717 | 36 |
SORBS1,KALRN,NEBL |
3.836e-02 | -3.26 | cellular macromolecule localization | biological process | GO:0070727 | 1962 | 10 | 18204 | 50 |
MACF1,SYNE1,LRP1B,FMN2,PARD3,DCLK2,GFAP,NRXN1,ERBB4,CAMK2G |
3.837e-02 | -3.26 | side of membrane | cellular component | GO:0098552 | 715 | 5 | 19108 | 50 |
NTM,DTNA,GPC5,LSAMP,GFAP |
3.840e-02 | -3.26 | KIF14 (kinesin family member 14) | protein interactions | 9928 | 1803 | 9 | 19454 | 50 |
MSI2,ABLIM1,NEBL,GFAP,PSD2,PARD3,SOX5,MACF1,SORBS1 |
3.855e-02 | -3.26 | axolemma | cellular component | GO:0030673 | 15 | 1 | 19108 | 50 |
SLC1A2 |
3.856e-02 | -3.26 | dendrite development | biological process | GO:0016358 | 113 | 2 | 18204 | 50 |
CTNND2,CTNNA2 |
3.861e-02 | -3.25 | Transport of inorganic cations/anions and amino acids/oligopeptides | REACTOME pathways | R-HSA-425393 | 107 | 2 | 10285 | 30 |
SLC4A4,SLC1A2 |
3.868e-02 | -3.25 | regulation of locomotion | biological process | GO:0040012 | 1164 | 7 | 18204 | 50 |
NRG3,NTRK3,ERBB4,TNC,MACF1,CTNNA2,PRKCA |
3.876e-02 | -3.25 | GOPC (golgi associated PDZ and coiled-coil motif containing) | protein interactions | 57120 | 291 | 3 | 19454 | 50 |
NTRK2,NTRK3,RPS6KA2 |
3.900e-02 | -3.24 | vascular process in circulatory system | biological process | GO:0003018 | 273 | 3 | 18204 | 50 |
ATP1A2,SLC4A4,SLC1A2 |
3.914e-02 | -3.24 | skin-leg-malignant_melanoma-nodular | COSMIC cancer mutations | skin-leg-malignant_melanoma-nodular | 258 | 3 | 16828 | 49 |
FMN2,SYNE1,SLC4A4 |
3.936e-02 | -3.23 | Rap1 signaling pathway | KEGG pathways | hsa04015 | 210 | 3 | 7161 | 26 |
PRKCA,ADCY2,PARD3 |
3.936e-02 | -3.23 | Rap1 signaling pathway | KEGG pathways | ko04015 | 210 | 3 | 7161 | 26 |
PRKCA,PARD3,ADCY2 |
3.943e-02 | -3.23 | human chr13q31.3 | chromosome location | human chr13q31.3 | 21 | 1 | 26134 | 50 |
GPC5 |
3.943e-02 | -3.23 | human chr10q23.1 | chromosome location | human chr10q23.1 | 21 | 1 | 26134 | 50 |
NRG3 |
3.950e-02 | -3.23 | basal plasma membrane | cellular component | GO:0009925 | 288 | 3 | 19108 | 50 |
ERBB4,SLC4A4,SLC14A1 |
3.959e-02 | -3.23 | NAD+ Signalling and Aging | SMPDB pathways | SMP0084271 | 11 | 1 | 1369 | 5 |
RORA |
3.971e-02 | -3.23 | gliogenesis | biological process | GO:0042063 | 275 | 3 | 18204 | 50 |
GFAP,NTRK2,PARD3 |
3.975e-02 | -3.23 | FH2_Formin | interpro domains | IPR015425 | 15 | 1 | 18521 | 50 |
FMN2 |
3.975e-02 | -3.23 | Sec7_C_sf | interpro domains | IPR023394 | 15 | 1 | 18521 | 50 |
PSD2 |
3.975e-02 | -3.23 | ATPase_P-typ_cation-transptr_C | interpro domains | IPR006068 | 15 | 1 | 18521 | 50 |
ATP1A2 |
3.975e-02 | -3.23 | Diacylglycerol_kinase_cat_dom | interpro domains | IPR001206 | 15 | 1 | 18521 | 50 |
DGKG |
3.975e-02 | -3.23 | FH2_Formin_sf | interpro domains | IPR042201 | 15 | 1 | 18521 | 50 |
FMN2 |
3.975e-02 | -3.23 | NTF2-like_dom_sf | interpro domains | IPR032710 | 15 | 1 | 18521 | 50 |
CAMK2G |
3.975e-02 | -3.23 | Sec7_dom_sf | interpro domains | IPR035999 | 15 | 1 | 18521 | 50 |
PSD2 |
3.988e-02 | -3.22 | low-density lipoprotein particle receptor activity | molecular function | GO:0005041 | 15 | 1 | 18094 | 49 |
LRP1B |
3.988e-02 | -3.22 | tropomyosin binding | molecular function | GO:0005523 | 15 | 1 | 18094 | 49 |
NEBL |
3.988e-02 | -3.22 | phosphatidylglycerol binding | molecular function | GO:1901611 | 15 | 1 | 18094 | 49 |
PITPNC1 |
3.988e-02 | -3.22 | 3'-5' DNA helicase activity | molecular function | GO:0043138 | 15 | 1 | 18094 | 49 |
NAV2 |
3.988e-02 | -3.22 | filamin binding | molecular function | GO:0031005 | 15 | 1 | 18094 | 49 |
NEBL |
3.988e-02 | -3.22 | BAD (BCL2 associated agonist of cell death) | protein interactions | 572 | 123 | 2 | 19454 | 50 |
PRKCA,RPS6KA2 |
3.999e-02 | -3.22 | Interleukin-2 signaling | REACTOME pathways | R-HSA-451927 | 262 | 3 | 10285 | 30 |
NRG3,ERBB4,CAMK2G |
4.002e-02 | -3.22 | solute:monoatomic cation symporter activity | molecular function | GO:0015294 | 117 | 2 | 18094 | 49 |
SLC4A4,SLC1A2 |
4.008e-02 | -3.22 | learning or memory | biological process | GO:0007611 | 276 | 3 | 18204 | 50 |
ATP1A2,NRXN1,NTRK2 |
4.009e-02 | -3.22 | GABAergic synapse | KEGG pathways | ko04727 | 88 | 2 | 7161 | 26 |
ADCY2,PRKCA |
4.009e-02 | -3.22 | GABAergic synapse | KEGG pathways | hsa04727 | 88 | 2 | 7161 | 26 |
ADCY2,PRKCA |
4.009e-02 | -3.22 | Gap junction | KEGG pathways | hsa04540 | 88 | 2 | 7161 | 26 |
PRKCA,ADCY2 |
4.009e-02 | -3.22 | Gap junction | KEGG pathways | ko04540 | 88 | 2 | 7161 | 26 |
ADCY2,PRKCA |
4.010e-02 | -3.22 | DCC mediated attractive signaling | REACTOME pathways | R-HSA-418885 | 14 | 1 | 10285 | 30 |
ABLIM1 |
4.015e-02 | -3.22 | rhabdomyosarcoma | COSMIC cancer mutations | rhabdomyosarcoma | 4150 | 18 | 16828 | 49 |
CDH20,LRP1B,ADCY2,FMN2,NTRK3,RYR3,TRPM3,NPAS3,GLIS3,MACF1,CAMK2G,NAV2,RORA,TNC,PARD3,SORBS1,SYNE1,CTNND2 |
4.035e-02 | -3.21 | IFFO2 (intermediate filament family orphan 2) | protein interactions | 126917 | 16 | 1 | 19454 | 50 |
GFAP |
4.035e-02 | -3.21 | RHO (rhodopsin) | protein interactions | 6010 | 16 | 1 | 19454 | 50 |
PRKCA |
4.035e-02 | -3.21 | TMEM134 (transmembrane protein 134) | protein interactions | 80194 | 16 | 1 | 19454 | 50 |
ERBB4 |
4.035e-02 | -3.21 | SYT4 (synaptotagmin 4) | protein interactions | 6860 | 16 | 1 | 19454 | 50 |
NRXN1 |
4.035e-02 | -3.21 | SLC6A9 (solute carrier family 6 member 9) | protein interactions | 6536 | 16 | 1 | 19454 | 50 |
PRKCA |
4.035e-02 | -3.21 | GABRR1 (gamma-aminobutyric acid type A receptor subunit rho1) | protein interactions | 2569 | 16 | 1 | 19454 | 50 |
PRKCA |
4.035e-02 | -3.21 | KLHL25 (kelch like family member 25) | protein interactions | 64410 | 16 | 1 | 19454 | 50 |
RPS6KA2 |
4.035e-02 | -3.21 | WASH6P (WASP family homolog 6, pseudogene) | protein interactions | 653440 | 16 | 1 | 19454 | 50 |
NTRK3 |
4.035e-02 | -3.21 | CAMK1G (calcium/calmodulin dependent protein kinase IG) | protein interactions | 57172 | 16 | 1 | 19454 | 50 |
CAMK2G |
4.035e-02 | -3.21 | AMMECR1L (AMMECR1 like) | protein interactions | 83607 | 16 | 1 | 19454 | 50 |
MACF1 |
4.035e-02 | -3.21 | SAPCD1 (suppressor APC domain containing 1) | protein interactions | 401251 | 16 | 1 | 19454 | 50 |
CTNNA2 |
4.035e-02 | -3.21 | DUS1L (dihydrouridine synthase 1 like) | protein interactions | 64118 | 16 | 1 | 19454 | 50 |
CAMK2G |
4.035e-02 | -3.21 | CNTNAP2 (contactin associated protein 2) | protein interactions | 26047 | 16 | 1 | 19454 | 50 |
MACF1 |
4.035e-02 | -3.21 | SYT9 (synaptotagmin 9) | protein interactions | 143425 | 16 | 1 | 19454 | 50 |
NRXN1 |
4.035e-02 | -3.21 | WWC3 (WWC family member 3) | protein interactions | 55841 | 16 | 1 | 19454 | 50 |
PRKCA |
4.035e-02 | -3.21 | SYTL2 (synaptotagmin like 2) | protein interactions | 54843 | 16 | 1 | 19454 | 50 |
NRXN1 |
4.035e-02 | -3.21 | GABRB3 (gamma-aminobutyric acid type A receptor subunit beta3) | protein interactions | 2562 | 16 | 1 | 19454 | 50 |
PRKCA |
4.035e-02 | -3.21 | ADAM18 (ADAM metallopeptidase domain 18) | protein interactions | 8749 | 16 | 1 | 19454 | 50 |
RPS6KA2 |
4.035e-02 | -3.21 | NRGN (neurogranin) | protein interactions | 4900 | 16 | 1 | 19454 | 50 |
PRKCA |
4.035e-02 | -3.21 | CDH12 (cadherin 12) | protein interactions | 1010 | 16 | 1 | 19454 | 50 |
CTNNA2 |
4.038e-02 | -3.21 | Signalling to ERKs | REACTOME pathways | R-HSA-187687 | 263 | 3 | 10285 | 30 |
NRG3,ERBB4,CAMK2G |
4.043e-02 | -3.21 | cerebellar Purkinje cell layer formation | biological process | GO:0021694 | 15 | 1 | 18204 | 50 |
RORA |
4.043e-02 | -3.21 | sarcoplasmic reticulum calcium ion transport | biological process | GO:0070296 | 15 | 1 | 18204 | 50 |
RYR3 |
4.043e-02 | -3.21 | positive regulation of glycogen biosynthetic process | biological process | GO:0045725 | 15 | 1 | 18204 | 50 |
SORBS1 |
4.043e-02 | -3.21 | response to caffeine | biological process | GO:0031000 | 15 | 1 | 18204 | 50 |
RYR3 |
4.043e-02 | -3.21 | negative regulation of sodium ion transmembrane transport | biological process | GO:1902306 | 15 | 1 | 18204 | 50 |
ATP1A2 |
4.043e-02 | -3.21 | peripheral nervous system neuron differentiation | biological process | GO:0048934 | 15 | 1 | 18204 | 50 |
NTRK2 |
4.043e-02 | -3.21 | neuroblast division | biological process | GO:0055057 | 15 | 1 | 18204 | 50 |
SOX5 |
4.043e-02 | -3.21 | peripheral nervous system neuron development | biological process | GO:0048935 | 15 | 1 | 18204 | 50 |
NTRK2 |
4.043e-02 | -3.21 | pyramidal neuron differentiation | biological process | GO:0021859 | 15 | 1 | 18204 | 50 |
DCLK2 |
4.043e-02 | -3.21 | regulation of neuron projection arborization | biological process | GO:0150011 | 15 | 1 | 18204 | 50 |
MACF1 |
4.043e-02 | -3.21 | protein homotrimerization | biological process | GO:0070207 | 15 | 1 | 18204 | 50 |
SLC1A2 |
4.043e-02 | -3.21 | intracellular potassium ion homeostasis | biological process | GO:0030007 | 15 | 1 | 18204 | 50 |
ATP1A2 |
4.047e-02 | -3.21 | TNK2 (tyrosine kinase non receptor 2) | protein interactions | 10188 | 124 | 2 | 19454 | 50 |
NTRK3,NTRK2 |
4.047e-02 | -3.21 | CEBPA (CCAAT enhancer binding protein alpha) | protein interactions | 1050 | 124 | 2 | 19454 | 50 |
MACF1,GFAP |
4.053e-02 | -3.21 | DAGK_cat | pfam domains | PF00781 | 15 | 1 | 17795 | 49 |
DGKG |
4.053e-02 | -3.21 | Sec7 | pfam domains | PF01369 | 15 | 1 | 17795 | 49 |
PSD2 |
4.053e-02 | -3.21 | FH2 | pfam domains | PF02181 | 15 | 1 | 17795 | 49 |
FMN2 |
4.053e-02 | -3.21 | CRAL_TRIO_2 | pfam domains | PF13716 | 15 | 1 | 17795 | 49 |
KALRN |
4.053e-02 | -3.21 | Cation_ATPase_C | pfam domains | PF00689 | 15 | 1 | 17795 | 49 |
ATP1A2 |
4.055e-02 | -3.21 | positive regulation of MAPK cascade | biological process | GO:0043410 | 473 | 4 | 18204 | 50 |
NTRK3,PRKCA,NTRK2,ERBB4 |
4.069e-02 | -3.20 | LZTS2 (leucine zipper tumor suppressor 2) | protein interactions | 84445 | 506 | 4 | 19454 | 50 |
SORBS1,GFAP,NEBL,PARD3 |
4.079e-02 | -3.20 | TJP1 (tight junction protein 1) | protein interactions | 7082 | 297 | 3 | 19454 | 50 |
NEBL,DTNA,PARD3 |
4.080e-02 | -3.20 | actin filament organization | biological process | GO:0007015 | 278 | 3 | 18204 | 50 |
NEBL,FMN2,SORBS1 |
4.101e-02 | -3.19 | Ig-like_dom_sf | interpro domains | IPR036179 | 483 | 4 | 18521 | 50 |
LSAMP,NTRK3,NTM,NTRK2 |
4.106e-02 | -3.19 | TCHP (trichoplein keratin filament binding) | protein interactions | 84260 | 125 | 2 | 19454 | 50 |
GFAP,PARD3 |
4.106e-02 | -3.19 | STXBP1 (syntaxin binding protein 1) | protein interactions | 6812 | 125 | 2 | 19454 | 50 |
PRKCA,GPM6A |
4.107e-02 | -3.19 | regulation of synapse assembly | biological process | GO:0051963 | 117 | 2 | 18204 | 50 |
NTRK2,NRXN1 |
4.115e-02 | -3.19 | FCERI mediated MAPK activation | REACTOME pathways | R-HSA-2871796 | 265 | 3 | 10285 | 30 |
ERBB4,NRG3,CAMK2G |
4.126e-02 | -3.19 | Integration of energy metabolism | REACTOME pathways | R-HSA-163685 | 111 | 2 | 10285 | 30 |
ADCY2,PRKCA |
4.127e-02 | -3.19 | human chr3q13.31 | chromosome location | human chr3q13.31 | 22 | 1 | 26134 | 50 |
LSAMP |
4.166e-02 | -3.18 | SYP (synaptophysin) | protein interactions | 6855 | 126 | 2 | 19454 | 50 |
PITPNC1,GPM6A |
4.215e-02 | -3.17 | MFAP5-mediated ovarian cancer cell motility and invasiveness | WikiPathways | WP3301 | 12 | 1 | 5310 | 19 |
RYR3 |
4.226e-02 | -3.16 | DES (desmin) | protein interactions | 1674 | 127 | 2 | 19454 | 50 |
DTNA,GFAP |
4.226e-02 | -3.16 | SCO2 (synthesis of cytochrome C oxidase 2) | protein interactions | 9997 | 127 | 2 | 19454 | 50 |
DCLK2,NTRK3 |
4.235e-02 | -3.16 | Sec7_dom | interpro domains | IPR000904 | 16 | 1 | 18521 | 50 |
PSD2 |
4.239e-02 | -3.16 | perinuclear region of cytoplasm | cellular component | GO:0048471 | 735 | 5 | 19108 | 50 |
NDRG2,SYNE1,FMN2,NTRK2,PRKCA |
4.248e-02 | -3.16 | lamin binding | molecular function | GO:0005521 | 16 | 1 | 18094 | 49 |
SYNE1 |
4.248e-02 | -3.16 | adenylate cyclase activity | molecular function | GO:0004016 | 16 | 1 | 18094 | 49 |
ADCY2 |
4.248e-02 | -3.16 | oxysterol binding | molecular function | GO:0008142 | 16 | 1 | 18094 | 49 |
RORA |
4.248e-02 | -3.16 | diacylglycerol-dependent serine/threonine kinase activity | molecular function | GO:0004697 | 16 | 1 | 18094 | 49 |
PRKCA |
4.261e-02 | -3.16 | Morphine addiction | KEGG pathways | hsa05032 | 91 | 2 | 7161 | 26 |
ADCY2,PRKCA |
4.261e-02 | -3.16 | Morphine addiction | KEGG pathways | ko05032 | 91 | 2 | 7161 | 26 |
PRKCA,ADCY2 |
4.265e-02 | -3.15 | Wnt signaling pathway | biological process | GO:0016055 | 283 | 3 | 18204 | 50 |
NDRG2,CTNND2,MACF1 |
4.269e-02 | -3.15 | - | gene3d domains | 2.60.200.40 | 14 | 1 | 14470 | 45 |
DGKG |
4.269e-02 | -3.15 | - | gene3d domains | 2.20.25.10 | 14 | 1 | 14470 | 45 |
TNC |
4.282e-02 | -3.15 | SHD (Src homology 2 domain containing transforming protein D) | protein interactions | 56961 | 17 | 1 | 19454 | 50 |
ERBB4 |
4.282e-02 | -3.15 | PAX4 (paired box 4) | protein interactions | 5078 | 17 | 1 | 19454 | 50 |
NTM |
4.282e-02 | -3.15 | MSANTD2 (Myb/SANT DNA binding domain containing 2) | protein interactions | 79684 | 17 | 1 | 19454 | 50 |
SOX5 |
4.282e-02 | -3.15 | CLEC4M (C-type lectin domain family 4 member M) | protein interactions | 10332 | 17 | 1 | 19454 | 50 |
GFAP |
4.282e-02 | -3.15 | NEU3 (neuraminidase 3) | protein interactions | 10825 | 17 | 1 | 19454 | 50 |
NTRK3 |
4.282e-02 | -3.15 | Shcbp1 (Shc SH2-domain binding protein 1) | protein interactions | 20419 | 17 | 1 | 19454 | 50 |
GPC5 |
4.282e-02 | -3.15 | TNNT2 (troponin T2, cardiac type) | protein interactions | 7139 | 17 | 1 | 19454 | 50 |
PRKCA |
4.282e-02 | -3.15 | PDE7A (phosphodiesterase 7A) | protein interactions | 5150 | 17 | 1 | 19454 | 50 |
PRKCA |
4.282e-02 | -3.15 | DPP6 (dipeptidyl peptidase like 6) | protein interactions | 1804 | 17 | 1 | 19454 | 50 |
GPM6A |
4.282e-02 | -3.15 | CYP3A4 (cytochrome P450 family 3 subfamily A member 4) | protein interactions | 1576 | 17 | 1 | 19454 | 50 |
PRKCA |
4.282e-02 | -3.15 | LIPT1 (lipoyltransferase 1) | protein interactions | 51601 | 17 | 1 | 19454 | 50 |
PRKCA |
4.282e-02 | -3.15 | SEPSECS (Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase) | protein interactions | 51091 | 17 | 1 | 19454 | 50 |
ABLIM1 |
4.282e-02 | -3.15 | TAGAP (T cell activation RhoGTPase activating protein) | protein interactions | 117289 | 17 | 1 | 19454 | 50 |
DTNA |
4.282e-02 | -3.15 | KRTAP19-3 (keratin associated protein 19-3) | protein interactions | 337970 | 17 | 1 | 19454 | 50 |
CAMK2G |
4.282e-02 | -3.15 | FAM163B (family with sequence similarity 163 member B) | protein interactions | 642968 | 17 | 1 | 19454 | 50 |
CAMK2G |
4.286e-02 | -3.15 | ATF7IP (activating transcription factor 7 interacting protein) | protein interactions | 55729 | 128 | 2 | 19454 | 50 |
SOX5,MACF1 |
4.286e-02 | -3.15 | PRKAR2B (protein kinase cAMP-dependent type II regulatory subunit beta) | protein interactions | 5577 | 128 | 2 | 19454 | 50 |
PRKCA,GPM6A |
4.286e-02 | -3.15 | SH3BP4 (SH3 domain binding protein 4) | protein interactions | 23677 | 128 | 2 | 19454 | 50 |
NTRK3,PARD3 |
4.286e-02 | -3.15 | FARP1 (FERM, ARH/RhoGEF and pleckstrin domain protein 1) | protein interactions | 10160 | 128 | 2 | 19454 | 50 |
PARD3,PSD2 |
4.289e-02 | -3.15 | LDLRB | prosite domains | PS51120 | 13 | 1 | 12186 | 41 |
LRP1B |
4.290e-02 | -3.15 | Adenylate cyclase inhibitory pathway | REACTOME pathways | R-HSA-170670 | 15 | 1 | 10285 | 30 |
ADCY2 |
4.290e-02 | -3.15 | WNT5A-dependent internalization of FZD4 | REACTOME pathways | R-HSA-5099900 | 15 | 1 | 10285 | 30 |
PRKCA |
4.290e-02 | -3.15 | Depolymerisation of the Nuclear Lamina | REACTOME pathways | R-HSA-4419969 | 15 | 1 | 10285 | 30 |
PRKCA |
4.290e-02 | -3.15 | Inhibition of adenylate cyclase pathway | REACTOME pathways | R-HSA-997269 | 15 | 1 | 10285 | 30 |
ADCY2 |
4.290e-02 | -3.15 | N-Glycan antennae elongation | REACTOME pathways | R-HSA-975577 | 15 | 1 | 10285 | 30 |
MGAT4C |
4.297e-02 | -3.15 | RAC1 (Rac family small GTPase 1) | protein interactions | 5879 | 1005 | 6 | 19454 | 50 |
FMN2,PARD3,KALRN,DTNA,PRKCA,MACF1 |
4.299e-02 | -3.15 | regulation of peptidyl-serine phosphorylation | biological process | GO:0033135 | 120 | 2 | 18204 | 50 |
NTRK2,NTRK3 |
4.307e-02 | -3.14 | nonribosomal peptide biosynthetic process | biological process | GO:0019184 | 16 | 1 | 18204 | 50 |
SLC1A2 |
4.307e-02 | -3.14 | regulation of postsynaptic neurotransmitter receptor internalization | biological process | GO:0099149 | 16 | 1 | 18204 | 50 |
SYNE1 |
4.307e-02 | -3.14 | regulation of amino acid transmembrane transport | biological process | GO:1903789 | 16 | 1 | 18204 | 50 |
ATP1A2 |
4.307e-02 | -3.14 | positive regulation of macrophage differentiation | biological process | GO:0045651 | 16 | 1 | 18204 | 50 |
PRKCA |
4.307e-02 | -3.14 | regulation of respiratory system process | biological process | GO:0044065 | 16 | 1 | 18204 | 50 |
ATP1A2 |
4.307e-02 | -3.14 | neuron cell-cell adhesion | biological process | GO:0007158 | 16 | 1 | 18204 | 50 |
NRXN1 |
4.307e-02 | -3.14 | regulation of amino acid import across plasma membrane | biological process | GO:0010958 | 16 | 1 | 18204 | 50 |
ATP1A2 |
4.307e-02 | -3.14 | locomotory exploration behavior | biological process | GO:0035641 | 16 | 1 | 18204 | 50 |
ATP1A2 |
4.311e-02 | -3.14 | human chr2q34 | chromosome location | human chr2q34 | 23 | 1 | 26134 | 50 |
ERBB4 |
4.311e-02 | -3.14 | human chr5p15.31 | chromosome location | human chr5p15.31 | 23 | 1 | 26134 | 50 |
ADCY2 |
4.313e-02 | -3.14 | Lactose Degradation | SMPDB pathways | SMP0000457 | 12 | 1 | 1369 | 5 |
ATP1A2 |
4.313e-02 | -3.14 | Lactose Intolerance | SMPDB pathways | SMP0000458 | 12 | 1 | 1369 | 5 |
ATP1A2 |
4.321e-02 | -3.14 | CARM1 (coactivator associated arginine methyltransferase 1) | protein interactions | 10498 | 304 | 3 | 19454 | 50 |
CAMK2G,DTNA,RORA |
4.346e-02 | -3.14 | Progesterone-mediated oocyte maturation | KEGG pathways | hsa04914 | 92 | 2 | 7161 | 26 |
RPS6KA2,ADCY2 |
4.346e-02 | -3.14 | Progesterone-mediated oocyte maturation | KEGG pathways | ko04914 | 92 | 2 | 7161 | 26 |
RPS6KA2,ADCY2 |
4.346e-02 | -3.14 | SLC38A2 (solute carrier family 38 member 2) | protein interactions | 54407 | 129 | 2 | 19454 | 50 |
RPS6KA2,PARD3 |
4.351e-02 | -3.13 | Interleukin-3, 5 and GM-CSF signaling | REACTOME pathways | R-HSA-512988 | 271 | 3 | 10285 | 30 |
NRG3,ERBB4,CAMK2G |
4.358e-02 | -3.13 | protein complex involved in cell-matrix adhesion | cellular component | GO:0098637 | 17 | 1 | 19108 | 50 |
TNC |
4.407e-02 | -3.12 | DVL1 (dishevelled segment polarity protein 1) | protein interactions | 1855 | 130 | 2 | 19454 | 50 |
RPS6KA2,PARD3 |
4.426e-02 | -3.12 | neuron projection terminus | cellular component | GO:0044306 | 128 | 2 | 19108 | 50 |
SLC1A2,NTRK2 |
4.444e-02 | -3.11 | ASX_HYDROXYL | prosite domains | PS00010 | 100 | 2 | 12186 | 41 |
NRXN1,LRP1B |
4.446e-02 | -3.11 | G Protein Signaling Pathways | WikiPathways | WP35 | 95 | 2 | 5310 | 19 |
ADCY2,PRKCA |
4.481e-02 | -3.11 | thyroid | COSMIC cancer mutations | thyroid | 9867 | 35 | 16828 | 49 |
SOX5,CTNND2,PSD2,TNC,ATP1A2,ADCY2,CDH20,LRP1B,GPC5,NDRG2,ERBB4,SLC4A4,NRXN1,LSAMP,NAV2,DCLK2,MACF1,RORA,KALRN,ABLIM1,SLC1A2,SYNE1,SLC14A1,PARD3,DGKG,FMN2,RPS6KA2,NTRK3,RYR3,PRKCA,DTNA,NRG3,GLIS3,GFAP,TRPM3 |
4.482e-02 | -3.11 | system process | biological process | GO:0003008 | 2015 | 10 | 18204 | 50 |
RYR3,CTNNA2,NAV2,SLC1A2,NTRK2,ABLIM1,ATP1A2,DTNA,SLC4A4,NRXN1 |
4.492e-02 | -3.10 | muscle cell differentiation | biological process | GO:0042692 | 289 | 3 | 18204 | 50 |
RORA,NEBL,SYNE1 |
4.493e-02 | -3.10 | ATP-NAD_kinase_N | interpro domains | IPR017438 | 17 | 1 | 18521 | 50 |
DGKG |
4.493e-02 | -3.10 | NAD/diacylglycerol_kinase_sf | interpro domains | IPR016064 | 17 | 1 | 18521 | 50 |
DGKG |
4.493e-02 | -3.10 | A/G_cyclase_CS | interpro domains | IPR018297 | 17 | 1 | 18521 | 50 |
ADCY2 |
4.499e-02 | -3.10 | ITCH (itchy E3 ubiquitin protein ligase) | protein interactions | 83737 | 309 | 3 | 19454 | 50 |
ERBB4,GLIS3,RORA |
4.507e-02 | -3.10 | ductal_carcinoma | COSMIC cancer mutations | ductal_carcinoma | 15798 | 49 | 16828 | 49 |
LSAMP,NPAS3,CDH20,TNC,CTNND2,SOX5,NTRK2,GFAP,TRPM3,NEBL,RFX4,NTRK3,SORBS1,SLC1A2,HPSE2,ABLIM1,RORA,GPM6A,NAV2,MACF1,SLC4A4,NRXN1,ERBB4,NDRG2,ADCY2,LRP1B,GPC5,ATP1A2,PSD2,CAMK2G,NKAIN3,GLIS3,SFXN5,NRG3,DTNA,RYR3,NTM,PRKCA,DGKG,FMN2,RPS6KA2,PARD3,SLC14A1,MSI2,SYNE1,PITPNC1,MGAT4C,KALRN,DCLK2 |
4.529e-02 | -3.09 | OPCML (opioid binding protein/cell adhesion molecule like) | protein interactions | 4978 | 18 | 1 | 19454 | 50 |
NTM |
4.529e-02 | -3.09 | SELL (selectin L) | protein interactions | 6402 | 18 | 1 | 19454 | 50 |
PRKCA |
4.529e-02 | -3.09 | ORF45 (ORF45) | protein interactions | 4961474 | 18 | 1 | 19454 | 50 |
RPS6KA2 |
4.529e-02 | -3.09 | NECTIN1 (nectin cell adhesion molecule 1) | protein interactions | 5818 | 18 | 1 | 19454 | 50 |
PARD3 |
4.529e-02 | -3.09 | Cnot2 (CCR4-NOT transcription complex, subunit 2) | protein interactions | 72068 | 18 | 1 | 19454 | 50 |
MACF1 |
4.529e-02 | -3.09 | ADAT2 (adenosine deaminase tRNA specific 2) | protein interactions | 134637 | 18 | 1 | 19454 | 50 |
NAV2 |
4.529e-02 | -3.09 | TTC29 (tetratricopeptide repeat domain 29) | protein interactions | 83894 | 18 | 1 | 19454 | 50 |
MACF1 |
4.529e-02 | -3.09 | ZNF224 (zinc finger protein 224) | protein interactions | 7767 | 18 | 1 | 19454 | 50 |
LRP1B |
4.529e-02 | -3.09 | ACAP1 (ArfGAP with coiled-coil, ankyrin repeat and PH domains 1) | protein interactions | 9744 | 18 | 1 | 19454 | 50 |
NEBL |
4.529e-02 | -3.09 | IRGC (immunity related GTPase cinema) | protein interactions | 56269 | 18 | 1 | 19454 | 50 |
RPS6KA2 |
4.530e-02 | -3.09 | ADD3 (adducin 3) | protein interactions | 120 | 132 | 2 | 19454 | 50 |
PRKCA,RPS6KA2 |
4.551e-02 | -3.09 | Z disc | cellular component | GO:0030018 | 130 | 2 | 19108 | 50 |
RYR3,NEBL |
4.553e-02 | -3.09 | NCAM signaling for neurite out-growth | REACTOME pathways | R-HSA-375165 | 276 | 3 | 10285 | 30 |
CAMK2G,ERBB4,NRG3 |
4.558e-02 | -3.09 | Cell-type Dependent Selectivity of CCK2R Signaling | WikiPathways | WP3679 | 13 | 1 | 5310 | 19 |
RYR3 |
4.560e-02 | -3.09 | action potential | biological process | GO:0001508 | 124 | 2 | 18204 | 50 |
ATP1A2,NTRK2 |
4.560e-02 | -3.09 | cardiocyte differentiation | biological process | GO:0035051 | 124 | 2 | 18204 | 50 |
NEBL,SYNE1 |
4.567e-02 | -3.09 | Arf Nucleotide-binding Site Opener,domain 2 | gene3d domains | 1.10.1000.11 | 15 | 1 | 14470 | 45 |
PSD2 |
4.567e-02 | -3.09 | Formin, FH2 domain | gene3d domains | 1.20.58.2220 | 15 | 1 | 14470 | 45 |
FMN2 |
4.567e-02 | -3.09 | inorganic ion transmembrane transport | biological process | GO:0098660 | 715 | 5 | 18204 | 50 |
ATP1A2,RYR3,GPM6A,TRPM3,SLC4A4 |
4.570e-02 | -3.09 | PKA activation | REACTOME pathways | R-HSA-163615 | 16 | 1 | 10285 | 30 |
ADCY2 |
4.570e-02 | -3.09 | Regulation of KIT signaling | REACTOME pathways | R-HSA-1433559 | 16 | 1 | 10285 | 30 |
PRKCA |
4.570e-02 | -3.09 | branch elongation of an epithelium | biological process | GO:0060602 | 17 | 1 | 18204 | 50 |
TNC |
4.570e-02 | -3.09 | cGMP metabolic process | biological process | GO:0046068 | 17 | 1 | 18204 | 50 |
RORA |
4.570e-02 | -3.09 | membrane depolarization during cardiac muscle cell action potential | biological process | GO:0086012 | 17 | 1 | 18204 | 50 |
ATP1A2 |
4.570e-02 | -3.09 | preganglionic parasympathetic fiber development | biological process | GO:0021783 | 17 | 1 | 18204 | 50 |
NAV2 |
4.570e-02 | -3.09 | T-helper 17 type immune response | biological process | GO:0072538 | 17 | 1 | 18204 | 50 |
RORA |
4.570e-02 | -3.09 | protein trimerization | biological process | GO:0070206 | 17 | 1 | 18204 | 50 |
SLC1A2 |
4.570e-02 | -3.09 | positive regulation of glycogen metabolic process | biological process | GO:0070875 | 17 | 1 | 18204 | 50 |
SORBS1 |
4.570e-02 | -3.09 | cellular response to ATP | biological process | GO:0071318 | 17 | 1 | 18204 | 50 |
RYR3 |
4.570e-02 | -3.09 | cell migration in hindbrain | biological process | GO:0021535 | 17 | 1 | 18204 | 50 |
CTNNA2 |
4.570e-02 | -3.09 | retinal rod cell differentiation | biological process | GO:0060221 | 17 | 1 | 18204 | 50 |
NTRK2 |
4.570e-02 | -3.09 | mammary gland epithelial cell differentiation | biological process | GO:0060644 | 17 | 1 | 18204 | 50 |
ERBB4 |
4.570e-02 | -3.09 | cell communication by electrical coupling involved in cardiac conduction | biological process | GO:0086064 | 17 | 1 | 18204 | 50 |
ATP1A2 |
4.579e-02 | -3.08 | signaling receptor binding | molecular function | GO:0005102 | 1493 | 8 | 18094 | 49 |
SORBS1,TNC,SYNE1,PRKCA,ERBB4,GFAP,NRXN1,NRG3 |
4.581e-02 | -3.08 | ZZ | pfam domains | PF00569 | 17 | 1 | 17795 | 49 |
DTNA |
4.626e-02 | -3.07 | actomyosin structure organization | biological process | GO:0031032 | 125 | 2 | 18204 | 50 |
SORBS1,NEBL |
4.626e-02 | -3.07 | mammary gland development | biological process | GO:0030879 | 125 | 2 | 18204 | 50 |
NRG3,ERBB4 |
4.627e-02 | -3.07 | basal part of cell | cellular component | GO:0045178 | 307 | 3 | 19108 | 50 |
SLC4A4,ERBB4,SLC14A1 |
4.631e-02 | -3.07 | cellular response to growth factor stimulus | biological process | GO:0071363 | 494 | 4 | 18204 | 50 |
SOX5,NTRK2,ERBB4,NTRK3 |
4.653e-02 | -3.07 | NUFIP1 (nuclear FMR1 interacting protein 1) | protein interactions | 26747 | 134 | 2 | 19454 | 50 |
GPM6A,NTM |
4.654e-02 | -3.07 | channel activity | molecular function | GO:0015267 | 502 | 4 | 18094 | 49 |
RYR3,GPM6A,TRPM3,SLC14A1 |
4.665e-02 | -3.07 | Succinate Signalling During Inflammation | SMPDB pathways | SMP0084634 | 13 | 1 | 1369 | 5 |
PRKCA |
4.665e-02 | -3.07 | Trehalose Degradation | SMPDB pathways | SMP0000467 | 13 | 1 | 1369 | 5 |
ATP1A2 |
4.682e-02 | -3.06 | passive transmembrane transporter activity | molecular function | GO:0022803 | 503 | 4 | 18094 | 49 |
GPM6A,TRPM3,SLC14A1,RYR3 |
4.693e-02 | -3.06 | limbic system development | biological process | GO:0021761 | 126 | 2 | 18204 | 50 |
DCLK2,ATP1A2 |
4.715e-02 | -3.05 | DVL2 (dishevelled segment polarity protein 2) | protein interactions | 1856 | 531 | 4 | 19454 | 50 |
SYNE1,MACF1,PRKCA,PARD3 |
4.716e-02 | -3.05 | Myo1c (myosin IC) | protein interactions | 17913 | 135 | 2 | 19454 | 50 |
CAMK2G,ABLIM1 |
4.720e-02 | -3.05 | Signal Transduction | REACTOME pathways | R-HSA-162582 | 2547 | 12 | 10285 | 30 |
PARD3,CAMK2G,ERBB4,GPC5,DGKG,PRKCA,ADCY2,NRG3,RPS6KA2,KALRN,NTRK2,GFAP |
4.722e-02 | -3.05 | central_nervous_system-brain-glioma-astrocytoma_Grade_IV | COSMIC cancer mutations | central_nervous_system-brain-glioma-astrocytoma_Grade_IV | 15813 | 49 | 16828 | 49 |
CDH20,NPAS3,LSAMP,NTRK2,SOX5,CTNND2,TNC,NTRK3,NEBL,RFX4,GFAP,TRPM3,NAV2,GPM6A,MACF1,RORA,ABLIM1,HPSE2,SORBS1,SLC1A2,ADCY2,LRP1B,GPC5,NDRG2,ERBB4,SLC4A4,NRXN1,CAMK2G,PSD2,ATP1A2,DGKG,FMN2,RPS6KA2,RYR3,NTM,PRKCA,DTNA,NRG3,GLIS3,SFXN5,NKAIN3,DCLK2,KALRN,MGAT4C,PITPNC1,SYNE1,MSI2,PARD3,SLC14A1 |
4.743e-02 | -3.05 | striated_muscle | COSMIC cancer mutations | striated_muscle | 4228 | 18 | 16828 | 49 |
TNC,PARD3,SORBS1,SYNE1,CTNND2,CAMK2G,MACF1,NAV2,RORA,TRPM3,GLIS3,NPAS3,CDH20,LRP1B,ADCY2,FMN2,NTRK3,RYR3 |
4.746e-02 | -3.05 | Growth_fac_rcpt_cys_sf | interpro domains | IPR009030 | 129 | 2 | 18521 | 50 |
ERBB4,LRP1B |
4.752e-02 | -3.05 | ATPase_P-typ_cation-transptr_N | interpro domains | IPR004014 | 18 | 1 | 18521 | 50 |
ATP1A2 |
4.752e-02 | -3.05 | A/G_cyclase | interpro domains | IPR001054 | 18 | 1 | 18521 | 50 |
ADCY2 |
4.752e-02 | -3.05 | Furin_repeat | interpro domains | IPR006212 | 18 | 1 | 18521 | 50 |
ERBB4 |
4.752e-02 | -3.05 | Nucleotide_cyclase | interpro domains | IPR029787 | 18 | 1 | 18521 | 50 |
ADCY2 |
4.760e-02 | -3.05 | response to amino acid | biological process | GO:0043200 | 127 | 2 | 18204 | 50 |
NTRK2,SLC1A2 |
4.766e-02 | -3.04 | phosphatidylcholine transporter activity | molecular function | GO:0008525 | 18 | 1 | 18094 | 49 |
PITPNC1 |
4.766e-02 | -3.04 | lipoprotein particle receptor activity | molecular function | GO:0030228 | 18 | 1 | 18094 | 49 |
LRP1B |
4.766e-02 | -3.04 | GABA receptor binding | molecular function | GO:0050811 | 18 | 1 | 18094 | 49 |
ERBB4 |
4.766e-02 | -3.04 | intracellularly gated calcium channel activity | molecular function | GO:0015278 | 18 | 1 | 18094 | 49 |
RYR3 |
4.766e-02 | -3.04 | acidic amino acid transmembrane transporter activity | molecular function | GO:0015172 | 18 | 1 | 18094 | 49 |
SLC1A2 |
4.766e-02 | -3.04 | heparan sulfate proteoglycan binding | molecular function | GO:0043395 | 18 | 1 | 18094 | 49 |
HPSE2 |
4.766e-02 | -3.04 | transmembrane receptor protein tyrosine kinase activator activity | molecular function | GO:0030297 | 18 | 1 | 18094 | 49 |
NRG3 |
4.772e-02 | -3.04 | haematopoietic_and_lymphoid_tissue-abdomen-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-abdomen-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 120 | 2 | 16828 | 49 |
FMN2,CTNND2 |
4.774e-02 | -3.04 | HBEGF (heparin binding EGF like growth factor) | protein interactions | 1839 | 19 | 1 | 19454 | 50 |
ERBB4 |
4.774e-02 | -3.04 | SYT7 (synaptotagmin 7) | protein interactions | 9066 | 19 | 1 | 19454 | 50 |
NRXN1 |
4.774e-02 | -3.04 | EGFL6 (EGF like domain multiple 6) | protein interactions | 25975 | 19 | 1 | 19454 | 50 |
LRP1B |
4.774e-02 | -3.04 | TRPV6 (transient receptor potential cation channel subfamily V member 6) | protein interactions | 55503 | 19 | 1 | 19454 | 50 |
PRKCA |
4.774e-02 | -3.04 | Mtx1 (metaxin 1) | protein interactions | 17827 | 19 | 1 | 19454 | 50 |
CAMK2G |
4.774e-02 | -3.04 | CNTNAP4 (contactin associated protein family member 4) | protein interactions | 85445 | 19 | 1 | 19454 | 50 |
MACF1 |
4.774e-02 | -3.04 | SPZ1 (spermatogenic leucine zipper 1) | protein interactions | 84654 | 19 | 1 | 19454 | 50 |
DTNA |
4.774e-02 | -3.04 | LTC4S (leukotriene C4 synthase) | protein interactions | 4056 | 19 | 1 | 19454 | 50 |
CAMK2G |
4.774e-02 | -3.04 | NLGN1 (neuroligin 1) | protein interactions | 22871 | 19 | 1 | 19454 | 50 |
NRXN1 |
4.774e-02 | -3.04 | KCNF1 (potassium voltage-gated channel modifier subfamily F member 1) | protein interactions | 3754 | 19 | 1 | 19454 | 50 |
GFAP |
4.774e-02 | -3.04 | PHYHIPL (phytanoyl-CoA 2-hydroxylase interacting protein like) | protein interactions | 84457 | 19 | 1 | 19454 | 50 |
GPM6A |
4.774e-02 | -3.04 | ANKRD13C (ankyrin repeat domain 13C) | protein interactions | 81573 | 19 | 1 | 19454 | 50 |
NTRK3 |
4.774e-02 | -3.04 | GCHFR (GTP cyclohydrolase I feedback regulator) | protein interactions | 2644 | 19 | 1 | 19454 | 50 |
NEBL |
4.774e-02 | -3.04 | C3orf62 (chromosome 3 open reading frame 62) | protein interactions | 375341 | 19 | 1 | 19454 | 50 |
ATP1A2 |
4.774e-02 | -3.04 | PDP2 (pyruvate dehydrogenase phosphatase catalytic subunit 2) | protein interactions | 57546 | 19 | 1 | 19454 | 50 |
GFAP |
4.774e-02 | -3.04 | OSM (oncostatin M) | protein interactions | 5008 | 19 | 1 | 19454 | 50 |
TRPM3 |
4.774e-02 | -3.04 | ZNF532 (zinc finger protein 532) | protein interactions | 55205 | 19 | 1 | 19454 | 50 |
ERBB4 |
4.774e-02 | -3.04 | JSRP1 (junctional sarcoplasmic reticulum protein 1) | protein interactions | 126306 | 19 | 1 | 19454 | 50 |
PRKCA |
4.774e-02 | -3.04 | RIT2 (Ras like without CAAX 2) | protein interactions | 6014 | 19 | 1 | 19454 | 50 |
DTNA |
4.779e-02 | -3.04 | NUDT19 (nudix hydrolase 19) | protein interactions | 390916 | 136 | 2 | 19454 | 50 |
GFAP,NTRK3 |
4.779e-02 | -3.04 | AHCYL2 (adenosylhomocysteinase like 2) | protein interactions | 23382 | 136 | 2 | 19454 | 50 |
NTRK3,RPS6KA2 |
4.781e-02 | -3.04 | Phosphatidylinositol signaling system | KEGG pathways | hsa04070 | 97 | 2 | 7161 | 26 |
DGKG,PRKCA |
4.781e-02 | -3.04 | Phosphatidylinositol signaling system | KEGG pathways | ko04070 | 97 | 2 | 7161 | 26 |
PRKCA,DGKG |
4.782e-02 | -3.04 | regulation of multicellular organismal development | biological process | GO:2000026 | 1484 | 8 | 18204 | 50 |
PARD3,SOX5,GFAP,NRXN1,ERBB4,MACF1,PRKCA,NTRK2 |
4.804e-02 | -3.04 | muscle system process | biological process | GO:0003012 | 297 | 3 | 18204 | 50 |
RYR3,ATP1A2,DTNA |
4.822e-02 | -3.03 | cell population proliferation | biological process | GO:0008283 | 726 | 5 | 18204 | 50 |
GFAP,SOX5,RORA,NDRG2,HPSE2 |
4.827e-02 | -3.03 | myelination | biological process | GO:0042552 | 128 | 2 | 18204 | 50 |
NTRK2,PARD3 |
4.832e-02 | -3.03 | regulation of protein kinase C signaling | biological process | GO:0090036 | 18 | 1 | 18204 | 50 |
DGKG |
4.832e-02 | -3.03 | cardiac myofibril assembly | biological process | GO:0055003 | 18 | 1 | 18204 | 50 |
NEBL |
4.832e-02 | -3.03 | positive regulation of circadian rhythm | biological process | GO:0042753 | 18 | 1 | 18204 | 50 |
RORA |
4.832e-02 | -3.03 | negative regulation of anoikis | biological process | GO:2000811 | 18 | 1 | 18204 | 50 |
NTRK2 |
4.832e-02 | -3.03 | negative regulation of sodium ion transport | biological process | GO:0010766 | 18 | 1 | 18204 | 50 |
ATP1A2 |
4.832e-02 | -3.03 | positive regulation of myelination | biological process | GO:0031643 | 18 | 1 | 18204 | 50 |
PARD3 |
4.832e-02 | -3.03 | dendritic spine morphogenesis | biological process | GO:0060997 | 18 | 1 | 18204 | 50 |
CTNND2 |
4.842e-02 | -3.03 | TBL1X (transducin beta like 1 X-linked) | protein interactions | 6907 | 137 | 2 | 19454 | 50 |
SOX5,DGKG |
4.843e-02 | -3.03 | Ras signaling in the CD4+ TCR pathway | Pathway Interaction DB | tcrraspathway | 11 | 1 | 2226 | 10 |
PRKCA |
4.843e-02 | -3.03 | oligoastrocytoma_Grade_II | COSMIC cancer mutations | oligoastrocytoma_Grade_II | 121 | 2 | 16828 | 49 |
CDH20,DTNA |
4.844e-02 | -3.03 | Guanylate_cyc | pfam domains | PF00211 | 18 | 1 | 17795 | 49 |
ADCY2 |
4.844e-02 | -3.03 | Cation_ATPase_N | pfam domains | PF00690 | 18 | 1 | 17795 | 49 |
ATP1A2 |
4.848e-02 | -3.03 | CREB phosphorylation through the activation of CaMKII | REACTOME pathways | R-HSA-442729 | 17 | 1 | 10285 | 30 |
CAMK2G |
4.848e-02 | -3.03 | PKA activation in glucagon signalling | REACTOME pathways | R-HSA-164378 | 17 | 1 | 10285 | 30 |
ADCY2 |
4.848e-02 | -3.03 | PKA-mediated phosphorylation of CREB | REACTOME pathways | R-HSA-111931 | 17 | 1 | 10285 | 30 |
ADCY2 |
4.848e-02 | -3.03 | TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | REACTOME pathways | R-HSA-2173791 | 17 | 1 | 10285 | 30 |
PARD3 |
4.848e-02 | -3.03 | Unblocking of NMDA receptor, glutamate binding and activation | REACTOME pathways | R-HSA-438066 | 17 | 1 | 10285 | 30 |
CAMK2G |
4.848e-02 | -3.03 | Trafficking of GluR2-containing AMPA receptors | REACTOME pathways | R-HSA-416993 | 17 | 1 | 10285 | 30 |
PRKCA |
4.859e-02 | -3.02 | cation-transporting ATPase complex | cellular component | GO:0090533 | 19 | 1 | 19108 | 50 |
ATP1A2 |
4.859e-02 | -3.02 | parallel fiber to Purkinje cell synapse | cellular component | GO:0098688 | 19 | 1 | 19108 | 50 |
GPM6A |
4.859e-02 | -3.02 | human chr18q12.1 | chromosome location | human chr18q12.1 | 26 | 1 | 26134 | 50 |
DTNA |
4.900e-02 | -3.02 | ERK Pathway in Huntington's Disease | WikiPathways | WP3853 | 14 | 1 | 5310 | 19 |
NTRK2 |
4.905e-02 | -3.01 | PRKAG1 (protein kinase AMP-activated non-catalytic subunit gamma 1) | protein interactions | 5571 | 138 | 2 | 19454 | 50 |
NTRK3,SFXN5 |
4.905e-02 | -3.01 | STAM2 (signal transducing adaptor molecule 2) | protein interactions | 10254 | 138 | 2 | 19454 | 50 |
NTRK3,NTRK2 |
4.932e-02 | -3.01 | FH2 | prosite domains | PS51444 | 15 | 1 | 12186 | 41 |
FMN2 |
4.932e-02 | -3.01 | DAGK | prosite domains | PS50146 | 15 | 1 | 12186 | 41 |
DGKG |
4.932e-02 | -3.01 | SEC7 | prosite domains | PS50190 | 15 | 1 | 12186 | 41 |
PSD2 |
4.959e-02 | -3.00 | Choline metabolism in cancer | KEGG pathways | ko05231 | 99 | 2 | 7161 | 26 |
DGKG,PRKCA |
4.959e-02 | -3.00 | Choline metabolism in cancer | KEGG pathways | hsa05231 | 99 | 2 | 7161 | 26 |
PRKCA,DGKG |
4.962e-02 | -3.00 | ensheathment of neurons | biological process | GO:0007272 | 130 | 2 | 18204 | 50 |
NTRK2,PARD3 |
4.962e-02 | -3.00 | axon ensheathment | biological process | GO:0008366 | 130 | 2 | 18204 | 50 |
PARD3,NTRK2 |
4.968e-02 | -3.00 | SPCS2 (signal peptidase complex subunit 2) | protein interactions | 9789 | 139 | 2 | 19454 | 50 |
MGAT4C,GPC5 |
4.968e-02 | -3.00 | MAGI1 (membrane associated guanylate kinase, WW and PDZ domain containing 1) | protein interactions | 9223 | 139 | 2 | 19454 | 50 |
PARD3,RPS6KA2 |
4.987e-02 | -3.00 | bone-humerus-chondrosarcoma | COSMIC cancer mutations | bone-humerus-chondrosarcoma | 123 | 2 | 16828 | 49 |
KALRN,LRP1B |